date generated: 2020-12-06
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 393.8656285
## 5_8S_rRNA 4.2647989
## A1BG -0.4250025
## A1CF 0.9452369
## A2M -0.4893072
## A3GALT2 -0.6719394
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 2408 |
| num_genes_in_profile | 18043 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 9487 |
| num_profile_genes_not_in_sets | 8556 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
| Gene sets metrics | |
|---|---|
| num_genesets | 2408 |
| num_genesets_excluded | 960 |
| num_genesets_included | 1448 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Top N= 50 gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Xenobiotics | 20 | 1.64e-07 | -0.6760 | 0.000238 |
| Plasma lipoprotein remodeling | 31 | 1.95e-06 | -0.4940 | 0.001410 |
| Fatty acids | 14 | 4.06e-06 | -0.7110 | 0.001820 |
| Collagen formation | 80 | 5.04e-06 | 0.2950 | 0.001820 |
| Collagen biosynthesis and modifying enzymes | 58 | 7.24e-06 | 0.3410 | 0.002100 |
| NR1H2 and NR1H3-mediated signaling | 48 | 3.30e-05 | -0.3460 | 0.007970 |
| Phase I - Functionalization of compounds | 91 | 4.09e-05 | -0.2490 | 0.008460 |
| Translation | 262 | 5.52e-05 | 0.1450 | 0.009990 |
| Interferon alpha/beta signaling | 63 | 7.04e-05 | -0.2900 | 0.010700 |
| Biological oxidations | 176 | 7.41e-05 | -0.1730 | 0.010700 |
| Assembly of active LPL and LIPC lipase complexes | 19 | 1.16e-04 | -0.5110 | 0.015200 |
| Cell death signalling via NRAGE, NRIF and NADE | 72 | 2.42e-04 | -0.2500 | 0.029200 |
| Cell junction organization | 85 | 3.01e-04 | -0.2270 | 0.031400 |
| Sulfur amino acid metabolism | 25 | 3.03e-04 | -0.4170 | 0.031400 |
| Phenylalanine and tyrosine metabolism | 11 | 3.55e-04 | -0.6220 | 0.033600 |
| Extracellular matrix organization | 274 | 3.72e-04 | 0.1250 | 0.033600 |
| Cytochrome P450 - arranged by substrate type | 58 | 4.24e-04 | -0.2680 | 0.036100 |
| p75 NTR receptor-mediated signalling | 92 | 4.71e-04 | -0.2110 | 0.037900 |
| Plasma lipoprotein assembly, remodeling, and clearance | 68 | 5.54e-04 | -0.2420 | 0.040700 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 5.62e-04 | -0.3190 | 0.040700 |
| Signal Transduction | 2386 | 7.12e-04 | -0.0429 | 0.049100 |
| Synthesis of substrates in N-glycan biosythesis | 61 | 8.69e-04 | 0.2470 | 0.055200 |
| Plasma lipoprotein assembly | 18 | 8.76e-04 | -0.4530 | 0.055200 |
| Death Receptor Signalling | 132 | 1.02e-03 | -0.1660 | 0.061300 |
| Keratan sulfate degradation | 12 | 1.08e-03 | 0.5450 | 0.061300 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 75 | 1.15e-03 | 0.2170 | 0.061300 |
| GPCR downstream signalling | 829 | 1.16e-03 | -0.0667 | 0.061300 |
| Miscellaneous substrates | 12 | 1.19e-03 | -0.5400 | 0.061300 |
| Chylomicron remodeling | 10 | 1.25e-03 | -0.5890 | 0.061300 |
| Factors involved in megakaryocyte development and platelet production | 124 | 1.27e-03 | -0.1680 | 0.061300 |
| Endosomal/Vacuolar pathway | 10 | 1.37e-03 | -0.5850 | 0.063500 |
| Platelet Aggregation (Plug Formation) | 37 | 1.43e-03 | -0.3030 | 0.063500 |
| Formation of the beta-catenin:TCF transactivating complex | 41 | 1.45e-03 | -0.2880 | 0.063500 |
| Regulation of lipid metabolism by PPARalpha | 116 | 1.58e-03 | -0.1700 | 0.067400 |
| Keratan sulfate/keratin metabolism | 31 | 1.64e-03 | 0.3270 | 0.067700 |
| Intrinsic Pathway of Fibrin Clot Formation | 23 | 1.77e-03 | -0.3770 | 0.068500 |
| Hemostasis | 582 | 1.81e-03 | -0.0759 | 0.068500 |
| Chromatin modifying enzymes | 208 | 1.90e-03 | -0.1250 | 0.068500 |
| Chromatin organization | 208 | 1.90e-03 | -0.1250 | 0.068500 |
| Mitochondrial translation initiation | 85 | 1.93e-03 | 0.1950 | 0.068500 |
| Rho GTPase cycle | 134 | 2.01e-03 | -0.1550 | 0.068500 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 2.05e-03 | -0.4600 | 0.068500 |
| Aflatoxin activation and detoxification | 18 | 2.05e-03 | -0.4200 | 0.068500 |
| Formation of Fibrin Clot (Clotting Cascade) | 37 | 2.08e-03 | -0.2920 | 0.068500 |
| Protein ubiquitination | 65 | 2.19e-03 | -0.2200 | 0.069700 |
| Signaling by GPCR | 895 | 2.26e-03 | -0.0605 | 0.069700 |
| Cytosolic tRNA aminoacylation | 23 | 2.26e-03 | 0.3680 | 0.069700 |
| p130Cas linkage to MAPK signaling for integrins | 15 | 2.31e-03 | -0.4540 | 0.069700 |
| NRAGE signals death through JNK | 56 | 2.38e-03 | -0.2350 | 0.070400 |
| Influenza Infection | 128 | 2.53e-03 | 0.1550 | 0.072500 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| Xenobiotics | 20 | 1.64e-07 | -6.76e-01 | 0.000238 |
| Plasma lipoprotein remodeling | 31 | 1.95e-06 | -4.94e-01 | 0.001410 |
| Fatty acids | 14 | 4.06e-06 | -7.11e-01 | 0.001820 |
| Collagen formation | 80 | 5.04e-06 | 2.95e-01 | 0.001820 |
| Collagen biosynthesis and modifying enzymes | 58 | 7.24e-06 | 3.41e-01 | 0.002100 |
| NR1H2 and NR1H3-mediated signaling | 48 | 3.30e-05 | -3.46e-01 | 0.007970 |
| Phase I - Functionalization of compounds | 91 | 4.09e-05 | -2.49e-01 | 0.008460 |
| Translation | 262 | 5.52e-05 | 1.45e-01 | 0.009990 |
| Interferon alpha/beta signaling | 63 | 7.04e-05 | -2.90e-01 | 0.010700 |
| Biological oxidations | 176 | 7.41e-05 | -1.73e-01 | 0.010700 |
| Assembly of active LPL and LIPC lipase complexes | 19 | 1.16e-04 | -5.11e-01 | 0.015200 |
| Cell death signalling via NRAGE, NRIF and NADE | 72 | 2.42e-04 | -2.50e-01 | 0.029200 |
| Cell junction organization | 85 | 3.01e-04 | -2.27e-01 | 0.031400 |
| Sulfur amino acid metabolism | 25 | 3.03e-04 | -4.17e-01 | 0.031400 |
| Phenylalanine and tyrosine metabolism | 11 | 3.55e-04 | -6.22e-01 | 0.033600 |
| Extracellular matrix organization | 274 | 3.72e-04 | 1.25e-01 | 0.033600 |
| Cytochrome P450 - arranged by substrate type | 58 | 4.24e-04 | -2.68e-01 | 0.036100 |
| p75 NTR receptor-mediated signalling | 92 | 4.71e-04 | -2.11e-01 | 0.037900 |
| Plasma lipoprotein assembly, remodeling, and clearance | 68 | 5.54e-04 | -2.42e-01 | 0.040700 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 5.62e-04 | -3.19e-01 | 0.040700 |
| Signal Transduction | 2386 | 7.12e-04 | -4.29e-02 | 0.049100 |
| Synthesis of substrates in N-glycan biosythesis | 61 | 8.69e-04 | 2.47e-01 | 0.055200 |
| Plasma lipoprotein assembly | 18 | 8.76e-04 | -4.53e-01 | 0.055200 |
| Death Receptor Signalling | 132 | 1.02e-03 | -1.66e-01 | 0.061300 |
| Keratan sulfate degradation | 12 | 1.08e-03 | 5.45e-01 | 0.061300 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 75 | 1.15e-03 | 2.17e-01 | 0.061300 |
| GPCR downstream signalling | 829 | 1.16e-03 | -6.67e-02 | 0.061300 |
| Miscellaneous substrates | 12 | 1.19e-03 | -5.40e-01 | 0.061300 |
| Chylomicron remodeling | 10 | 1.25e-03 | -5.89e-01 | 0.061300 |
| Factors involved in megakaryocyte development and platelet production | 124 | 1.27e-03 | -1.68e-01 | 0.061300 |
| Endosomal/Vacuolar pathway | 10 | 1.37e-03 | -5.85e-01 | 0.063500 |
| Platelet Aggregation (Plug Formation) | 37 | 1.43e-03 | -3.03e-01 | 0.063500 |
| Formation of the beta-catenin:TCF transactivating complex | 41 | 1.45e-03 | -2.88e-01 | 0.063500 |
| Regulation of lipid metabolism by PPARalpha | 116 | 1.58e-03 | -1.70e-01 | 0.067400 |
| Keratan sulfate/keratin metabolism | 31 | 1.64e-03 | 3.27e-01 | 0.067700 |
| Intrinsic Pathway of Fibrin Clot Formation | 23 | 1.77e-03 | -3.77e-01 | 0.068500 |
| Hemostasis | 582 | 1.81e-03 | -7.59e-02 | 0.068500 |
| Chromatin modifying enzymes | 208 | 1.90e-03 | -1.25e-01 | 0.068500 |
| Chromatin organization | 208 | 1.90e-03 | -1.25e-01 | 0.068500 |
| Mitochondrial translation initiation | 85 | 1.93e-03 | 1.95e-01 | 0.068500 |
| Rho GTPase cycle | 134 | 2.01e-03 | -1.55e-01 | 0.068500 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 2.05e-03 | -4.60e-01 | 0.068500 |
| Aflatoxin activation and detoxification | 18 | 2.05e-03 | -4.20e-01 | 0.068500 |
| Formation of Fibrin Clot (Clotting Cascade) | 37 | 2.08e-03 | -2.92e-01 | 0.068500 |
| Protein ubiquitination | 65 | 2.19e-03 | -2.20e-01 | 0.069700 |
| Signaling by GPCR | 895 | 2.26e-03 | -6.05e-02 | 0.069700 |
| Cytosolic tRNA aminoacylation | 23 | 2.26e-03 | 3.68e-01 | 0.069700 |
| p130Cas linkage to MAPK signaling for integrins | 15 | 2.31e-03 | -4.54e-01 | 0.069700 |
| NRAGE signals death through JNK | 56 | 2.38e-03 | -2.35e-01 | 0.070400 |
| Influenza Infection | 128 | 2.53e-03 | 1.55e-01 | 0.072500 |
| Keratan sulfate biosynthesis | 26 | 2.55e-03 | 3.42e-01 | 0.072500 |
| Cell-cell junction organization | 60 | 2.73e-03 | -2.24e-01 | 0.076000 |
| Gluconeogenesis | 31 | 2.99e-03 | -3.08e-01 | 0.081700 |
| PPARA activates gene expression | 114 | 3.05e-03 | -1.61e-01 | 0.081700 |
| Generation of second messenger molecules | 28 | 3.40e-03 | -3.20e-01 | 0.088800 |
| Chylomicron assembly | 10 | 3.44e-03 | -5.34e-01 | 0.088800 |
| Defects in vitamin and cofactor metabolism | 22 | 3.60e-03 | -3.59e-01 | 0.091400 |
| Assembly of collagen fibrils and other multimeric structures | 50 | 3.70e-03 | 2.37e-01 | 0.092300 |
| TRAF6 mediated IRF7 activation | 26 | 3.81e-03 | -3.28e-01 | 0.093400 |
| SRP-dependent cotranslational protein targeting to membrane | 89 | 4.19e-03 | 1.76e-01 | 0.099600 |
| Crosslinking of collagen fibrils | 10 | 4.20e-03 | 5.23e-01 | 0.099600 |
| Viral mRNA Translation | 66 | 4.26e-03 | 2.03e-01 | 0.099600 |
| Signaling by NOTCH1 | 69 | 4.36e-03 | -1.98e-01 | 0.100000 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 71 | 4.58e-03 | 1.95e-01 | 0.104000 |
| Mitochondrial translation termination | 85 | 4.67e-03 | 1.78e-01 | 0.104000 |
| Mitochondrial translation elongation | 85 | 4.75e-03 | 1.77e-01 | 0.104000 |
| Major pathway of rRNA processing in the nucleolus and cytosol | 157 | 5.17e-03 | 1.29e-01 | 0.112000 |
| rRNA processing in the nucleus and cytosol | 166 | 5.32e-03 | 1.25e-01 | 0.112000 |
| Extra-nuclear estrogen signaling | 71 | 5.34e-03 | 1.91e-01 | 0.112000 |
| Collagen chain trimerization | 35 | 5.86e-03 | 2.69e-01 | 0.121000 |
| Selenoamino acid metabolism | 91 | 5.96e-03 | 1.67e-01 | 0.121000 |
| mRNA Splicing - Major Pathway | 169 | 6.02e-03 | -1.23e-01 | 0.121000 |
| Cell-extracellular matrix interactions | 16 | 6.49e-03 | -3.93e-01 | 0.129000 |
| Cell-Cell communication | 117 | 7.04e-03 | -1.44e-01 | 0.136000 |
| mRNA Splicing | 177 | 7.04e-03 | -1.18e-01 | 0.136000 |
| RNA Polymerase III Abortive And Retractive Initiation | 37 | 7.82e-03 | -2.53e-01 | 0.147000 |
| RNA Polymerase III Transcription | 37 | 7.82e-03 | -2.53e-01 | 0.147000 |
| Biotin transport and metabolism | 11 | 8.67e-03 | -4.57e-01 | 0.161000 |
| Intra-Golgi traffic | 42 | 9.18e-03 | 2.32e-01 | 0.166000 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 16 | 9.31e-03 | -3.76e-01 | 0.166000 |
| Diseases of hemostasis | 16 | 9.31e-03 | -3.76e-01 | 0.166000 |
| Complement cascade | 76 | 9.57e-03 | -1.72e-01 | 0.169000 |
| Mitochondrial translation | 91 | 9.99e-03 | 1.56e-01 | 0.173000 |
| PKA activation in glucagon signalling | 16 | 1.00e-02 | -3.72e-01 | 0.173000 |
| Tight junction interactions | 28 | 1.05e-02 | -2.80e-01 | 0.176000 |
| Peptide chain elongation | 66 | 1.05e-02 | 1.82e-01 | 0.176000 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 14 | 1.07e-02 | 3.94e-01 | 0.179000 |
| Respiratory electron transport | 95 | 1.10e-02 | 1.51e-01 | 0.181000 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | 78 | 1.11e-02 | 1.66e-01 | 0.181000 |
| Defensins | 27 | 1.13e-02 | -2.82e-01 | 0.182000 |
| Activated NOTCH1 Transmits Signal to the Nucleus | 30 | 1.15e-02 | -2.67e-01 | 0.182000 |
| E3 ubiquitin ligases ubiquitinate target proteins | 46 | 1.19e-02 | -2.14e-01 | 0.188000 |
| Myogenesis | 29 | 1.24e-02 | -2.68e-01 | 0.193000 |
| Zinc influx into cells by the SLC39 gene family | 10 | 1.28e-02 | 4.55e-01 | 0.197000 |
| Eukaryotic Translation Elongation | 70 | 1.31e-02 | 1.71e-01 | 0.200000 |
| Eukaryotic Translation Termination | 70 | 1.35e-02 | 1.71e-01 | 0.202000 |
| tRNA processing in the mitochondrion | 18 | 1.36e-02 | -3.36e-01 | 0.202000 |
| DARPP-32 events | 23 | 1.44e-02 | -2.95e-01 | 0.213000 |
| Elastic fibre formation | 38 | 1.47e-02 | 2.29e-01 | 0.214000 |
| Signaling by NOTCH | 184 | 1.60e-02 | -1.03e-01 | 0.230000 |
| Complex I biogenesis | 53 | 1.60e-02 | 1.91e-01 | 0.230000 |
| Activation of HOX genes during differentiation | 67 | 1.68e-02 | -1.69e-01 | 0.237000 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | 67 | 1.68e-02 | -1.69e-01 | 0.237000 |
| Signaling by Insulin receptor | 76 | 1.75e-02 | 1.58e-01 | 0.244000 |
| tRNA Aminoacylation | 41 | 1.78e-02 | 2.14e-01 | 0.246000 |
| Metabolism of lipids | 692 | 1.83e-02 | -5.28e-02 | 0.250000 |
| Regulation of IFNA signaling | 24 | 1.85e-02 | -2.78e-01 | 0.250000 |
| IL-6-type cytokine receptor ligand interactions | 17 | 1.89e-02 | -3.29e-01 | 0.251000 |
| LDL clearance | 18 | 1.97e-02 | 3.17e-01 | 0.251000 |
| Antimicrobial peptides | 58 | 1.99e-02 | -1.77e-01 | 0.251000 |
| Influenza Viral RNA Transcription and Replication | 109 | 2.01e-02 | 1.29e-01 | 0.251000 |
| Asparagine N-linked glycosylation | 268 | 2.01e-02 | 8.26e-02 | 0.251000 |
| Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 116 | 2.03e-02 | 1.25e-01 | 0.251000 |
| Pausing and recovery of Tat-mediated HIV elongation | 32 | 2.03e-02 | -2.37e-01 | 0.251000 |
| Tat-mediated HIV elongation arrest and recovery | 32 | 2.03e-02 | -2.37e-01 | 0.251000 |
| Peptide ligand-binding receptors | 161 | 2.03e-02 | -1.06e-01 | 0.251000 |
| Glycosaminoglycan metabolism | 117 | 2.03e-02 | 1.24e-01 | 0.251000 |
| PI-3K cascade:FGFR3 | 18 | 2.05e-02 | 3.15e-01 | 0.252000 |
| Developmental Biology | 905 | 2.12e-02 | -4.54e-02 | 0.258000 |
| Oncogenic MAPK signaling | 77 | 2.21e-02 | -1.51e-01 | 0.267000 |
| Synthesis of PC | 28 | 2.30e-02 | -2.48e-01 | 0.276000 |
| FGFR3 mutant receptor activation | 12 | 2.39e-02 | 3.77e-01 | 0.282000 |
| Signaling by activated point mutants of FGFR3 | 12 | 2.39e-02 | 3.77e-01 | 0.282000 |
| Downstream signaling of activated FGFR3 | 25 | 2.45e-02 | 2.60e-01 | 0.286000 |
| RNA Polymerase III Transcription Termination | 19 | 2.63e-02 | -2.95e-01 | 0.302000 |
| Selenocysteine synthesis | 69 | 2.63e-02 | 1.55e-01 | 0.302000 |
| Signaling by NTRK3 (TRKC) | 17 | 2.65e-02 | 3.11e-01 | 0.302000 |
| Glyoxylate metabolism and glycine degradation | 30 | 2.69e-02 | -2.33e-01 | 0.303000 |
| Formation of the cornified envelope | 39 | 2.71e-02 | -2.05e-01 | 0.303000 |
| FGFR3 ligand binding and activation | 13 | 2.74e-02 | 3.53e-01 | 0.303000 |
| FGFR3c ligand binding and activation | 13 | 2.74e-02 | 3.53e-01 | 0.303000 |
| Sialic acid metabolism | 32 | 2.86e-02 | 2.24e-01 | 0.314000 |
| Integrin signaling | 27 | 2.92e-02 | -2.42e-01 | 0.317000 |
| Regulated proteolysis of p75NTR | 11 | 2.93e-02 | -3.79e-01 | 0.317000 |
| SHC-mediated cascade:FGFR3 | 18 | 2.98e-02 | 2.96e-01 | 0.320000 |
| Semaphorin interactions | 63 | 3.02e-02 | -1.58e-01 | 0.321000 |
| PKA activation | 16 | 3.04e-02 | -3.13e-01 | 0.321000 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 52 | 3.08e-02 | 1.73e-01 | 0.323000 |
| Other interleukin signaling | 22 | 3.14e-02 | -2.65e-01 | 0.327000 |
| Immune System | 1931 | 3.22e-02 | -2.98e-02 | 0.333000 |
| RAF-independent MAPK1/3 activation | 23 | 3.24e-02 | -2.58e-01 | 0.333000 |
| RA biosynthesis pathway | 18 | 3.26e-02 | 2.91e-01 | 0.333000 |
| Signaling by BRAF and RAF fusions | 61 | 3.29e-02 | -1.58e-01 | 0.333000 |
| Synthesis of IP2, IP, and Ins in the cytosol | 14 | 3.31e-02 | 3.29e-01 | 0.333000 |
| Diseases of DNA repair | 10 | 3.35e-02 | 3.88e-01 | 0.334000 |
| Transferrin endocytosis and recycling | 29 | 3.37e-02 | 2.28e-01 | 0.334000 |
| Neurotransmitter clearance | 10 | 3.39e-02 | -3.87e-01 | 0.334000 |
| Downregulation of TGF-beta receptor signaling | 25 | 3.44e-02 | 2.44e-01 | 0.337000 |
| Eicosanoids | 12 | 3.55e-02 | -3.51e-01 | 0.345000 |
| HIV elongation arrest and recovery | 34 | 3.65e-02 | -2.07e-01 | 0.350000 |
| Pausing and recovery of HIV elongation | 34 | 3.65e-02 | -2.07e-01 | 0.350000 |
| Role of second messengers in netrin-1 signaling | 10 | 3.69e-02 | 3.81e-01 | 0.351000 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 27 | 3.72e-02 | -2.32e-01 | 0.352000 |
| Interleukin-6 family signaling | 24 | 3.75e-02 | -2.45e-01 | 0.352000 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | 53 | 3.80e-02 | -1.65e-01 | 0.354000 |
| Synthesis of PIPs at the late endosome membrane | 11 | 3.81e-02 | 3.61e-01 | 0.354000 |
| Metabolism of proteins | 1819 | 3.84e-02 | 2.96e-02 | 0.354000 |
| Activation of SMO | 18 | 3.94e-02 | 2.81e-01 | 0.361000 |
| IGF1R signaling cascade | 51 | 4.05e-02 | 1.66e-01 | 0.366000 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 90 | 4.11e-02 | 1.25e-01 | 0.366000 |
| Nonsense-Mediated Decay (NMD) | 90 | 4.11e-02 | 1.25e-01 | 0.366000 |
| Vasopressin regulates renal water homeostasis via Aquaporins | 41 | 4.11e-02 | -1.84e-01 | 0.366000 |
| Activation of gene expression by SREBF (SREBP) | 41 | 4.12e-02 | -1.84e-01 | 0.366000 |
| Retinoid metabolism and transport | 39 | 4.18e-02 | -1.88e-01 | 0.368000 |
| Class I peroxisomal membrane protein import | 18 | 4.21e-02 | -2.77e-01 | 0.368000 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 13 | 4.21e-02 | 3.26e-01 | 0.368000 |
| Dermatan sulfate biosynthesis | 11 | 4.37e-02 | 3.51e-01 | 0.375000 |
| rRNA processing | 187 | 4.41e-02 | 8.54e-02 | 0.375000 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 85 | 4.42e-02 | 1.26e-01 | 0.375000 |
| G alpha (i) signalling events | 350 | 4.51e-02 | -6.24e-02 | 0.375000 |
| Recycling of bile acids and salts | 15 | 4.51e-02 | -2.99e-01 | 0.375000 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
| Signaling by NOTCH1 in Cancer | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
| Regulation of expression of SLITs and ROBOs | 145 | 4.59e-02 | 9.61e-02 | 0.375000 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 74 | 4.64e-02 | -1.34e-01 | 0.375000 |
| Kinesins | 40 | 4.65e-02 | -1.82e-01 | 0.375000 |
| Hedgehog 'on' state | 83 | 4.67e-02 | 1.26e-01 | 0.375000 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 87 | 4.69e-02 | 1.23e-01 | 0.375000 |
| DNA Damage Recognition in GG-NER | 37 | 4.71e-02 | -1.89e-01 | 0.375000 |
| Transcriptional regulation by RUNX3 | 88 | 4.87e-02 | -1.22e-01 | 0.385000 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 4.97e-02 | -2.11e-01 | 0.390000 |
| Nucleotide Excision Repair | 106 | 4.98e-02 | -1.10e-01 | 0.390000 |
| Formation of a pool of free 40S subunits | 77 | 5.09e-02 | 1.29e-01 | 0.393000 |
| Aquaporin-mediated transport | 49 | 5.11e-02 | -1.61e-01 | 0.393000 |
| Cap-dependent Translation Initiation | 93 | 5.13e-02 | 1.17e-01 | 0.393000 |
| Eukaryotic Translation Initiation | 93 | 5.13e-02 | 1.17e-01 | 0.393000 |
| Transcriptional regulation of white adipocyte differentiation | 81 | 5.16e-02 | -1.25e-01 | 0.393000 |
| RHO GTPases activate PAKs | 21 | 5.20e-02 | -2.45e-01 | 0.394000 |
| RMTs methylate histone arginines | 36 | 5.32e-02 | -1.86e-01 | 0.402000 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | 21 | 5.36e-02 | -2.43e-01 | 0.402000 |
| FRS-mediated FGFR3 signaling | 20 | 5.43e-02 | 2.49e-01 | 0.406000 |
| FOXO-mediated transcription | 64 | 5.50e-02 | -1.39e-01 | 0.409000 |
| Signaling by NOTCH3 | 44 | 5.63e-02 | -1.66e-01 | 0.414000 |
| Translocation of ZAP-70 to Immunological synapse | 14 | 5.66e-02 | -2.94e-01 | 0.414000 |
| NS1 Mediated Effects on Host Pathways | 40 | 5.67e-02 | 1.74e-01 | 0.414000 |
| Neuronal System | 375 | 5.72e-02 | -5.73e-02 | 0.416000 |
| Vitamin D (calciferol) metabolism | 11 | 5.74e-02 | -3.31e-01 | 0.416000 |
| Phospholipase C-mediated cascade; FGFR3 | 13 | 5.82e-02 | 3.03e-01 | 0.418000 |
| Diseases of glycosylation | 134 | 5.84e-02 | 9.48e-02 | 0.418000 |
| Mitotic Metaphase and Anaphase | 219 | 5.91e-02 | 7.41e-02 | 0.420000 |
| Postmitotic nuclear pore complex (NPC) reformation | 26 | 5.92e-02 | 2.14e-01 | 0.420000 |
| Sema4D induced cell migration and growth-cone collapse | 20 | 5.99e-02 | -2.43e-01 | 0.423000 |
| Keratinization | 123 | 6.01e-02 | 9.82e-02 | 0.423000 |
| Diseases associated with glycosaminoglycan metabolism | 39 | 6.08e-02 | 1.74e-01 | 0.425000 |
| Notch-HLH transcription pathway | 26 | 6.18e-02 | -2.12e-01 | 0.430000 |
| FOXO-mediated transcription of cell death genes | 14 | 6.22e-02 | -2.88e-01 | 0.430000 |
| Transcriptional regulation of pluripotent stem cells | 29 | 6.29e-02 | -2.00e-01 | 0.430000 |
| IRS-related events triggered by IGF1R | 50 | 6.30e-02 | 1.52e-01 | 0.430000 |
| Pre-NOTCH Processing in Golgi | 18 | 6.31e-02 | -2.53e-01 | 0.430000 |
| Metabolism | 1943 | 6.32e-02 | -2.58e-02 | 0.430000 |
| Molecules associated with elastic fibres | 28 | 6.38e-02 | 2.02e-01 | 0.431000 |
| Iron uptake and transport | 54 | 6.40e-02 | 1.46e-01 | 0.431000 |
| Sema4D in semaphorin signaling | 24 | 6.44e-02 | -2.18e-01 | 0.431000 |
| Signaling by FGFR3 in disease | 22 | 6.51e-02 | 2.27e-01 | 0.431000 |
| Signaling by FGFR3 point mutants in cancer | 22 | 6.51e-02 | 2.27e-01 | 0.431000 |
| Processing of Capped Intron-Containing Pre-mRNA | 228 | 6.52e-02 | -7.09e-02 | 0.431000 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | 24 | 6.57e-02 | -2.17e-01 | 0.432000 |
| Regulation of beta-cell development | 39 | 6.62e-02 | -1.70e-01 | 0.434000 |
| The citric acid (TCA) cycle and respiratory electron transport | 165 | 6.70e-02 | 8.27e-02 | 0.437000 |
| Zinc transporters | 17 | 6.75e-02 | 2.56e-01 | 0.438000 |
| Mitotic Anaphase | 218 | 6.78e-02 | 7.18e-02 | 0.438000 |
| rRNA processing in the mitochondrion | 21 | 6.80e-02 | -2.30e-01 | 0.438000 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | 20 | 6.96e-02 | -2.34e-01 | 0.443000 |
| Mitochondrial protein import | 62 | 7.00e-02 | 1.33e-01 | 0.443000 |
| ROS and RNS production in phagocytes | 34 | 7.01e-02 | 1.80e-01 | 0.443000 |
| IRS-mediated signalling | 47 | 7.07e-02 | 1.52e-01 | 0.443000 |
| PI3K Cascade | 43 | 7.08e-02 | 1.59e-01 | 0.443000 |
| Synthesis of PIPs at the Golgi membrane | 17 | 7.09e-02 | 2.53e-01 | 0.443000 |
| MAPK3 (ERK1) activation | 10 | 7.13e-02 | -3.29e-01 | 0.443000 |
| Mitochondrial iron-sulfur cluster biogenesis | 11 | 7.13e-02 | 3.14e-01 | 0.443000 |
| Listeria monocytogenes entry into host cells | 19 | 7.16e-02 | -2.39e-01 | 0.443000 |
| Diseases of carbohydrate metabolism | 32 | 7.33e-02 | -1.83e-01 | 0.452000 |
| Regulation of TP53 Activity through Acetylation | 28 | 7.36e-02 | -1.95e-01 | 0.452000 |
| ERBB2 Regulates Cell Motility | 15 | 7.41e-02 | 2.66e-01 | 0.453000 |
| Defects in cobalamin (B12) metabolism | 14 | 7.48e-02 | -2.75e-01 | 0.455000 |
| Innate Immune System | 964 | 7.69e-02 | -3.38e-02 | 0.466000 |
| PD-1 signaling | 19 | 7.89e-02 | -2.33e-01 | 0.474000 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | 11 | 7.90e-02 | -3.06e-01 | 0.474000 |
| cGMP effects | 15 | 7.96e-02 | -2.61e-01 | 0.476000 |
| Glutathione conjugation | 30 | 8.04e-02 | -1.84e-01 | 0.478000 |
| Late endosomal microautophagy | 30 | 8.06e-02 | -1.84e-01 | 0.478000 |
| Diseases associated with the TLR signaling cascade | 20 | 8.28e-02 | 2.24e-01 | 0.488000 |
| Diseases of Immune System | 20 | 8.28e-02 | 2.24e-01 | 0.488000 |
| RIP-mediated NFkB activation via ZBP1 | 15 | 8.50e-02 | 2.57e-01 | 0.496000 |
| Downstream signaling of activated FGFR2 | 30 | 8.50e-02 | 1.82e-01 | 0.496000 |
| Metabolism of steroids | 133 | 8.61e-02 | -8.62e-02 | 0.497000 |
| Synthesis of PIPs at the early endosome membrane | 16 | 8.61e-02 | 2.48e-01 | 0.497000 |
| Class A/1 (Rhodopsin-like receptors) | 280 | 8.64e-02 | -5.96e-02 | 0.497000 |
| Membrane binding and targetting of GAG proteins | 13 | 8.70e-02 | -2.74e-01 | 0.497000 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 8.70e-02 | -2.74e-01 | 0.497000 |
| Metabolism of fat-soluble vitamins | 43 | 8.71e-02 | -1.51e-01 | 0.497000 |
| Metabolism of folate and pterines | 17 | 8.91e-02 | -2.38e-01 | 0.506000 |
| G alpha (s) signalling events | 322 | 9.00e-02 | -5.50e-02 | 0.507000 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 20 | 9.03e-02 | -2.19e-01 | 0.507000 |
| O-linked glycosylation of mucins | 55 | 9.05e-02 | 1.32e-01 | 0.507000 |
| NOTCH1 Intracellular Domain Regulates Transcription | 43 | 9.08e-02 | -1.49e-01 | 0.507000 |
| L1CAM interactions | 98 | 9.19e-02 | -9.86e-02 | 0.509000 |
| Tandem pore domain potassium channels | 11 | 9.32e-02 | -2.92e-01 | 0.509000 |
| Degradation of cysteine and homocysteine | 11 | 9.34e-02 | -2.92e-01 | 0.509000 |
| Metabolism of nucleotides | 95 | 9.35e-02 | 9.96e-02 | 0.509000 |
| PI-3K cascade:FGFR2 | 23 | 9.47e-02 | 2.01e-01 | 0.509000 |
| HIV Transcription Initiation | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
| RNA Polymerase II HIV Promoter Escape | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
| RNA Polymerase II Promoter Escape | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
| RNA Polymerase II Transcription Initiation | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
| GP1b-IX-V activation signalling | 10 | 1.02e-01 | -2.99e-01 | 0.537000 |
| TNFR1-induced proapoptotic signaling | 13 | 1.03e-01 | -2.61e-01 | 0.537000 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
| Signaling by RAS mutants | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
| Signaling by moderate kinase activity BRAF mutants | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
| Signaling downstream of RAS mutants | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
| Formation of RNA Pol II elongation complex | 59 | 1.04e-01 | -1.23e-01 | 0.537000 |
| RNA Polymerase II Transcription Elongation | 59 | 1.04e-01 | -1.23e-01 | 0.537000 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 29 | 1.04e-01 | -1.75e-01 | 0.537000 |
| Translation of structural proteins | 27 | 1.04e-01 | -1.81e-01 | 0.537000 |
| Downstream signaling of activated FGFR1 | 31 | 1.04e-01 | 1.69e-01 | 0.537000 |
| Negative regulation of MAPK pathway | 42 | 1.05e-01 | -1.44e-01 | 0.541000 |
| Activation of the pre-replicative complex | 32 | 1.07e-01 | 1.65e-01 | 0.545000 |
| Insulin receptor signalling cascade | 53 | 1.08e-01 | 1.28e-01 | 0.550000 |
| PI3K events in ERBB2 signaling | 16 | 1.09e-01 | 2.32e-01 | 0.551000 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 1.09e-01 | -1.93e-01 | 0.551000 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 1.10e-01 | -2.07e-01 | 0.552000 |
| Interferon Signaling | 177 | 1.10e-01 | -6.97e-02 | 0.552000 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | 30 | 1.11e-01 | -1.68e-01 | 0.553000 |
| Trafficking of AMPA receptors | 30 | 1.11e-01 | -1.68e-01 | 0.553000 |
| ESR-mediated signaling | 164 | 1.11e-01 | 7.21e-02 | 0.554000 |
| Adenylate cyclase inhibitory pathway | 14 | 1.12e-01 | -2.45e-01 | 0.556000 |
| Smooth Muscle Contraction | 33 | 1.13e-01 | -1.60e-01 | 0.556000 |
| Chondroitin sulfate biosynthesis | 20 | 1.13e-01 | 2.05e-01 | 0.557000 |
| Transcriptional regulation by RUNX2 | 117 | 1.13e-01 | 8.48e-02 | 0.557000 |
| Signaling by NTRK2 (TRKB) | 25 | 1.15e-01 | 1.82e-01 | 0.562000 |
| Reversible hydration of carbon dioxide | 12 | 1.16e-01 | -2.62e-01 | 0.562000 |
| Metal ion SLC transporters | 26 | 1.16e-01 | 1.78e-01 | 0.562000 |
| HATs acetylate histones | 84 | 1.16e-01 | -9.92e-02 | 0.562000 |
| PI3K events in ERBB4 signaling | 10 | 1.17e-01 | 2.86e-01 | 0.562000 |
| Transport of organic anions | 12 | 1.17e-01 | -2.61e-01 | 0.562000 |
| Prolactin receptor signaling | 15 | 1.18e-01 | -2.33e-01 | 0.562000 |
| ER Quality Control Compartment (ERQC) | 19 | 1.18e-01 | 2.07e-01 | 0.562000 |
| RNA Polymerase III Transcription Initiation | 32 | 1.18e-01 | -1.60e-01 | 0.562000 |
| ERK/MAPK targets | 21 | 1.19e-01 | -1.97e-01 | 0.562000 |
| Formation of TC-NER Pre-Incision Complex | 50 | 1.19e-01 | -1.28e-01 | 0.562000 |
| RHO GTPases Activate ROCKs | 19 | 1.19e-01 | -2.06e-01 | 0.562000 |
| RHO GTPases Activate NADPH Oxidases | 23 | 1.20e-01 | 1.87e-01 | 0.565000 |
| Signaling by Rho GTPases | 373 | 1.21e-01 | -4.69e-02 | 0.566000 |
| PKMTs methylate histone lysines | 43 | 1.21e-01 | -1.37e-01 | 0.566000 |
| Pre-NOTCH Expression and Processing | 64 | 1.23e-01 | -1.12e-01 | 0.570000 |
| SHC-mediated cascade:FGFR2 | 23 | 1.23e-01 | 1.86e-01 | 0.570000 |
| TGF-beta receptor signaling activates SMADs | 30 | 1.25e-01 | 1.62e-01 | 0.578000 |
| Hyaluronan metabolism | 17 | 1.26e-01 | 2.14e-01 | 0.581000 |
| Striated Muscle Contraction | 34 | 1.26e-01 | -1.51e-01 | 0.581000 |
| Nucleobase catabolism | 36 | 1.27e-01 | 1.47e-01 | 0.581000 |
| Common Pathway of Fibrin Clot Formation | 20 | 1.28e-01 | -1.97e-01 | 0.583000 |
| Chemokine receptors bind chemokines | 42 | 1.28e-01 | -1.36e-01 | 0.583000 |
| DNA Replication Pre-Initiation | 82 | 1.29e-01 | 9.71e-02 | 0.583000 |
| Global Genome Nucleotide Excision Repair (GG-NER) | 82 | 1.29e-01 | -9.70e-02 | 0.583000 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 22 | 1.30e-01 | -1.87e-01 | 0.585000 |
| Base-Excision Repair, AP Site Formation | 27 | 1.30e-01 | 1.68e-01 | 0.585000 |
| Regulation of gene expression by Hypoxia-inducible Factor | 11 | 1.31e-01 | -2.63e-01 | 0.585000 |
| Metabolism of cofactors | 18 | 1.31e-01 | 2.05e-01 | 0.585000 |
| Deposition of new CENPA-containing nucleosomes at the centromere | 35 | 1.32e-01 | 1.47e-01 | 0.585000 |
| Nucleosome assembly | 35 | 1.32e-01 | 1.47e-01 | 0.585000 |
| Regulation of Complement cascade | 68 | 1.32e-01 | -1.06e-01 | 0.586000 |
| Insulin receptor recycling | 25 | 1.33e-01 | 1.73e-01 | 0.589000 |
| Signal transduction by L1 | 21 | 1.34e-01 | -1.89e-01 | 0.590000 |
| Budding and maturation of HIV virion | 25 | 1.35e-01 | -1.73e-01 | 0.590000 |
| RUNX2 regulates osteoblast differentiation | 24 | 1.35e-01 | 1.76e-01 | 0.590000 |
| Cleavage of the damaged pyrimidine | 25 | 1.36e-01 | 1.72e-01 | 0.590000 |
| Depyrimidination | 25 | 1.36e-01 | 1.72e-01 | 0.590000 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 25 | 1.36e-01 | 1.72e-01 | 0.590000 |
| mRNA decay by 5' to 3' exoribonuclease | 15 | 1.38e-01 | -2.21e-01 | 0.593000 |
| Interleukin-2 signaling | 12 | 1.38e-01 | -2.47e-01 | 0.593000 |
| tRNA processing in the nucleus | 57 | 1.38e-01 | 1.13e-01 | 0.593000 |
| Phase 4 - resting membrane potential | 18 | 1.41e-01 | -2.01e-01 | 0.593000 |
| Adenylate cyclase activating pathway | 10 | 1.43e-01 | -2.68e-01 | 0.593000 |
| Assembly Of The HIV Virion | 15 | 1.43e-01 | -2.19e-01 | 0.593000 |
| Regulation of gene expression in beta cells | 21 | 1.43e-01 | -1.85e-01 | 0.593000 |
| Uptake and actions of bacterial toxins | 26 | 1.43e-01 | -1.66e-01 | 0.593000 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 1.43e-01 | 1.50e-01 | 0.593000 |
| FGFR2 ligand binding and activation | 19 | 1.44e-01 | 1.94e-01 | 0.593000 |
| ECM proteoglycans | 53 | 1.44e-01 | 1.16e-01 | 0.593000 |
| FGFR1c ligand binding and activation | 11 | 1.45e-01 | 2.54e-01 | 0.593000 |
| Signaling by activated point mutants of FGFR1 | 11 | 1.45e-01 | 2.54e-01 | 0.593000 |
| Dual incision in TC-NER | 61 | 1.45e-01 | -1.08e-01 | 0.593000 |
| FGFRL1 modulation of FGFR1 signaling | 13 | 1.45e-01 | 2.33e-01 | 0.593000 |
| Activated point mutants of FGFR2 | 17 | 1.45e-01 | 2.04e-01 | 0.593000 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.45e-01 | -2.43e-01 | 0.593000 |
| alpha-linolenic acid (ALA) metabolism | 12 | 1.45e-01 | -2.43e-01 | 0.593000 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 46 | 1.45e-01 | -1.24e-01 | 0.593000 |
| Regulation of IFNG signaling | 14 | 1.46e-01 | 2.25e-01 | 0.593000 |
| Pexophagy | 10 | 1.46e-01 | -2.66e-01 | 0.593000 |
| Transmission across Chemical Synapses | 241 | 1.46e-01 | -5.44e-02 | 0.593000 |
| Repression of WNT target genes | 14 | 1.46e-01 | -2.24e-01 | 0.593000 |
| Signaling by ERBB2 in Cancer | 24 | 1.47e-01 | 1.71e-01 | 0.593000 |
| Signaling by RAF1 mutants | 38 | 1.48e-01 | -1.36e-01 | 0.594000 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 37 | 1.48e-01 | -1.37e-01 | 0.594000 |
| Selective autophagy | 56 | 1.48e-01 | -1.12e-01 | 0.594000 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | 26 | 1.49e-01 | -1.64e-01 | 0.595000 |
| Peroxisomal protein import | 60 | 1.51e-01 | -1.07e-01 | 0.602000 |
| Adherens junctions interactions | 31 | 1.53e-01 | -1.48e-01 | 0.607000 |
| Regulation of TP53 Activity through Phosphorylation | 84 | 1.54e-01 | 9.00e-02 | 0.608000 |
| Killing mechanisms | 12 | 1.54e-01 | 2.38e-01 | 0.608000 |
| WNT5:FZD7-mediated leishmania damping | 12 | 1.54e-01 | 2.38e-01 | 0.608000 |
| Formation of the ternary complex, and subsequently, the 43S complex | 44 | 1.55e-01 | 1.24e-01 | 0.611000 |
| Muscle contraction | 177 | 1.56e-01 | -6.18e-02 | 0.613000 |
| Dual Incision in GG-NER | 39 | 1.57e-01 | -1.31e-01 | 0.615000 |
| PKA-mediated phosphorylation of CREB | 18 | 1.59e-01 | -1.92e-01 | 0.620000 |
| O-linked glycosylation | 102 | 1.59e-01 | 8.07e-02 | 0.620000 |
| Fc epsilon receptor (FCERI) signaling | 153 | 1.61e-01 | 6.57e-02 | 0.626000 |
| Chaperone Mediated Autophagy | 18 | 1.63e-01 | -1.90e-01 | 0.629000 |
| FCERI mediated MAPK activation | 56 | 1.63e-01 | 1.08e-01 | 0.631000 |
| Nuclear Events (kinase and transcription factor activation) | 60 | 1.67e-01 | -1.03e-01 | 0.642000 |
| BMAL1:CLOCK,NPAS2 activates circadian gene expression | 27 | 1.68e-01 | -1.53e-01 | 0.643000 |
| Ribosomal scanning and start codon recognition | 50 | 1.68e-01 | 1.13e-01 | 0.643000 |
| PRC2 methylates histones and DNA | 23 | 1.71e-01 | -1.65e-01 | 0.649000 |
| Metabolism of vitamins and cofactors | 179 | 1.71e-01 | -5.94e-02 | 0.649000 |
| ZBP1(DAI) mediated induction of type I IFNs | 19 | 1.71e-01 | 1.81e-01 | 0.649000 |
| Establishment of Sister Chromatid Cohesion | 11 | 1.72e-01 | 2.38e-01 | 0.649000 |
| Signaling by TGFB family members | 96 | 1.72e-01 | 8.06e-02 | 0.649000 |
| Regulation of TLR by endogenous ligand | 15 | 1.73e-01 | -2.03e-01 | 0.649000 |
| COPII-mediated vesicle transport | 61 | 1.73e-01 | -1.01e-01 | 0.649000 |
| G alpha (12/13) signalling events | 76 | 1.73e-01 | -9.03e-02 | 0.649000 |
| Mucopolysaccharidoses | 11 | 1.74e-01 | -2.37e-01 | 0.649000 |
| Interactions of Rev with host cellular proteins | 36 | 1.74e-01 | 1.31e-01 | 0.649000 |
| FRS-mediated FGFR2 signaling | 25 | 1.74e-01 | 1.57e-01 | 0.649000 |
| DAG and IP3 signaling | 38 | 1.75e-01 | -1.27e-01 | 0.649000 |
| Initial triggering of complement | 45 | 1.75e-01 | -1.17e-01 | 0.649000 |
| Effects of PIP2 hydrolysis | 27 | 1.76e-01 | -1.50e-01 | 0.649000 |
| Activated NTRK2 signals through FRS2 and FRS3 | 11 | 1.76e-01 | 2.36e-01 | 0.649000 |
| Signaling by Leptin | 11 | 1.77e-01 | -2.35e-01 | 0.649000 |
| M Phase | 347 | 1.78e-01 | 4.22e-02 | 0.650000 |
| Separation of Sister Chromatids | 166 | 1.78e-01 | 6.06e-02 | 0.650000 |
| AKT phosphorylates targets in the cytosol | 14 | 1.78e-01 | -2.08e-01 | 0.650000 |
| EML4 and NUDC in mitotic spindle formation | 95 | 1.79e-01 | 7.99e-02 | 0.650000 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 12 | 1.79e-01 | -2.24e-01 | 0.651000 |
| G beta:gamma signalling through BTK | 17 | 1.80e-01 | 1.88e-01 | 0.651000 |
| Receptor Mediated Mitophagy | 11 | 1.80e-01 | -2.33e-01 | 0.651000 |
| N-glycan antennae elongation in the medial/trans-Golgi | 23 | 1.82e-01 | 1.61e-01 | 0.655000 |
| Assembly of the pre-replicative complex | 66 | 1.83e-01 | 9.49e-02 | 0.655000 |
| Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 13 | 1.83e-01 | 2.13e-01 | 0.655000 |
| G1/S Transition | 127 | 1.85e-01 | 6.81e-02 | 0.663000 |
| Epigenetic regulation of gene expression | 94 | 1.87e-01 | -7.89e-02 | 0.665000 |
| SHC1 events in ERBB2 signaling | 22 | 1.87e-01 | 1.62e-01 | 0.666000 |
| Integration of energy metabolism | 102 | 1.88e-01 | -7.56e-02 | 0.666000 |
| Transport of the SLBP Dependant Mature mRNA | 35 | 1.89e-01 | 1.28e-01 | 0.667000 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 14 | 1.89e-01 | -2.03e-01 | 0.667000 |
| Transport of the SLBP independent Mature mRNA | 34 | 1.89e-01 | 1.30e-01 | 0.667000 |
| Folding of actin by CCT/TriC | 10 | 1.90e-01 | -2.39e-01 | 0.667000 |
| Mitophagy | 26 | 1.90e-01 | -1.48e-01 | 0.667000 |
| Activation of the AP-1 family of transcription factors | 10 | 1.92e-01 | 2.38e-01 | 0.671000 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 23 | 1.92e-01 | 1.57e-01 | 0.671000 |
| Carnitine metabolism | 11 | 1.93e-01 | -2.27e-01 | 0.671000 |
| MECP2 regulates neuronal receptors and channels | 16 | 1.93e-01 | 1.88e-01 | 0.671000 |
| TP53 Regulates Transcription of DNA Repair Genes | 61 | 1.94e-01 | -9.63e-02 | 0.671000 |
| Syndecan interactions | 19 | 1.96e-01 | 1.72e-01 | 0.674000 |
| Translation initiation complex formation | 49 | 1.96e-01 | 1.07e-01 | 0.674000 |
| Resolution of D-Loop Structures | 33 | 1.96e-01 | 1.30e-01 | 0.674000 |
| Glucagon signaling in metabolic regulation | 30 | 1.96e-01 | -1.36e-01 | 0.674000 |
| G-protein mediated events | 51 | 1.98e-01 | -1.04e-01 | 0.677000 |
| FGFR2c ligand binding and activation | 13 | 1.98e-01 | 2.06e-01 | 0.677000 |
| Downstream signaling of activated FGFR4 | 26 | 2.00e-01 | 1.45e-01 | 0.682000 |
| Sphingolipid de novo biosynthesis | 43 | 2.01e-01 | -1.13e-01 | 0.683000 |
| HuR (ELAVL1) binds and stabilizes mRNA | 10 | 2.02e-01 | -2.33e-01 | 0.683000 |
| NOTCH3 Intracellular Domain Regulates Transcription | 22 | 2.03e-01 | -1.57e-01 | 0.683000 |
| Nuclear import of Rev protein | 33 | 2.04e-01 | 1.28e-01 | 0.683000 |
| SHC1 events in ERBB4 signaling | 14 | 2.04e-01 | 1.96e-01 | 0.683000 |
| Cell Cycle, Mitotic | 485 | 2.04e-01 | 3.38e-02 | 0.683000 |
| Interleukin-10 signaling | 38 | 2.04e-01 | -1.19e-01 | 0.683000 |
| Phase II - Conjugation of compounds | 79 | 2.04e-01 | -8.26e-02 | 0.683000 |
| Diseases of signal transduction by growth factor receptors and second messengers | 367 | 2.06e-01 | -3.85e-02 | 0.685000 |
| Cell Cycle Checkpoints | 252 | 2.06e-01 | 4.63e-02 | 0.685000 |
| Post-chaperonin tubulin folding pathway | 18 | 2.06e-01 | 1.72e-01 | 0.685000 |
| Signaling by ERBB2 | 47 | 2.07e-01 | 1.06e-01 | 0.687000 |
| Asymmetric localization of PCP proteins | 62 | 2.08e-01 | 9.25e-02 | 0.688000 |
| The role of Nef in HIV-1 replication and disease pathogenesis | 27 | 2.11e-01 | -1.39e-01 | 0.693000 |
| Cristae formation | 27 | 2.11e-01 | 1.39e-01 | 0.693000 |
| Nitric oxide stimulates guanylate cyclase | 19 | 2.12e-01 | -1.66e-01 | 0.695000 |
| Costimulation by the CD28 family | 65 | 2.13e-01 | -8.93e-02 | 0.695000 |
| N-Glycan antennae elongation | 14 | 2.13e-01 | 1.92e-01 | 0.695000 |
| Resolution of Sister Chromatid Cohesion | 103 | 2.14e-01 | 7.09e-02 | 0.695000 |
| Collagen degradation | 37 | 2.14e-01 | 1.18e-01 | 0.695000 |
| Calnexin/calreticulin cycle | 24 | 2.14e-01 | 1.46e-01 | 0.695000 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 24 | 2.15e-01 | -1.46e-01 | 0.695000 |
| PI-3K cascade:FGFR1 | 21 | 2.16e-01 | 1.56e-01 | 0.695000 |
| Nephrin family interactions | 21 | 2.17e-01 | 1.56e-01 | 0.695000 |
| Beta defensins | 18 | 2.17e-01 | -1.68e-01 | 0.695000 |
| CaM pathway | 32 | 2.18e-01 | -1.26e-01 | 0.695000 |
| Calmodulin induced events | 32 | 2.18e-01 | -1.26e-01 | 0.695000 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 2.19e-01 | 8.38e-02 | 0.695000 |
| Recognition of DNA damage by PCNA-containing replication complex | 28 | 2.19e-01 | -1.34e-01 | 0.695000 |
| PCP/CE pathway | 90 | 2.20e-01 | 7.48e-02 | 0.695000 |
| Interactions of Vpr with host cellular proteins | 34 | 2.20e-01 | 1.21e-01 | 0.695000 |
| SLC transporter disorders | 96 | 2.21e-01 | 7.23e-02 | 0.695000 |
| Disorders of transmembrane transporters | 171 | 2.22e-01 | 5.42e-02 | 0.695000 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 2.23e-01 | 7.39e-02 | 0.695000 |
| Amplification of signal from the kinetochores | 91 | 2.23e-01 | 7.39e-02 | 0.695000 |
| Signaling by FGFR in disease | 60 | 2.23e-01 | 9.10e-02 | 0.695000 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | 44 | 2.23e-01 | -1.06e-01 | 0.695000 |
| HIV Transcription Elongation | 44 | 2.23e-01 | -1.06e-01 | 0.695000 |
| Tat-mediated elongation of the HIV-1 transcript | 44 | 2.23e-01 | -1.06e-01 | 0.695000 |
| Vitamin B5 (pantothenate) metabolism | 15 | 2.24e-01 | 1.81e-01 | 0.695000 |
| ABC-family proteins mediated transport | 98 | 2.24e-01 | 7.11e-02 | 0.695000 |
| Signaling by ERBB2 KD Mutants | 23 | 2.24e-01 | 1.46e-01 | 0.695000 |
| Adrenaline,noradrenaline inhibits insulin secretion | 27 | 2.25e-01 | 1.35e-01 | 0.695000 |
| Rev-mediated nuclear export of HIV RNA | 34 | 2.25e-01 | 1.20e-01 | 0.695000 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 30 | 2.28e-01 | 1.27e-01 | 0.699000 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | 68 | 2.28e-01 | -8.45e-02 | 0.699000 |
| RHO GTPases activate CIT | 19 | 2.28e-01 | -1.60e-01 | 0.699000 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 14 | 2.28e-01 | -1.86e-01 | 0.699000 |
| NRIF signals cell death from the nucleus | 15 | 2.29e-01 | -1.80e-01 | 0.699000 |
| TICAM1, RIP1-mediated IKK complex recruitment | 16 | 2.30e-01 | 1.73e-01 | 0.702000 |
| GRB2 events in ERBB2 signaling | 16 | 2.31e-01 | 1.73e-01 | 0.702000 |
| FGFR1 mutant receptor activation | 30 | 2.32e-01 | 1.26e-01 | 0.702000 |
| O-glycosylation of TSR domain-containing proteins | 37 | 2.32e-01 | 1.14e-01 | 0.702000 |
| PERK regulates gene expression | 31 | 2.32e-01 | 1.24e-01 | 0.702000 |
| Signaling by FGFR3 | 38 | 2.33e-01 | 1.12e-01 | 0.702000 |
| Circadian Clock | 68 | 2.33e-01 | -8.36e-02 | 0.702000 |
| DNA Damage Bypass | 44 | 2.34e-01 | -1.04e-01 | 0.702000 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 2.35e-01 | 1.35e-01 | 0.702000 |
| p75NTR signals via NF-kB | 14 | 2.35e-01 | -1.83e-01 | 0.702000 |
| Signaling by TGF-beta Receptor Complex | 69 | 2.36e-01 | 8.25e-02 | 0.704000 |
| Phospholipase C-mediated cascade; FGFR2 | 18 | 2.37e-01 | 1.61e-01 | 0.704000 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 2.38e-01 | 1.65e-01 | 0.704000 |
| Other semaphorin interactions | 19 | 2.38e-01 | -1.56e-01 | 0.704000 |
| Activation of BH3-only proteins | 27 | 2.39e-01 | -1.31e-01 | 0.704000 |
| Metabolism of water-soluble vitamins and cofactors | 119 | 2.39e-01 | -6.25e-02 | 0.704000 |
| FGFR2 mutant receptor activation | 31 | 2.40e-01 | 1.22e-01 | 0.704000 |
| Potential therapeutics for SARS | 76 | 2.40e-01 | -7.80e-02 | 0.704000 |
| KSRP (KHSRP) binds and destabilizes mRNA | 17 | 2.40e-01 | 1.65e-01 | 0.704000 |
| PI-3K cascade:FGFR4 | 19 | 2.41e-01 | 1.56e-01 | 0.704000 |
| SUMOylation of chromatin organization proteins | 56 | 2.41e-01 | 9.06e-02 | 0.704000 |
| Translesion synthesis by REV1 | 15 | 2.41e-01 | -1.75e-01 | 0.704000 |
| CDT1 association with the CDC6:ORC:origin complex | 57 | 2.43e-01 | 8.95e-02 | 0.707000 |
| Signaling by NOTCH2 | 29 | 2.44e-01 | -1.25e-01 | 0.710000 |
| Maturation of nucleoprotein | 10 | 2.45e-01 | -2.12e-01 | 0.711000 |
| DCC mediated attractive signaling | 14 | 2.48e-01 | -1.78e-01 | 0.717000 |
| Interleukin-1 family signaling | 131 | 2.48e-01 | 5.84e-02 | 0.717000 |
| Nuclear signaling by ERBB4 | 30 | 2.49e-01 | -1.22e-01 | 0.717000 |
| Signaling by FGFR2 in disease | 41 | 2.49e-01 | 1.04e-01 | 0.717000 |
| Aspartate and asparagine metabolism | 10 | 2.49e-01 | 2.10e-01 | 0.717000 |
| WNT5A-dependent internalization of FZD4 | 15 | 2.50e-01 | 1.71e-01 | 0.718000 |
| Translesion Synthesis by POLH | 16 | 2.52e-01 | -1.65e-01 | 0.721000 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 2.53e-01 | 1.60e-01 | 0.721000 |
| GPCR ligand binding | 396 | 2.53e-01 | -3.35e-02 | 0.721000 |
| Synthesis of very long-chain fatty acyl-CoAs | 24 | 2.58e-01 | -1.34e-01 | 0.722000 |
| Passive transport by Aquaporins | 12 | 2.58e-01 | -1.89e-01 | 0.722000 |
| Chondroitin sulfate/dermatan sulfate metabolism | 49 | 2.58e-01 | 9.34e-02 | 0.722000 |
| Regulation of RUNX2 expression and activity | 71 | 2.58e-01 | 7.76e-02 | 0.722000 |
| Metabolic disorders of biological oxidation enzymes | 32 | 2.59e-01 | 1.15e-01 | 0.722000 |
| Signaling by high-kinase activity BRAF mutants | 34 | 2.59e-01 | -1.12e-01 | 0.722000 |
| Acetylcholine binding and downstream events | 13 | 2.61e-01 | -1.80e-01 | 0.722000 |
| Postsynaptic nicotinic acetylcholine receptors | 13 | 2.61e-01 | -1.80e-01 | 0.722000 |
| Dectin-2 family | 21 | 2.61e-01 | 1.42e-01 | 0.722000 |
| Mitotic Spindle Checkpoint | 107 | 2.62e-01 | 6.28e-02 | 0.722000 |
| ERKs are inactivated | 12 | 2.62e-01 | -1.87e-01 | 0.722000 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | 78 | 2.63e-01 | 7.33e-02 | 0.722000 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | 44 | 2.64e-01 | -9.74e-02 | 0.722000 |
| Condensation of Prometaphase Chromosomes | 10 | 2.64e-01 | -2.04e-01 | 0.722000 |
| Cross-presentation of soluble exogenous antigens (endosomes) | 49 | 2.65e-01 | 9.21e-02 | 0.722000 |
| ERBB2 Activates PTK6 Signaling | 13 | 2.65e-01 | 1.79e-01 | 0.722000 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 33 | 2.65e-01 | 1.12e-01 | 0.722000 |
| Glycerophospholipid biosynthesis | 124 | 2.66e-01 | -5.79e-02 | 0.722000 |
| Disorders of Developmental Biology | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
| Disorders of Nervous System Development | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
| Loss of function of MECP2 in Rett syndrome | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
| Pervasive developmental disorders | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
| Nuclear Envelope (NE) Reassembly | 64 | 2.66e-01 | 8.04e-02 | 0.722000 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | 14 | 2.67e-01 | -1.72e-01 | 0.722000 |
| SUMOylation of transcription cofactors | 43 | 2.67e-01 | -9.78e-02 | 0.722000 |
| RAB geranylgeranylation | 60 | 2.67e-01 | 8.28e-02 | 0.722000 |
| G1/S-Specific Transcription | 29 | 2.68e-01 | 1.19e-01 | 0.722000 |
| PLC beta mediated events | 50 | 2.68e-01 | -9.07e-02 | 0.722000 |
| Frs2-mediated activation | 12 | 2.68e-01 | -1.85e-01 | 0.722000 |
| Regulation of HSF1-mediated heat shock response | 76 | 2.69e-01 | 7.34e-02 | 0.722000 |
| CD28 dependent Vav1 pathway | 12 | 2.69e-01 | -1.84e-01 | 0.722000 |
| SHC-mediated cascade:FGFR1 | 21 | 2.69e-01 | 1.39e-01 | 0.722000 |
| Transcriptional activation of mitochondrial biogenesis | 52 | 2.70e-01 | -8.84e-02 | 0.723000 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 50 | 2.71e-01 | 9.00e-02 | 0.723000 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 176 | 2.72e-01 | 4.81e-02 | 0.723000 |
| InlB-mediated entry of Listeria monocytogenes into host cell | 14 | 2.72e-01 | -1.69e-01 | 0.723000 |
| Biosynthesis of DHA-derived SPMs | 15 | 2.73e-01 | 1.64e-01 | 0.723000 |
| Ovarian tumor domain proteases | 35 | 2.73e-01 | -1.07e-01 | 0.723000 |
| SUMOylation of ubiquitinylation proteins | 38 | 2.74e-01 | 1.03e-01 | 0.723000 |
| Orc1 removal from chromatin | 69 | 2.74e-01 | 7.62e-02 | 0.723000 |
| SARS-CoV-1 Infection | 47 | 2.75e-01 | -9.21e-02 | 0.725000 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | 10 | 2.75e-01 | -1.99e-01 | 0.725000 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 120 | 2.77e-01 | -5.74e-02 | 0.729000 |
| MASTL Facilitates Mitotic Progression | 10 | 2.79e-01 | -1.98e-01 | 0.730000 |
| Activation of ATR in response to replication stress | 36 | 2.80e-01 | 1.04e-01 | 0.730000 |
| Metabolism of polyamines | 58 | 2.80e-01 | 8.21e-02 | 0.730000 |
| RUNX2 regulates bone development | 30 | 2.80e-01 | 1.14e-01 | 0.730000 |
| G-protein activation | 27 | 2.80e-01 | 1.20e-01 | 0.730000 |
| Olfactory Signaling Pathway | 197 | 2.81e-01 | -4.45e-02 | 0.731000 |
| Transport of inorganic cations/anions and amino acids/oligopeptides | 105 | 2.82e-01 | 6.08e-02 | 0.731000 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 10 | 2.83e-01 | 1.96e-01 | 0.733000 |
| G2/M Checkpoints | 134 | 2.84e-01 | 5.37e-02 | 0.734000 |
| Trafficking of GluR2-containing AMPA receptors | 17 | 2.85e-01 | -1.50e-01 | 0.736000 |
| Regulation of FZD by ubiquitination | 19 | 2.86e-01 | 1.42e-01 | 0.736000 |
| Signaling by the B Cell Receptor (BCR) | 131 | 2.88e-01 | 5.38e-02 | 0.740000 |
| RORA activates gene expression | 18 | 2.88e-01 | -1.45e-01 | 0.740000 |
| Hyaluronan uptake and degradation | 12 | 2.90e-01 | 1.76e-01 | 0.741000 |
| Pre-NOTCH Transcription and Translation | 48 | 2.92e-01 | -8.79e-02 | 0.741000 |
| Signaling by FGFR1 in disease | 37 | 2.92e-01 | 1.00e-01 | 0.741000 |
| Formation of HIV elongation complex in the absence of HIV Tat | 46 | 2.93e-01 | -8.97e-02 | 0.741000 |
| Erythrocytes take up carbon dioxide and release oxygen | 11 | 2.93e-01 | -1.83e-01 | 0.741000 |
| O2/CO2 exchange in erythrocytes | 11 | 2.93e-01 | -1.83e-01 | 0.741000 |
| Spry regulation of FGF signaling | 14 | 2.93e-01 | -1.62e-01 | 0.741000 |
| HS-GAG degradation | 20 | 2.93e-01 | -1.36e-01 | 0.741000 |
| NIK-->noncanonical NF-kB signaling | 57 | 2.93e-01 | 8.05e-02 | 0.741000 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 31 | 2.94e-01 | 1.09e-01 | 0.742000 |
| Switching of origins to a post-replicative state | 88 | 2.95e-01 | 6.46e-02 | 0.742000 |
| Presynaptic nicotinic acetylcholine receptors | 11 | 2.95e-01 | -1.82e-01 | 0.742000 |
| Fatty acyl-CoA biosynthesis | 35 | 2.98e-01 | -1.02e-01 | 0.747000 |
| Defective GALNT12 causes colorectal cancer 1 (CRCS1) | 12 | 2.98e-01 | 1.73e-01 | 0.747000 |
| HSF1-dependent transactivation | 30 | 3.00e-01 | -1.09e-01 | 0.750000 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 35 | 3.01e-01 | -1.01e-01 | 0.751000 |
| SHC-mediated cascade:FGFR4 | 19 | 3.02e-01 | 1.37e-01 | 0.751000 |
| Dopamine Neurotransmitter Release Cycle | 23 | 3.02e-01 | 1.24e-01 | 0.751000 |
| p75NTR recruits signalling complexes | 12 | 3.03e-01 | -1.72e-01 | 0.752000 |
| Homologous DNA Pairing and Strand Exchange | 41 | 3.03e-01 | 9.29e-02 | 0.752000 |
| Transcriptional regulation by RUNX1 | 188 | 3.04e-01 | -4.35e-02 | 0.753000 |
| Regulation of MECP2 expression and activity | 30 | 3.05e-01 | -1.08e-01 | 0.754000 |
| Defective B3GALTL causes Peters-plus syndrome (PpS) | 36 | 3.08e-01 | 9.83e-02 | 0.758000 |
| Biosynthesis of specialized proresolving mediators (SPMs) | 17 | 3.08e-01 | 1.43e-01 | 0.758000 |
| Phosphorylation of CD3 and TCR zeta chains | 18 | 3.09e-01 | -1.39e-01 | 0.758000 |
| Depolymerisation of the Nuclear Lamina | 15 | 3.09e-01 | 1.52e-01 | 0.758000 |
| RAS processing | 19 | 3.10e-01 | 1.34e-01 | 0.759000 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | 60 | 3.10e-01 | -7.57e-02 | 0.759000 |
| Translesion synthesis by POLK | 16 | 3.13e-01 | -1.46e-01 | 0.763000 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 3.13e-01 | 1.76e-01 | 0.763000 |
| CDC6 association with the ORC:origin complex | 11 | 3.14e-01 | 1.75e-01 | 0.765000 |
| Interleukin-6 signaling | 11 | 3.16e-01 | -1.75e-01 | 0.767000 |
| FCERI mediated NF-kB activation | 100 | 3.17e-01 | 5.80e-02 | 0.767000 |
| EPHA-mediated growth cone collapse | 15 | 3.17e-01 | -1.49e-01 | 0.767000 |
| Downstream signal transduction | 29 | 3.18e-01 | -1.07e-01 | 0.767000 |
| Neurotransmitter receptors and postsynaptic signal transmission | 176 | 3.18e-01 | -4.37e-02 | 0.767000 |
| Signaling by FGFR1 | 47 | 3.19e-01 | 8.41e-02 | 0.768000 |
| tRNA modification in the nucleus and cytosol | 42 | 3.21e-01 | 8.85e-02 | 0.771000 |
| Interaction between L1 and Ankyrins | 29 | 3.22e-01 | -1.06e-01 | 0.771000 |
| Post-translational protein phosphorylation | 104 | 3.22e-01 | -5.63e-02 | 0.771000 |
| Gap junction assembly | 17 | 3.23e-01 | -1.39e-01 | 0.772000 |
| Interleukin-37 signaling | 20 | 3.24e-01 | 1.27e-01 | 0.774000 |
| TNFR1-induced NFkappaB signaling pathway | 26 | 3.26e-01 | -1.11e-01 | 0.777000 |
| Amino acids regulate mTORC1 | 50 | 3.27e-01 | 8.02e-02 | 0.777000 |
| TICAM1-dependent activation of IRF3/IRF7 | 10 | 3.27e-01 | 1.79e-01 | 0.777000 |
| Synthesis of IP3 and IP4 in the cytosol | 26 | 3.29e-01 | -1.11e-01 | 0.777000 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 3.29e-01 | 1.01e-01 | 0.777000 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 3.29e-01 | 1.01e-01 | 0.777000 |
| Degradation of the extracellular matrix | 104 | 3.29e-01 | 5.54e-02 | 0.777000 |
| S Phase | 158 | 3.30e-01 | 4.49e-02 | 0.777000 |
| SHC1 events in EGFR signaling | 14 | 3.30e-01 | 1.50e-01 | 0.777000 |
| Unfolded Protein Response (UPR) | 91 | 3.30e-01 | 5.91e-02 | 0.777000 |
| SUMOylation of intracellular receptors | 30 | 3.31e-01 | -1.03e-01 | 0.777000 |
| Diseases associated with N-glycosylation of proteins | 16 | 3.33e-01 | 1.40e-01 | 0.778000 |
| Nervous system development | 514 | 3.34e-01 | -2.50e-02 | 0.778000 |
| Signaling by FGFR | 79 | 3.34e-01 | 6.29e-02 | 0.778000 |
| Anti-inflammatory response favouring Leishmania parasite infection | 174 | 3.34e-01 | -4.25e-02 | 0.778000 |
| Leishmania parasite growth and survival | 174 | 3.34e-01 | -4.25e-02 | 0.778000 |
| Presynaptic phase of homologous DNA pairing and strand exchange | 38 | 3.35e-01 | 9.05e-02 | 0.778000 |
| Glucose metabolism | 87 | 3.35e-01 | -5.98e-02 | 0.778000 |
| Amine ligand-binding receptors | 36 | 3.36e-01 | 9.26e-02 | 0.779000 |
| Chromosome Maintenance | 98 | 3.39e-01 | 5.59e-02 | 0.784000 |
| Fanconi Anemia Pathway | 35 | 3.40e-01 | -9.32e-02 | 0.784000 |
| Signaling by PDGFR in disease | 19 | 3.40e-01 | -1.26e-01 | 0.784000 |
| FGFR1 ligand binding and activation | 15 | 3.43e-01 | 1.41e-01 | 0.790000 |
| Transport of bile salts and organic acids, metal ions and amine compounds | 80 | 3.46e-01 | 6.10e-02 | 0.794000 |
| Inflammasomes | 20 | 3.49e-01 | 1.21e-01 | 0.798000 |
| RAF activation | 32 | 3.49e-01 | -9.57e-02 | 0.798000 |
| Constitutive Signaling by Aberrant PI3K in Cancer | 74 | 3.50e-01 | 6.28e-02 | 0.798000 |
| Non-integrin membrane-ECM interactions | 41 | 3.52e-01 | 8.41e-02 | 0.798000 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | 10 | 3.52e-01 | 1.70e-01 | 0.798000 |
| Cellular hexose transport | 19 | 3.52e-01 | -1.23e-01 | 0.798000 |
| Role of LAT2/NTAL/LAB on calcium mobilization | 40 | 3.52e-01 | 8.50e-02 | 0.798000 |
| CS/DS degradation | 14 | 3.53e-01 | 1.43e-01 | 0.798000 |
| ADORA2B mediated anti-inflammatory cytokines production | 114 | 3.53e-01 | -5.04e-02 | 0.798000 |
| Classical antibody-mediated complement activation | 32 | 3.53e-01 | 9.49e-02 | 0.798000 |
| FRS-mediated FGFR1 signaling | 23 | 3.53e-01 | 1.12e-01 | 0.798000 |
| Nuclear Envelope Breakdown | 50 | 3.54e-01 | 7.57e-02 | 0.799000 |
| DSCAM interactions | 11 | 3.57e-01 | 1.61e-01 | 0.799000 |
| Synthesis of PIPs at the plasma membrane | 51 | 3.57e-01 | -7.46e-02 | 0.799000 |
| Opioid Signalling | 86 | 3.57e-01 | -5.75e-02 | 0.799000 |
| Metabolism of non-coding RNA | 51 | 3.58e-01 | 7.44e-02 | 0.799000 |
| snRNP Assembly | 51 | 3.58e-01 | 7.44e-02 | 0.799000 |
| ADP signalling through P2Y purinoceptor 1 | 23 | 3.58e-01 | 1.11e-01 | 0.799000 |
| Cytokine Signaling in Immune system | 801 | 3.59e-01 | -1.91e-02 | 0.799000 |
| Pyrimidine salvage | 10 | 3.60e-01 | -1.67e-01 | 0.799000 |
| Activation of NF-kappaB in B cells | 63 | 3.60e-01 | 6.67e-02 | 0.799000 |
| RHO GTPases Activate Formins | 118 | 3.61e-01 | 4.88e-02 | 0.799000 |
| Signaling by BMP | 26 | 3.61e-01 | 1.04e-01 | 0.799000 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 3.61e-01 | -1.52e-01 | 0.799000 |
| Free fatty acids regulate insulin secretion | 10 | 3.63e-01 | -1.66e-01 | 0.799000 |
| Acyl chain remodelling of PI | 16 | 3.63e-01 | 1.31e-01 | 0.799000 |
| Autodegradation of the E3 ubiquitin ligase COP1 | 48 | 3.64e-01 | 7.57e-02 | 0.799000 |
| The NLRP3 inflammasome | 15 | 3.64e-01 | 1.35e-01 | 0.799000 |
| Cholesterol biosynthesis | 22 | 3.65e-01 | 1.12e-01 | 0.799000 |
| ATF6 (ATF6-alpha) activates chaperones | 12 | 3.65e-01 | -1.51e-01 | 0.799000 |
| Platelet activation, signaling and aggregation | 252 | 3.65e-01 | -3.32e-02 | 0.799000 |
| Vpu mediated degradation of CD4 | 50 | 3.66e-01 | 7.40e-02 | 0.799000 |
| Regulation of Apoptosis | 51 | 3.66e-01 | 7.32e-02 | 0.799000 |
| Cell Cycle | 608 | 3.66e-01 | 2.15e-02 | 0.799000 |
| Heparan sulfate/heparin (HS-GAG) metabolism | 51 | 3.67e-01 | -7.30e-02 | 0.799000 |
| SARS-CoV Infections | 138 | 3.68e-01 | -4.45e-02 | 0.799000 |
| Endogenous sterols | 24 | 3.70e-01 | 1.06e-01 | 0.802000 |
| HDACs deacetylate histones | 39 | 3.70e-01 | -8.30e-02 | 0.802000 |
| Laminin interactions | 23 | 3.72e-01 | -1.08e-01 | 0.805000 |
| Nuclear Receptor transcription pathway | 53 | 3.73e-01 | -7.08e-02 | 0.805000 |
| CDK-mediated phosphorylation and removal of Cdc6 | 70 | 3.74e-01 | 6.15e-02 | 0.805000 |
| Caspase-mediated cleavage of cytoskeletal proteins | 12 | 3.74e-01 | 1.48e-01 | 0.805000 |
| Signaling by FGFR3 fusions in cancer | 10 | 3.74e-01 | 1.62e-01 | 0.805000 |
| IRE1alpha activates chaperones | 50 | 3.75e-01 | 7.25e-02 | 0.807000 |
| Neurexins and neuroligins | 54 | 3.76e-01 | 6.96e-02 | 0.808000 |
| PINK1-PRKN Mediated Mitophagy | 19 | 3.79e-01 | -1.17e-01 | 0.811000 |
| SLC-mediated transmembrane transport | 240 | 3.86e-01 | 3.25e-02 | 0.824000 |
| Export of Viral Ribonucleoproteins from Nucleus | 32 | 3.87e-01 | 8.84e-02 | 0.824000 |
| FGFR4 ligand binding and activation | 13 | 3.88e-01 | 1.38e-01 | 0.824000 |
| Tryptophan catabolism | 14 | 3.88e-01 | -1.33e-01 | 0.824000 |
| TCF dependent signaling in response to WNT | 177 | 3.89e-01 | -3.76e-02 | 0.824000 |
| Negative regulators of DDX58/IFIH1 signaling | 31 | 3.89e-01 | -8.94e-02 | 0.824000 |
| Pentose phosphate pathway | 14 | 3.90e-01 | 1.33e-01 | 0.824000 |
| Signaling by Retinoic Acid | 39 | 3.90e-01 | 7.96e-02 | 0.824000 |
| Signaling by NTRK1 (TRKA) | 113 | 3.91e-01 | -4.68e-02 | 0.824000 |
| Cyclin A:Cdk2-associated events at S phase entry | 83 | 3.91e-01 | 5.45e-02 | 0.824000 |
| HDR through Homologous Recombination (HRR) | 63 | 3.91e-01 | 6.25e-02 | 0.824000 |
| Acyl chain remodelling of PG | 17 | 3.92e-01 | 1.20e-01 | 0.824000 |
| Processing of DNA double-strand break ends | 66 | 3.92e-01 | 6.09e-02 | 0.824000 |
| Clathrin-mediated endocytosis | 139 | 3.94e-01 | -4.19e-02 | 0.827000 |
| PI Metabolism | 80 | 3.95e-01 | 5.51e-02 | 0.827000 |
| FRS-mediated FGFR4 signaling | 21 | 3.96e-01 | 1.07e-01 | 0.828000 |
| Interconversion of nucleotide di- and triphosphates | 28 | 3.98e-01 | 9.24e-02 | 0.831000 |
| Regulation of TNFR1 signaling | 34 | 3.99e-01 | -8.36e-02 | 0.831000 |
| Binding and Uptake of Ligands by Scavenger Receptors | 63 | 3.99e-01 | 6.14e-02 | 0.831000 |
| Ion transport by P-type ATPases | 52 | 4.00e-01 | -6.75e-02 | 0.831000 |
| Cellular responses to stress | 475 | 4.00e-01 | 2.26e-02 | 0.831000 |
| Ca-dependent events | 34 | 4.01e-01 | -8.33e-02 | 0.831000 |
| XBP1(S) activates chaperone genes | 48 | 4.03e-01 | 6.98e-02 | 0.834000 |
| Meiotic recombination | 37 | 4.03e-01 | 7.95e-02 | 0.834000 |
| IKK complex recruitment mediated by RIP1 | 18 | 4.04e-01 | 1.14e-01 | 0.834000 |
| Ub-specific processing proteases | 160 | 4.06e-01 | -3.81e-02 | 0.837000 |
| Transport of Ribonucleoproteins into the Host Nucleus | 31 | 4.08e-01 | 8.58e-02 | 0.837000 |
| SUMOylation of DNA damage response and repair proteins | 73 | 4.09e-01 | 5.59e-02 | 0.837000 |
| SCF-beta-TrCP mediated degradation of Emi1 | 53 | 4.10e-01 | 6.55e-02 | 0.837000 |
| Autophagy | 122 | 4.11e-01 | -4.31e-02 | 0.837000 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | 23 | 4.11e-01 | -9.90e-02 | 0.837000 |
| Ephrin signaling | 19 | 4.11e-01 | -1.09e-01 | 0.837000 |
| Signaling by ERBB2 TMD/JMD mutants | 20 | 4.12e-01 | 1.06e-01 | 0.837000 |
| The canonical retinoid cycle in rods (twilight vision) | 23 | 4.12e-01 | 9.88e-02 | 0.837000 |
| The phototransduction cascade | 31 | 4.13e-01 | 8.50e-02 | 0.837000 |
| Downstream signaling events of B Cell Receptor (BCR) | 76 | 4.13e-01 | 5.43e-02 | 0.837000 |
| Intrinsic Pathway for Apoptosis | 46 | 4.14e-01 | -6.96e-02 | 0.837000 |
| Signaling by VEGF | 100 | 4.15e-01 | -4.72e-02 | 0.837000 |
| WNT ligand biogenesis and trafficking | 25 | 4.15e-01 | -9.42e-02 | 0.837000 |
| Regulation of PTEN gene transcription | 58 | 4.16e-01 | -6.18e-02 | 0.837000 |
| Constitutive Signaling by AKT1 E17K in Cancer | 25 | 4.16e-01 | -9.41e-02 | 0.837000 |
| FCGR3A-mediated IL10 synthesis | 64 | 4.16e-01 | -5.88e-02 | 0.837000 |
| CD28 dependent PI3K/Akt signaling | 22 | 4.16e-01 | 1.00e-01 | 0.837000 |
| Translesion synthesis by POLI | 16 | 4.16e-01 | -1.17e-01 | 0.837000 |
| Energy dependent regulation of mTOR by LKB1-AMPK | 28 | 4.17e-01 | 8.86e-02 | 0.838000 |
| SUMOylation of SUMOylation proteins | 34 | 4.19e-01 | 8.00e-02 | 0.841000 |
| Apoptotic cleavage of cell adhesion proteins | 11 | 4.21e-01 | -1.40e-01 | 0.841000 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 4.21e-01 | -1.24e-01 | 0.841000 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 4.21e-01 | -1.24e-01 | 0.841000 |
| Suppression of phagosomal maturation | 12 | 4.22e-01 | -1.34e-01 | 0.841000 |
| PCNA-Dependent Long Patch Base Excision Repair | 20 | 4.23e-01 | -1.03e-01 | 0.841000 |
| Cargo recognition for clathrin-mediated endocytosis | 102 | 4.24e-01 | -4.59e-02 | 0.841000 |
| DNA methylation | 15 | 4.24e-01 | -1.19e-01 | 0.841000 |
| Uptake and function of anthrax toxins | 10 | 4.25e-01 | -1.46e-01 | 0.841000 |
| Autodegradation of Cdh1 by Cdh1:APC/C | 61 | 4.25e-01 | 5.91e-02 | 0.841000 |
| DNA Replication | 123 | 4.26e-01 | 4.16e-02 | 0.841000 |
| Glutamate and glutamine metabolism | 13 | 4.26e-01 | 1.27e-01 | 0.841000 |
| Vpr-mediated nuclear import of PICs | 32 | 4.26e-01 | 8.12e-02 | 0.841000 |
| Negative regulation of MET activity | 20 | 4.27e-01 | -1.03e-01 | 0.841000 |
| Recycling pathway of L1 | 27 | 4.27e-01 | -8.83e-02 | 0.841000 |
| NF-kB is activated and signals survival | 11 | 4.29e-01 | -1.38e-01 | 0.843000 |
| Antigen processing-Cross presentation | 93 | 4.30e-01 | 4.74e-02 | 0.843000 |
| Downregulation of ERBB2 signaling | 26 | 4.32e-01 | 8.90e-02 | 0.847000 |
| Dectin-1 mediated noncanonical NF-kB signaling | 60 | 4.35e-01 | 5.83e-02 | 0.847000 |
| Insulin processing | 27 | 4.35e-01 | -8.68e-02 | 0.847000 |
| Nucleobase biosynthesis | 13 | 4.35e-01 | 1.25e-01 | 0.847000 |
| Metalloprotease DUBs | 18 | 4.36e-01 | 1.06e-01 | 0.847000 |
| MET activates PTK2 signaling | 18 | 4.37e-01 | -1.06e-01 | 0.847000 |
| Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 49 | 4.37e-01 | 6.41e-02 | 0.847000 |
| p53-Independent DNA Damage Response | 49 | 4.37e-01 | 6.41e-02 | 0.847000 |
| p53-Independent G1/S DNA damage checkpoint | 49 | 4.37e-01 | 6.41e-02 | 0.847000 |
| Cell surface interactions at the vascular wall | 153 | 4.39e-01 | -3.63e-02 | 0.847000 |
| Defective CFTR causes cystic fibrosis | 59 | 4.40e-01 | 5.82e-02 | 0.847000 |
| Metabolism of amino acids and derivatives | 337 | 4.41e-01 | -2.45e-02 | 0.847000 |
| NGF-stimulated transcription | 39 | 4.41e-01 | -7.13e-02 | 0.847000 |
| HSF1 activation | 24 | 4.42e-01 | -9.07e-02 | 0.847000 |
| Cellular responses to external stimuli | 481 | 4.42e-01 | 2.05e-02 | 0.847000 |
| RUNX3 regulates NOTCH signaling | 12 | 4.42e-01 | -1.28e-01 | 0.847000 |
| Cyclin A/B1/B2 associated events during G2/M transition | 23 | 4.42e-01 | 9.26e-02 | 0.847000 |
| FOXO-mediated transcription of cell cycle genes | 16 | 4.44e-01 | -1.11e-01 | 0.847000 |
| Deubiquitination | 232 | 4.45e-01 | -2.91e-02 | 0.847000 |
| MET receptor recycling | 10 | 4.46e-01 | 1.39e-01 | 0.847000 |
| CLEC7A (Dectin-1) signaling | 95 | 4.46e-01 | 4.52e-02 | 0.847000 |
| RNA Polymerase I Promoter Escape | 38 | 4.47e-01 | 7.14e-02 | 0.847000 |
| Nicotinate metabolism | 31 | 4.47e-01 | 7.89e-02 | 0.847000 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | 24 | 4.48e-01 | -8.95e-02 | 0.847000 |
| Deadenylation-dependent mRNA decay | 51 | 4.48e-01 | -6.14e-02 | 0.847000 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | 11 | 4.48e-01 | -1.32e-01 | 0.847000 |
| Prolonged ERK activation events | 14 | 4.49e-01 | -1.17e-01 | 0.847000 |
| Cargo concentration in the ER | 29 | 4.49e-01 | -8.12e-02 | 0.847000 |
| Pyrimidine catabolism | 12 | 4.50e-01 | -1.26e-01 | 0.847000 |
| RNA Polymerase I Transcription Termination | 28 | 4.50e-01 | 8.25e-02 | 0.847000 |
| Regulation of ornithine decarboxylase (ODC) | 50 | 4.51e-01 | 6.17e-02 | 0.847000 |
| SUMOylation of DNA replication proteins | 44 | 4.51e-01 | 6.57e-02 | 0.847000 |
| Platelet Adhesion to exposed collagen | 13 | 4.51e-01 | -1.21e-01 | 0.847000 |
| MAPK targets/ Nuclear events mediated by MAP kinases | 30 | 4.53e-01 | -7.92e-02 | 0.847000 |
| Heme biosynthesis | 13 | 4.53e-01 | 1.20e-01 | 0.847000 |
| Axon guidance | 491 | 4.53e-01 | -1.98e-02 | 0.847000 |
| C-type lectin receptors (CLRs) | 128 | 4.54e-01 | 3.84e-02 | 0.847000 |
| Scavenging by Class A Receptors | 17 | 4.54e-01 | 1.05e-01 | 0.847000 |
| Potassium Channels | 98 | 4.55e-01 | -4.37e-02 | 0.847000 |
| Regulation of TP53 Activity through Association with Co-factors | 13 | 4.57e-01 | -1.19e-01 | 0.848000 |
| Transcriptional Regulation by VENTX | 36 | 4.58e-01 | -7.15e-02 | 0.848000 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | 48 | 4.58e-01 | 6.20e-02 | 0.848000 |
| Cyclin E associated events during G1/S transition | 81 | 4.58e-01 | 4.77e-02 | 0.848000 |
| Stabilization of p53 | 52 | 4.58e-01 | 5.95e-02 | 0.848000 |
| Regulation of PTEN stability and activity | 67 | 4.59e-01 | 5.24e-02 | 0.848000 |
| GAB1 signalosome | 17 | 4.59e-01 | 1.04e-01 | 0.848000 |
| Creatine metabolism | 10 | 4.60e-01 | -1.35e-01 | 0.849000 |
| Rap1 signalling | 14 | 4.61e-01 | -1.14e-01 | 0.849000 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 11 | 4.61e-01 | 1.28e-01 | 0.849000 |
| Cellular Senescence | 136 | 4.62e-01 | -3.65e-02 | 0.849000 |
| STING mediated induction of host immune responses | 16 | 4.63e-01 | -1.06e-01 | 0.849000 |
| TRAF3-dependent IRF activation pathway | 12 | 4.65e-01 | -1.22e-01 | 0.851000 |
| Elevation of cytosolic Ca2+ levels | 16 | 4.66e-01 | 1.05e-01 | 0.851000 |
| Signaling by Hedgehog | 132 | 4.66e-01 | 3.67e-02 | 0.851000 |
| G beta:gamma signalling through PLC beta | 19 | 4.66e-01 | 9.65e-02 | 0.851000 |
| Synthesis of PA | 37 | 4.67e-01 | 6.91e-02 | 0.851000 |
| Gene expression (Transcription) | 1222 | 4.68e-01 | -1.24e-02 | 0.851000 |
| Regulation of RUNX1 Expression and Activity | 23 | 4.68e-01 | -8.75e-02 | 0.851000 |
| GABA synthesis, release, reuptake and degradation | 19 | 4.68e-01 | -9.61e-02 | 0.851000 |
| mRNA Capping | 27 | 4.71e-01 | 8.02e-02 | 0.854000 |
| Pregnenolone biosynthesis | 11 | 4.71e-01 | 1.26e-01 | 0.854000 |
| HCMV Infection | 89 | 4.74e-01 | -4.39e-02 | 0.858000 |
| TCR signaling | 108 | 4.75e-01 | -3.98e-02 | 0.859000 |
| MAP kinase activation | 60 | 4.77e-01 | -5.31e-02 | 0.860000 |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 13 | 4.77e-01 | 1.14e-01 | 0.860000 |
| Class B/2 (Secretin family receptors) | 85 | 4.77e-01 | 4.46e-02 | 0.860000 |
| Activation of BAD and translocation to mitochondria | 15 | 4.80e-01 | -1.05e-01 | 0.861000 |
| Regulation of pyruvate dehydrogenase (PDH) complex | 16 | 4.80e-01 | -1.02e-01 | 0.861000 |
| Interleukin-20 family signaling | 23 | 4.81e-01 | -8.50e-02 | 0.861000 |
| Josephin domain DUBs | 10 | 4.81e-01 | 1.29e-01 | 0.861000 |
| HDR through Single Strand Annealing (SSA) | 37 | 4.82e-01 | 6.68e-02 | 0.861000 |
| ADP signalling through P2Y purinoceptor 12 | 21 | 4.82e-01 | 8.85e-02 | 0.861000 |
| Negative regulation of FGFR3 signaling | 27 | 4.83e-01 | 7.79e-02 | 0.861000 |
| Signaling by FGFR2 | 67 | 4.84e-01 | 4.95e-02 | 0.861000 |
| TRP channels | 25 | 4.85e-01 | 8.08e-02 | 0.861000 |
| Resolution of Abasic Sites (AP sites) | 37 | 4.87e-01 | 6.61e-02 | 0.861000 |
| Interleukin receptor SHC signaling | 27 | 4.87e-01 | -7.73e-02 | 0.861000 |
| Regulation of actin dynamics for phagocytic cup formation | 85 | 4.87e-01 | -4.36e-02 | 0.861000 |
| MyD88 cascade initiated on plasma membrane | 76 | 4.87e-01 | -4.61e-02 | 0.861000 |
| Toll Like Receptor 10 (TLR10) Cascade | 76 | 4.87e-01 | -4.61e-02 | 0.861000 |
| Toll Like Receptor 5 (TLR5) Cascade | 76 | 4.87e-01 | -4.61e-02 | 0.861000 |
| Signal amplification | 31 | 4.90e-01 | 7.16e-02 | 0.864000 |
| Platelet sensitization by LDL | 16 | 4.91e-01 | 9.95e-02 | 0.864000 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | 19 | 4.91e-01 | 9.13e-02 | 0.864000 |
| Inactivation, recovery and regulation of the phototransduction cascade | 30 | 4.91e-01 | 7.27e-02 | 0.864000 |
| G alpha (z) signalling events | 47 | 4.94e-01 | -5.76e-02 | 0.868000 |
| COPI-dependent Golgi-to-ER retrograde traffic | 78 | 4.95e-01 | -4.48e-02 | 0.868000 |
| Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 54 | 4.97e-01 | 5.35e-02 | 0.869000 |
| Mitotic Prometaphase | 182 | 4.98e-01 | 2.92e-02 | 0.869000 |
| Signaling by ROBO receptors | 190 | 4.98e-01 | 2.86e-02 | 0.869000 |
| Transcription of E2F targets under negative control by DREAM complex | 19 | 4.98e-01 | 8.98e-02 | 0.869000 |
| Degradation of DVL | 55 | 4.98e-01 | 5.28e-02 | 0.869000 |
| Arachidonic acid metabolism | 53 | 5.02e-01 | 5.34e-02 | 0.874000 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | 23 | 5.02e-01 | -8.08e-02 | 0.874000 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 56 | 5.03e-01 | 5.17e-02 | 0.874000 |
| Phospholipase C-mediated cascade: FGFR1 | 16 | 5.04e-01 | 9.66e-02 | 0.874000 |
| DNA Double-Strand Break Repair | 131 | 5.04e-01 | 3.38e-02 | 0.874000 |
| Glucagon-type ligand receptors | 30 | 5.05e-01 | 7.03e-02 | 0.875000 |
| Trafficking and processing of endosomal TLR | 12 | 5.06e-01 | 1.11e-01 | 0.876000 |
| Activation of kainate receptors upon glutamate binding | 29 | 5.08e-01 | 7.11e-02 | 0.876000 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 5.08e-01 | 1.02e-01 | 0.876000 |
| Signaling by ERBB4 | 55 | 5.08e-01 | -5.16e-02 | 0.876000 |
| SCF(Skp2)-mediated degradation of p27/p21 | 58 | 5.09e-01 | 5.02e-02 | 0.876000 |
| Signaling by ERBB2 ECD mutants | 14 | 5.13e-01 | 1.01e-01 | 0.879000 |
| Regulation of RAS by GAPs | 66 | 5.13e-01 | 4.66e-02 | 0.879000 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | 81 | 5.13e-01 | -4.21e-02 | 0.879000 |
| Interferon gamma signaling | 77 | 5.14e-01 | -4.30e-02 | 0.879000 |
| Response of EIF2AK1 (HRI) to heme deficiency | 15 | 5.14e-01 | 9.72e-02 | 0.879000 |
| Gastrin-CREB signalling pathway via PKC and MAPK | 17 | 5.15e-01 | 9.13e-02 | 0.879000 |
| Purine catabolism | 18 | 5.15e-01 | 8.87e-02 | 0.879000 |
| Interleukin-15 signaling | 14 | 5.17e-01 | -1.00e-01 | 0.880000 |
| Scavenging of heme from plasma | 38 | 5.17e-01 | 6.07e-02 | 0.880000 |
| Centrosome maturation | 79 | 5.18e-01 | -4.21e-02 | 0.880000 |
| Recruitment of mitotic centrosome proteins and complexes | 79 | 5.18e-01 | -4.21e-02 | 0.880000 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | 11 | 5.20e-01 | -1.12e-01 | 0.883000 |
| Adaptive Immune System | 688 | 5.21e-01 | -1.44e-02 | 0.883000 |
| Host Interactions of HIV factors | 124 | 5.22e-01 | 3.33e-02 | 0.883000 |
| Heme degradation | 13 | 5.23e-01 | -1.02e-01 | 0.883000 |
| Sema3A PAK dependent Axon repulsion | 15 | 5.23e-01 | -9.53e-02 | 0.883000 |
| Phase 2 - plateau phase | 14 | 5.26e-01 | 9.79e-02 | 0.888000 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 5.27e-01 | 8.38e-02 | 0.889000 |
| Formation of tubulin folding intermediates by CCT/TriC | 21 | 5.28e-01 | -7.95e-02 | 0.889000 |
| RNA Polymerase III Chain Elongation | 14 | 5.29e-01 | -9.72e-02 | 0.889000 |
| Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) | 12 | 5.30e-01 | 1.05e-01 | 0.890000 |
| APC/C:Cdc20 mediated degradation of Cyclin B | 22 | 5.30e-01 | -7.73e-02 | 0.890000 |
| G beta:gamma signalling through PI3Kgamma | 24 | 5.32e-01 | 7.37e-02 | 0.892000 |
| Synthesis of PE | 13 | 5.34e-01 | 9.97e-02 | 0.892000 |
| Synthesis of DNA | 116 | 5.34e-01 | 3.35e-02 | 0.892000 |
| Triglyceride catabolism | 23 | 5.36e-01 | -7.46e-02 | 0.892000 |
| Leishmania infection | 254 | 5.36e-01 | -2.26e-02 | 0.892000 |
| G alpha (q) signalling events | 199 | 5.36e-01 | -2.55e-02 | 0.892000 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | 12 | 5.37e-01 | -1.03e-01 | 0.892000 |
| Regulation of innate immune responses to cytosolic DNA | 13 | 5.37e-01 | 9.90e-02 | 0.892000 |
| Purine ribonucleoside monophosphate biosynthesis | 10 | 5.38e-01 | 1.13e-01 | 0.892000 |
| Cargo trafficking to the periciliary membrane | 49 | 5.38e-01 | 5.09e-02 | 0.892000 |
| VEGFR2 mediated vascular permeability | 26 | 5.39e-01 | -6.96e-02 | 0.893000 |
| Removal of the Flap Intermediate | 13 | 5.43e-01 | 9.75e-02 | 0.898000 |
| Fertilization | 20 | 5.44e-01 | -7.83e-02 | 0.898000 |
| Regulation of PLK1 Activity at G2/M Transition | 83 | 5.45e-01 | -3.85e-02 | 0.898000 |
| Base Excision Repair | 54 | 5.45e-01 | 4.76e-02 | 0.898000 |
| CLEC7A (Dectin-1) induces NFAT activation | 11 | 5.45e-01 | -1.05e-01 | 0.898000 |
| RNA polymerase II transcribes snRNA genes | 68 | 5.46e-01 | -4.23e-02 | 0.899000 |
| Gene Silencing by RNA | 85 | 5.47e-01 | 3.78e-02 | 0.899000 |
| Interleukin-2 family signaling | 42 | 5.47e-01 | -5.37e-02 | 0.899000 |
| GRB2 events in EGFR signaling | 13 | 5.48e-01 | 9.62e-02 | 0.899000 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | 10 | 5.49e-01 | 1.09e-01 | 0.899000 |
| DNA Repair | 281 | 5.49e-01 | -2.08e-02 | 0.899000 |
| Processive synthesis on the lagging strand | 14 | 5.53e-01 | 9.15e-02 | 0.902000 |
| RNA Polymerase II Transcription | 1089 | 5.54e-01 | -1.07e-02 | 0.902000 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 49 | 5.54e-01 | 4.88e-02 | 0.902000 |
| Telomere C-strand synthesis initiation | 13 | 5.54e-01 | 9.47e-02 | 0.902000 |
| Mitotic Prophase | 89 | 5.55e-01 | 3.62e-02 | 0.902000 |
| Response to elevated platelet cytosolic Ca2+ | 128 | 5.55e-01 | -3.02e-02 | 0.902000 |
| Cellular response to hypoxia | 73 | 5.56e-01 | -3.99e-02 | 0.902000 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 50 | 5.57e-01 | -4.81e-02 | 0.902000 |
| Phosphorylation of the APC/C | 19 | 5.57e-01 | -7.78e-02 | 0.902000 |
| Intracellular signaling by second messengers | 306 | 5.59e-01 | -1.95e-02 | 0.903000 |
| EPH-Ephrin signaling | 90 | 5.60e-01 | -3.56e-02 | 0.903000 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 11 | 5.61e-01 | -1.01e-01 | 0.903000 |
| rRNA modification in the nucleus and cytosol | 57 | 5.62e-01 | 4.45e-02 | 0.903000 |
| Metabolism of porphyrins | 24 | 5.62e-01 | -6.84e-02 | 0.903000 |
| HS-GAG biosynthesis | 28 | 5.62e-01 | -6.33e-02 | 0.903000 |
| Purine salvage | 13 | 5.63e-01 | 9.28e-02 | 0.903000 |
| CD22 mediated BCR regulation | 31 | 5.63e-01 | 6.01e-02 | 0.903000 |
| Hh mutants abrogate ligand secretion | 57 | 5.63e-01 | 4.43e-02 | 0.903000 |
| Transcriptional regulation of granulopoiesis | 40 | 5.64e-01 | -5.27e-02 | 0.904000 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | 21 | 5.65e-01 | -7.25e-02 | 0.904000 |
| Metabolism of nitric oxide: NOS3 activation and regulation | 14 | 5.67e-01 | -8.85e-02 | 0.904000 |
| Nuclear Pore Complex (NPC) Disassembly | 34 | 5.67e-01 | 5.68e-02 | 0.904000 |
| Antigen processing: Ubiquitination & Proteasome degradation | 290 | 5.67e-01 | -1.96e-02 | 0.904000 |
| Tie2 Signaling | 18 | 5.68e-01 | 7.78e-02 | 0.904000 |
| Beta-catenin phosphorylation cascade | 16 | 5.71e-01 | 8.19e-02 | 0.907000 |
| Ubiquitin-dependent degradation of Cyclin D | 50 | 5.71e-01 | 4.63e-02 | 0.907000 |
| Phospholipase C-mediated cascade; FGFR4 | 14 | 5.72e-01 | 8.73e-02 | 0.907000 |
| EGFR downregulation | 30 | 5.73e-01 | -5.94e-02 | 0.907000 |
| Glycosphingolipid metabolism | 41 | 5.73e-01 | 5.09e-02 | 0.907000 |
| Hedgehog ligand biogenesis | 62 | 5.73e-01 | 4.14e-02 | 0.907000 |
| Golgi-to-ER retrograde transport | 111 | 5.74e-01 | -3.09e-02 | 0.907000 |
| MyD88 dependent cascade initiated on endosome | 80 | 5.76e-01 | -3.62e-02 | 0.908000 |
| Apoptotic factor-mediated response | 14 | 5.76e-01 | 8.63e-02 | 0.908000 |
| Signaling by EGFR | 49 | 5.76e-01 | -4.62e-02 | 0.908000 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | 30 | 5.77e-01 | 5.89e-02 | 0.908000 |
| Fcgamma receptor (FCGR) dependent phagocytosis | 110 | 5.77e-01 | -3.08e-02 | 0.908000 |
| Rab regulation of trafficking | 117 | 5.79e-01 | 2.97e-02 | 0.908000 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 5.79e-01 | -7.78e-02 | 0.908000 |
| Response of Mtb to phagocytosis | 22 | 5.79e-01 | -6.83e-02 | 0.908000 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 17 | 5.80e-01 | 7.74e-02 | 0.908000 |
| Transcription of the HIV genome | 68 | 5.81e-01 | 3.87e-02 | 0.908000 |
| Lysine catabolism | 12 | 5.81e-01 | -9.20e-02 | 0.908000 |
| TNFs bind their physiological receptors | 27 | 5.82e-01 | -6.12e-02 | 0.908000 |
| CD209 (DC-SIGN) signaling | 19 | 5.84e-01 | -7.26e-02 | 0.908000 |
| Membrane Trafficking | 579 | 5.84e-01 | -1.34e-02 | 0.908000 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 98 | 5.84e-01 | 3.20e-02 | 0.908000 |
| Fatty acid metabolism | 164 | 5.86e-01 | -2.47e-02 | 0.908000 |
| Cyclin D associated events in G1 | 43 | 5.86e-01 | -4.80e-02 | 0.908000 |
| G1 Phase | 43 | 5.86e-01 | -4.80e-02 | 0.908000 |
| DAP12 signaling | 29 | 5.86e-01 | 5.84e-02 | 0.908000 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | 15 | 5.88e-01 | -8.09e-02 | 0.908000 |
| Interleukin-27 signaling | 11 | 5.89e-01 | -9.41e-02 | 0.908000 |
| VEGFR2 mediated cell proliferation | 19 | 5.90e-01 | 7.15e-02 | 0.908000 |
| Mitotic G1 phase and G1/S transition | 143 | 5.92e-01 | 2.60e-02 | 0.908000 |
| Thromboxane signalling through TP receptor | 22 | 5.93e-01 | 6.59e-02 | 0.908000 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 11 | 5.94e-01 | 9.29e-02 | 0.908000 |
| Nicotinamide salvaging | 19 | 5.94e-01 | 7.07e-02 | 0.908000 |
| EPH-ephrin mediated repulsion of cells | 48 | 5.94e-01 | 4.44e-02 | 0.908000 |
| RHO GTPases activate IQGAPs | 11 | 5.95e-01 | -9.26e-02 | 0.908000 |
| NoRC negatively regulates rRNA expression | 54 | 5.95e-01 | 4.18e-02 | 0.908000 |
| tRNA processing | 118 | 5.95e-01 | 2.83e-02 | 0.908000 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 17 | 5.96e-01 | 7.44e-02 | 0.908000 |
| Meiotic synapsis | 41 | 5.96e-01 | -4.79e-02 | 0.908000 |
| Glycogen storage diseases | 14 | 5.97e-01 | -8.17e-02 | 0.908000 |
| Toll-like Receptor Cascades | 138 | 5.98e-01 | -2.60e-02 | 0.908000 |
| Metabolism of carbohydrates | 275 | 5.98e-01 | 1.85e-02 | 0.908000 |
| Presynaptic function of Kainate receptors | 20 | 6.00e-01 | 6.78e-02 | 0.908000 |
| Interleukin-17 signaling | 68 | 6.00e-01 | -3.68e-02 | 0.908000 |
| Caspase activation via Death Receptors in the presence of ligand | 11 | 6.01e-01 | 9.11e-02 | 0.908000 |
| Regulation of APC/C activators between G1/S and early anaphase | 78 | 6.01e-01 | 3.43e-02 | 0.908000 |
| Activation of GABAB receptors | 42 | 6.01e-01 | -4.66e-02 | 0.908000 |
| GABA B receptor activation | 42 | 6.01e-01 | -4.66e-02 | 0.908000 |
| Transcriptional regulation by small RNAs | 54 | 6.01e-01 | 4.11e-02 | 0.908000 |
| Long-term potentiation | 22 | 6.02e-01 | -6.42e-02 | 0.908000 |
| Sphingolipid metabolism | 84 | 6.02e-01 | -3.29e-02 | 0.908000 |
| HDMs demethylate histones | 21 | 6.06e-01 | -6.50e-02 | 0.913000 |
| Signaling by cytosolic FGFR1 fusion mutants | 17 | 6.06e-01 | 7.22e-02 | 0.913000 |
| Mitotic Telophase/Cytokinesis | 13 | 6.10e-01 | -8.17e-02 | 0.913000 |
| Degradation of GLI2 by the proteasome | 56 | 6.12e-01 | 3.92e-02 | 0.913000 |
| ATF4 activates genes in response to endoplasmic reticulum stress | 26 | 6.12e-01 | 5.74e-02 | 0.913000 |
| VLDLR internalisation and degradation | 12 | 6.13e-01 | -8.44e-02 | 0.913000 |
| Senescence-Associated Secretory Phenotype (SASP) | 56 | 6.13e-01 | -3.90e-02 | 0.913000 |
| Triglyceride metabolism | 36 | 6.14e-01 | -4.86e-02 | 0.913000 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) | 35 | 6.14e-01 | -4.92e-02 | 0.913000 |
| NOTCH4 Intracellular Domain Regulates Transcription | 18 | 6.15e-01 | -6.86e-02 | 0.913000 |
| Cytochrome c-mediated apoptotic response | 11 | 6.17e-01 | -8.72e-02 | 0.913000 |
| Viral Messenger RNA Synthesis | 41 | 6.17e-01 | 4.52e-02 | 0.913000 |
| p53-Dependent G1 DNA Damage Response | 61 | 6.18e-01 | 3.70e-02 | 0.913000 |
| p53-Dependent G1/S DNA damage checkpoint | 61 | 6.18e-01 | 3.70e-02 | 0.913000 |
| Signaling by WNT | 271 | 6.18e-01 | -1.76e-02 | 0.913000 |
| Signaling by PDGF | 50 | 6.19e-01 | -4.07e-02 | 0.913000 |
| IRAK4 deficiency (TLR2/4) | 10 | 6.20e-01 | 9.07e-02 | 0.913000 |
| Regulation of RUNX3 expression and activity | 52 | 6.20e-01 | 3.98e-02 | 0.913000 |
| Serotonin Neurotransmitter Release Cycle | 18 | 6.20e-01 | 6.75e-02 | 0.913000 |
| MAP2K and MAPK activation | 38 | 6.21e-01 | -4.64e-02 | 0.913000 |
| Caspase activation via extrinsic apoptotic signalling pathway | 21 | 6.22e-01 | 6.21e-02 | 0.913000 |
| mTORC1-mediated signalling | 22 | 6.22e-01 | -6.06e-02 | 0.913000 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 40 | 6.23e-01 | -4.49e-02 | 0.913000 |
| Platelet degranulation | 123 | 6.25e-01 | -2.55e-02 | 0.913000 |
| Signaling by NOTCH4 | 78 | 6.26e-01 | -3.19e-02 | 0.913000 |
| Recruitment of NuMA to mitotic centrosomes | 78 | 6.27e-01 | -3.19e-02 | 0.913000 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 53 | 6.27e-01 | 3.86e-02 | 0.913000 |
| Metabolism of steroid hormones | 27 | 6.28e-01 | -5.39e-02 | 0.913000 |
| Downstream TCR signaling | 88 | 6.28e-01 | -2.99e-02 | 0.913000 |
| Activation of G protein gated Potassium channels | 28 | 6.28e-01 | 5.29e-02 | 0.913000 |
| G protein gated Potassium channels | 28 | 6.28e-01 | 5.29e-02 | 0.913000 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 28 | 6.28e-01 | 5.29e-02 | 0.913000 |
| G1/S DNA Damage Checkpoints | 62 | 6.28e-01 | 3.55e-02 | 0.913000 |
| Negative epigenetic regulation of rRNA expression | 57 | 6.30e-01 | 3.69e-02 | 0.913000 |
| Regulation of TP53 Activity through Methylation | 16 | 6.31e-01 | 6.94e-02 | 0.913000 |
| Golgi Associated Vesicle Biogenesis | 54 | 6.32e-01 | -3.77e-02 | 0.913000 |
| Cleavage of the damaged purine | 20 | 6.32e-01 | 6.19e-02 | 0.913000 |
| Depurination | 20 | 6.32e-01 | 6.19e-02 | 0.913000 |
| Recognition and association of DNA glycosylase with site containing an affected purine | 20 | 6.32e-01 | 6.19e-02 | 0.913000 |
| Mitochondrial tRNA aminoacylation | 20 | 6.32e-01 | 6.18e-02 | 0.913000 |
| Transport of Mature Transcript to Cytoplasm | 80 | 6.33e-01 | 3.09e-02 | 0.913000 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 13 | 6.33e-01 | -7.64e-02 | 0.913000 |
| Defective EXT2 causes exostoses 2 | 13 | 6.33e-01 | -7.64e-02 | 0.913000 |
| Signaling by EGFR in Cancer | 23 | 6.33e-01 | 5.75e-02 | 0.913000 |
| SUMOylation of DNA methylation proteins | 16 | 6.36e-01 | -6.83e-02 | 0.916000 |
| Post-translational protein modification | 1276 | 6.37e-01 | 7.92e-03 | 0.916000 |
| Diseases associated with O-glycosylation of proteins | 62 | 6.38e-01 | 3.45e-02 | 0.917000 |
| Diseases associated with glycosylation precursor biosynthesis | 18 | 6.38e-01 | 6.40e-02 | 0.917000 |
| DNA Double Strand Break Response | 46 | 6.39e-01 | 4.00e-02 | 0.917000 |
| Beta-catenin independent WNT signaling | 142 | 6.40e-01 | 2.28e-02 | 0.917000 |
| Digestion | 16 | 6.41e-01 | 6.73e-02 | 0.917000 |
| IRF3-mediated induction of type I IFN | 13 | 6.41e-01 | -7.46e-02 | 0.917000 |
| MHC class II antigen presentation | 94 | 6.42e-01 | -2.77e-02 | 0.918000 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 79 | 6.44e-01 | -3.01e-02 | 0.919000 |
| Association of TriC/CCT with target proteins during biosynthesis | 38 | 6.44e-01 | -4.33e-02 | 0.919000 |
| Homology Directed Repair | 104 | 6.45e-01 | 2.61e-02 | 0.919000 |
| Early Phase of HIV Life Cycle | 13 | 6.46e-01 | 7.36e-02 | 0.919000 |
| Miscellaneous transport and binding events | 23 | 6.46e-01 | -5.53e-02 | 0.919000 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 12 | 6.46e-01 | 7.65e-02 | 0.919000 |
| ABC transporter disorders | 75 | 6.47e-01 | 3.06e-02 | 0.919000 |
| Post-translational modification: synthesis of GPI-anchored proteins | 84 | 6.49e-01 | 2.87e-02 | 0.920000 |
| DNA Damage/Telomere Stress Induced Senescence | 41 | 6.49e-01 | -4.10e-02 | 0.920000 |
| GPVI-mediated activation cascade | 32 | 6.51e-01 | 4.62e-02 | 0.921000 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 129 | 6.53e-01 | -2.30e-02 | 0.923000 |
| Condensation of Prophase Chromosomes | 24 | 6.53e-01 | -5.30e-02 | 0.923000 |
| SUMOylation of RNA binding proteins | 45 | 6.55e-01 | 3.85e-02 | 0.925000 |
| MTOR signalling | 38 | 6.57e-01 | -4.17e-02 | 0.925000 |
| Cohesin Loading onto Chromatin | 10 | 6.57e-01 | -8.11e-02 | 0.925000 |
| Methylation | 14 | 6.57e-01 | -6.85e-02 | 0.925000 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 13 | 6.60e-01 | 7.06e-02 | 0.925000 |
| Loss of Nlp from mitotic centrosomes | 67 | 6.60e-01 | -3.11e-02 | 0.925000 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 67 | 6.60e-01 | -3.11e-02 | 0.925000 |
| Cellular response to heat stress | 92 | 6.61e-01 | 2.65e-02 | 0.926000 |
| RHO GTPases activate PKNs | 44 | 6.63e-01 | -3.80e-02 | 0.927000 |
| ER to Golgi Anterograde Transport | 126 | 6.64e-01 | -2.24e-02 | 0.927000 |
| Signaling by NODAL | 17 | 6.64e-01 | -6.09e-02 | 0.927000 |
| E2F mediated regulation of DNA replication | 21 | 6.64e-01 | 5.48e-02 | 0.927000 |
| GLI3 is processed to GLI3R by the proteasome | 57 | 6.65e-01 | 3.32e-02 | 0.927000 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 6.67e-01 | -5.07e-02 | 0.928000 |
| Gap junction trafficking and regulation | 27 | 6.68e-01 | -4.77e-02 | 0.928000 |
| Interleukin-7 signaling | 23 | 6.68e-01 | 5.16e-02 | 0.928000 |
| Constitutive Signaling by EGFRvIII | 14 | 6.69e-01 | 6.59e-02 | 0.928000 |
| Signaling by EGFRvIII in Cancer | 14 | 6.69e-01 | 6.59e-02 | 0.928000 |
| Metabolism of Angiotensinogen to Angiotensins | 18 | 6.70e-01 | -5.81e-02 | 0.928000 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 19 | 6.70e-01 | -5.64e-02 | 0.928000 |
| Neurodegenerative Diseases | 19 | 6.70e-01 | -5.64e-02 | 0.928000 |
| Prostacyclin signalling through prostacyclin receptor | 18 | 6.71e-01 | 5.78e-02 | 0.928000 |
| Generic Transcription Pathway | 973 | 6.72e-01 | -8.07e-03 | 0.928000 |
| Transcriptional Regulation by TP53 | 341 | 6.72e-01 | -1.33e-02 | 0.928000 |
| Eicosanoid ligand-binding receptors | 13 | 6.73e-01 | -6.77e-02 | 0.928000 |
| Signaling by NTRKs | 132 | 6.75e-01 | 2.12e-02 | 0.930000 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 42 | 6.76e-01 | 3.73e-02 | 0.930000 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 30 | 6.79e-01 | 4.37e-02 | 0.930000 |
| Acetylcholine Neurotransmitter Release Cycle | 17 | 6.79e-01 | 5.81e-02 | 0.930000 |
| Processing of Intronless Pre-mRNAs | 18 | 6.79e-01 | -5.64e-02 | 0.930000 |
| Sodium/Calcium exchangers | 11 | 6.80e-01 | 7.18e-02 | 0.930000 |
| Degradation of beta-catenin by the destruction complex | 82 | 6.80e-01 | 2.64e-02 | 0.930000 |
| activated TAK1 mediates p38 MAPK activation | 18 | 6.80e-01 | 5.61e-02 | 0.930000 |
| CD28 co-stimulation | 33 | 6.80e-01 | -4.15e-02 | 0.930000 |
| MET promotes cell motility | 29 | 6.81e-01 | -4.41e-02 | 0.930000 |
| Peptide hormone metabolism | 84 | 6.82e-01 | -2.59e-02 | 0.930000 |
| APC/C-mediated degradation of cell cycle proteins | 85 | 6.83e-01 | 2.56e-02 | 0.930000 |
| Regulation of mitotic cell cycle | 85 | 6.83e-01 | 2.56e-02 | 0.930000 |
| Amino acid transport across the plasma membrane | 32 | 6.84e-01 | 4.16e-02 | 0.930000 |
| Bile acid and bile salt metabolism | 37 | 6.84e-01 | -3.87e-02 | 0.930000 |
| Signaling by FGFR4 | 38 | 6.85e-01 | 3.81e-02 | 0.930000 |
| Signaling by PDGFRA extracellular domain mutants | 12 | 6.86e-01 | 6.75e-02 | 0.930000 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 6.86e-01 | 6.75e-02 | 0.930000 |
| Vif-mediated degradation of APOBEC3G | 51 | 6.87e-01 | 3.26e-02 | 0.931000 |
| Synaptic adhesion-like molecules | 21 | 6.88e-01 | -5.06e-02 | 0.931000 |
| Toll Like Receptor 9 (TLR9) Cascade | 84 | 6.89e-01 | -2.53e-02 | 0.931000 |
| Interleukin-12 family signaling | 49 | 6.89e-01 | 3.31e-02 | 0.931000 |
| Surfactant metabolism | 24 | 6.90e-01 | -4.70e-02 | 0.931000 |
| Glycolysis | 68 | 6.91e-01 | -2.79e-02 | 0.932000 |
| SUMOylation of transcription factors | 17 | 6.92e-01 | -5.55e-02 | 0.932000 |
| Attenuation phase | 21 | 6.94e-01 | -4.96e-02 | 0.934000 |
| PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 14 | 6.96e-01 | -6.02e-02 | 0.936000 |
| Glutathione synthesis and recycling | 12 | 6.99e-01 | 6.46e-02 | 0.938000 |
| Glycogen synthesis | 14 | 6.99e-01 | 5.98e-02 | 0.938000 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 16 | 7.01e-01 | 5.55e-02 | 0.939000 |
| Inwardly rectifying K+ channels | 33 | 7.03e-01 | 3.83e-02 | 0.940000 |
| Defective B4GALT7 causes EDS, progeroid type | 19 | 7.03e-01 | 5.04e-02 | 0.940000 |
| Peroxisomal lipid metabolism | 27 | 7.04e-01 | -4.22e-02 | 0.940000 |
| Signal attenuation | 10 | 7.06e-01 | -6.88e-02 | 0.940000 |
| FLT3 Signaling | 282 | 7.07e-01 | 1.30e-02 | 0.940000 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 28 | 7.07e-01 | -4.10e-02 | 0.940000 |
| NCAM1 interactions | 31 | 7.07e-01 | 3.90e-02 | 0.940000 |
| Post NMDA receptor activation events | 59 | 7.08e-01 | -2.82e-02 | 0.940000 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 102 | 7.08e-01 | 2.15e-02 | 0.940000 |
| RAF/MAP kinase cascade | 268 | 7.08e-01 | 1.33e-02 | 0.940000 |
| RHO GTPases activate KTN1 | 10 | 7.08e-01 | -6.83e-02 | 0.940000 |
| Protein localization | 156 | 7.09e-01 | -1.73e-02 | 0.940000 |
| UCH proteinases | 85 | 7.11e-01 | 2.33e-02 | 0.941000 |
| TBC/RABGAPs | 44 | 7.12e-01 | 3.22e-02 | 0.941000 |
| Calcitonin-like ligand receptors | 10 | 7.13e-01 | 6.71e-02 | 0.941000 |
| Signaling by KIT in disease | 20 | 7.13e-01 | -4.75e-02 | 0.941000 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 7.13e-01 | -4.75e-02 | 0.941000 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 12 | 7.13e-01 | 6.12e-02 | 0.941000 |
| Nucleotide-like (purinergic) receptors | 15 | 7.16e-01 | -5.43e-02 | 0.941000 |
| Alpha-protein kinase 1 signaling pathway | 10 | 7.17e-01 | -6.63e-02 | 0.941000 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 71 | 7.17e-01 | 2.49e-02 | 0.941000 |
| Negative regulation of the PI3K/AKT network | 109 | 7.17e-01 | 2.01e-02 | 0.941000 |
| Nucleotide salvage | 22 | 7.18e-01 | -4.45e-02 | 0.941000 |
| Signal regulatory protein family interactions | 12 | 7.18e-01 | -6.02e-02 | 0.941000 |
| Phase 0 - rapid depolarisation | 30 | 7.19e-01 | 3.79e-02 | 0.941000 |
| ER-Phagosome pathway | 80 | 7.20e-01 | 2.32e-02 | 0.941000 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 7.21e-01 | 4.73e-02 | 0.941000 |
| Negative regulation of NOTCH4 signaling | 52 | 7.21e-01 | 2.86e-02 | 0.941000 |
| Reduction of cytosolic Ca++ levels | 12 | 7.23e-01 | -5.90e-02 | 0.941000 |
| Class I MHC mediated antigen processing & presentation | 345 | 7.24e-01 | -1.11e-02 | 0.941000 |
| VEGFA-VEGFR2 Pathway | 91 | 7.25e-01 | -2.13e-02 | 0.941000 |
| Protein folding | 94 | 7.26e-01 | 2.09e-02 | 0.941000 |
| Retrograde neurotrophin signalling | 14 | 7.27e-01 | 5.38e-02 | 0.941000 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 7.28e-01 | -6.06e-02 | 0.941000 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 27 | 7.29e-01 | 3.86e-02 | 0.941000 |
| MET activates RAS signaling | 11 | 7.29e-01 | -6.04e-02 | 0.941000 |
| Lewis blood group biosynthesis | 14 | 7.29e-01 | 5.34e-02 | 0.941000 |
| Organic anion transporters | 10 | 7.30e-01 | -6.31e-02 | 0.941000 |
| Telomere C-strand (Lagging Strand) Synthesis | 33 | 7.30e-01 | 3.47e-02 | 0.941000 |
| Assembly and cell surface presentation of NMDA receptors | 23 | 7.31e-01 | 4.15e-02 | 0.941000 |
| PI3K/AKT Signaling in Cancer | 100 | 7.31e-01 | 1.99e-02 | 0.941000 |
| Interleukin-35 Signalling | 11 | 7.32e-01 | -5.97e-02 | 0.941000 |
| Initiation of Nuclear Envelope (NE) Reformation | 16 | 7.34e-01 | -4.90e-02 | 0.941000 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 17 | 7.35e-01 | 4.75e-02 | 0.941000 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | 17 | 7.35e-01 | 4.75e-02 | 0.941000 |
| Transcriptional Regulation by E2F6 | 32 | 7.35e-01 | 3.46e-02 | 0.941000 |
| HIV Infection | 220 | 7.36e-01 | 1.32e-02 | 0.941000 |
| Cytosolic iron-sulfur cluster assembly | 13 | 7.37e-01 | 5.38e-02 | 0.941000 |
| Beta-oxidation of very long chain fatty acids | 10 | 7.37e-01 | 6.13e-02 | 0.941000 |
| B-WICH complex positively regulates rRNA expression | 39 | 7.38e-01 | 3.10e-02 | 0.941000 |
| Regulation of PTEN mRNA translation | 21 | 7.38e-01 | 4.22e-02 | 0.941000 |
| RHO GTPases Activate WASPs and WAVEs | 35 | 7.40e-01 | -3.24e-02 | 0.941000 |
| Lysosphingolipid and LPA receptors | 14 | 7.40e-01 | 5.11e-02 | 0.941000 |
| HCMV Early Events | 67 | 7.40e-01 | 2.34e-02 | 0.941000 |
| TNF signaling | 43 | 7.41e-01 | -2.91e-02 | 0.941000 |
| CRMPs in Sema3A signaling | 16 | 7.43e-01 | -4.74e-02 | 0.941000 |
| Norepinephrine Neurotransmitter Release Cycle | 18 | 7.43e-01 | 4.47e-02 | 0.941000 |
| Degradation of AXIN | 52 | 7.43e-01 | 2.63e-02 | 0.941000 |
| RAB GEFs exchange GTP for GDP on RABs | 85 | 7.43e-01 | 2.06e-02 | 0.941000 |
| Glutamate Neurotransmitter Release Cycle | 24 | 7.43e-01 | 3.87e-02 | 0.941000 |
| TNFR2 non-canonical NF-kB pathway | 96 | 7.43e-01 | 1.94e-02 | 0.941000 |
| Downregulation of ERBB2:ERBB3 signaling | 12 | 7.44e-01 | -5.45e-02 | 0.941000 |
| Integrin cell surface interactions | 60 | 7.44e-01 | -2.44e-02 | 0.941000 |
| Erythropoietin activates RAS | 14 | 7.45e-01 | 5.03e-02 | 0.941000 |
| Ion channel transport | 170 | 7.45e-01 | 1.45e-02 | 0.941000 |
| Neutrophil degranulation | 449 | 7.45e-01 | -8.96e-03 | 0.941000 |
| Signaling by Activin | 13 | 7.46e-01 | 5.19e-02 | 0.941000 |
| RNA Polymerase II Pre-transcription Events | 79 | 7.46e-01 | -2.11e-02 | 0.941000 |
| Negative regulation of FGFR2 signaling | 32 | 7.47e-01 | 3.30e-02 | 0.941000 |
| Thrombin signalling through proteinase activated receptors (PARs) | 30 | 7.48e-01 | 3.39e-02 | 0.942000 |
| Platelet calcium homeostasis | 28 | 7.50e-01 | 3.48e-02 | 0.942000 |
| Digestion and absorption | 21 | 7.51e-01 | -4.00e-02 | 0.942000 |
| MAPK6/MAPK4 signaling | 86 | 7.51e-01 | -1.98e-02 | 0.942000 |
| Signaling by Hippo | 20 | 7.55e-01 | -4.04e-02 | 0.942000 |
| RNA Polymerase II Transcription Termination | 63 | 7.55e-01 | 2.28e-02 | 0.942000 |
| Termination of translesion DNA synthesis | 30 | 7.55e-01 | -3.29e-02 | 0.942000 |
| Signaling by Receptor Tyrosine Kinases | 468 | 7.55e-01 | 8.43e-03 | 0.942000 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 39 | 7.56e-01 | -2.88e-02 | 0.942000 |
| Ras activation upon Ca2+ influx through NMDA receptor | 19 | 7.56e-01 | 4.12e-02 | 0.942000 |
| RNA Pol II CTD phosphorylation and interaction with CE | 25 | 7.56e-01 | 3.59e-02 | 0.942000 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 25 | 7.56e-01 | 3.59e-02 | 0.942000 |
| RET signaling | 39 | 7.57e-01 | -2.86e-02 | 0.942000 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 7.58e-01 | -4.32e-02 | 0.942000 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 7.58e-01 | -4.32e-02 | 0.942000 |
| Protein methylation | 14 | 7.58e-01 | 4.76e-02 | 0.942000 |
| Disease | 1436 | 7.59e-01 | -4.86e-03 | 0.943000 |
| Degradation of GLI1 by the proteasome | 57 | 7.60e-01 | 2.34e-02 | 0.943000 |
| Creation of C4 and C2 activators | 38 | 7.62e-01 | -2.84e-02 | 0.944000 |
| Regulation of localization of FOXO transcription factors | 11 | 7.62e-01 | -5.27e-02 | 0.944000 |
| Vesicle-mediated transport | 640 | 7.63e-01 | -7.01e-03 | 0.944000 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 11 | 7.63e-01 | 5.25e-02 | 0.944000 |
| Apoptosis induced DNA fragmentation | 12 | 7.65e-01 | -4.98e-02 | 0.945000 |
| Inhibition of DNA recombination at telomere | 29 | 7.65e-01 | -3.20e-02 | 0.945000 |
| Toll Like Receptor 4 (TLR4) Cascade | 114 | 7.68e-01 | -1.60e-02 | 0.948000 |
| VxPx cargo-targeting to cilium | 21 | 7.70e-01 | -3.69e-02 | 0.948000 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | 10 | 7.70e-01 | 5.33e-02 | 0.948000 |
| HCMV Late Events | 61 | 7.70e-01 | -2.16e-02 | 0.948000 |
| Positive epigenetic regulation of rRNA expression | 52 | 7.72e-01 | -2.32e-02 | 0.949000 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 64 | 7.73e-01 | -2.08e-02 | 0.950000 |
| Prefoldin mediated transfer of substrate to CCT/TriC | 25 | 7.78e-01 | -3.25e-02 | 0.955000 |
| Bicarbonate transporters | 10 | 7.83e-01 | 5.04e-02 | 0.959000 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 7.83e-01 | -3.39e-02 | 0.959000 |
| Defective B3GAT3 causes JDSSDHD | 19 | 7.85e-01 | 3.61e-02 | 0.959000 |
| GABA receptor activation | 58 | 7.85e-01 | -2.07e-02 | 0.959000 |
| Branched-chain amino acid catabolism | 21 | 7.86e-01 | -3.43e-02 | 0.959000 |
| Processive synthesis on the C-strand of the telomere | 18 | 7.86e-01 | 3.70e-02 | 0.959000 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | 10 | 7.86e-01 | -4.96e-02 | 0.959000 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 13 | 7.89e-01 | -4.28e-02 | 0.960000 |
| Activation of NMDA receptors and postsynaptic events | 71 | 7.89e-01 | -1.83e-02 | 0.960000 |
| Interleukin-12 signaling | 39 | 7.91e-01 | 2.46e-02 | 0.960000 |
| Unwinding of DNA | 12 | 7.91e-01 | -4.41e-02 | 0.960000 |
| RIPK1-mediated regulated necrosis | 24 | 7.92e-01 | 3.11e-02 | 0.960000 |
| Regulated Necrosis | 24 | 7.92e-01 | 3.11e-02 | 0.960000 |
| Regulation of necroptotic cell death | 24 | 7.92e-01 | 3.11e-02 | 0.960000 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | 10 | 7.94e-01 | 4.76e-02 | 0.962000 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | 24 | 7.95e-01 | 3.06e-02 | 0.963000 |
| Protein-protein interactions at synapses | 84 | 7.96e-01 | 1.63e-02 | 0.963000 |
| Ca2+ pathway | 60 | 7.97e-01 | -1.92e-02 | 0.963000 |
| Toll Like Receptor 3 (TLR3) Cascade | 85 | 8.00e-01 | -1.59e-02 | 0.966000 |
| Physiological factors | 12 | 8.01e-01 | 4.20e-02 | 0.966000 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 70 | 8.04e-01 | 1.72e-02 | 0.969000 |
| eNOS activation | 10 | 8.04e-01 | 4.53e-02 | 0.969000 |
| Programmed Cell Death | 172 | 8.05e-01 | 1.09e-02 | 0.969000 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | 35 | 8.08e-01 | -2.38e-02 | 0.970000 |
| Diseases of mitotic cell cycle | 35 | 8.08e-01 | -2.38e-02 | 0.970000 |
| Phospholipid metabolism | 203 | 8.12e-01 | -9.71e-03 | 0.970000 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 45 | 8.12e-01 | 2.05e-02 | 0.970000 |
| TP53 Regulates Transcription of Cell Cycle Genes | 47 | 8.13e-01 | 2.00e-02 | 0.970000 |
| Signaling by Non-Receptor Tyrosine Kinases | 53 | 8.14e-01 | 1.87e-02 | 0.970000 |
| Signaling by PTK6 | 53 | 8.14e-01 | 1.87e-02 | 0.970000 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 15 | 8.14e-01 | -3.50e-02 | 0.970000 |
| Processing of SMDT1 | 14 | 8.16e-01 | 3.60e-02 | 0.970000 |
| Acyl chain remodelling of PC | 26 | 8.16e-01 | -2.64e-02 | 0.970000 |
| Inositol phosphate metabolism | 47 | 8.17e-01 | 1.96e-02 | 0.970000 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | 41 | 8.17e-01 | 2.09e-02 | 0.970000 |
| Urea cycle | 10 | 8.17e-01 | -4.22e-02 | 0.970000 |
| PIWI-interacting RNA (piRNA) biogenesis | 26 | 8.18e-01 | 2.61e-02 | 0.970000 |
| Deadenylation of mRNA | 20 | 8.19e-01 | 2.96e-02 | 0.970000 |
| Antiviral mechanism by IFN-stimulated genes | 77 | 8.19e-01 | 1.51e-02 | 0.970000 |
| Mitochondrial biogenesis | 86 | 8.19e-01 | -1.42e-02 | 0.970000 |
| Voltage gated Potassium channels | 41 | 8.20e-01 | 2.06e-02 | 0.970000 |
| RNA Polymerase I Promoter Opening | 13 | 8.21e-01 | 3.63e-02 | 0.970000 |
| Mitochondrial calcium ion transport | 21 | 8.21e-01 | -2.86e-02 | 0.970000 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | 55 | 8.22e-01 | -1.75e-02 | 0.970000 |
| Gamma-carboxylation of protein precursors | 10 | 8.22e-01 | -4.10e-02 | 0.970000 |
| Regulation of insulin secretion | 74 | 8.23e-01 | -1.50e-02 | 0.970000 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 20 | 8.23e-01 | 2.88e-02 | 0.970000 |
| Deactivation of the beta-catenin transactivating complex | 39 | 8.24e-01 | -2.06e-02 | 0.970000 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | 73 | 8.28e-01 | 1.47e-02 | 0.970000 |
| Glycogen breakdown (glycogenolysis) | 14 | 8.29e-01 | -3.34e-02 | 0.970000 |
| APC/C:Cdc20 mediated degradation of Securin | 65 | 8.29e-01 | 1.55e-02 | 0.970000 |
| NOTCH2 intracellular domain regulates transcription | 10 | 8.29e-01 | 3.95e-02 | 0.970000 |
| RNA Polymerase I Transcription Initiation | 44 | 8.29e-01 | -1.88e-02 | 0.970000 |
| Transport of Mature mRNA Derived from an Intronless Transcript | 40 | 8.30e-01 | 1.96e-02 | 0.970000 |
| Diseases associated with visual transduction | 13 | 8.31e-01 | 3.43e-02 | 0.970000 |
| Diseases of the neuronal system | 13 | 8.31e-01 | 3.43e-02 | 0.970000 |
| Retinoid cycle disease events | 13 | 8.31e-01 | 3.43e-02 | 0.970000 |
| FCGR3A-mediated phagocytosis | 84 | 8.31e-01 | -1.35e-02 | 0.970000 |
| Leishmania phagocytosis | 84 | 8.31e-01 | -1.35e-02 | 0.970000 |
| Parasite infection | 84 | 8.31e-01 | -1.35e-02 | 0.970000 |
| CTLA4 inhibitory signaling | 21 | 8.31e-01 | -2.68e-02 | 0.970000 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 31 | 8.33e-01 | -2.19e-02 | 0.970000 |
| ISG15 antiviral mechanism | 69 | 8.33e-01 | 1.47e-02 | 0.970000 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | 22 | 8.33e-01 | 2.59e-02 | 0.970000 |
| Extension of Telomeres | 50 | 8.35e-01 | 1.71e-02 | 0.971000 |
| Removal of the Flap Intermediate from the C-strand | 16 | 8.37e-01 | 2.98e-02 | 0.972000 |
| Neurotransmitter release cycle | 51 | 8.37e-01 | -1.66e-02 | 0.972000 |
| Negative regulation of FGFR4 signaling | 28 | 8.40e-01 | -2.21e-02 | 0.973000 |
| BBSome-mediated cargo-targeting to cilium | 22 | 8.40e-01 | 2.49e-02 | 0.973000 |
| Aggrephagy | 20 | 8.41e-01 | -2.60e-02 | 0.973000 |
| Cytosolic sensors of pathogen-associated DNA | 55 | 8.41e-01 | -1.57e-02 | 0.973000 |
| Dissolution of Fibrin Clot | 11 | 8.42e-01 | 3.48e-02 | 0.973000 |
| Late Phase of HIV Life Cycle | 130 | 8.44e-01 | 1.00e-02 | 0.974000 |
| Signaling by Nuclear Receptors | 235 | 8.44e-01 | -7.48e-03 | 0.974000 |
| A tetrasaccharide linker sequence is required for GAG synthesis | 25 | 8.44e-01 | -2.27e-02 | 0.974000 |
| MAPK family signaling cascades | 312 | 8.47e-01 | -6.38e-03 | 0.975000 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 16 | 8.47e-01 | -2.78e-02 | 0.975000 |
| Role of phospholipids in phagocytosis | 52 | 8.49e-01 | 1.52e-02 | 0.975000 |
| Chaperonin-mediated protein folding | 88 | 8.49e-01 | -1.17e-02 | 0.975000 |
| AURKA Activation by TPX2 | 70 | 8.50e-01 | -1.31e-02 | 0.975000 |
| Visual phototransduction | 92 | 8.51e-01 | 1.13e-02 | 0.975000 |
| Transport of small molecules | 687 | 8.53e-01 | -4.17e-03 | 0.975000 |
| HIV Life Cycle | 142 | 8.54e-01 | 8.97e-03 | 0.975000 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | 10 | 8.54e-01 | 3.36e-02 | 0.975000 |
| Pyruvate metabolism and Citric Acid (TCA) cycle | 53 | 8.54e-01 | -1.46e-02 | 0.975000 |
| PTEN Regulation | 146 | 8.54e-01 | 8.81e-03 | 0.975000 |
| Macroautophagy | 108 | 8.55e-01 | -1.02e-02 | 0.975000 |
| DNA strand elongation | 31 | 8.55e-01 | -1.90e-02 | 0.975000 |
| Activation of the phototransduction cascade | 10 | 8.55e-01 | 3.33e-02 | 0.975000 |
| P2Y receptors | 11 | 8.56e-01 | 3.17e-02 | 0.975000 |
| Basigin interactions | 25 | 8.56e-01 | -2.09e-02 | 0.975000 |
| Infection with Mycobacterium tuberculosis | 26 | 8.57e-01 | -2.04e-02 | 0.975000 |
| Mitotic G2-G2/M phases | 178 | 8.58e-01 | 7.80e-03 | 0.975000 |
| Signaling by Interleukins | 413 | 8.58e-01 | -5.14e-03 | 0.975000 |
| Polymerase switching on the C-strand of the telomere | 25 | 8.61e-01 | 2.02e-02 | 0.977000 |
| Signalling to RAS | 19 | 8.62e-01 | 2.31e-02 | 0.977000 |
| Apoptotic execution phase | 51 | 8.62e-01 | -1.41e-02 | 0.977000 |
| mRNA decay by 3' to 5' exoribonuclease | 16 | 8.62e-01 | -2.50e-02 | 0.977000 |
| mRNA 3'-end processing | 55 | 8.63e-01 | 1.34e-02 | 0.977000 |
| Mitochondrial Fatty Acid Beta-Oxidation | 36 | 8.64e-01 | 1.65e-02 | 0.977000 |
| Reproduction | 87 | 8.64e-01 | -1.06e-02 | 0.977000 |
| Presynaptic depolarization and calcium channel opening | 12 | 8.67e-01 | 2.80e-02 | 0.977000 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 19 | 8.68e-01 | 2.20e-02 | 0.977000 |
| Metabolism of amine-derived hormones | 17 | 8.68e-01 | -2.32e-02 | 0.977000 |
| Regulation of TP53 Activity | 149 | 8.69e-01 | -7.85e-03 | 0.977000 |
| Caspase activation via Dependence Receptors in the absence of ligand | 10 | 8.69e-01 | 3.02e-02 | 0.977000 |
| FCERI mediated Ca+2 mobilization | 55 | 8.70e-01 | 1.28e-02 | 0.977000 |
| MAPK1/MAPK3 signaling | 274 | 8.72e-01 | 5.67e-03 | 0.977000 |
| Processing and activation of SUMO | 10 | 8.72e-01 | 2.94e-02 | 0.977000 |
| Netrin-1 signaling | 49 | 8.73e-01 | -1.32e-02 | 0.977000 |
| Mismatch Repair | 14 | 8.74e-01 | 2.44e-02 | 0.977000 |
| SARS-CoV-2 Infection | 64 | 8.74e-01 | -1.14e-02 | 0.977000 |
| Stimuli-sensing channels | 97 | 8.75e-01 | 9.26e-03 | 0.977000 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
| Toll Like Receptor 2 (TLR2) Cascade | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
| Toll Like Receptor TLR1:TLR2 Cascade | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
| Toll Like Receptor TLR6:TLR2 Cascade | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | 19 | 8.75e-01 | -2.08e-02 | 0.977000 |
| trans-Golgi Network Vesicle Budding | 70 | 8.78e-01 | -1.06e-02 | 0.979000 |
| Regulation of TP53 Expression and Degradation | 34 | 8.79e-01 | 1.51e-02 | 0.979000 |
| ABC transporters in lipid homeostasis | 17 | 8.80e-01 | 2.12e-02 | 0.979000 |
| NOD1/2 Signaling Pathway | 30 | 8.82e-01 | 1.57e-02 | 0.979000 |
| Infectious disease | 757 | 8.83e-01 | -3.16e-03 | 0.979000 |
| Transcriptional Regulation by MECP2 | 57 | 8.83e-01 | 1.13e-02 | 0.979000 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | 20 | 8.84e-01 | -1.88e-02 | 0.979000 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 20 | 8.84e-01 | -1.88e-02 | 0.979000 |
| Interleukin-4 and Interleukin-13 signaling | 102 | 8.84e-01 | -8.33e-03 | 0.979000 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 10 | 8.85e-01 | 2.64e-02 | 0.979000 |
| Activation of RAC1 | 13 | 8.87e-01 | -2.27e-02 | 0.979000 |
| Termination of O-glycan biosynthesis | 19 | 8.88e-01 | 1.87e-02 | 0.979000 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 8.88e-01 | 2.03e-02 | 0.979000 |
| NCAM signaling for neurite out-growth | 52 | 8.88e-01 | 1.12e-02 | 0.979000 |
| Organelle biogenesis and maintenance | 265 | 8.89e-01 | -4.97e-03 | 0.979000 |
| Receptor-type tyrosine-protein phosphatases | 19 | 8.90e-01 | 1.83e-02 | 0.979000 |
| Amyloid fiber formation | 56 | 8.90e-01 | -1.07e-02 | 0.979000 |
| Meiosis | 67 | 8.91e-01 | 9.71e-03 | 0.979000 |
| Incretin synthesis, secretion, and inactivation | 22 | 8.91e-01 | 1.68e-02 | 0.979000 |
| Regulation of TP53 Degradation | 33 | 8.92e-01 | -1.36e-02 | 0.979000 |
| MyD88-independent TLR4 cascade | 87 | 8.92e-01 | -8.39e-03 | 0.979000 |
| TRIF(TICAM1)-mediated TLR4 signaling | 87 | 8.92e-01 | -8.39e-03 | 0.979000 |
| Leading Strand Synthesis | 13 | 8.93e-01 | 2.14e-02 | 0.979000 |
| Polymerase switching | 13 | 8.93e-01 | 2.14e-02 | 0.979000 |
| DAP12 interactions | 38 | 8.96e-01 | 1.23e-02 | 0.980000 |
| RHO GTPase Effectors | 249 | 8.97e-01 | 4.77e-03 | 0.981000 |
| G-protein beta:gamma signalling | 31 | 8.99e-01 | -1.32e-02 | 0.982000 |
| Regulation of signaling by NODAL | 10 | 9.00e-01 | -2.29e-02 | 0.982000 |
| COPI-mediated anterograde transport | 77 | 9.01e-01 | 8.23e-03 | 0.982000 |
| Activation of Ca-permeable Kainate Receptor | 10 | 9.01e-01 | 2.27e-02 | 0.982000 |
| Ionotropic activity of kainate receptors | 10 | 9.01e-01 | 2.27e-02 | 0.982000 |
| G2/M DNA damage checkpoint | 64 | 9.02e-01 | 8.92e-03 | 0.982000 |
| Nonhomologous End-Joining (NHEJ) | 40 | 9.05e-01 | 1.09e-02 | 0.985000 |
| Pyruvate metabolism | 29 | 9.07e-01 | 1.25e-02 | 0.986000 |
| Formation of Incision Complex in GG-NER | 42 | 9.09e-01 | -1.02e-02 | 0.986000 |
| Ion homeostasis | 47 | 9.09e-01 | -9.63e-03 | 0.986000 |
| Retrograde transport at the Trans-Golgi-Network | 46 | 9.09e-01 | -9.71e-03 | 0.986000 |
| MicroRNA (miRNA) biogenesis | 24 | 9.10e-01 | -1.33e-02 | 0.986000 |
| Gamma carboxylation, hypusine formation and arylsulfatase activation | 37 | 9.12e-01 | 1.06e-02 | 0.987000 |
| Apoptosis | 162 | 9.12e-01 | 5.03e-03 | 0.987000 |
| Processing of Capped Intronless Pre-mRNA | 26 | 9.13e-01 | -1.24e-02 | 0.987000 |
| LGI-ADAM interactions | 14 | 9.15e-01 | -1.65e-02 | 0.988000 |
| Glycogen metabolism | 25 | 9.16e-01 | -1.21e-02 | 0.988000 |
| Telomere Maintenance | 73 | 9.17e-01 | -7.06e-03 | 0.988000 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 13 | 9.17e-01 | -1.66e-02 | 0.988000 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 9.18e-01 | 1.71e-02 | 0.988000 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | 31 | 9.19e-01 | -1.05e-02 | 0.988000 |
| Intraflagellar transport | 38 | 9.20e-01 | -9.42e-03 | 0.988000 |
| Activation of Matrix Metalloproteinases | 30 | 9.21e-01 | 1.05e-02 | 0.988000 |
| MET activates RAP1 and RAC1 | 11 | 9.21e-01 | -1.72e-02 | 0.988000 |
| Transport of vitamins, nucleosides, and related molecules | 42 | 9.23e-01 | 8.64e-03 | 0.988000 |
| TP53 Regulates Transcription of Cell Death Genes | 34 | 9.24e-01 | 9.47e-03 | 0.988000 |
| HDR through MMEJ (alt-NHEJ) | 10 | 9.24e-01 | -1.73e-02 | 0.988000 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | 86 | 9.25e-01 | -5.89e-03 | 0.988000 |
| Negative regulation of FGFR1 signaling | 30 | 9.26e-01 | -9.86e-03 | 0.988000 |
| Oxidative Stress Induced Senescence | 69 | 9.26e-01 | 6.51e-03 | 0.988000 |
| Transport to the Golgi and subsequent modification | 154 | 9.30e-01 | 4.13e-03 | 0.988000 |
| Neddylation | 226 | 9.30e-01 | -3.37e-03 | 0.988000 |
| G2/M Transition | 176 | 9.31e-01 | 3.81e-03 | 0.988000 |
| SIRT1 negatively regulates rRNA expression | 18 | 9.32e-01 | 1.16e-02 | 0.988000 |
| Regulation of KIT signaling | 16 | 9.33e-01 | -1.22e-02 | 0.988000 |
| Misspliced GSK3beta mutants stabilize beta-catenin | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
| S33 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
| S37 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
| S45 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
| T41 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
| phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
| Detoxification of Reactive Oxygen Species | 33 | 9.33e-01 | 8.46e-03 | 0.988000 |
| Signaling by Erythropoietin | 25 | 9.33e-01 | 9.69e-03 | 0.988000 |
| Gap junction trafficking | 25 | 9.34e-01 | 9.62e-03 | 0.988000 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | 52 | 9.36e-01 | -6.45e-03 | 0.989000 |
| Organic cation/anion/zwitterion transport | 12 | 9.36e-01 | 1.33e-02 | 0.989000 |
| Diseases of programmed cell death | 25 | 9.38e-01 | 9.03e-03 | 0.990000 |
| p38MAPK events | 13 | 9.39e-01 | 1.22e-02 | 0.991000 |
| TRAF6 mediated NF-kB activation | 19 | 9.40e-01 | -9.94e-03 | 0.991000 |
| Interleukin-1 signaling | 95 | 9.40e-01 | 4.44e-03 | 0.991000 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 74 | 9.44e-01 | 4.76e-03 | 0.992000 |
| Anchoring of the basal body to the plasma membrane | 94 | 9.44e-01 | 4.19e-03 | 0.992000 |
| Hedgehog 'off' state | 96 | 9.44e-01 | -4.12e-03 | 0.992000 |
| TP53 Regulates Metabolic Genes | 83 | 9.45e-01 | 4.36e-03 | 0.992000 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 23 | 9.46e-01 | 8.22e-03 | 0.992000 |
| Synthesis, secretion, and deacylation of Ghrelin | 18 | 9.46e-01 | 9.28e-03 | 0.992000 |
| G beta:gamma signalling through CDC42 | 19 | 9.49e-01 | -8.41e-03 | 0.995000 |
| Activation of the TFAP2 (AP-2) family of transcription factors | 11 | 9.51e-01 | 1.07e-02 | 0.996000 |
| Growth hormone receptor signaling | 24 | 9.52e-01 | -7.11e-03 | 0.997000 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | 15 | 9.52e-01 | 8.89e-03 | 0.997000 |
| SUMO E3 ligases SUMOylate target proteins | 158 | 9.54e-01 | -2.69e-03 | 0.997000 |
| Unblocking of NMDA receptors, glutamate binding and activation | 20 | 9.56e-01 | 7.15e-03 | 0.999000 |
| Signaling by FGFR4 in disease | 11 | 9.57e-01 | -9.44e-03 | 0.999000 |
| Metabolism of RNA | 632 | 9.57e-01 | -1.25e-03 | 0.999000 |
| Telomere Extension By Telomerase | 23 | 9.58e-01 | 6.35e-03 | 0.999000 |
| Cardiac conduction | 116 | 9.59e-01 | -2.77e-03 | 0.999000 |
| Acyl chain remodelling of PE | 26 | 9.60e-01 | 5.64e-03 | 0.999000 |
| Platelet homeostasis | 81 | 9.61e-01 | 3.18e-03 | 0.999000 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | 12 | 9.61e-01 | 8.11e-03 | 0.999000 |
| FCGR activation | 39 | 9.62e-01 | -4.41e-03 | 0.999000 |
| Apoptotic cleavage of cellular proteins | 38 | 9.63e-01 | -4.35e-03 | 0.999000 |
| Citric acid cycle (TCA cycle) | 22 | 9.64e-01 | -5.48e-03 | 0.999000 |
| Formation of ATP by chemiosmotic coupling | 15 | 9.65e-01 | -6.64e-03 | 0.999000 |
| Formation of the Early Elongation Complex | 31 | 9.68e-01 | 4.16e-03 | 0.999000 |
| Formation of the HIV-1 Early Elongation Complex | 31 | 9.68e-01 | 4.16e-03 | 0.999000 |
| Polo-like kinase mediated events | 15 | 9.70e-01 | -5.56e-03 | 0.999000 |
| Synthesis of bile acids and bile salts | 29 | 9.71e-01 | -3.91e-03 | 0.999000 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 71 | 9.71e-01 | -2.45e-03 | 0.999000 |
| RNA Polymerase I Promoter Clearance | 56 | 9.72e-01 | 2.69e-03 | 0.999000 |
| RNA Polymerase I Transcription | 56 | 9.72e-01 | 2.69e-03 | 0.999000 |
| Plasma lipoprotein clearance | 32 | 9.72e-01 | -3.54e-03 | 0.999000 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | 13 | 9.72e-01 | 5.53e-03 | 0.999000 |
| Lysosome Vesicle Biogenesis | 34 | 9.73e-01 | 3.40e-03 | 0.999000 |
| SUMOylation | 164 | 9.73e-01 | 1.51e-03 | 0.999000 |
| Cytosolic sulfonation of small molecules | 23 | 9.74e-01 | -3.90e-03 | 0.999000 |
| Oncogene Induced Senescence | 30 | 9.74e-01 | -3.40e-03 | 0.999000 |
| Signalling to ERKs | 33 | 9.77e-01 | 2.96e-03 | 0.999000 |
| Signaling by MET | 66 | 9.79e-01 | -1.86e-03 | 0.999000 |
| PECAM1 interactions | 11 | 9.80e-01 | 4.46e-03 | 0.999000 |
| APC-Cdc20 mediated degradation of Nek2A | 24 | 9.80e-01 | 2.99e-03 | 0.999000 |
| Lagging Strand Synthesis | 19 | 9.81e-01 | -3.10e-03 | 0.999000 |
| Estrogen-dependent gene expression | 96 | 9.83e-01 | -1.28e-03 | 0.999000 |
| Signaling by FGFR2 IIIa TM | 17 | 9.83e-01 | 3.02e-03 | 0.999000 |
| COPI-independent Golgi-to-ER retrograde traffic | 33 | 9.84e-01 | 1.98e-03 | 0.999000 |
| Triglyceride biosynthesis | 13 | 9.88e-01 | -2.38e-03 | 0.999000 |
| Signaling by SCF-KIT | 42 | 9.88e-01 | -1.32e-03 | 0.999000 |
| Packaging Of Telomere Ends | 16 | 9.88e-01 | -2.12e-03 | 0.999000 |
| Regulation of signaling by CBL | 18 | 9.89e-01 | -1.82e-03 | 0.999000 |
| AMER1 mutants destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
| APC truncation mutants have impaired AXIN binding | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
| AXIN missense mutants destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
| AXIN mutants destabilize the destruction complex, activating WNT signaling | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
| Truncations of AMER1 destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
| truncated APC mutants destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
| SUMOylation of immune response proteins | 10 | 9.91e-01 | 2.07e-03 | 0.999000 |
| Cell recruitment (pro-inflammatory response) | 23 | 9.91e-01 | -1.30e-03 | 0.999000 |
| Purinergic signaling in leishmaniasis infection | 23 | 9.91e-01 | -1.30e-03 | 0.999000 |
| Cilium Assembly | 179 | 9.92e-01 | -4.51e-04 | 0.999000 |
| PIP3 activates AKT signaling | 269 | 9.92e-01 | -3.58e-04 | 0.999000 |
| Na+/Cl- dependent neurotransmitter transporters | 18 | 9.92e-01 | -1.34e-03 | 0.999000 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 19 | 9.93e-01 | 1.18e-03 | 0.999000 |
| Acyl chain remodelling of PS | 21 | 9.93e-01 | 1.04e-03 | 0.999000 |
| Signaling by WNT in cancer | 33 | 9.94e-01 | -8.16e-04 | 0.999000 |
| FGFR2 alternative splicing | 23 | 9.94e-01 | -8.73e-04 | 0.999000 |
| ATF6 (ATF6-alpha) activates chaperone genes | 10 | 9.95e-01 | 1.22e-03 | 0.999000 |
| EPHB-mediated forward signaling | 33 | 9.96e-01 | 5.38e-04 | 0.999000 |
| Blood group systems biosynthesis | 18 | 9.96e-01 | -7.06e-04 | 0.999000 |
| Carboxyterminal post-translational modifications of tubulin | 33 | 9.96e-01 | 4.66e-04 | 0.999000 |
| G0 and Early G1 | 27 | 9.97e-01 | 4.56e-04 | 0.999000 |
| Golgi Cisternae Pericentriolar Stack Reorganization | 12 | 9.97e-01 | -6.75e-04 | 0.999000 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 13 | 9.97e-01 | 5.80e-04 | 0.999000 |
| Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 9.98e-01 | 3.52e-04 | 0.999000 |
| Diseases of metabolism | 230 | 9.99e-01 | -7.18e-05 | 0.999000 |
| mRNA Splicing - Minor Pathway | 48 | 1.00e+00 | -3.13e-05 | 1.000000 |
Xenobiotics
| 1408 | |
|---|---|
| set | Xenobiotics |
| setSize | 20 |
| pANOVA | 1.64e-07 |
| s.dist | -0.676 |
| p.adjustANOVA | 0.000238 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| AHRR | -8688.0 |
| CYP2F1 | -8491.0 |
| CYP2C18 | -7923.5 |
| CYP1A2 | -6798.0 |
| CYP2W1 | -3941.0 |
| CYP2S1 | -1638.0 |
| CYP2J2 | -235.0 |
| CYP1A1 | 359.0 |
| ARNT2 | 1509.0 |
| AHR | 2943.5 |
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| AHRR | -8688.0 |
| CYP2F1 | -8491.0 |
| CYP2C18 | -7923.5 |
| CYP1A2 | -6798.0 |
| CYP2W1 | -3941.0 |
| CYP2S1 | -1638.0 |
| CYP2J2 | -235.0 |
| CYP1A1 | 359.0 |
| ARNT2 | 1509.0 |
| AHR | 2943.5 |
Plasma lipoprotein remodeling
| 884 | |
|---|---|
| set | Plasma lipoprotein remodeling |
| setSize | 31 |
| pANOVA | 1.95e-06 |
| s.dist | -0.494 |
| p.adjustANOVA | 0.00141 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOC3 | -8904.0 |
| CIDEC | -8897.0 |
| ABCG1 | -8866.0 |
| APOE | -8836.0 |
| MBTPS2 | -8761.0 |
| APOA5 | -8466.0 |
| MBTPS1 | -7804.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| APOF | -7268.0 |
| CREB3L3 | -7263.0 |
| LCAT | -6772.0 |
| APOA4 | -6758.0 |
| ANGPTL3 | -6400.0 |
| FURIN | -6399.0 |
| ANGPTL4 | -6243.0 |
| LIPC | -5932.0 |
| LMF2 | -5317.0 |
| LIPG | -5216.0 |
| FGF21 | -5116.0 |
| GeneID | Gene Rank |
|---|---|
| APOC3 | -8904.0 |
| CIDEC | -8897.0 |
| ABCG1 | -8866.0 |
| APOE | -8836.0 |
| MBTPS2 | -8761.0 |
| APOA5 | -8466.0 |
| MBTPS1 | -7804.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| APOF | -7268.0 |
| CREB3L3 | -7263.0 |
| LCAT | -6772.0 |
| APOA4 | -6758.0 |
| ANGPTL3 | -6400.0 |
| FURIN | -6399.0 |
| ANGPTL4 | -6243.0 |
| LIPC | -5932.0 |
| LMF2 | -5317.0 |
| LIPG | -5216.0 |
| FGF21 | -5116.0 |
| ANGPTL8 | -4094.0 |
| LPA | -3826.0 |
| GPIHBP1 | -3404.0 |
| LPL | -2467.0 |
| PLTP | -2003.0 |
| APOA1 | -547.0 |
| APOB | 573.0 |
| PCSK5 | 3308.0 |
| PCSK6 | 4262.0 |
| LMF1 | 4677.0 |
| ALB | 7970.0 |
Fatty acids
| 414 | |
|---|---|
| set | Fatty acids |
| setSize | 14 |
| pANOVA | 4.06e-06 |
| s.dist | -0.711 |
| p.adjustANOVA | 0.00182 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2F1 | -8491.0 |
| CYP4F2 | -8108.0 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4F12 | -7728.5 |
| CYP4B1 | -6651.0 |
| CYP4F3 | -4081.0 |
| CYP2J2 | -235.0 |
| CYP4F22 | 4080.0 |
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2F1 | -8491.0 |
| CYP4F2 | -8108.0 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4F12 | -7728.5 |
| CYP4B1 | -6651.0 |
| CYP4F3 | -4081.0 |
| CYP2J2 | -235.0 |
| CYP4F22 | 4080.0 |
Collagen formation
| 212 | |
|---|---|
| set | Collagen formation |
| setSize | 80 |
| pANOVA | 5.04e-06 |
| s.dist | 0.295 |
| p.adjustANOVA | 0.00182 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| COL1A2 | 8941 |
| LOX | 8924 |
| LAMC2 | 8913 |
| COL17A1 | 8726 |
| COL11A2 | 8584 |
| COL13A1 | 8432 |
| P4HA3 | 8415 |
| COL16A1 | 8364 |
| LOXL2 | 8342 |
| PCOLCE | 8334 |
| P4HA2 | 8315 |
| SERPINH1 | 8239 |
| ADAMTS2 | 8086 |
| COL8A2 | 8066 |
| COL1A1 | 7952 |
| COL9A1 | 7923 |
| MMP3 | 7551 |
| MMP9 | 7518 |
| COL12A1 | 7478 |
| ADAMTS3 | 7408 |
| GeneID | Gene Rank |
|---|---|
| COL1A2 | 8941 |
| LOX | 8924 |
| LAMC2 | 8913 |
| COL17A1 | 8726 |
| COL11A2 | 8584 |
| COL13A1 | 8432 |
| P4HA3 | 8415 |
| COL16A1 | 8364 |
| LOXL2 | 8342 |
| PCOLCE | 8334 |
| P4HA2 | 8315 |
| SERPINH1 | 8239 |
| ADAMTS2 | 8086 |
| COL8A2 | 8066 |
| COL1A1 | 7952 |
| COL9A1 | 7923 |
| MMP3 | 7551 |
| MMP9 | 7518 |
| COL12A1 | 7478 |
| ADAMTS3 | 7408 |
| BMP1 | 7235 |
| COL5A1 | 7233 |
| COL8A1 | 7168 |
| COL2A1 | 7114 |
| LOXL1 | 7085 |
| PCOLCE2 | 6917 |
| PPIB | 6887 |
| COL11A1 | 6757 |
| LAMB3 | 6421 |
| TLL2 | 6245 |
| LOXL4 | 6012 |
| P3H2 | 5928 |
| DST | 5910 |
| P4HA1 | 5544 |
| COL14A1 | 5203 |
| ADAMTS14 | 4789 |
| COL6A2 | 4759 |
| PLOD3 | 4609 |
| TLL1 | 4083 |
| MMP20 | 3915 |
| COL3A1 | 3907 |
| P3H3 | 3882 |
| COL26A1 | 3774 |
| COL6A1 | 3749 |
| COL4A6 | 3630 |
| COL23A1 | 3188 |
| COL5A2 | 3064 |
| CRTAP | 2918 |
| MMP7 | 2736 |
| CTSS | 2396 |
| P3H1 | 2050 |
| CD151 | 1741 |
| COL27A1 | 951 |
| PLOD1 | 638 |
| COL19A1 | 452 |
| COL4A3 | 385 |
| MMP13 | -756 |
| COL5A3 | -869 |
| COLGALT1 | -898 |
| CTSB | -1337 |
| LOXL3 | -2045 |
| P4HB | -2423 |
| COL28A1 | -2995 |
| COL4A5 | -3059 |
| COL6A6 | -3769 |
| COL4A1 | -4472 |
| CTSV | -4546 |
| COL4A2 | -4819 |
| COL18A1 | -5131 |
| COL6A5 | -5779 |
| ITGA6 | -5895 |
| COL15A1 | -6154 |
| LAMA3 | -6177 |
| ITGB4 | -6853 |
| PXDN | -7676 |
| COL9A2 | -7743 |
| COLGALT2 | -7793 |
| PLOD2 | -7959 |
| COL25A1 | -8293 |
| PLEC | -9079 |
Collagen biosynthesis and modifying enzymes
| 209 | |
|---|---|
| set | Collagen biosynthesis and modifying enzymes |
| setSize | 58 |
| pANOVA | 7.24e-06 |
| s.dist | 0.341 |
| p.adjustANOVA | 0.0021 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| COL1A2 | 8941 |
| COL17A1 | 8726 |
| COL11A2 | 8584 |
| COL13A1 | 8432 |
| P4HA3 | 8415 |
| COL16A1 | 8364 |
| PCOLCE | 8334 |
| P4HA2 | 8315 |
| SERPINH1 | 8239 |
| ADAMTS2 | 8086 |
| COL8A2 | 8066 |
| COL1A1 | 7952 |
| COL9A1 | 7923 |
| COL12A1 | 7478 |
| ADAMTS3 | 7408 |
| BMP1 | 7235 |
| COL5A1 | 7233 |
| COL8A1 | 7168 |
| COL2A1 | 7114 |
| PCOLCE2 | 6917 |
| GeneID | Gene Rank |
|---|---|
| COL1A2 | 8941 |
| COL17A1 | 8726 |
| COL11A2 | 8584 |
| COL13A1 | 8432 |
| P4HA3 | 8415 |
| COL16A1 | 8364 |
| PCOLCE | 8334 |
| P4HA2 | 8315 |
| SERPINH1 | 8239 |
| ADAMTS2 | 8086 |
| COL8A2 | 8066 |
| COL1A1 | 7952 |
| COL9A1 | 7923 |
| COL12A1 | 7478 |
| ADAMTS3 | 7408 |
| BMP1 | 7235 |
| COL5A1 | 7233 |
| COL8A1 | 7168 |
| COL2A1 | 7114 |
| PCOLCE2 | 6917 |
| PPIB | 6887 |
| COL11A1 | 6757 |
| TLL2 | 6245 |
| P3H2 | 5928 |
| P4HA1 | 5544 |
| COL14A1 | 5203 |
| ADAMTS14 | 4789 |
| COL6A2 | 4759 |
| PLOD3 | 4609 |
| TLL1 | 4083 |
| COL3A1 | 3907 |
| P3H3 | 3882 |
| COL26A1 | 3774 |
| COL6A1 | 3749 |
| COL4A6 | 3630 |
| COL23A1 | 3188 |
| COL5A2 | 3064 |
| CRTAP | 2918 |
| P3H1 | 2050 |
| COL27A1 | 951 |
| PLOD1 | 638 |
| COL19A1 | 452 |
| COL4A3 | 385 |
| COL5A3 | -869 |
| COLGALT1 | -898 |
| P4HB | -2423 |
| COL28A1 | -2995 |
| COL4A5 | -3059 |
| COL6A6 | -3769 |
| COL4A1 | -4472 |
| COL4A2 | -4819 |
| COL18A1 | -5131 |
| COL6A5 | -5779 |
| COL15A1 | -6154 |
| COL9A2 | -7743 |
| COLGALT2 | -7793 |
| PLOD2 | -7959 |
| COL25A1 | -8293 |
NR1H2 and NR1H3-mediated signaling
| 751 | |
|---|---|
| set | NR1H2 and NR1H3-mediated signaling |
| setSize | 48 |
| pANOVA | 3.3e-05 |
| s.dist | -0.346 |
| p.adjustANOVA | 0.00797 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PLIN1 | -9007.0 |
| APOC1 | -8963.0 |
| ABCG1 | -8866.0 |
| APOE | -8836.0 |
| PCK1 | -8806.0 |
| TNRC6B | -8577.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| AGO4 | -8424.0 |
| NCOR1 | -8129.0 |
| RXRB | -7956.0 |
| FASN | -7594.0 |
| APOC2 | -7531.5 |
| NR1H3 | -7384.0 |
| NCOA1 | -6733.0 |
| ANGPTL3 | -6400.0 |
| EEPD1 | -6385.0 |
| ABCA1 | -6097.0 |
| AGO1 | -5804.0 |
| GPS2 | -5694.0 |
| GeneID | Gene Rank |
|---|---|
| PLIN1 | -9007.0 |
| APOC1 | -8963.0 |
| ABCG1 | -8866.0 |
| APOE | -8836.0 |
| PCK1 | -8806.0 |
| TNRC6B | -8577.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| AGO4 | -8424.0 |
| NCOR1 | -8129.0 |
| RXRB | -7956.0 |
| FASN | -7594.0 |
| APOC2 | -7531.5 |
| NR1H3 | -7384.0 |
| NCOA1 | -6733.0 |
| ANGPTL3 | -6400.0 |
| EEPD1 | -6385.0 |
| ABCA1 | -6097.0 |
| AGO1 | -5804.0 |
| GPS2 | -5694.0 |
| TNRC6C | -5527.0 |
| MIR144 | -5518.0 |
| AGO2 | -5246.0 |
| RXRA | -5221.0 |
| TBL1XR1 | -5183.0 |
| MYLIP | -5032.0 |
| NR1H2 | -4967.0 |
| SREBF1 | -4592.0 |
| APOD | -4213.0 |
| KDM1B | -3115.0 |
| SCD | -2989.0 |
| KDM3A | -2751.0 |
| ABCG5 | -2445.0 |
| FABP6 | -2049.0 |
| PLTP | -2003.0 |
| APOC4 | -1990.0 |
| MIR33A | -1119.0 |
| EP300 | 1591.0 |
| TBL1X | 1601.5 |
| HDAC3 | 5550.0 |
| MIR26A1 | 5951.0 |
| MOV10 | 6056.0 |
| ABCG8 | 6224.0 |
| MIR26A2 | 6542.0 |
| AGO3 | 7448.0 |
| TNRC6A | 7675.0 |
| NRIP1 | 8401.0 |
| KDM1A | 8614.0 |
Phase I - Functionalization of compounds
| 870 | |
|---|---|
| set | Phase I - Functionalization of compounds |
| setSize | 91 |
| pANOVA | 4.09e-05 |
| s.dist | -0.249 |
| p.adjustANOVA | 0.00846 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CES2 | -9059.0 |
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| CYB5B | -8813.0 |
| CES1 | -8705.0 |
| AHRR | -8688.0 |
| CYP2F1 | -8491.0 |
| CYP46A1 | -8248.0 |
| CYP4F2 | -8108.0 |
| CYP2C18 | -7923.5 |
| ALDH2 | -7822.5 |
| GeneID | Gene Rank |
|---|---|
| CES2 | -9059.0 |
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| CYB5B | -8813.0 |
| CES1 | -8705.0 |
| AHRR | -8688.0 |
| CYP2F1 | -8491.0 |
| CYP46A1 | -8248.0 |
| CYP4F2 | -8108.0 |
| CYP2C18 | -7923.5 |
| ALDH2 | -7822.5 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4F12 | -7728.5 |
| ACSS1 | -7584.0 |
| FMO2 | -7251.0 |
| CMBL | -7011.0 |
| FMO3 | -6965.0 |
| CYP1A2 | -6798.0 |
| NCOA1 | -6733.0 |
| CYP4B1 | -6651.0 |
| MAOA | -6052.0 |
| AIP | -5975.0 |
| POR | -5945.0 |
| CYP26B1 | -5722.0 |
| SMOX | -5524.0 |
| RXRA | -5221.0 |
| NCOA2 | -5184.0 |
| CYB5R3 | -5151.0 |
| ALDH1B1 | -4681.0 |
| CYP24A1 | -4478.0 |
| CYP4F3 | -4081.0 |
| CYP2W1 | -3941.0 |
| ALDH1A1 | -3766.0 |
| CYP27B1 | -3689.0 |
| MAOB | -3229.0 |
| HSP90AB1 | -3151.0 |
| EPHX1 | -2961.0 |
| CYP4V2 | -2726.0 |
| ADH7 | -2536.0 |
| ACSS2 | -2133.0 |
| PAOX | -1652.5 |
| CYP2S1 | -1638.0 |
| CBR3 | -1562.5 |
| CYP2R1 | -1234.0 |
| CYP2J2 | -235.0 |
| CYP1A1 | 359.0 |
| AADAC | 480.0 |
| AOC3 | 784.0 |
| CYP51A1 | 1117.0 |
| CYP27A1 | 1302.0 |
| CYP8B1 | 1456.0 |
| AOC1 | 1466.0 |
| ARNT2 | 1509.0 |
| CYP19A1 | 1797.0 |
| CYP21A2 | 2301.0 |
| CYP2U1 | 2375.0 |
| ADH5 | 2725.0 |
| AHR | 2943.5 |
| CYP7A1 | 3065.0 |
| POMC | 3261.0 |
| CYP4F22 | 4080.0 |
| MTARC2 | 4279.0 |
| PTGES3 | 4369.0 |
| FDX2 | 4488.5 |
| FDX1 | 4538.0 |
| NR1H4 | 4600.0 |
| BPHL | 4818.0 |
| ALDH3A1 | 4826.0 |
| PTGS1 | 4865.0 |
| CYP7B1 | 4950.0 |
| MTARC1 | 5152.5 |
| FMO1 | 5603.0 |
| TBXAS1 | 5711.0 |
| CYP26A1 | 5725.0 |
| CYP39A1 | 6053.0 |
| CYP11A1 | 6250.0 |
| NQO2 | 6527.0 |
| CYP26C1 | 7324.0 |
| CYP1B1 | 8673.0 |
| PTGIS | 8898.0 |
Translation
| 1345 | |
|---|---|
| set | Translation |
| setSize | 262 |
| pANOVA | 5.52e-05 |
| s.dist | 0.145 |
| p.adjustANOVA | 0.00999 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL13A | 8957 |
| RPL3 | 8943 |
| MRPS14 | 8926 |
| RPS15A | 8920 |
| RPL29 | 8919 |
| RPS16 | 8907 |
| RPL6 | 8889 |
| MRPS24 | 8562 |
| MRPL1 | 8558 |
| MRPS28 | 8557 |
| MRPS18B | 8556 |
| MRPL36 | 8464 |
| SSR2 | 8391 |
| TRAM1 | 8349 |
| PTCD3 | 8263 |
| NARS1 | 8198 |
| EIF3E | 8145 |
| MARS2 | 8097 |
| PPA2 | 8059 |
| RPL37 | 8039 |
| GeneID | Gene Rank |
|---|---|
| RPL13A | 8957.0 |
| RPL3 | 8943.0 |
| MRPS14 | 8926.0 |
| RPS15A | 8920.0 |
| RPL29 | 8919.0 |
| RPS16 | 8907.0 |
| RPL6 | 8889.0 |
| MRPS24 | 8562.0 |
| MRPL1 | 8558.0 |
| MRPS28 | 8557.0 |
| MRPS18B | 8556.0 |
| MRPL36 | 8464.0 |
| SSR2 | 8391.0 |
| TRAM1 | 8349.0 |
| PTCD3 | 8263.0 |
| NARS1 | 8198.0 |
| EIF3E | 8145.0 |
| MARS2 | 8097.0 |
| PPA2 | 8059.0 |
| RPL37 | 8039.0 |
| SRP9 | 7935.0 |
| NARS2 | 7888.0 |
| DAP3 | 7885.0 |
| EIF2B1 | 7876.0 |
| EPRS1 | 7828.0 |
| TARS1 | 7731.0 |
| GARS1 | 7641.0 |
| MRPS35 | 7617.0 |
| CHCHD1 | 7563.0 |
| HARS2 | 7559.0 |
| PARS2 | 7528.0 |
| RPL30 | 7370.0 |
| RPS27A | 7369.0 |
| IARS1 | 7272.0 |
| PPA1 | 7256.0 |
| MRPL2 | 7250.0 |
| RPL7A | 7100.0 |
| RPS23 | 7033.0 |
| MRPL17 | 7018.0 |
| SEC61A1 | 6972.0 |
| MRPL14 | 6867.0 |
| WARS1 | 6861.0 |
| HARS1 | 6860.0 |
| EIF4A2 | 6640.0 |
| RPS18 | 6557.0 |
| RPLP2 | 6538.0 |
| RPL10L | 6517.0 |
| EARS2 | 6509.0 |
| RPS15 | 6242.0 |
| RPS5 | 6228.0 |
| AIMP1 | 6191.0 |
| MRPL24 | 6176.0 |
| MRPL42 | 6072.0 |
| EEF1E1 | 5978.5 |
| RPL22 | 5939.0 |
| MRPL45 | 5839.0 |
| MRPS2 | 5800.0 |
| RPS14 | 5784.0 |
| RPL31 | 5673.0 |
| MRPL50 | 5621.0 |
| SRP72 | 5465.0 |
| SSR4 | 5408.0 |
| MRPL40 | 5368.0 |
| RPN2 | 5298.0 |
| RPS26 | 5195.0 |
| EIF2S1 | 5177.0 |
| MRPL22 | 5146.0 |
| MTIF3 | 5074.0 |
| MRPL46 | 4943.0 |
| GSPT1 | 4905.0 |
| RPL9 | 4882.0 |
| CARS1 | 4806.0 |
| RPS3A | 4794.0 |
| EEF1A1 | 4762.0 |
| MRPL20 | 4603.0 |
| MRPL47 | 4579.0 |
| MRPS33 | 4506.0 |
| RPL19 | 4494.0 |
| MRPL12 | 4269.0 |
| MRPS9 | 4258.0 |
| MARS1 | 4257.0 |
| RPL5 | 4255.0 |
| RPS21 | 4017.0 |
| DARS1 | 3988.0 |
| GADD45GIP1 | 3958.0 |
| MRPS6 | 3955.0 |
| MRPL44 | 3931.0 |
| MRPL3 | 3905.0 |
| EEF1B2 | 3903.0 |
| SSR3 | 3879.0 |
| EIF2S2 | 3845.0 |
| MRPL11 | 3798.0 |
| MRPL13 | 3789.0 |
| RPS13 | 3688.0 |
| MRPL35 | 3604.0 |
| EIF5 | 3580.0 |
| EIF1AX | 3548.0 |
| MRPL32 | 3475.0 |
| RPS8 | 3383.0 |
| MRPL18 | 3358.0 |
| MRPL10 | 3267.0 |
| MRPL33 | 3221.0 |
| MRPL43 | 3190.0 |
| RPS28 | 3175.0 |
| AIMP2 | 3169.0 |
| RPL7 | 3151.0 |
| EIF2B3 | 3068.0 |
| SEC61B | 3048.0 |
| RARS2 | 3043.0 |
| SRP19 | 2991.0 |
| RPL27 | 2912.0 |
| RPL18 | 2790.0 |
| LARS2 | 2718.0 |
| EIF2B2 | 2716.0 |
| RPS3 | 2715.0 |
| GSPT2 | 2691.0 |
| MRPL52 | 2647.0 |
| MRPS18C | 2564.0 |
| RPS4X | 2555.0 |
| MRPS16 | 2548.0 |
| MRPL19 | 2510.0 |
| RPS11 | 2321.0 |
| EIF3J | 2169.0 |
| EIF4A1 | 2154.0 |
| DDOST | 2136.0 |
| MRPL27 | 2126.0 |
| RPS19 | 2111.0 |
| RPL37A | 2071.0 |
| FARSA | 1906.0 |
| SEC11A | 1883.0 |
| MRPS23 | 1674.0 |
| APEH | 1541.0 |
| SPCS2 | 1359.0 |
| RPL36 | 1297.0 |
| EIF3C | 1287.5 |
| EIF3B | 1269.0 |
| MTIF2 | 1252.0 |
| MRPL21 | 1230.0 |
| MRPL15 | 1187.0 |
| YARS1 | 1102.0 |
| FARS2 | 980.0 |
| SPCS3 | 834.0 |
| GFM2 | 816.0 |
| LARS1 | 795.0 |
| MRPL55 | 741.0 |
| RPL10A | 667.0 |
| KARS1 | 648.0 |
| MRPL53 | 586.0 |
| MRPL49 | 582.0 |
| SRPRA | 471.0 |
| MRPL54 | 450.0 |
| MRPL39 | 395.0 |
| MRPS31 | 362.0 |
| RPL11 | 231.0 |
| RPL21 | 231.0 |
| EIF2S3 | 137.5 |
| MRPS30 | 45.0 |
| EIF4E | 41.0 |
| ETF1 | -32.0 |
| MRPS34 | -44.0 |
| MRPS5 | -53.0 |
| TUFM | -107.0 |
| MRPS7 | -161.0 |
| SRP54 | -175.0 |
| SEC11C | -221.0 |
| RPS25 | -242.0 |
| MRPS15 | -371.0 |
| EIF2B4 | -372.0 |
| RARS1 | -424.0 |
| MRPS12 | -431.0 |
| EEF1G | -647.0 |
| RPLP1 | -660.0 |
| MRPS11 | -799.0 |
| EIF3M | -835.0 |
| SRPRB | -853.0 |
| EEF1A2 | -854.0 |
| MRPS26 | -888.0 |
| YARS2 | -1090.0 |
| MRPL48 | -1212.0 |
| MRPS22 | -1452.0 |
| MRPL9 | -1492.0 |
| RPSA | -1493.0 |
| FARSB | -1497.0 |
| RPS2 | -1703.0 |
| MRPS18A | -1837.0 |
| RPS17 | -1958.0 |
| RPS10 | -1984.5 |
| RPL23 | -2023.0 |
| RPL18A | -2151.0 |
| RPS7 | -2157.0 |
| UBA52 | -2166.0 |
| MRPL16 | -2312.0 |
| RPN1 | -2344.0 |
| EIF4H | -2444.0 |
| MRPS10 | -2682.0 |
| MRPS27 | -2810.0 |
| SEC61G | -2848.0 |
| EEF1D | -2901.0 |
| MRPL58 | -3023.0 |
| RPS27L | -3093.0 |
| RPL35 | -3206.0 |
| IARS2 | -3217.0 |
| RPL24 | -3268.0 |
| MRPS25 | -3279.0 |
| RPL28 | -3293.0 |
| EIF3L | -3353.0 |
| EIF3F | -3615.0 |
| MTFMT | -3773.0 |
| EIF5B | -3801.0 |
| MRPL28 | -3922.0 |
| SPCS1 | -3937.0 |
| EIF3D | -4062.0 |
| SRP68 | -4122.0 |
| MRPL38 | -4142.0 |
| RPL8 | -4167.0 |
| OXA1L | -4251.0 |
| EEF2 | -4255.0 |
| MRPL34 | -4385.0 |
| MRPL41 | -4451.0 |
| MRPL30 | -4489.5 |
| TRMT112 | -4639.0 |
| EIF3A | -4675.0 |
| MRPL4 | -4800.0 |
| DARS2 | -4831.0 |
| N6AMT1 | -4864.0 |
| MRRF | -4989.0 |
| TSFM | -5028.0 |
| VARS1 | -5052.0 |
| AARS1 | -5067.0 |
| EIF3G | -5370.0 |
| SEC61A2 | -5387.0 |
| EIF3H | -5607.0 |
| SARS1 | -5612.0 |
| GFM1 | -5626.0 |
| RPL38 | -5629.0 |
| ERAL1 | -5635.0 |
| SRP14 | -5681.0 |
| EIF2B5 | -5686.0 |
| RPS6 | -5720.0 |
| SARS2 | -5926.5 |
| MRPS21 | -6064.0 |
| RPL15 | -6128.0 |
| TARS2 | -6151.0 |
| MTRF1L | -6305.0 |
| MRPS36 | -6427.0 |
| AARS2 | -6494.0 |
| EIF4EBP1 | -6644.0 |
| RPL23A | -6843.0 |
| MRPL51 | -6884.0 |
| WARS2 | -7035.0 |
| RPL3L | -7058.0 |
| RPL13 | -7209.0 |
| MRPL37 | -7284.0 |
| VARS2 | -7367.0 |
| SSR1 | -7497.0 |
| RPS9 | -7535.0 |
| MRPS17 | -7874.5 |
| EIF3K | -8130.0 |
| CARS2 | -8624.0 |
| FAU | -8625.0 |
| EIF4G1 | -8658.0 |
| RPL35A | -8900.0 |
Interferon alpha/beta signaling
| 586 | |
|---|---|
| set | Interferon alpha/beta signaling |
| setSize | 63 |
| pANOVA | 7.04e-05 |
| s.dist | -0.29 |
| p.adjustANOVA | 0.0107 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| OAS1 | -9078.0 |
| IP6K2 | -8814.0 |
| IRF5 | -8770.0 |
| OAS3 | -8197.0 |
| HLA-A | -8118.5 |
| HLA-B | -8118.5 |
| HLA-C | -8118.5 |
| HLA-E | -8118.5 |
| HLA-F | -8118.5 |
| HLA-G | -8118.5 |
| MX1 | -7569.0 |
| IFNAR1 | -7388.0 |
| IFIT3 | -7329.0 |
| RSAD2 | -7050.0 |
| USP18 | -6844.5 |
| STAT2 | -6464.0 |
| IRF6 | -5882.0 |
| IFITM1 | -5649.0 |
| IFITM2 | -5649.0 |
| IFITM3 | -5649.0 |
| GeneID | Gene Rank |
|---|---|
| OAS1 | -9078.0 |
| IP6K2 | -8814.0 |
| IRF5 | -8770.0 |
| OAS3 | -8197.0 |
| HLA-A | -8118.5 |
| HLA-B | -8118.5 |
| HLA-C | -8118.5 |
| HLA-E | -8118.5 |
| HLA-F | -8118.5 |
| HLA-G | -8118.5 |
| MX1 | -7569.0 |
| IFNAR1 | -7388.0 |
| IFIT3 | -7329.0 |
| RSAD2 | -7050.0 |
| USP18 | -6844.5 |
| STAT2 | -6464.0 |
| IRF6 | -5882.0 |
| IFITM1 | -5649.0 |
| IFITM2 | -5649.0 |
| IFITM3 | -5649.0 |
| JAK1 | -5621.0 |
| IFNA1 | -5355.0 |
| IFNA10 | -5355.0 |
| IFNA14 | -5355.0 |
| IFNA16 | -5355.0 |
| IFNA17 | -5355.0 |
| IFNA2 | -5355.0 |
| IFNA21 | -5355.0 |
| IFNA4 | -5355.0 |
| IFNA5 | -5355.0 |
| IFNA6 | -5355.0 |
| IFNA7 | -5355.0 |
| IFNA8 | -5355.0 |
| ISG20 | -5075.0 |
| IRF1 | -4752.0 |
| IRF7 | -4727.0 |
| BST2 | -4688.0 |
| IRF9 | -4680.0 |
| ADAR | -4323.0 |
| GBP2 | -3613.0 |
| IRF3 | -3543.0 |
| IFIT2 | -3196.0 |
| IFNAR2 | -3030.0 |
| TYK2 | -2663.0 |
| IRF8 | -2275.0 |
| OASL | -2132.0 |
| ISG15 | 1321.0 |
| EGR1 | 3598.0 |
| PTPN11 | 3701.0 |
| IFI35 | 3793.0 |
| SOCS3 | 3999.0 |
| PTPN6 | 4670.0 |
| ABCE1 | 4834.0 |
| IRF2 | 5903.0 |
| IRF4 | 6589.0 |
| PTPN1 | 6830.0 |
| SOCS1 | 6890.0 |
| OAS2 | 7501.0 |
| XAF1 | 7601.0 |
| RNASEL | 7612.0 |
| PSMB8 | 7643.0 |
| STAT1 | 8658.0 |
| SAMHD1 | 8677.0 |
Biological oxidations
| 119 | |
|---|---|
| set | Biological oxidations |
| setSize | 176 |
| pANOVA | 7.41e-05 |
| s.dist | -0.173 |
| p.adjustANOVA | 0.0107 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UGT1A1 | -9062.0 |
| CES2 | -9059.0 |
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| SULT2A1 | -9051.0 |
| GSTM2 | -9046.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| SULT1C2 | -8909.0 |
| CYB5B | -8813.0 |
| MAT1A | -8783.0 |
| GSTA5 | -8728.0 |
| CES1 | -8705.0 |
| GeneID | Gene Rank |
|---|---|
| UGT1A1 | -9062.0 |
| CES2 | -9059.0 |
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| SULT2A1 | -9051.0 |
| GSTM2 | -9046.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| SULT1C2 | -8909.0 |
| CYB5B | -8813.0 |
| MAT1A | -8783.0 |
| GSTA5 | -8728.0 |
| CES1 | -8705.0 |
| GSTZ1 | -8695.0 |
| AHRR | -8688.0 |
| GSTT2 | -8637.5 |
| GSTT2B | -8637.5 |
| UGT2A3 | -8632.0 |
| CYP2F1 | -8491.0 |
| SULT1E1 | -8483.5 |
| DPEP1 | -8348.0 |
| CYP46A1 | -8248.0 |
| MGST1 | -8188.0 |
| CYP4F2 | -8108.0 |
| GSTM1 | -8025.0 |
| GGT6 | -7974.0 |
| CYP2C18 | -7923.5 |
| ALDH2 | -7822.5 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4F12 | -7728.5 |
| SLC35B3 | -7717.0 |
| AKR7L | -7680.0 |
| ACSS1 | -7584.0 |
| MTRR | -7315.0 |
| FMO2 | -7251.0 |
| AKR7A3 | -7174.0 |
| GSTP1 | -7158.0 |
| ABHD14B | -7139.0 |
| CMBL | -7011.0 |
| FMO3 | -6965.0 |
| CYP1A2 | -6798.0 |
| NCOA1 | -6733.0 |
| CYP4B1 | -6651.0 |
| ACSM5 | -6562.0 |
| COMT | -6362.0 |
| MAOA | -6052.0 |
| ACSM4 | -6045.0 |
| AIP | -5975.0 |
| POR | -5945.0 |
| GGT5 | -5861.0 |
| CYP26B1 | -5722.0 |
| SMOX | -5524.0 |
| RXRA | -5221.0 |
| NCOA2 | -5184.0 |
| CYB5R3 | -5151.0 |
| GSTM3 | -5144.0 |
| MTR | -5111.0 |
| DPEP2 | -4879.0 |
| N6AMT1 | -4864.0 |
| SLC26A1 | -4701.0 |
| ALDH1B1 | -4681.0 |
| TRMT112 | -4639.0 |
| CYP24A1 | -4478.0 |
| CYP4F3 | -4081.0 |
| CYP2W1 | -3941.0 |
| SLC26A2 | -3919.0 |
| ALDH1A1 | -3766.0 |
| CYP27B1 | -3689.0 |
| AHCY | -3314.0 |
| GGT7 | -3254.0 |
| PODXL2 | -3241.0 |
| MAOB | -3229.0 |
| GSTK1 | -3187.0 |
| CHAC1 | -3179.0 |
| HSP90AB1 | -3151.0 |
| EPHX1 | -2961.0 |
| SLC35D1 | -2880.0 |
| CYP4V2 | -2726.0 |
| ADH7 | -2536.0 |
| ESD | -2500.0 |
| SULT1A3 | -2333.5 |
| SULT1A4 | -2333.5 |
| ACSS2 | -2133.0 |
| AS3MT | -1670.0 |
| PAOX | -1652.5 |
| CYP2S1 | -1638.0 |
| CBR3 | -1562.5 |
| GSS | -1324.0 |
| CYP2R1 | -1234.0 |
| AKR1A1 | -841.0 |
| GSTO2 | -624.0 |
| UGT3A2 | -338.5 |
| CYP2J2 | -235.0 |
| GGCT | -62.5 |
| BPNT1 | 105.0 |
| ACY1 | 106.5 |
| CYP1A1 | 359.0 |
| AADAC | 480.0 |
| GGT1 | 592.0 |
| SULT1A1 | 746.0 |
| SULT1A2 | 746.0 |
| AOC3 | 784.0 |
| GCLC | 786.0 |
| CYP51A1 | 1117.0 |
| SULT6B1 | 1206.0 |
| CYP27A1 | 1302.0 |
| CYP8B1 | 1456.0 |
| AOC1 | 1466.0 |
| ARNT2 | 1509.0 |
| CYP19A1 | 1797.0 |
| CYP21A2 | 2301.0 |
| MGST2 | 2307.0 |
| CYP2U1 | 2375.0 |
| HPGDS | 2411.0 |
| TPST2 | 2499.0 |
| ADH5 | 2725.0 |
| AHR | 2943.5 |
| CYP7A1 | 3065.0 |
| ACY3 | 3112.0 |
| POMC | 3261.0 |
| GSTM4 | 3592.0 |
| NAT1 | 3626.5 |
| NAT2 | 3626.5 |
| CYP4F22 | 4080.0 |
| SULT1B1 | 4254.0 |
| MTARC2 | 4279.0 |
| PAPSS1 | 4326.0 |
| PTGES3 | 4369.0 |
| FDX2 | 4488.5 |
| FDX1 | 4538.0 |
| NR1H4 | 4600.0 |
| SULT4A1 | 4631.0 |
| MGST3 | 4742.0 |
| BPHL | 4818.0 |
| ALDH3A1 | 4826.0 |
| PTGS1 | 4865.0 |
| CYP7B1 | 4950.0 |
| MTARC1 | 5152.5 |
| PAPSS2 | 5409.0 |
| FMO1 | 5603.0 |
| SLC35B2 | 5607.0 |
| TBXAS1 | 5711.0 |
| CYP26A1 | 5725.0 |
| CNDP2 | 6042.0 |
| CYP39A1 | 6053.0 |
| UGP2 | 6062.0 |
| UGDH | 6178.0 |
| CYP11A1 | 6250.0 |
| CHAC2 | 6274.0 |
| NQO2 | 6527.0 |
| ACSM1 | 6711.0 |
| GLYAT | 6865.0 |
| MAT2A | 6915.0 |
| GCLM | 6937.0 |
| DPEP3 | 7176.0 |
| OPLAH | 7290.0 |
| CYP26C1 | 7324.0 |
| NNMT | 7566.0 |
| TPMT | 8205.0 |
| MAT2B | 8229.0 |
| GSTO1 | 8455.0 |
| SULT2B1 | 8608.0 |
| CYP1B1 | 8673.0 |
| BPNT2 | 8715.0 |
| TPST1 | 8787.0 |
| ABHD10 | 8844.0 |
| PTGIS | 8898.0 |
Assembly of active LPL and LIPC lipase complexes
| 96 | |
|---|---|
| set | Assembly of active LPL and LIPC lipase complexes |
| setSize | 19 |
| pANOVA | 0.000116 |
| s.dist | -0.511 |
| p.adjustANOVA | 0.0152 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CIDEC | -8897.0 |
| MBTPS2 | -8761.0 |
| APOA5 | -8466.0 |
| MBTPS1 | -7804.0 |
| APOC2 | -7531.5 |
| CREB3L3 | -7263.0 |
| APOA4 | -6758.0 |
| ANGPTL3 | -6400.0 |
| FURIN | -6399.0 |
| ANGPTL4 | -6243.0 |
| LIPC | -5932.0 |
| LMF2 | -5317.0 |
| FGF21 | -5116.0 |
| ANGPTL8 | -4094.0 |
| GPIHBP1 | -3404.0 |
| LPL | -2467.0 |
| PCSK5 | 3308.0 |
| PCSK6 | 4262.0 |
| LMF1 | 4677.0 |
| GeneID | Gene Rank |
|---|---|
| CIDEC | -8897.0 |
| MBTPS2 | -8761.0 |
| APOA5 | -8466.0 |
| MBTPS1 | -7804.0 |
| APOC2 | -7531.5 |
| CREB3L3 | -7263.0 |
| APOA4 | -6758.0 |
| ANGPTL3 | -6400.0 |
| FURIN | -6399.0 |
| ANGPTL4 | -6243.0 |
| LIPC | -5932.0 |
| LMF2 | -5317.0 |
| FGF21 | -5116.0 |
| ANGPTL8 | -4094.0 |
| GPIHBP1 | -3404.0 |
| LPL | -2467.0 |
| PCSK5 | 3308.0 |
| PCSK6 | 4262.0 |
| LMF1 | 4677.0 |
Cell death signalling via NRAGE, NRIF and NADE
| 169 | |
|---|---|
| set | Cell death signalling via NRAGE, NRIF and NADE |
| setSize | 72 |
| pANOVA | 0.000242 |
| s.dist | -0.25 |
| p.adjustANOVA | 0.0292 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834 |
| ARHGEF1 | -8718 |
| OBSCN | -8574 |
| ARHGEF7 | -8534 |
| PLEKHG5 | -8454 |
| ITSN1 | -8377 |
| MAGED1 | -8312 |
| ARHGEF11 | -8287 |
| NCSTN | -8213 |
| NGFR | -8192 |
| ARHGEF40 | -7699 |
| MCF2 | -7686 |
| ARHGEF16 | -7667 |
| ABR | -7655 |
| MCF2L | -7517 |
| ARHGEF5 | -7293 |
| PLEKHG2 | -7206 |
| VAV3 | -7088 |
| ARHGEF17 | -6885 |
| ARHGEF10L | -6624 |
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834.0 |
| ARHGEF1 | -8718.0 |
| OBSCN | -8574.0 |
| ARHGEF7 | -8534.0 |
| PLEKHG5 | -8454.0 |
| ITSN1 | -8377.0 |
| MAGED1 | -8312.0 |
| ARHGEF11 | -8287.0 |
| NCSTN | -8213.0 |
| NGFR | -8192.0 |
| ARHGEF40 | -7699.0 |
| MCF2 | -7686.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| MCF2L | -7517.0 |
| ARHGEF5 | -7293.0 |
| PLEKHG2 | -7206.0 |
| VAV3 | -7088.0 |
| ARHGEF17 | -6885.0 |
| ARHGEF10L | -6624.0 |
| UBC | -6432.0 |
| APH1B | -6387.0 |
| TRIO | -6348.0 |
| BCL2L11 | -6346.0 |
| FGD4 | -6196.0 |
| FGD1 | -5982.0 |
| YWHAE | -5754.0 |
| ARHGEF19 | -5545.0 |
| SQSTM1 | -5320.0 |
| ARHGEF6 | -5311.0 |
| CASP2 | -5200.0 |
| AKAP13 | -5190.0 |
| NET1 | -4984.0 |
| NGEF | -4851.0 |
| ARHGEF38 | -4562.0 |
| CASP3 | -4363.0 |
| BEX3 | -3892.0 |
| PSEN1 | -3548.0 |
| PREX1 | -3045.0 |
| SOS1 | -2808.0 |
| ARHGEF18 | -2547.5 |
| TRAF6 | -2185.0 |
| AATF | -2176.0 |
| PSEN2 | -2171.5 |
| UBA52 | -2166.0 |
| PSENEN | -1907.0 |
| ARHGEF39 | -1272.0 |
| ARHGEF10 | -775.0 |
| ARHGEF15 | -470.0 |
| ARHGEF33 | -451.0 |
| KALRN | -177.0 |
| BAD | 928.0 |
| APH1A | 1110.0 |
| VAV1 | 1912.0 |
| RAC1 | 2240.0 |
| NGF | 2470.0 |
| FGD2 | 4170.0 |
| ITGB3BP | 4443.0 |
| TIAM2 | 4841.0 |
| RASGRF2 | 5220.0 |
| GNA13 | 5282.0 |
| VAV2 | 5813.0 |
| MAPK8 | 5956.0 |
| ARHGEF12 | 6104.0 |
| FGD3 | 6255.0 |
| TIAM1 | 6942.0 |
| ECT2 | 7350.0 |
| RPS27A | 7369.0 |
| ARHGEF3 | 7632.0 |
| SOS2 | 7658.0 |
| ARHGEF2 | 7980.0 |
| ARHGEF26 | 8302.0 |
Cell junction organization
| 170 | |
|---|---|
| set | Cell junction organization |
| setSize | 85 |
| pANOVA | 0.000301 |
| s.dist | -0.227 |
| p.adjustANOVA | 0.0314 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PLEC | -9079.0 |
| PXN | -9019.0 |
| CLDN10 | -8984.0 |
| CLDN2 | -8877.0 |
| SDK2 | -8789.0 |
| FERMT2 | -8675.0 |
| CDH4 | -8642.0 |
| PARVB | -8581.0 |
| NECTIN2 | -8501.0 |
| FBLIM1 | -8331.0 |
| JUP | -8056.0 |
| CDH5 | -8036.0 |
| FLNC | -8034.0 |
| CLDN7 | -7969.5 |
| CLDN14 | -7884.0 |
| PARD3 | -7779.0 |
| VASP | -7621.0 |
| ANG | -7566.0 |
| CDH13 | -7131.0 |
| CLDN9 | -7005.0 |
| GeneID | Gene Rank |
|---|---|
| PLEC | -9079.0 |
| PXN | -9019.0 |
| CLDN10 | -8984.0 |
| CLDN2 | -8877.0 |
| SDK2 | -8789.0 |
| FERMT2 | -8675.0 |
| CDH4 | -8642.0 |
| PARVB | -8581.0 |
| NECTIN2 | -8501.0 |
| FBLIM1 | -8331.0 |
| JUP | -8056.0 |
| CDH5 | -8036.0 |
| FLNC | -8034.0 |
| CLDN7 | -7969.5 |
| CLDN14 | -7884.0 |
| PARD3 | -7779.0 |
| VASP | -7621.0 |
| ANG | -7566.0 |
| CDH13 | -7131.0 |
| CLDN9 | -7005.0 |
| ITGB4 | -6853.0 |
| CDH9 | -6602.0 |
| TESK1 | -6401.0 |
| PATJ | -6367.0 |
| PARD6G | -6344.0 |
| CLDN1 | -6211.0 |
| LAMA3 | -6177.0 |
| CLDN4 | -6023.0 |
| CTNND1 | -6002.0 |
| LIMS1 | -5950.0 |
| ITGA6 | -5895.0 |
| NECTIN1 | -5893.0 |
| CLDN3 | -5590.0 |
| PARD6B | -5450.0 |
| ARHGEF6 | -5311.0 |
| CRB3 | -5128.0 |
| CLDN23 | -5078.0 |
| CDH15 | -4795.0 |
| CDH17 | -4741.0 |
| CTNNA1 | -4715.0 |
| CDH1 | -4511.0 |
| CDH12 | -4207.0 |
| F11R | -3912.0 |
| LIMS2 | -3484.0 |
| CDH10 | -3034.0 |
| AFDN | -2352.0 |
| CLDN19 | -2269.0 |
| CLDN8 | -2194.0 |
| PRKCI | -2165.0 |
| NECTIN4 | -2014.0 |
| CLDN16 | -1562.5 |
| CDH8 | -850.0 |
| CLDN18 | -282.0 |
| CADM2 | 70.0 |
| CLDN11 | 725.0 |
| CDH3 | 1031.0 |
| ACTN1 | 1114.0 |
| CD151 | 1741.0 |
| CTNNB1 | 1809.0 |
| ILK | 1817.0 |
| PVR | 2238.0 |
| CDH24 | 2287.0 |
| CDH18 | 2439.0 |
| ITGB1 | 2469.0 |
| RSU1 | 2530.0 |
| FLNA | 2688.0 |
| PARVA | 3142.0 |
| CLDN20 | 3374.0 |
| CLDN15 | 3865.0 |
| MPP5 | 3925.0 |
| CDH11 | 4613.0 |
| CLDN5 | 4896.0 |
| CDH6 | 5171.0 |
| CDH2 | 5589.0 |
| DST | 5910.0 |
| CLDN12 | 5952.0 |
| CLDN6 | 6032.0 |
| PARD6A | 6114.0 |
| CDH7 | 6360.0 |
| LAMB3 | 6421.0 |
| NECTIN3 | 6461.0 |
| CADM3 | 7556.0 |
| CADM1 | 8716.0 |
| COL17A1 | 8726.0 |
| LAMC2 | 8913.0 |
Sulfur amino acid metabolism
| 1231 | |
|---|---|
| set | Sulfur amino acid metabolism |
| setSize | 25 |
| pANOVA | 0.000303 |
| s.dist | -0.417 |
| p.adjustANOVA | 0.0314 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MAT1A | -8783.0 |
| CDO1 | -8662.0 |
| CBS | -8643.5 |
| CBSL | -8643.5 |
| CSAD | -8554.0 |
| BHMT | -8229.0 |
| APIP | -8053.0 |
| BHMT2 | -8052.0 |
| MTRR | -7315.0 |
| MPST | -6695.0 |
| MRI1 | -5775.0 |
| CTH | -5465.0 |
| MTR | -5111.0 |
| TST | -3834.0 |
| SUOX | -3648.0 |
| AHCY | -3314.0 |
| ADI1 | -3222.0 |
| TXN2 | -1312.0 |
| ENOPH1 | -504.0 |
| SLC25A10 | 1159.5 |
| GeneID | Gene Rank |
|---|---|
| MAT1A | -8783.0 |
| CDO1 | -8662.0 |
| CBS | -8643.5 |
| CBSL | -8643.5 |
| CSAD | -8554.0 |
| BHMT | -8229.0 |
| APIP | -8053.0 |
| BHMT2 | -8052.0 |
| MTRR | -7315.0 |
| MPST | -6695.0 |
| MRI1 | -5775.0 |
| CTH | -5465.0 |
| MTR | -5111.0 |
| TST | -3834.0 |
| SUOX | -3648.0 |
| AHCY | -3314.0 |
| ADI1 | -3222.0 |
| TXN2 | -1312.0 |
| ENOPH1 | -504.0 |
| SLC25A10 | 1159.5 |
| GOT2 | 2252.0 |
| TSTD1 | 2351.0 |
| ETHE1 | 2775.0 |
| MTAP | 4294.5 |
| GOT1 | 5480.0 |
Phenylalanine and tyrosine metabolism
| 872 | |
|---|---|
| set | Phenylalanine and tyrosine metabolism |
| setSize | 11 |
| pANOVA | 0.000355 |
| s.dist | -0.622 |
| p.adjustANOVA | 0.0336 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL4I1 | -8943.0 |
| GSTZ1 | -8695.0 |
| PAH | -8599.0 |
| HPD | -8142.0 |
| HGD | -7311.0 |
| FAH | -6438.0 |
| QDPR | -5654.0 |
| PCBD1 | -5138.0 |
| ASRGL1 | -4963.0 |
| TAT | -1127.0 |
| KYAT1 | 2675.5 |
| GeneID | Gene Rank |
|---|---|
| IL4I1 | -8943.0 |
| GSTZ1 | -8695.0 |
| PAH | -8599.0 |
| HPD | -8142.0 |
| HGD | -7311.0 |
| FAH | -6438.0 |
| QDPR | -5654.0 |
| PCBD1 | -5138.0 |
| ASRGL1 | -4963.0 |
| TAT | -1127.0 |
| KYAT1 | 2675.5 |
Extracellular matrix organization
| 382 | |
|---|---|
| set | Extracellular matrix organization |
| setSize | 274 |
| pANOVA | 0.000372 |
| s.dist | 0.125 |
| p.adjustANOVA | 0.0336 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| COL1A2 | 8941 |
| LOX | 8924 |
| LAMC2 | 8913 |
| COMP | 8906 |
| DDR1 | 8892 |
| TGFB2 | 8828 |
| VCAM1 | 8798 |
| EFEMP2 | 8730 |
| COL17A1 | 8726 |
| THBS1 | 8627 |
| COL11A2 | 8584 |
| NRXN1 | 8487 |
| COL13A1 | 8432 |
| GDF5 | 8430 |
| P4HA3 | 8415 |
| LAMA2 | 8370 |
| COL16A1 | 8364 |
| LOXL2 | 8342 |
| PCOLCE | 8334 |
| NCAN | 8319 |
| GeneID | Gene Rank |
|---|---|
| COL1A2 | 8941.0 |
| LOX | 8924.0 |
| LAMC2 | 8913.0 |
| COMP | 8906.0 |
| DDR1 | 8892.0 |
| TGFB2 | 8828.0 |
| VCAM1 | 8798.0 |
| EFEMP2 | 8730.0 |
| COL17A1 | 8726.0 |
| THBS1 | 8627.0 |
| COL11A2 | 8584.0 |
| NRXN1 | 8487.0 |
| COL13A1 | 8432.0 |
| GDF5 | 8430.0 |
| P4HA3 | 8415.0 |
| LAMA2 | 8370.0 |
| COL16A1 | 8364.0 |
| LOXL2 | 8342.0 |
| PCOLCE | 8334.0 |
| NCAN | 8319.0 |
| P4HA2 | 8315.0 |
| SERPINH1 | 8239.0 |
| ASPN | 8232.0 |
| HTRA1 | 8144.0 |
| TRAPPC4 | 8123.0 |
| ADAMTS2 | 8086.0 |
| COL8A2 | 8066.0 |
| ITGA2 | 8050.0 |
| COL1A1 | 7952.0 |
| CAST | 7947.0 |
| CD47 | 7939.0 |
| COL9A1 | 7923.0 |
| IBSP | 7884.0 |
| PHYKPL | 7845.0 |
| VCAN | 7807.0 |
| DCN | 7802.0 |
| FMOD | 7779.0 |
| ITGA9 | 7572.0 |
| MMP3 | 7551.0 |
| MMP2 | 7540.0 |
| MMP9 | 7518.0 |
| TNC | 7516.0 |
| MATN4 | 7494.0 |
| COL12A1 | 7478.0 |
| DMD | 7463.0 |
| MFAP5 | 7417.0 |
| ADAMTS3 | 7408.0 |
| OPTC | 7380.0 |
| SDC1 | 7316.0 |
| BMP1 | 7235.0 |
| COL5A1 | 7233.0 |
| MMP16 | 7188.0 |
| COL8A1 | 7168.0 |
| COL2A1 | 7114.0 |
| LOXL1 | 7085.0 |
| FBLN5 | 7064.0 |
| ACAN | 7037.0 |
| PCOLCE2 | 6917.0 |
| FN1 | 6913.0 |
| PPIB | 6887.0 |
| CTSK | 6859.0 |
| COL11A1 | 6757.0 |
| TIMP2 | 6680.0 |
| LTBP1 | 6514.0 |
| CASK | 6499.0 |
| SDC2 | 6449.0 |
| BSG | 6428.0 |
| LAMB3 | 6421.0 |
| CMA1 | 6414.0 |
| ADAM9 | 6383.0 |
| CAPN8 | 6351.0 |
| BMP2 | 6309.0 |
| CD44 | 6282.0 |
| ADAMTS8 | 6254.0 |
| TLL2 | 6245.0 |
| LTBP2 | 6149.0 |
| DDR2 | 6135.0 |
| SPARC | 6116.0 |
| ITGA11 | 6092.0 |
| LOXL4 | 6012.0 |
| TNN | 5931.0 |
| P3H2 | 5928.0 |
| DST | 5910.0 |
| FBN1 | 5838.0 |
| BGN | 5787.0 |
| HAPLN1 | 5604.0 |
| P4HA1 | 5544.0 |
| COL14A1 | 5203.0 |
| MFAP2 | 5009.0 |
| FBN2 | 5007.0 |
| ADAM19 | 4993.0 |
| CAPN6 | 4958.0 |
| MFAP4 | 4885.0 |
| ADAMTS14 | 4789.0 |
| COL6A2 | 4759.0 |
| LAMA1 | 4727.0 |
| PLOD3 | 4609.0 |
| NTN4 | 4587.0 |
| ICAM4 | 4394.0 |
| MATN3 | 4328.0 |
| BMP4 | 4187.0 |
| ITGA7 | 4112.0 |
| TLL1 | 4083.0 |
| MMP20 | 3915.0 |
| COL3A1 | 3907.0 |
| P3H3 | 3882.0 |
| ICAM5 | 3799.0 |
| COL26A1 | 3774.0 |
| ADAMTS9 | 3756.0 |
| COL6A1 | 3749.0 |
| ADAMTS5 | 3692.0 |
| COL4A6 | 3630.0 |
| ADAMTS16 | 3486.0 |
| CTRB1 | 3316.5 |
| CTRB2 | 3316.5 |
| COL23A1 | 3188.0 |
| ADAMTS1 | 3176.0 |
| COL5A2 | 3064.0 |
| ICAM1 | 3053.0 |
| MMP14 | 2974.0 |
| CRTAP | 2918.0 |
| FGF2 | 2815.0 |
| BMP7 | 2742.0 |
| MMP7 | 2736.0 |
| PTPRS | 2729.0 |
| CTSD | 2669.5 |
| ITGB1 | 2469.0 |
| CTSS | 2396.0 |
| ITGA10 | 2327.0 |
| ITGAV | 2243.0 |
| MADCAM1 | 2232.0 |
| P3H1 | 2050.0 |
| MMP1 | 2049.0 |
| CD151 | 1741.0 |
| ELN | 1616.0 |
| ADAMTS18 | 1599.0 |
| KLK2 | 1449.5 |
| CAPN1 | 1166.0 |
| ACTN1 | 1114.0 |
| ADAM12 | 1062.0 |
| COL27A1 | 951.0 |
| LUM | 941.0 |
| CAPN9 | 896.0 |
| CAPN11 | 818.0 |
| TGFB3 | 801.0 |
| MMP17 | 768.0 |
| FBLN2 | 754.0 |
| PLOD1 | 638.0 |
| LTBP3 | 636.0 |
| NID1 | 625.0 |
| DSPP | 575.0 |
| COL19A1 | 452.0 |
| COL4A3 | 385.0 |
| CTSG | 231.0 |
| LAMB1 | 139.0 |
| CAPN7 | 118.0 |
| BMP10 | 36.0 |
| CAPN13 | 4.0 |
| PRSS1 | -190.0 |
| PRSS2 | -190.0 |
| MMP12 | -309.0 |
| ITGB2 | -462.0 |
| ELANE | -671.0 |
| MMP13 | -756.0 |
| LRP4 | -808.0 |
| COL5A3 | -869.0 |
| COLGALT1 | -898.0 |
| MATN1 | -987.0 |
| AGRN | -1136.0 |
| KLK7 | -1148.0 |
| TGFB1 | -1162.0 |
| DMP1 | -1207.0 |
| TIMP1 | -1254.0 |
| CTSB | -1337.0 |
| ITGB8 | -1484.0 |
| MMP19 | -1645.0 |
| FBLN1 | -1728.0 |
| ITGAL | -1761.0 |
| PRKCA | -1808.0 |
| CAPN15 | -1858.0 |
| JAM2 | -1946.0 |
| SCUBE1 | -1981.0 |
| SDC3 | -2040.0 |
| LOXL3 | -2045.0 |
| ADAM17 | -2112.0 |
| LAMA4 | -2168.0 |
| ITGA8 | -2280.0 |
| P4HB | -2423.0 |
| ADAM8 | -2497.0 |
| EFEMP1 | -2671.0 |
| ICAM2 | -2737.0 |
| LTBP4 | -2926.0 |
| SDC4 | -2987.0 |
| COL28A1 | -2995.0 |
| COL4A5 | -3059.0 |
| ITGA1 | -3067.0 |
| JAM3 | -3140.0 |
| CAPN5 | -3167.0 |
| CAPN2 | -3290.0 |
| SERPINE1 | -3327.0 |
| ITGB3 | -3380.5 |
| LAMC1 | -3476.0 |
| PSEN1 | -3548.0 |
| HSPG2 | -3764.0 |
| COL6A6 | -3769.0 |
| A2M | -3884.0 |
| F11R | -3912.0 |
| SCUBE3 | -4132.0 |
| CAPN10 | -4166.0 |
| ITGB6 | -4238.0 |
| ITGA4 | -4297.0 |
| CASP3 | -4363.0 |
| CEACAM1 | -4406.5 |
| CEACAM6 | -4406.5 |
| CEACAM8 | -4406.5 |
| COL4A1 | -4472.0 |
| CAPN12 | -4477.0 |
| CDH1 | -4511.0 |
| CTSV | -4546.0 |
| COL4A2 | -4819.0 |
| PDGFB | -4881.0 |
| MMP24 | -4965.0 |
| SPOCK3 | -5006.0 |
| ADAMTS4 | -5074.0 |
| MFAP3 | -5088.0 |
| COL18A1 | -5131.0 |
| LAMC3 | -5168.0 |
| LAMA5 | -5206.0 |
| ITGAX | -5237.0 |
| ITGAE | -5312.0 |
| ADAM10 | -5402.0 |
| KDR | -5733.0 |
| COL6A5 | -5779.0 |
| MUSK | -5811.0 |
| ITGA6 | -5895.0 |
| KLKB1 | -6048.0 |
| COL15A1 | -6154.0 |
| LAMA3 | -6177.0 |
| MMP15 | -6347.0 |
| FURIN | -6399.0 |
| ITGA3 | -6852.0 |
| ITGB4 | -6853.0 |
| ADAM15 | -6936.0 |
| TMPRSS6 | -6939.0 |
| MMP11 | -7212.0 |
| ITGA2B | -7222.0 |
| PDGFA | -7301.0 |
| TNR | -7305.0 |
| CAPNS1 | -7620.0 |
| SPP1 | -7652.0 |
| PXDN | -7676.0 |
| LAMB2 | -7709.0 |
| COL9A2 | -7743.0 |
| ITGA5 | -7756.0 |
| BCAN | -7782.0 |
| COLGALT2 | -7793.0 |
| MMP8 | -7832.0 |
| ITGB7 | -7863.0 |
| PLOD2 | -7959.0 |
| DAG1 | -7964.0 |
| FGG | -8035.0 |
| NCSTN | -8213.0 |
| NID2 | -8273.0 |
| COL25A1 | -8293.0 |
| CAPN3 | -8435.0 |
| FGA | -8696.0 |
| TTR | -8839.0 |
| VTN | -8869.5 |
| NCAM1 | -8937.0 |
| SH3PXD2A | -8986.0 |
| PLG | -9005.0 |
| ITGAM | -9020.0 |
| FGB | -9053.0 |
| PLEC | -9079.0 |
Cytochrome P450 - arranged by substrate type
| 239 | |
|---|---|
| set | Cytochrome P450 - arranged by substrate type |
| setSize | 58 |
| pANOVA | 0.000424 |
| s.dist | -0.268 |
| p.adjustANOVA | 0.0361 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| AHRR | -8688.0 |
| CYP2F1 | -8491.0 |
| CYP46A1 | -8248.0 |
| CYP4F2 | -8108.0 |
| CYP2C18 | -7923.5 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4F12 | -7728.5 |
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP2A6 | -9057.0 |
| CYP2A7 | -9057.0 |
| CYP4F8 | -9040.0 |
| CYP2D6 | -9035.5 |
| CYP2E1 | -8999.0 |
| CYP3A4 | -8991.0 |
| CYP3A43 | -8991.0 |
| CYP3A5 | -8991.0 |
| CYP3A7 | -8991.0 |
| ARNT | -8977.0 |
| AHRR | -8688.0 |
| CYP2F1 | -8491.0 |
| CYP46A1 | -8248.0 |
| CYP4F2 | -8108.0 |
| CYP2C18 | -7923.5 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4F12 | -7728.5 |
| CYP1A2 | -6798.0 |
| NCOA1 | -6733.0 |
| CYP4B1 | -6651.0 |
| POR | -5945.0 |
| CYP26B1 | -5722.0 |
| RXRA | -5221.0 |
| NCOA2 | -5184.0 |
| CYP24A1 | -4478.0 |
| CYP4F3 | -4081.0 |
| CYP2W1 | -3941.0 |
| CYP27B1 | -3689.0 |
| CYP4V2 | -2726.0 |
| CYP2S1 | -1638.0 |
| CYP2R1 | -1234.0 |
| CYP2J2 | -235.0 |
| CYP1A1 | 359.0 |
| CYP51A1 | 1117.0 |
| CYP27A1 | 1302.0 |
| CYP8B1 | 1456.0 |
| ARNT2 | 1509.0 |
| CYP19A1 | 1797.0 |
| CYP21A2 | 2301.0 |
| CYP2U1 | 2375.0 |
| AHR | 2943.5 |
| CYP7A1 | 3065.0 |
| POMC | 3261.0 |
| CYP4F22 | 4080.0 |
| FDX2 | 4488.5 |
| FDX1 | 4538.0 |
| NR1H4 | 4600.0 |
| CYP7B1 | 4950.0 |
| TBXAS1 | 5711.0 |
| CYP26A1 | 5725.0 |
| CYP39A1 | 6053.0 |
| CYP11A1 | 6250.0 |
| CYP26C1 | 7324.0 |
| CYP1B1 | 8673.0 |
| PTGIS | 8898.0 |
p75 NTR receptor-mediated signalling
| 1433 | |
|---|---|
| set | p75 NTR receptor-mediated signalling |
| setSize | 92 |
| pANOVA | 0.000471 |
| s.dist | -0.211 |
| p.adjustANOVA | 0.0379 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834 |
| ARHGEF1 | -8718 |
| OBSCN | -8574 |
| ARHGEF7 | -8534 |
| PLEKHG5 | -8454 |
| ITSN1 | -8377 |
| MAGED1 | -8312 |
| ARHGEF11 | -8287 |
| RTN4 | -8274 |
| NCSTN | -8213 |
| NGFR | -8192 |
| ARHGEF40 | -7699 |
| MCF2 | -7686 |
| ARHGEF16 | -7667 |
| ABR | -7655 |
| MCF2L | -7517 |
| ARHGEF5 | -7293 |
| PLEKHG2 | -7206 |
| VAV3 | -7088 |
| ARHGEF17 | -6885 |
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834.0 |
| ARHGEF1 | -8718.0 |
| OBSCN | -8574.0 |
| ARHGEF7 | -8534.0 |
| PLEKHG5 | -8454.0 |
| ITSN1 | -8377.0 |
| MAGED1 | -8312.0 |
| ARHGEF11 | -8287.0 |
| RTN4 | -8274.0 |
| NCSTN | -8213.0 |
| NGFR | -8192.0 |
| ARHGEF40 | -7699.0 |
| MCF2 | -7686.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| MCF2L | -7517.0 |
| ARHGEF5 | -7293.0 |
| PLEKHG2 | -7206.0 |
| VAV3 | -7088.0 |
| ARHGEF17 | -6885.0 |
| ARHGEF10L | -6624.0 |
| UBC | -6432.0 |
| APH1B | -6387.0 |
| TRIO | -6348.0 |
| BCL2L11 | -6346.0 |
| FGD4 | -6196.0 |
| FGD1 | -5982.0 |
| MAG | -5858.0 |
| YWHAE | -5754.0 |
| ARHGEF19 | -5545.0 |
| SQSTM1 | -5320.0 |
| ARHGEF6 | -5311.0 |
| CASP2 | -5200.0 |
| AKAP13 | -5190.0 |
| NET1 | -4984.0 |
| NGEF | -4851.0 |
| ARHGEF38 | -4562.0 |
| CASP3 | -4363.0 |
| RIPK2 | -4098.0 |
| BEX3 | -3892.0 |
| PRDM4 | -3727.0 |
| PSEN1 | -3548.0 |
| MYD88 | -3411.0 |
| PREX1 | -3045.0 |
| SOS1 | -2808.0 |
| ARHGDIA | -2696.0 |
| NFKB1 | -2579.0 |
| ARHGEF18 | -2547.5 |
| LINGO1 | -2353.0 |
| TRAF6 | -2185.0 |
| AATF | -2176.0 |
| PSEN2 | -2171.5 |
| UBA52 | -2166.0 |
| PRKCI | -2165.0 |
| ADAM17 | -2112.0 |
| RELA | -2108.0 |
| PSENEN | -1907.0 |
| OMG | -1376.0 |
| ARHGEF39 | -1272.0 |
| ARHGEF10 | -775.0 |
| RHOA | -640.0 |
| ARHGEF15 | -470.0 |
| ARHGEF33 | -451.0 |
| KALRN | -177.0 |
| IRAK1 | 791.0 |
| BAD | 928.0 |
| SORCS3 | 985.0 |
| APH1A | 1110.0 |
| VAV1 | 1912.0 |
| RAC1 | 2240.0 |
| NGF | 2470.0 |
| HDAC2 | 3553.0 |
| IKBKB | 4039.0 |
| FGD2 | 4170.0 |
| ITGB3BP | 4443.0 |
| TIAM2 | 4841.0 |
| RASGRF2 | 5220.0 |
| GNA13 | 5282.0 |
| HDAC3 | 5550.0 |
| SMPD2 | 5759.0 |
| VAV2 | 5813.0 |
| MAPK8 | 5956.0 |
| ARHGEF12 | 6104.0 |
| FGD3 | 6255.0 |
| TIAM1 | 6942.0 |
| HDAC1 | 7175.0 |
| ECT2 | 7350.0 |
| RPS27A | 7369.0 |
| ARHGEF3 | 7632.0 |
| SOS2 | 7658.0 |
| ARHGEF2 | 7980.0 |
| ARHGEF26 | 8302.0 |
Plasma lipoprotein assembly, remodeling, and clearance
| 882 | |
|---|---|
| set | Plasma lipoprotein assembly, remodeling, and clearance |
| setSize | 68 |
| pANOVA | 0.000554 |
| s.dist | -0.242 |
| p.adjustANOVA | 0.0407 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOC1 | -8963.0 |
| APOC3 | -8904.0 |
| CIDEC | -8897.0 |
| ABCG1 | -8866.0 |
| SCARB1 | -8857.0 |
| APOE | -8836.0 |
| MBTPS2 | -8761.0 |
| APOA5 | -8466.0 |
| CUBN | -8462.0 |
| LSR | -8207.0 |
| MTTP | -8003.0 |
| MBTPS1 | -7804.0 |
| PRKACA | -7713.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| NR1H3 | -7384.0 |
| APOF | -7268.0 |
| CREB3L3 | -7263.0 |
| LCAT | -6772.0 |
| APOA4 | -6758.0 |
| GeneID | Gene Rank |
|---|---|
| APOC1 | -8963.0 |
| APOC3 | -8904.0 |
| CIDEC | -8897.0 |
| ABCG1 | -8866.0 |
| SCARB1 | -8857.0 |
| APOE | -8836.0 |
| MBTPS2 | -8761.0 |
| APOA5 | -8466.0 |
| CUBN | -8462.0 |
| LSR | -8207.0 |
| MTTP | -8003.0 |
| MBTPS1 | -7804.0 |
| PRKACA | -7713.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| NR1H3 | -7384.0 |
| APOF | -7268.0 |
| CREB3L3 | -7263.0 |
| LCAT | -6772.0 |
| APOA4 | -6758.0 |
| PRKACB | -6707.0 |
| ANGPTL3 | -6400.0 |
| FURIN | -6399.0 |
| ANGPTL4 | -6243.0 |
| PCSK9 | -6169.0 |
| ABCA1 | -6097.0 |
| LIPC | -5932.0 |
| AP2A1 | -5700.0 |
| LMF2 | -5317.0 |
| LIPG | -5216.0 |
| FGF21 | -5116.0 |
| MYLIP | -5032.0 |
| NR1H2 | -4967.0 |
| VLDLR | -4329.0 |
| ANGPTL8 | -4094.0 |
| A2M | -3884.0 |
| LPA | -3826.0 |
| GPIHBP1 | -3404.0 |
| LPL | -2467.0 |
| P4HB | -2423.0 |
| PLTP | -2003.0 |
| APOC4 | -1990.0 |
| AMN | -1681.0 |
| AP2S1 | -1453.0 |
| APOA1 | -547.0 |
| LDLRAP1 | 515.0 |
| APOB | 573.0 |
| SAR1B | 1055.0 |
| AP2M1 | 1347.0 |
| ZDHHC8 | 2324.0 |
| LDLR | 2957.0 |
| PCSK5 | 3308.0 |
| PCSK6 | 4262.0 |
| AP2B1 | 4289.0 |
| CLTC | 4525.0 |
| LMF1 | 4677.0 |
| NPC2 | 5620.0 |
| AP2A2 | 6431.0 |
| HDLBP | 6636.0 |
| APOBR | 6980.0 |
| SOAT1 | 7007.0 |
| NPC1 | 7043.0 |
| LIPA | 7213.0 |
| BMP1 | 7235.0 |
| SOAT2 | 7523.0 |
| ALB | 7970.0 |
| NCEH1 | 8324.0 |
| CLTA | 8586.0 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
| 752 | |
|---|---|
| set | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux |
| setSize | 39 |
| pANOVA | 0.000562 |
| s.dist | -0.319 |
| p.adjustANOVA | 0.0407 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOC1 | -8963.0 |
| ABCG1 | -8866.0 |
| APOE | -8836.0 |
| TNRC6B | -8577.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| AGO4 | -8424.0 |
| NCOR1 | -8129.0 |
| RXRB | -7956.0 |
| APOC2 | -7531.5 |
| NR1H3 | -7384.0 |
| NCOA1 | -6733.0 |
| EEPD1 | -6385.0 |
| ABCA1 | -6097.0 |
| AGO1 | -5804.0 |
| GPS2 | -5694.0 |
| TNRC6C | -5527.0 |
| MIR144 | -5518.0 |
| AGO2 | -5246.0 |
| RXRA | -5221.0 |
| GeneID | Gene Rank |
|---|---|
| APOC1 | -8963.0 |
| ABCG1 | -8866.0 |
| APOE | -8836.0 |
| TNRC6B | -8577.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| AGO4 | -8424.0 |
| NCOR1 | -8129.0 |
| RXRB | -7956.0 |
| APOC2 | -7531.5 |
| NR1H3 | -7384.0 |
| NCOA1 | -6733.0 |
| EEPD1 | -6385.0 |
| ABCA1 | -6097.0 |
| AGO1 | -5804.0 |
| GPS2 | -5694.0 |
| TNRC6C | -5527.0 |
| MIR144 | -5518.0 |
| AGO2 | -5246.0 |
| RXRA | -5221.0 |
| TBL1XR1 | -5183.0 |
| NR1H2 | -4967.0 |
| APOD | -4213.0 |
| KDM1B | -3115.0 |
| KDM3A | -2751.0 |
| ABCG5 | -2445.0 |
| PLTP | -2003.0 |
| APOC4 | -1990.0 |
| MIR33A | -1119.0 |
| EP300 | 1591.0 |
| TBL1X | 1601.5 |
| HDAC3 | 5550.0 |
| MIR26A1 | 5951.0 |
| MOV10 | 6056.0 |
| ABCG8 | 6224.0 |
| MIR26A2 | 6542.0 |
| AGO3 | 7448.0 |
| TNRC6A | 7675.0 |
| KDM1A | 8614.0 |
Signal Transduction
| 1139 | |
|---|---|
| set | Signal Transduction |
| setSize | 2386 |
| pANOVA | 0.000712 |
| s.dist | -0.0429 |
| p.adjustANOVA | 0.0491 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -9063 |
| C5 | -9060 |
| FGB | -9053 |
| RDH16 | -9052 |
| KNG1 | -9050 |
| TAS1R2 | -9042 |
| PAK1 | -9034 |
| CRHR2 | -9033 |
| STARD8 | -9030 |
| MXD4 | -9029 |
| PXN | -9019 |
| TLE1 | -9016 |
| SAG | -9009 |
| PLIN1 | -9007 |
| PLG | -9005 |
| EDNRA | -8998 |
| IGF2 | -8965 |
| APOC1 | -8963 |
| GFAP | -8957 |
| PDE4D | -8956 |
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -9063.0 |
| C5 | -9060.0 |
| FGB | -9053.0 |
| RDH16 | -9052.0 |
| KNG1 | -9050.0 |
| TAS1R2 | -9042.0 |
| PAK1 | -9034.0 |
| CRHR2 | -9033.0 |
| STARD8 | -9030.0 |
| MXD4 | -9029.0 |
| PXN | -9019.0 |
| TLE1 | -9016.0 |
| SAG | -9009.0 |
| PLIN1 | -9007.0 |
| PLG | -9005.0 |
| EDNRA | -8998.0 |
| IGF2 | -8965.0 |
| APOC1 | -8963.0 |
| GFAP | -8957.0 |
| PDE4D | -8956.0 |
| MYO9B | -8944.0 |
| SRGAP2 | -8939.0 |
| NCAM1 | -8937.0 |
| PTGER3 | -8925.0 |
| CDKN1A | -8923.0 |
| PDE2A | -8915.0 |
| AKR1B10 | -8911.0 |
| APOC3 | -8904.0 |
| CAMK2B | -8898.0 |
| CENPP | -8891.0 |
| FOXO4 | -8887.0 |
| MEF2A | -8883.0 |
| PRKAR2B | -8880.0 |
| NTRK1 | -8876.0 |
| MYH14 | -8868.0 |
| ABCG1 | -8866.0 |
| PDE11A | -8842.0 |
| TTR | -8839.0 |
| PDGFRB | -8838.0 |
| APOE | -8836.0 |
| ARHGEF37 | -8834.0 |
| NDC80 | -8832.0 |
| IL2RB | -8825.0 |
| DNM2 | -8817.0 |
| ARHGAP17 | -8816.0 |
| NRG1 | -8815.0 |
| PCK1 | -8806.0 |
| PLPPR3 | -8805.0 |
| PSME3 | -8804.0 |
| CHD8 | -8792.0 |
| CSNK2B | -8791.0 |
| HPN | -8779.0 |
| CCL28 | -8774.0 |
| RGS17 | -8772.0 |
| RRH | -8768.0 |
| WNT4 | -8755.0 |
| PDGFC | -8753.0 |
| TAS1R3 | -8751.0 |
| DGKE | -8747.0 |
| NR4A1 | -8745.0 |
| SGO2 | -8734.0 |
| NTSR1 | -8726.0 |
| CYFIP1 | -8724.0 |
| ARHGEF1 | -8718.0 |
| LIMK1 | -8717.0 |
| INSR | -8709.0 |
| IKZF1 | -8704.0 |
| FGA | -8696.0 |
| ZNF217 | -8689.0 |
| P2RY14 | -8673.0 |
| ADORA1 | -8671.0 |
| NEDD4L | -8665.0 |
| EIF4G1 | -8658.0 |
| REST | -8650.0 |
| RPS6KA1 | -8610.0 |
| CXCR1 | -8608.0 |
| GNAS | -8601.0 |
| FOSB | -8589.0 |
| PBX1 | -8578.0 |
| TNRC6B | -8577.0 |
| RGS14 | -8576.0 |
| OBSCN | -8574.0 |
| PPP2R5C | -8572.0 |
| PSMD11 | -8559.0 |
| OPHN1 | -8557.0 |
| GSK3B | -8548.0 |
| ARHGEF7 | -8534.0 |
| RARA | -8531.0 |
| RGS5 | -8529.0 |
| RGS20 | -8516.0 |
| GRK6 | -8511.0 |
| NCOR2 | -8506.0 |
| PPARG | -8498.0 |
| NUMB | -8494.0 |
| CCL11 | -8487.0 |
| GMIP | -8479.0 |
| PPP3CC | -8476.0 |
| CDC37 | -8475.0 |
| SPRED3 | -8474.0 |
| KDM4A | -8470.5 |
| RGS6 | -8457.0 |
| PLEKHG5 | -8454.0 |
| CSNK1G2 | -8450.0 |
| CDC42 | -8440.0 |
| USP2 | -8432.0 |
| PDE1B | -8427.0 |
| AGO4 | -8424.0 |
| POLR2E | -8423.0 |
| ATP6V0D1 | -8410.0 |
| ETV4 | -8397.0 |
| PLB1 | -8395.0 |
| PSMB10 | -8393.0 |
| PLPPR1 | -8390.0 |
| ITSN1 | -8377.0 |
| PLCB4 | -8376.0 |
| LIN7B | -8366.0 |
| RBFOX2 | -8362.0 |
| PTK2 | -8355.0 |
| CXCR6 | -8347.0 |
| MRTFA | -8345.0 |
| TSC2 | -8340.0 |
| GRB10 | -8326.0 |
| CXCR3 | -8323.0 |
| ARAP2 | -8318.0 |
| TRH | -8317.0 |
| MAGED1 | -8312.0 |
| CHRM3 | -8311.0 |
| ATF1 | -8305.0 |
| HNRNPH1 | -8301.0 |
| SH2D2A | -8300.0 |
| STAT6 | -8298.0 |
| CHN2 | -8291.5 |
| ARHGEF11 | -8287.0 |
| RTN4 | -8274.0 |
| USP4 | -8272.0 |
| WASF2 | -8271.0 |
| VIPR1 | -8263.0 |
| IFT88 | -8255.0 |
| RNF41 | -8243.0 |
| AMOT | -8241.0 |
| MADD | -8225.0 |
| NCSTN | -8213.0 |
| GALR2 | -8209.0 |
| BAIAP2 | -8193.0 |
| NGFR | -8192.0 |
| DEPDC7 | -8183.0 |
| RBP4 | -8178.0 |
| KMT2D | -8177.0 |
| DGKZ | -8155.0 |
| TEC | -8139.0 |
| GPSM3 | -8134.0 |
| MYC | -8133.0 |
| NCOR1 | -8129.0 |
| NUP43 | -8128.0 |
| PRKAR2A | -8106.0 |
| EVL | -8105.0 |
| TCF12 | -8098.0 |
| PIK3AP1 | -8096.0 |
| SRC | -8095.0 |
| TAX1BP3 | -8093.0 |
| CHD4 | -8089.5 |
| VIP | -8083.0 |
| ACVR1C | -8082.0 |
| CDK1 | -8079.0 |
| WIPF2 | -8075.0 |
| GLP2R | -8069.0 |
| UBE2D3 | -8068.0 |
| JUP | -8056.0 |
| NPY | -8050.0 |
| LPAR5 | -8048.0 |
| ATP6V0A2 | -8039.0 |
| CDH5 | -8036.0 |
| FGG | -8035.0 |
| H2BC1 | -8026.0 |
| NUP85 | -8017.0 |
| HDAC5 | -8016.0 |
| NPY1R | -8014.0 |
| ARHGAP20 | -8012.0 |
| NR3C1 | -8004.0 |
| XK | -7994.0 |
| PDE4C | -7992.5 |
| ADRB3 | -7987.5 |
| STAT5B | -7980.0 |
| QRFPR | -7977.0 |
| PLCB3 | -7957.0 |
| RXRB | -7956.0 |
| ASH2L | -7949.0 |
| LEPR | -7925.0 |
| NEDD4 | -7922.0 |
| ARC | -7921.0 |
| ARHGAP6 | -7915.0 |
| DUSP10 | -7908.0 |
| RUVBL1 | -7902.0 |
| CCNT1 | -7896.0 |
| NPFFR1 | -7883.0 |
| OR52W1 | -7878.0 |
| DAGLB | -7867.0 |
| NTS | -7866.0 |
| PSMB9 | -7864.0 |
| AGT | -7862.0 |
| PTPRA | -7844.0 |
| DKK4 | -7836.0 |
| RGS2 | -7801.0 |
| PARD3 | -7779.0 |
| ZDHHC9 | -7778.0 |
| EDN3 | -7773.0 |
| SYNGAP1 | -7758.0 |
| COL9A2 | -7743.0 |
| HDAC9 | -7742.0 |
| DUSP4 | -7719.0 |
| PRKACA | -7713.0 |
| LAMB2 | -7709.0 |
| GFRA2 | -7703.0 |
| GPR27 | -7702.0 |
| ARHGEF40 | -7699.0 |
| CYFIP2 | -7693.0 |
| BMPR1B | -7692.0 |
| MCF2 | -7686.0 |
| TACC3 | -7685.0 |
| RBPJ | -7670.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| SPP1 | -7652.0 |
| RTP2 | -7650.0 |
| GNAI1 | -7649.0 |
| WAS | -7636.0 |
| CDK5R1 | -7635.0 |
| CSF2RB | -7632.0 |
| RXFP2 | -7630.0 |
| RFNG | -7625.0 |
| BCAR1 | -7614.0 |
| RPGRIP1L | -7611.0 |
| PDE1C | -7601.0 |
| FASN | -7594.0 |
| POU2F1 | -7582.0 |
| MGLL | -7581.0 |
| RHPN1 | -7579.0 |
| GREM2 | -7567.0 |
| S100A8 | -7563.0 |
| AKT1S1 | -7553.0 |
| DGKB | -7547.0 |
| PTGER4 | -7545.0 |
| ADORA2B | -7537.0 |
| RASA4 | -7533.5 |
| APOC2 | -7531.5 |
| AXIN2 | -7523.0 |
| ATF2 | -7522.0 |
| MCF2L | -7517.0 |
| CNTN1 | -7515.0 |
| SCRIB | -7509.0 |
| SMARCA4 | -7503.0 |
| ABHD12 | -7496.0 |
| PORCN | -7494.0 |
| CDC20 | -7493.0 |
| PHLPP1 | -7491.0 |
| ADRA2B | -7489.0 |
| IHH | -7487.0 |
| PELP1 | -7485.0 |
| STRADA | -7482.0 |
| SPC24 | -7479.0 |
| DAB2IP | -7464.0 |
| CCDC88C | -7459.0 |
| CASP9 | -7456.0 |
| RING1 | -7450.0 |
| PTK2B | -7442.0 |
| RAC2 | -7433.0 |
| CHD1 | -7428.0 |
| PAK3 | -7424.0 |
| BUB3 | -7420.0 |
| NFATC1 | -7417.0 |
| MDM2 | -7403.0 |
| APOA2 | -7400.0 |
| LEO1 | -7393.0 |
| NR1H3 | -7384.0 |
| IFT52 | -7374.0 |
| STAT3 | -7372.0 |
| GRK3 | -7362.0 |
| LAMTOR5 | -7358.0 |
| RASGRP2 | -7350.0 |
| TNFAIP3 | -7318.0 |
| GNG4 | -7316.0 |
| DGKG | -7310.0 |
| SPTBN2 | -7304.0 |
| PDGFA | -7301.0 |
| PIP4K2A | -7295.0 |
| ARHGEF5 | -7293.0 |
| PTPN3 | -7286.0 |
| VWF | -7285.0 |
| CSNK1E | -7277.5 |
| DLG4 | -7276.0 |
| TRIB1 | -7257.0 |
| VEGFD | -7250.0 |
| CNR1 | -7245.0 |
| ITGA2B | -7222.0 |
| ARHGAP12 | -7221.0 |
| SRMS | -7215.0 |
| PLEKHG2 | -7206.0 |
| ARHGAP8 | -7192.5 |
| WNT10A | -7189.0 |
| CHRM5 | -7183.0 |
| LIMK2 | -7173.0 |
| PARP1 | -7161.0 |
| GPC4 | -7160.0 |
| HDAC6 | -7154.0 |
| PRKCE | -7128.0 |
| NEURL1 | -7123.0 |
| GNAL | -7120.0 |
| S1PR1 | -7115.0 |
| GATAD2B | -7106.0 |
| KIF2C | -7103.0 |
| PIK3R2 | -7098.5 |
| VAV3 | -7088.0 |
| EPAS1 | -7087.0 |
| RTP3 | -7086.0 |
| STRAP | -7077.0 |
| ABL1 | -7066.0 |
| TNKS2 | -7057.0 |
| LEF1 | -7053.0 |
| RGS8 | -7040.0 |
| MFNG | -7025.0 |
| CCR9 | -7000.0 |
| CSF2RA | -6994.0 |
| PHC1 | -6987.0 |
| DUSP7 | -6984.0 |
| GNA14 | -6980.0 |
| RBP1 | -6975.0 |
| AVPR2 | -6968.0 |
| GRAP2 | -6960.0 |
| ARHGAP35 | -6956.0 |
| NUDC | -6950.0 |
| CDK9 | -6949.0 |
| POLR2L | -6941.0 |
| SMAD4 | -6937.0 |
| PPARD | -6930.0 |
| PLXND1 | -6922.0 |
| SPTB | -6905.0 |
| CD28 | -6902.0 |
| ATN1 | -6896.0 |
| KLC3 | -6887.0 |
| ARHGEF17 | -6885.0 |
| ADCY6 | -6882.0 |
| PTGER2 | -6876.0 |
| KL | -6866.0 |
| ITGA3 | -6852.0 |
| OR51E1 | -6846.0 |
| RASGRP3 | -6839.0 |
| AAMP | -6822.0 |
| CNKSR1 | -6817.0 |
| PGF | -6799.0 |
| GPR39 | -6779.0 |
| CNR2 | -6771.0 |
| ADCY4 | -6759.0 |
| APOA4 | -6758.0 |
| ARRB2 | -6754.0 |
| ECE1 | -6749.0 |
| NCOA1 | -6733.0 |
| MYH9 | -6722.0 |
| NOG | -6719.0 |
| CCL19 | -6713.0 |
| MAP2K5 | -6709.0 |
| PRKACB | -6707.0 |
| ICMT | -6702.0 |
| WWP1 | -6699.0 |
| LYL1 | -6681.0 |
| AMOTL1 | -6677.0 |
| PSAP | -6675.0 |
| TAOK1 | -6649.0 |
| EIF4EBP1 | -6644.0 |
| ARHGEF10L | -6624.0 |
| GPAM | -6619.0 |
| IL3RA | -6604.0 |
| HSD17B6 | -6589.0 |
| S1PR4 | -6587.0 |
| EZH2 | -6564.0 |
| TMED2 | -6563.0 |
| PLK1 | -6555.0 |
| OTUD7B | -6540.0 |
| KIF5A | -6521.0 |
| RASGEF1A | -6517.0 |
| HIF1A | -6513.0 |
| RAPGEF3 | -6504.0 |
| TSHR | -6499.0 |
| HTR7 | -6482.0 |
| RASAL1 | -6479.0 |
| RASAL2 | -6477.0 |
| CXCR5 | -6476.0 |
| RALGDS | -6468.5 |
| SGK1 | -6445.0 |
| FGF10 | -6441.0 |
| PMF1 | -6435.0 |
| ADCY2 | -6434.0 |
| UBC | -6432.0 |
| RBBP7 | -6428.0 |
| ESRP2 | -6418.0 |
| ANGPTL3 | -6400.0 |
| FURIN | -6399.0 |
| CENPM | -6395.0 |
| APH1B | -6387.0 |
| EEPD1 | -6385.0 |
| SYK | -6379.0 |
| WLS | -6377.0 |
| TRIO | -6348.0 |
| BCL2L11 | -6346.0 |
| LRRC7 | -6336.0 |
| PRKAB1 | -6325.0 |
| TCF4 | -6313.0 |
| SSTR1 | -6304.0 |
| C3 | -6303.0 |
| USP21 | -6295.0 |
| CHRM4 | -6286.0 |
| CLASP1 | -6270.0 |
| GPR132 | -6259.0 |
| PPP2CA | -6258.0 |
| CER1 | -6253.0 |
| PIK3R6 | -6249.0 |
| CSNK2A2 | -6247.0 |
| MYO9A | -6231.0 |
| RHOH | -6217.0 |
| REEP6 | -6204.0 |
| PPP2R5A | -6197.0 |
| FGD4 | -6196.0 |
| TCF7 | -6192.0 |
| TAC3 | -6187.0 |
| WNT6 | -6186.0 |
| LAMA3 | -6177.0 |
| MAP2K2 | -6140.5 |
| TAB1 | -6122.0 |
| KAT2A | -6099.0 |
| ABCA1 | -6097.0 |
| RDH8 | -6074.0 |
| RAMP2 | -6073.0 |
| YWHAH | -6072.0 |
| FZD3 | -6063.0 |
| BRAP | -6050.0 |
| TACR1 | -6047.0 |
| ITPR3 | -6046.0 |
| PTGDR2 | -6038.0 |
| OR52I1 | -6033.5 |
| OR52I2 | -6033.5 |
| GATAD2A | -6019.0 |
| IRAK4 | -6013.0 |
| CTNND1 | -6002.0 |
| STAM | -6001.0 |
| PCP2 | -6000.0 |
| ST3GAL3 | -5996.0 |
| PDK4 | -5994.0 |
| PSMB2 | -5987.0 |
| SNAI1 | -5985.0 |
| FGD1 | -5982.0 |
| SYVN1 | -5980.0 |
| BCL9L | -5979.0 |
| DYNC1I2 | -5974.0 |
| TACR3 | -5973.0 |
| DOCK7 | -5972.0 |
| OR6S1 | -5969.0 |
| USF1 | -5967.0 |
| PDK2 | -5965.0 |
| LFNG | -5964.0 |
| AKT2 | -5958.0 |
| ACTR3 | -5956.0 |
| CD80 | -5911.0 |
| IFT122 | -5901.0 |
| CIT | -5900.0 |
| GNG12 | -5884.0 |
| PPP1CA | -5881.0 |
| TCF7L1 | -5873.0 |
| SKA1 | -5866.0 |
| PTPRK | -5860.0 |
| MAG | -5858.0 |
| WNT2B | -5857.0 |
| PIP5K1C | -5851.0 |
| ITPR2 | -5837.0 |
| WNT5B | -5821.0 |
| DAAM1 | -5816.0 |
| NEFL | -5814.0 |
| FCER2 | -5807.0 |
| AGO1 | -5804.0 |
| POLR2A | -5792.0 |
| FGF6 | -5789.0 |
| HGS | -5785.0 |
| TJP1 | -5784.0 |
| SUCNR1 | -5782.0 |
| COL6A5 | -5779.0 |
| FGFR2 | -5766.0 |
| FES | -5763.0 |
| HSPB1 | -5762.0 |
| KEL | -5755.0 |
| YWHAE | -5754.0 |
| DLG1 | -5738.0 |
| KDR | -5733.0 |
| CYP26B1 | -5722.0 |
| RPS6 | -5720.0 |
| WNT8B | -5701.0 |
| AP2A1 | -5700.0 |
| GPS2 | -5694.0 |
| NOTCH1 | -5689.0 |
| RAMP1 | -5656.0 |
| P2RY6 | -5637.0 |
| JAK1 | -5621.0 |
| WWP2 | -5615.0 |
| ACTB | -5609.0 |
| SH2B2 | -5588.0 |
| CCNE1 | -5587.0 |
| CHD3 | -5584.0 |
| AGTR1 | -5580.0 |
| KSR1 | -5570.0 |
| RHOJ | -5569.0 |
| PSMD3 | -5566.0 |
| RHOBTB1 | -5555.0 |
| PTH1R | -5552.0 |
| CREBBP | -5548.0 |
| ARHGEF19 | -5545.0 |
| LRP2 | -5544.0 |
| UHMK1 | -5539.0 |
| TNRC6C | -5527.0 |
| MYL9 | -5522.0 |
| MIR144 | -5518.0 |
| GREB1 | -5516.0 |
| SPC25 | -5506.0 |
| TACR2 | -5487.0 |
| PIK3R5 | -5482.0 |
| RANGAP1 | -5473.0 |
| DUSP6 | -5469.0 |
| WASL | -5468.0 |
| ARHGAP32 | -5460.0 |
| MET | -5458.0 |
| NRP2 | -5449.0 |
| TFDP1 | -5433.0 |
| ARHGAP9 | -5430.0 |
| TSC1 | -5416.0 |
| DLL4 | -5410.0 |
| OS9 | -5407.0 |
| PDE7B | -5405.0 |
| ADAM10 | -5402.0 |
| GOLGA7 | -5400.0 |
| JAK3 | -5397.0 |
| PSMA8 | -5390.0 |
| PSMD1 | -5382.0 |
| DTX4 | -5348.0 |
| BIRC2 | -5344.0 |
| RPTOR | -5338.0 |
| OR6K6 | -5329.0 |
| FOXH1 | -5328.0 |
| ATP2A3 | -5325.0 |
| SQSTM1 | -5320.0 |
| MAP3K11 | -5319.0 |
| TSHB | -5315.0 |
| PAQR3 | -5314.0 |
| ARHGEF6 | -5311.0 |
| FGFR4 | -5296.0 |
| PSMB7 | -5278.0 |
| CARM1 | -5274.0 |
| FASLG | -5271.0 |
| GNAT2 | -5270.0 |
| NOTCH3 | -5268.0 |
| SH3GL2 | -5262.0 |
| AGO2 | -5246.0 |
| PLCG1 | -5242.0 |
| RLBP1 | -5232.0 |
| IFT140 | -5228.0 |
| PTGER1 | -5226.0 |
| RXRA | -5221.0 |
| CXCR4 | -5218.0 |
| MAP2K1 | -5210.0 |
| LAMA5 | -5206.0 |
| CASP2 | -5200.0 |
| AKAP13 | -5190.0 |
| NCOA2 | -5184.0 |
| TBL1XR1 | -5183.0 |
| WNT16 | -5176.0 |
| LAMC3 | -5168.0 |
| ARHGDIB | -5167.0 |
| PRKCH | -5149.5 |
| GNAO1 | -5147.0 |
| TNFSF10 | -5140.0 |
| OR6N2 | -5135.0 |
| ARHGAP11A | -5134.0 |
| TLN1 | -5122.0 |
| DOCK3 | -5112.0 |
| RNF43 | -5105.5 |
| CCL22 | -5101.0 |
| RCVRN | -5100.0 |
| PKN1 | -5082.0 |
| CENPF | -5077.0 |
| ALDH8A1 | -5065.0 |
| STRN | -5063.0 |
| TLE5 | -5058.0 |
| MEF2D | -5054.0 |
| HECW1 | -5044.0 |
| SSTR4 | -5037.0 |
| LRP5 | -5036.0 |
| MYLIP | -5032.0 |
| NMUR1 | -5014.0 |
| STAT5A | -5013.0 |
| TTC21B | -5004.0 |
| RALB | -4998.0 |
| NET1 | -4984.0 |
| PRKAR1A | -4970.0 |
| NR1H2 | -4967.0 |
| KIF14 | -4955.0 |
| RNF31 | -4944.5 |
| P2RY10 | -4936.0 |
| ARHGAP21 | -4926.0 |
| IRS2 | -4925.0 |
| SYDE2 | -4921.0 |
| POLR2C | -4917.0 |
| MATK | -4914.0 |
| VPS35 | -4902.0 |
| NSL1 | -4888.0 |
| SPTBN5 | -4887.0 |
| PDGFB | -4881.0 |
| TRAF1 | -4878.0 |
| NPHP4 | -4868.0 |
| PIP5K1B | -4857.0 |
| NGEF | -4851.0 |
| PSMC3 | -4849.0 |
| CXCL9 | -4847.0 |
| BCL2L1 | -4845.0 |
| ADGRE5 | -4844.0 |
| GAL | -4837.0 |
| POFUT1 | -4833.0 |
| COL4A2 | -4819.0 |
| HDAC4 | -4813.0 |
| ARHGAP1 | -4806.0 |
| CRHBP | -4802.0 |
| DKK2 | -4799.0 |
| CPT1B | -4789.0 |
| RUNX3 | -4786.0 |
| APLNR | -4782.0 |
| ADCY10 | -4780.0 |
| RSPO4 | -4776.0 |
| H3-4 | -4773.0 |
| PML | -4770.0 |
| PYGO1 | -4769.0 |
| NPW | -4751.0 |
| IL6R | -4743.0 |
| PIK3CD | -4740.0 |
| KREMEN1 | -4725.0 |
| CTNNA1 | -4715.0 |
| RRAGB | -4707.0 |
| GRM5 | -4699.0 |
| BRAF | -4678.0 |
| NCOA3 | -4671.0 |
| PDE4A | -4632.0 |
| RNF146 | -4630.0 |
| TERT | -4625.0 |
| TJP2 | -4621.5 |
| TAS2R60 | -4610.0 |
| HEYL | -4599.0 |
| GNB4 | -4593.0 |
| SREBF1 | -4592.0 |
| RARB | -4591.0 |
| PTK6 | -4590.0 |
| XCR1 | -4583.0 |
| FST | -4568.0 |
| ARHGEF38 | -4562.0 |
| PDE6A | -4543.0 |
| SALL4 | -4534.0 |
| FNTB | -4523.5 |
| CDH1 | -4511.0 |
| RGS3 | -4491.0 |
| FPR2 | -4479.5 |
| FPR3 | -4479.5 |
| COL4A1 | -4472.0 |
| ELMO2 | -4459.0 |
| IQGAP3 | -4455.0 |
| CCR6 | -4453.0 |
| LRAT | -4448.0 |
| DHRS3 | -4431.0 |
| GNAI2 | -4425.0 |
| MC5R | -4388.0 |
| DTX2 | -4386.0 |
| ADRA1D | -4383.0 |
| SOX7 | -4376.0 |
| CASP3 | -4363.0 |
| PIP4K2B | -4348.0 |
| MAPK6 | -4338.0 |
| PDPK1 | -4325.0 |
| PTCH2 | -4298.0 |
| ACTR2 | -4296.0 |
| SFN | -4282.0 |
| PSMC4 | -4280.0 |
| DVL1 | -4267.0 |
| ESRP1 | -4259.0 |
| SMAD5 | -4252.0 |
| STARD13 | -4246.0 |
| TCF7L2 | -4244.0 |
| MAF1 | -4232.0 |
| ANGPT1 | -4231.0 |
| PROKR2 | -4225.0 |
| APOD | -4213.0 |
| IGF2BP1 | -4204.0 |
| FBXW7 | -4203.0 |
| DGKH | -4197.0 |
| GPR4 | -4192.0 |
| RAPGEF1 | -4177.0 |
| ZWINT | -4173.0 |
| GDF2 | -4169.0 |
| GRPR | -4160.0 |
| GZMB | -4156.0 |
| TAS2R3 | -4153.0 |
| LEP | -4134.0 |
| NUP133 | -4126.0 |
| PRKAG3 | -4120.0 |
| RIPK2 | -4098.0 |
| HTR1F | -4088.0 |
| RPS6KB1 | -4087.0 |
| KAT5 | -4080.0 |
| LRIG1 | -4079.0 |
| NMT2 | -4070.0 |
| BDKRB2 | -4057.0 |
| PLCB1 | -4053.0 |
| DTX1 | -4049.0 |
| ATP6V0E2 | -4048.0 |
| ADCY1 | -4044.0 |
| ACVRL1 | -4036.0 |
| CFLAR | -4023.0 |
| LPAR6 | -4022.0 |
| TNFRSF1A | -4011.0 |
| FMNL3 | -4009.0 |
| ATP2A1 | -4002.0 |
| MIR206 | -4000.0 |
| VANGL2 | -3997.0 |
| SSTR3 | -3984.0 |
| PRC1 | -3983.0 |
| RHO | -3979.0 |
| PHC3 | -3939.0 |
| MIR302A | -3935.0 |
| GRM8 | -3921.0 |
| GHRHR | -3915.0 |
| F11R | -3912.0 |
| MYLK | -3905.0 |
| DUSP16 | -3902.0 |
| CAMK2A | -3898.0 |
| GNB1 | -3895.0 |
| BEX3 | -3892.0 |
| MCHR1 | -3891.0 |
| A2M | -3884.0 |
| C3AR1 | -3874.0 |
| MYH11 | -3840.0 |
| OR52B2 | -3822.0 |
| NPB | -3820.0 |
| DNAJB1 | -3819.0 |
| UTS2 | -3797.0 |
| PSMD7 | -3791.0 |
| RAG1 | -3788.0 |
| CCL4 | -3785.5 |
| JAK2 | -3777.0 |
| COL6A6 | -3769.0 |
| PHC2 | -3767.0 |
| ALDH1A1 | -3766.0 |
| HSPG2 | -3764.0 |
| GABRQ | -3752.0 |
| TNF | -3751.0 |
| TLE3 | -3738.0 |
| PRDM4 | -3727.0 |
| CBL | -3706.0 |
| RPS6KA3 | -3698.0 |
| PTPN7 | -3695.0 |
| CHRM1 | -3677.0 |
| APBB1IP | -3673.0 |
| RANBP10 | -3667.0 |
| WNT9A | -3665.0 |
| CBX6 | -3654.0 |
| SPPL2B | -3638.0 |
| H2BC3 | -3635.0 |
| PPP2CB | -3632.0 |
| GNRHR | -3625.0 |
| F2 | -3616.0 |
| H2BC12 | -3610.0 |
| IL6 | -3607.0 |
| CXCL11 | -3606.0 |
| RHOV | -3598.0 |
| DGKK | -3596.0 |
| DYNLL2 | -3587.0 |
| ELK1 | -3586.0 |
| PTPRJ | -3574.0 |
| ROR1 | -3567.0 |
| GPC2 | -3565.0 |
| PTH2 | -3564.0 |
| PSEN1 | -3548.0 |
| H2AJ | -3539.0 |
| GDI2 | -3504.0 |
| MIR106B | -3491.0 |
| KANK1 | -3487.0 |
| PRKCQ | -3483.0 |
| PPP2R1A | -3477.0 |
| LAMC1 | -3476.0 |
| GPR84 | -3469.0 |
| RGR | -3467.0 |
| MLST8 | -3465.0 |
| MIR150 | -3462.0 |
| RXFP1 | -3454.0 |
| ZW10 | -3417.0 |
| MYD88 | -3411.0 |
| GPIHBP1 | -3404.0 |
| ROCK2 | -3394.0 |
| CCR3 | -3385.0 |
| LCK | -3384.0 |
| RASGRF1 | -3383.0 |
| ITGB3 | -3380.5 |
| ACKR4 | -3367.0 |
| SOX13 | -3366.0 |
| OR5B2 | -3361.0 |
| PPP1R12B | -3357.0 |
| VCP | -3356.0 |
| GRB2 | -3336.0 |
| SERPINE1 | -3327.0 |
| CLASP2 | -3322.0 |
| EDN1 | -3312.0 |
| PTGIR | -3311.0 |
| ARHGAP39 | -3310.0 |
| LRP10 | -3298.0 |
| OR51E2 | -3273.0 |
| GSK3A | -3260.0 |
| SGO1 | -3255.0 |
| GPR31 | -3246.0 |
| CD55 | -3223.0 |
| IFT172 | -3218.0 |
| HTR5A | -3216.0 |
| GTF2F2 | -3213.0 |
| GTF2F1 | -3198.0 |
| GPR183 | -3193.0 |
| JAG2 | -3181.0 |
| MIR22 | -3163.0 |
| FABP7 | -3155.0 |
| HSP90AB1 | -3151.0 |
| GUCA1B | -3130.0 |
| HEBP1 | -3127.0 |
| OR8H1 | -3118.0 |
| OR8H2 | -3118.0 |
| OR8H3 | -3118.0 |
| KDM1B | -3115.0 |
| SPTBN4 | -3105.0 |
| PSMD4 | -3087.0 |
| RHOB | -3080.0 |
| ATP6V1B1 | -3077.0 |
| GNG7 | -3060.0 |
| COL4A5 | -3059.0 |
| ACTN2 | -3058.0 |
| B4GALT1 | -3055.0 |
| PREX1 | -3045.0 |
| MUC20 | -3040.0 |
| GPR161 | -3021.0 |
| PSME1 | -3015.0 |
| SCD | -2989.0 |
| SDC4 | -2987.0 |
| ABHD17A | -2953.0 |
| WNT7B | -2916.0 |
| CENPO | -2904.0 |
| PYGO2 | -2886.0 |
| EVC2 | -2863.0 |
| GNA11 | -2862.0 |
| IL6ST | -2837.0 |
| FAM13A | -2836.0 |
| GPNMB | -2829.0 |
| PTEN | -2811.0 |
| HHIP | -2809.0 |
| SOS1 | -2808.0 |
| NRG3 | -2799.0 |
| SSTR5 | -2799.0 |
| GLI3 | -2791.0 |
| PRKCG | -2783.0 |
| KHDRBS2 | -2776.0 |
| RACGAP1 | -2770.0 |
| CCL17 | -2763.0 |
| KDM3A | -2751.0 |
| NOTCH4 | -2740.0 |
| CYP4V2 | -2726.0 |
| GTF2A2 | -2725.0 |
| RIT1 | -2710.0 |
| LYN | -2708.0 |
| CUL1 | -2706.0 |
| ARHGDIA | -2696.0 |
| RANBP9 | -2692.0 |
| TYK2 | -2663.0 |
| PPP3CA | -2656.0 |
| ADORA2A | -2639.0 |
| YAP1 | -2635.0 |
| CCL2 | -2628.0 |
| ABI2 | -2625.0 |
| CDK5 | -2600.0 |
| DDX5 | -2584.0 |
| NFKB1 | -2579.0 |
| SMC1A | -2578.0 |
| FLT1 | -2576.0 |
| IL5RA | -2567.0 |
| NAB2 | -2564.0 |
| ARHGAP31 | -2557.0 |
| TRIB3 | -2550.0 |
| ARHGEF18 | -2547.5 |
| APLN | -2542.0 |
| RBBP4 | -2539.0 |
| IQGAP2 | -2507.0 |
| RPS6KA5 | -2499.0 |
| HEY1 | -2485.0 |
| PPBP | -2477.0 |
| PDK1 | -2473.0 |
| LPL | -2467.0 |
| E2F3 | -2466.0 |
| SMC3 | -2449.0 |
| IQCE | -2446.0 |
| ABCG5 | -2445.0 |
| WNT8A | -2439.0 |
| WIF1 | -2426.0 |
| P4HB | -2423.0 |
| P2RY2 | -2415.0 |
| GGA3 | -2414.0 |
| DNER | -2407.0 |
| ATP6V1B2 | -2392.0 |
| OR8G1 | -2378.5 |
| OR8G5 | -2378.5 |
| EPGN | -2373.0 |
| RSPO3 | -2372.0 |
| KNTC1 | -2370.0 |
| VEGFB | -2366.0 |
| LINGO1 | -2353.0 |
| ADCY5 | -2343.0 |
| CUL5 | -2339.0 |
| FMNL1 | -2291.0 |
| FZD7 | -2287.0 |
| PENK | -2272.0 |
| SPOP | -2270.0 |
| REEP2 | -2261.0 |
| HRAS | -2253.0 |
| NOTUM | -2252.0 |
| MYH10 | -2249.0 |
| CX3CL1 | -2245.0 |
| FLT4 | -2242.0 |
| DNAL4 | -2239.0 |
| SH2B3 | -2226.0 |
| UCHL5 | -2219.0 |
| OR10G2 | -2217.0 |
| FPR1 | -2214.0 |
| TFDP2 | -2213.0 |
| PPP5C | -2209.0 |
| LTB4R | -2187.0 |
| TRAF6 | -2185.0 |
| CLIP3 | -2179.0 |
| AATF | -2176.0 |
| PSEN2 | -2171.5 |
| TBP | -2169.0 |
| LAMA4 | -2168.0 |
| UBA52 | -2166.0 |
| PRKCI | -2165.0 |
| DUSP8 | -2153.0 |
| RGS1 | -2147.0 |
| MBD3 | -2136.0 |
| RCOR1 | -2134.0 |
| S100A9 | -2129.0 |
| RLN3 | -2119.0 |
| ARHGAP26 | -2118.0 |
| ADAM17 | -2112.0 |
| RELA | -2108.0 |
| GPC3 | -2107.0 |
| KISS1 | -2106.0 |
| USP9X | -2105.0 |
| ADM2 | -2081.0 |
| CCKAR | -2081.0 |
| CCR4 | -2081.0 |
| GNG13 | -2081.0 |
| MIR34A | -2081.0 |
| MIR449B | -2081.0 |
| OPN1LW | -2081.0 |
| OPN1MW | -2081.0 |
| OR7E24 | -2063.0 |
| FABP6 | -2049.0 |
| LGR5 | -2042.0 |
| SDC3 | -2040.0 |
| DACT1 | -2031.0 |
| NPFF | -2026.0 |
| RHOT2 | -2024.0 |
| RHOD | -2015.0 |
| OR5P2 | -2010.0 |
| HGFAC | -2009.0 |
| PPID | -2004.0 |
| PLTP | -2003.0 |
| APOC4 | -1990.0 |
| MAML1 | -1974.0 |
| PSMB5 | -1949.0 |
| H3-3A | -1923.0 |
| OR6Y1 | -1916.0 |
| OR8K3 | -1912.0 |
| GABRG2 | -1909.5 |
| PSENEN | -1907.0 |
| EGR3 | -1895.0 |
| PRKAG2 | -1889.0 |
| RARG | -1886.0 |
| YWHAG | -1883.0 |
| PLPPR5 | -1872.0 |
| FOSL1 | -1864.0 |
| OTULIN | -1856.0 |
| WNT7A | -1849.0 |
| OR2F1 | -1842.5 |
| OR2F2 | -1842.5 |
| VRK3 | -1839.0 |
| RCC2 | -1836.0 |
| GPR176 | -1832.0 |
| HDAC11 | -1830.0 |
| USP8 | -1825.0 |
| F2RL2 | -1823.0 |
| OR11A1 | -1818.0 |
| ADCY9 | -1812.0 |
| OR10K1 | -1811.0 |
| PRKCA | -1808.0 |
| POLR2F | -1805.0 |
| HDAC7 | -1803.0 |
| EPN1 | -1801.0 |
| CAV2 | -1799.0 |
| DSN1 | -1798.0 |
| GHSR | -1789.0 |
| DAGLA | -1781.0 |
| PDHA1 | -1776.0 |
| GPR55 | -1771.0 |
| OR5G3 | -1752.5 |
| CCKBR | -1743.0 |
| PSMD10 | -1732.0 |
| RHOU | -1725.0 |
| IL1RL1 | -1724.0 |
| CAV1 | -1723.0 |
| RIPK1 | -1717.0 |
| MAPK13 | -1710.0 |
| MAPK12 | -1705.0 |
| SOCS6 | -1702.0 |
| CBX2 | -1695.0 |
| SIRT6 | -1692.0 |
| CXCL10 | -1631.0 |
| HES1 | -1625.0 |
| EGFR | -1624.0 |
| GATA3 | -1622.0 |
| CXCL16 | -1619.0 |
| MYL12B | -1606.0 |
| EREG | -1562.5 |
| GABRB2 | -1562.5 |
| OR10V1 | -1562.5 |
| OR14J1 | -1562.5 |
| OR1I1 | -1562.5 |
| OR1Q1 | -1562.5 |
| OR4A15 | -1562.5 |
| OR4P4 | -1562.5 |
| OR56B4 | -1562.5 |
| OR5M11 | -1562.5 |
| OR5P3 | -1562.5 |
| OR5T1 | -1562.5 |
| OR5T3 | -1562.5 |
| OR6C2 | -1562.5 |
| OR6C68 | -1562.5 |
| OR8B8 | -1562.5 |
| PSMB11 | -1562.5 |
| OR5AK2 | -1523.0 |
| OR5AK3P | -1523.0 |
| TAS2R14 | -1512.0 |
| NF2 | -1495.0 |
| ARHGAP29 | -1488.0 |
| TAB2 | -1485.0 |
| METAP1 | -1481.0 |
| DHRS4 | -1472.5 |
| STK4 | -1468.0 |
| GALR1 | -1455.0 |
| AP2S1 | -1453.0 |
| NPSR1 | -1445.0 |
| WNT3 | -1443.0 |
| SP1 | -1438.0 |
| TRADD | -1426.0 |
| PPP1R14A | -1424.0 |
| CCND1 | -1414.0 |
| TRHR | -1407.0 |
| WNT3A | -1406.0 |
| RACK1 | -1396.0 |
| KDM4B | -1378.0 |
| OMG | -1376.0 |
| EDNRB | -1365.0 |
| RASAL3 | -1364.0 |
| OR4B1 | -1361.5 |
| TRAT1 | -1354.0 |
| FRS2 | -1340.0 |
| GPC6 | -1334.0 |
| NDE1 | -1332.0 |
| RHOBTB2 | -1304.0 |
| PLXNB1 | -1301.0 |
| KIF2A | -1295.0 |
| CASR | -1291.0 |
| DLL1 | -1289.0 |
| C5AR1 | -1280.0 |
| UBE2D1 | -1275.0 |
| ARHGEF39 | -1272.0 |
| RGS13 | -1258.0 |
| TEK | -1251.0 |
| CCR7 | -1237.0 |
| MIR19A | -1229.0 |
| GRM6 | -1224.0 |
| OR10A3 | -1219.5 |
| OR10A6 | -1219.5 |
| HTR4 | -1218.0 |
| GPR45 | -1179.0 |
| TGFB1 | -1162.0 |
| EPS15 | -1160.0 |
| GPR143 | -1156.0 |
| YWHAB | -1151.0 |
| USF2 | -1149.0 |
| MIR200B | -1147.0 |
| KHDRBS1 | -1146.0 |
| GPR35 | -1144.0 |
| CXCL13 | -1141.0 |
| AGRN | -1136.0 |
| OR9G1 | -1126.0 |
| PSMD8 | -1124.0 |
| MIR33A | -1119.0 |
| GPSM2 | -1112.0 |
| JUNB | -1108.0 |
| CDK5R2 | -1106.0 |
| NOTCH2 | -1097.0 |
| CDC42EP2 | -1096.0 |
| TGFA | -1093.0 |
| DRD5 | -987.0 |
| GABRA1 | -987.0 |
| IL2 | -987.0 |
| MIR19B1 | -987.0 |
| MTNR1A | -987.0 |
| OR10J5 | -987.0 |
| OR11G2 | -987.0 |
| OR12D3 | -987.0 |
| OR1A1 | -987.0 |
| OR1A2 | -987.0 |
| OR1J4 | -987.0 |
| OR1P1 | -987.0 |
| OR2A1 | -987.0 |
| OR2T1 | -987.0 |
| OR2W3 | -987.0 |
| OR4C16 | -987.0 |
| OR4C6 | -987.0 |
| OR51G2 | -987.0 |
| OR51Q1 | -987.0 |
| OR52E4 | -987.0 |
| OR5AL1 | -987.0 |
| OR5R1 | -987.0 |
| OR7G1 | -987.0 |
| OR8B12 | -987.0 |
| OR8B2 | -987.0 |
| OR8B3 | -987.0 |
| OR8D4 | -987.0 |
| OR9K2 | -987.0 |
| PROK1 | -987.0 |
| RBP2 | -987.0 |
| TAAR5 | -987.0 |
| TAS2R1 | -987.0 |
| ARHGAP40 | -907.5 |
| CHRM2 | -907.5 |
| FGFBP1 | -907.5 |
| OR2B11 | -907.5 |
| OR2H1 | -907.5 |
| OR2H2 | -907.5 |
| OR4D1 | -907.5 |
| OR52M1 | -907.5 |
| OR2T29 | -895.0 |
| OR2T4 | -895.0 |
| OR2T5 | -895.0 |
| DUSP9 | -893.0 |
| OR5B3 | -884.0 |
| OR4C15 | -879.0 |
| ACVR1B | -867.0 |
| CDKN2B | -860.0 |
| TLE2 | -858.0 |
| SPTA1 | -830.0 |
| ITCH | -823.0 |
| KREMEN2 | -783.0 |
| ARHGEF10 | -775.0 |
| H2AZ1 | -773.0 |
| DRAP1 | -757.0 |
| PRR5 | -751.0 |
| PPP3CB | -748.0 |
| ADAP1 | -745.0 |
| KLB | -739.0 |
| CALCR | -738.0 |
| OR14C36 | -733.5 |
| OR52N2 | -733.5 |
| OR56B2P | -733.5 |
| OR7G2 | -733.5 |
| OPRL1 | -730.0 |
| TNS4 | -726.0 |
| OR5AC1 | -686.0 |
| RGS4 | -680.0 |
| SMAD1 | -668.0 |
| HCRTR1 | -648.0 |
| FOXO6 | -645.0 |
| RHOA | -640.0 |
| CCR10 | -637.0 |
| STAM2 | -609.0 |
| RETSAT | -602.0 |
| EGR4 | -567.0 |
| MEN1 | -556.0 |
| APOA1 | -547.0 |
| GFRA3 | -543.0 |
| BCL9 | -533.0 |
| OR2AK2 | -519.5 |
| OR5H1 | -519.5 |
| OR5H14 | -519.5 |
| OR5H15 | -519.5 |
| OR5H6 | -519.5 |
| MECOM | -508.0 |
| PPP1R15A | -495.0 |
| PEA15 | -488.0 |
| FOXA1 | -485.0 |
| WDR83 | -482.0 |
| ARHGEF15 | -470.0 |
| NCF4 | -467.0 |
| PDE6B | -466.0 |
| BRS3 | -461.0 |
| ARAF | -453.0 |
| ARHGEF33 | -451.0 |
| KLHL12 | -450.0 |
| ATP6V0D2 | -449.0 |
| YWHAZ | -416.0 |
| GPHB5 | -374.0 |
| FZD9 | -370.0 |
| FADD | -344.0 |
| MIR20A | -338.5 |
| OR52D1 | -338.5 |
| NPY5R | -309.0 |
| OR10G3 | -309.0 |
| OR4A47 | -309.0 |
| OR4F6 | -309.0 |
| OR51F2 | -309.0 |
| OR52P1P | -309.0 |
| OR9A4 | -309.0 |
| CGA | -282.0 |
| ATP6V1G3 | -280.0 |
| DGKD | -273.0 |
| ARHGAP30 | -260.0 |
| AREG | -256.0 |
| RTKN | -253.0 |
| REEP1 | -250.0 |
| REEP5 | -211.0 |
| CAMKK2 | -200.0 |
| CXCL12 | -188.0 |
| OPRD1 | -187.0 |
| FER | -185.0 |
| KALRN | -177.0 |
| FOS | -162.0 |
| EPS15L1 | -152.0 |
| RHOF | -150.0 |
| PRKAB2 | -149.0 |
| CXXC4 | -148.0 |
| OR7D4 | -133.0 |
| OR5AN1 | -121.5 |
| OR1N1 | -118.0 |
| RGS18 | -112.0 |
| GNB5 | -108.0 |
| CALM1 | -83.0 |
| OR10AG1 | -40.0 |
| SMAD3 | -28.0 |
| GPR37L1 | -27.0 |
| ARRB1 | -23.0 |
| PDK3 | -21.0 |
| GPR65 | -16.0 |
| REEP3 | -8.0 |
| CYBA | -1.0 |
| ERBB3 | 1.0 |
| FKBP4 | 5.0 |
| OR6B2 | 6.5 |
| OR6B3 | 6.5 |
| OR4F17 | 11.0 |
| OR4F4 | 11.0 |
| OR4F5 | 11.0 |
| SMURF2 | 17.0 |
| GRIN2B | 27.0 |
| BMP10 | 36.0 |
| EIF4E | 41.0 |
| AVPR1A | 53.0 |
| CD19 | 55.0 |
| RAC3 | 84.0 |
| PIK3CA | 85.0 |
| GNA15 | 89.0 |
| RBX1 | 95.0 |
| ERLEC1 | 99.0 |
| DOCK1 | 104.0 |
| BCR | 111.0 |
| H2AZ2 | 124.0 |
| LAMB1 | 139.0 |
| TAS2R4 | 142.0 |
| CALCB | 231.0 |
| CNGA1 | 231.0 |
| FFAR1 | 231.0 |
| IAPP | 231.0 |
| IL5 | 231.0 |
| MC3R | 231.0 |
| MIR17 | 231.0 |
| MIR34B | 231.0 |
| NPBWR1 | 231.0 |
| OR10W1 | 231.0 |
| OR13F1 | 231.0 |
| OR13J1 | 231.0 |
| OR1B1 | 231.0 |
| OR1J1 | 231.0 |
| OR1M1 | 231.0 |
| OR2A14 | 231.0 |
| OR2A5 | 231.0 |
| OR2AP1 | 231.0 |
| OR2L13 | 231.0 |
| OR2Y1 | 231.0 |
| OR4A16 | 231.0 |
| OR4C11 | 231.0 |
| OR4C12 | 231.0 |
| OR4C3 | 231.0 |
| OR4D11 | 231.0 |
| OR4D2 | 231.0 |
| OR4D6 | 231.0 |
| OR4F15 | 231.0 |
| OR4X2 | 231.0 |
| OR51F1 | 231.0 |
| OR52E2 | 231.0 |
| OR52H1 | 231.0 |
| OR52L1 | 231.0 |
| OR52R1 | 231.0 |
| OR56B1 | 231.0 |
| OR5A1 | 231.0 |
| OR5B17 | 231.0 |
| OR5L1 | 231.0 |
| OR5L2 | 231.0 |
| OR5M8 | 231.0 |
| OR6X1 | 231.0 |
| OR8K5 | 231.0 |
| OR9Q2 | 231.0 |
| PIK3CB | 231.0 |
| PTH2R | 231.0 |
| RGS21 | 231.0 |
| RTP1 | 231.0 |
| TAAR8 | 231.0 |
| TAS2R7 | 231.0 |
| FGF20 | 321.0 |
| FGF8 | 321.0 |
| LHCGR | 340.5 |
| GIP | 344.0 |
| OR5C1 | 346.0 |
| NOX3 | 352.0 |
| TAS2R42 | 355.0 |
| DLGAP5 | 369.0 |
| FGF17 | 383.0 |
| COL4A3 | 385.0 |
| NMT1 | 404.0 |
| FGFRL1 | 407.0 |
| MAPK11 | 409.0 |
| OR2B2 | 420.0 |
| DVL3 | 421.0 |
| RAD21 | 438.0 |
| FGF1 | 442.0 |
| NPY4R | 446.5 |
| OXT | 449.0 |
| PSMC5 | 451.0 |
| SHOC2 | 454.0 |
| PRLHR | 457.0 |
| WASF3 | 462.0 |
| IL3 | 466.0 |
| OR4K15 | 540.0 |
| OR6C1 | 540.0 |
| TAS2R19 | 549.0 |
| TAS2R20 | 549.0 |
| TAS2R30 | 549.0 |
| TAS2R31 | 549.0 |
| TAS2R43 | 549.0 |
| TAS2R46 | 549.0 |
| TAS2R50 | 549.0 |
| DKK1 | 556.0 |
| OPN4 | 560.0 |
| OR8A1 | 563.0 |
| APOB | 573.0 |
| ADCYAP1 | 576.0 |
| FLRT1 | 578.0 |
| GAS8 | 584.0 |
| PPP2R5D | 596.0 |
| PIK3R3 | 597.5 |
| BAMBI | 601.0 |
| KIF18A | 607.0 |
| GNRH1 | 612.0 |
| F2RL1 | 616.0 |
| NEURL1B | 617.0 |
| NSMAF | 620.0 |
| GALNT3 | 621.0 |
| ARHGAP44 | 622.0 |
| DISP2 | 632.0 |
| CDC25C | 650.0 |
| PSMD14 | 673.0 |
| OR5W2 | 676.0 |
| GPR17 | 677.0 |
| PPEF1 | 686.0 |
| GRM3 | 693.0 |
| MAPRE1 | 694.0 |
| OR2AG1 | 700.0 |
| TAC1 | 700.0 |
| RHOG | 709.0 |
| ERBB2 | 722.0 |
| PREX2 | 727.0 |
| ATP2A2 | 736.0 |
| RAF1 | 737.0 |
| CBX4 | 766.0 |
| SYDE1 | 773.0 |
| ACTA2 | 781.0 |
| IRAK1 | 791.0 |
| RGS16 | 809.0 |
| F2RL3 | 826.0 |
| ATP6V1G1 | 828.0 |
| OR52E6 | 842.0 |
| OR52E8 | 842.0 |
| OR8D1 | 842.0 |
| FSHR | 861.5 |
| INS | 861.5 |
| OR4M1 | 861.5 |
| OR4M2 | 861.5 |
| OR4X1 | 861.5 |
| OR51B6 | 861.5 |
| OR51I2 | 861.5 |
| PYY | 861.5 |
| FFAR3 | 896.0 |
| OR10C1 | 896.0 |
| OR10S1 | 896.0 |
| OR2V1 | 896.0 |
| OR4K5 | 896.0 |
| OR51A2 | 896.0 |
| OR51A4 | 896.0 |
| OR51V1 | 896.0 |
| OR52K2 | 896.0 |
| OR2V2 | 917.5 |
| OR2Z1 | 917.5 |
| OPN5 | 921.0 |
| BAD | 928.0 |
| TAS2R13 | 930.0 |
| NUP107 | 935.0 |
| RAP1A | 937.0 |
| NLN | 943.0 |
| RHOQ | 950.0 |
| SPRED1 | 953.0 |
| CCL3 | 960.0 |
| SORCS3 | 985.0 |
| GNG5 | 992.0 |
| KIF2B | 996.0 |
| PTBP1 | 1021.0 |
| RRAGD | 1040.0 |
| EEF2K | 1044.0 |
| PDHA2 | 1046.0 |
| RHPN2 | 1059.0 |
| ADAM12 | 1062.0 |
| SEC13 | 1065.0 |
| MIR181C | 1066.0 |
| GHRH | 1070.0 |
| BIRC5 | 1082.0 |
| GLI1 | 1088.0 |
| OR10H1 | 1093.5 |
| OR10H5 | 1093.5 |
| QRFP | 1095.0 |
| APH1A | 1110.0 |
| SKP1 | 1129.0 |
| UBE2M | 1137.0 |
| MIR25 | 1148.0 |
| CAMK4 | 1172.0 |
| NUF2 | 1173.0 |
| CCNK | 1182.0 |
| GRM2 | 1192.0 |
| FFAR4 | 1193.0 |
| GRK2 | 1198.0 |
| RGL1 | 1218.0 |
| KLC2 | 1226.0 |
| MOB1A | 1227.0 |
| TRIP10 | 1231.0 |
| SH2B1 | 1236.0 |
| SH3KBP1 | 1239.0 |
| TAS2R10 | 1246.0 |
| SRGAP3 | 1255.0 |
| PRKCZ | 1256.0 |
| CENPN | 1272.0 |
| CTTN | 1289.0 |
| GNAT3 | 1292.0 |
| RPS6KA2 | 1294.0 |
| CENPU | 1295.0 |
| SSTR2 | 1311.0 |
| NCKAP1 | 1318.0 |
| HEY2 | 1323.0 |
| HGF | 1325.0 |
| AP2M1 | 1347.0 |
| SOX2 | 1368.0 |
| STAP2 | 1378.0 |
| XCL1 | 1380.5 |
| XCL2 | 1380.5 |
| OR52E5 | 1404.0 |
| OR2AG2 | 1419.5 |
| OR7C2 | 1419.5 |
| OR8U1 | 1419.5 |
| TAAR1 | 1419.5 |
| GDI1 | 1433.0 |
| KLK2 | 1449.5 |
| KLK3 | 1449.5 |
| DIAPH2 | 1453.0 |
| ARHGAP33 | 1479.0 |
| RBCK1 | 1484.0 |
| AKT1 | 1488.0 |
| ARHGAP27 | 1497.0 |
| ATP6V1D | 1526.0 |
| OR4N5 | 1533.0 |
| MST1 | 1542.0 |
| PRKCD | 1551.0 |
| WIPF3 | 1562.0 |
| GPR83 | 1568.0 |
| DRD3 | 1587.0 |
| EP300 | 1591.0 |
| PSMD9 | 1596.5 |
| TBL1X | 1601.5 |
| ADCY3 | 1612.0 |
| ACVR2B | 1614.0 |
| GRK1 | 1615.0 |
| ADM | 1625.0 |
| GPR15 | 1643.0 |
| TRAF2 | 1651.0 |
| APOM | 1657.0 |
| PDE3B | 1668.0 |
| TAB3 | 1681.0 |
| JUN | 1686.0 |
| NRP1 | 1688.0 |
| CBX8 | 1695.0 |
| OR13C3 | 1717.0 |
| PSMD12 | 1729.0 |
| ATP6V1E1 | 1734.0 |
| PSMB3 | 1735.0 |
| CRHR1 | 1747.0 |
| RYK | 1765.0 |
| LAMTOR1 | 1769.0 |
| CDC14B | 1785.0 |
| NRAS | 1786.0 |
| GUCY2D | 1791.0 |
| ATP6V0A4 | 1802.0 |
| SDR16C5 | 1807.0 |
| CTNNB1 | 1809.0 |
| HRH4 | 1810.0 |
| SFPQ | 1818.0 |
| PROK2 | 1822.0 |
| DGKQ | 1845.0 |
| CSN2 | 1876.0 |
| FGF3 | 1876.0 |
| GPRC6A | 1876.0 |
| HHAT | 1886.0 |
| PNLIP | 1909.0 |
| VAV1 | 1912.0 |
| PPP1CB | 1917.0 |
| ARPC4 | 1946.0 |
| GRP | 1947.0 |
| CXCL6 | 1966.0 |
| GALR3 | 1969.0 |
| NRTN | 1970.0 |
| RAB4B | 1972.5 |
| FRS3 | 1979.0 |
| SCTR | 1986.0 |
| PSMB1 | 1994.0 |
| GDNF | 2000.0 |
| PSMB4 | 2009.0 |
| KIF7 | 2020.0 |
| DNM3 | 2027.0 |
| BOC | 2047.0 |
| OR6K3 | 2052.0 |
| FZD4 | 2057.0 |
| CSNK2A1 | 2059.5 |
| MAPK1 | 2063.0 |
| SUZ12 | 2083.0 |
| CFTR | 2088.0 |
| KITLG | 2099.0 |
| LRP8 | 2101.0 |
| USP13 | 2108.0 |
| JUND | 2121.0 |
| KTN1 | 2123.0 |
| HTR2B | 2125.0 |
| INHBB | 2128.0 |
| MST1R | 2138.0 |
| OR2T12 | 2143.0 |
| OR2T33 | 2143.0 |
| OR2T8 | 2143.0 |
| RRAGA | 2158.0 |
| DHH | 2159.0 |
| FRAT1 | 2162.0 |
| RTP4 | 2164.0 |
| MC2R | 2177.0 |
| DRD2 | 2184.0 |
| CRK | 2198.0 |
| TMED5 | 2200.0 |
| ADCY7 | 2210.0 |
| POLR2B | 2214.0 |
| DYNLL1 | 2216.0 |
| NOXA1 | 2226.0 |
| RAC1 | 2240.0 |
| OR2AT4 | 2241.0 |
| ITGAV | 2243.0 |
| PFN2 | 2246.0 |
| ARHGAP4 | 2279.0 |
| LATS2 | 2288.0 |
| PSMD2 | 2314.0 |
| OR6C70 | 2316.5 |
| PSMA1 | 2318.0 |
| CFL1 | 2322.0 |
| OFD1 | 2335.0 |
| P2RY12 | 2339.0 |
| CENPQ | 2367.0 |
| OR6C76 | 2370.0 |
| MIB2 | 2372.0 |
| SFRP1 | 2381.0 |
| RBL1 | 2395.0 |
| INPP5B | 2405.0 |
| FGF4 | 2406.0 |
| YY1 | 2410.0 |
| TAGAP | 2414.0 |
| GAB2 | 2423.0 |
| SCT | 2430.0 |
| RASA2 | 2440.0 |
| NOS3 | 2441.0 |
| ITGB1 | 2469.0 |
| NGF | 2470.0 |
| WNT5A | 2473.0 |
| GRK5 | 2483.0 |
| IL1RAP | 2513.0 |
| RGS22 | 2514.0 |
| PAK2 | 2520.0 |
| MAPK3 | 2532.0 |
| PSMF1 | 2535.0 |
| BMI1 | 2614.5 |
| NCK2 | 2619.0 |
| RSPO1 | 2627.0 |
| ARHGAP25 | 2629.0 |
| PRKCB | 2630.0 |
| APC | 2637.0 |
| MTA2 | 2644.0 |
| ERCC6L | 2649.0 |
| CTSD | 2669.5 |
| FGFBP3 | 2673.0 |
| YWHAQ | 2683.0 |
| FLNA | 2688.0 |
| KSR2 | 2694.0 |
| WWC1 | 2697.0 |
| ATP6V1E2 | 2719.0 |
| CENPH | 2724.0 |
| PTPRS | 2729.0 |
| GPR68 | 2735.0 |
| MMP7 | 2736.0 |
| GPHA2 | 2779.0 |
| BCL2 | 2785.0 |
| ARHGAP23 | 2812.0 |
| HCRT | 2813.0 |
| FGF2 | 2815.0 |
| TBXA2R | 2824.0 |
| MAP3K7 | 2825.0 |
| ADRB2 | 2844.0 |
| TIAL1 | 2849.0 |
| GAB1 | 2850.0 |
| RXRG | 2860.0 |
| HCAR2 | 2866.5 |
| HCAR3 | 2866.5 |
| CRKL | 2879.0 |
| WNT1 | 2881.0 |
| KIDINS220 | 2893.0 |
| GRAP | 2913.0 |
| CAMKMT | 2915.0 |
| NCKAP1L | 2932.0 |
| KLC4 | 2935.0 |
| LATS1 | 2938.0 |
| GABRG3 | 2949.0 |
| LDLR | 2957.0 |
| AMOTL2 | 2960.0 |
| KAT2B | 2962.0 |
| MAPKAPK2 | 2978.0 |
| SEPTIN7 | 2983.0 |
| GUCY2F | 3001.0 |
| WIPF1 | 3006.0 |
| PSME4 | 3023.0 |
| PDE8B | 3035.5 |
| SNW1 | 3076.0 |
| SPRED2 | 3077.0 |
| CCR1 | 3082.0 |
| ATP6AP1 | 3091.0 |
| PHLPP2 | 3120.0 |
| CRABP2 | 3127.0 |
| FLT3 | 3128.0 |
| IKBKG | 3133.0 |
| NELFB | 3135.0 |
| GNA12 | 3137.0 |
| ASCL1 | 3141.0 |
| PDYN | 3143.0 |
| NOXO1 | 3155.0 |
| LAMTOR3 | 3167.0 |
| CDCA8 | 3177.0 |
| ST3GAL6 | 3182.0 |
| CCL23 | 3192.0 |
| STMN1 | 3198.0 |
| FGF23 | 3205.0 |
| SKI | 3211.0 |
| SHH | 3214.0 |
| NLK | 3218.0 |
| KCTD6 | 3219.0 |
| HCAR1 | 3224.0 |
| FLRT2 | 3256.0 |
| POMC | 3261.0 |
| AVP | 3271.0 |
| PEBP1 | 3284.0 |
| SHARPIN | 3295.0 |
| GNG3 | 3307.0 |
| PCSK5 | 3308.0 |
| PDE1A | 3353.0 |
| ID4 | 3360.0 |
| F2R | 3369.0 |
| LPAR1 | 3370.0 |
| USP7 | 3382.0 |
| CPT1A | 3390.0 |
| RGS7 | 3418.0 |
| DIAPH3 | 3419.0 |
| GNAT1 | 3423.0 |
| ERBB4 | 3432.0 |
| FAM13B | 3460.0 |
| PRKAA1 | 3464.0 |
| HDAC10 | 3474.0 |
| POLR2I | 3477.0 |
| POLR2D | 3487.0 |
| P2RY4 | 3493.0 |
| CCRL2 | 3501.0 |
| MTOR | 3550.0 |
| LGR6 | 3551.0 |
| HDAC2 | 3553.0 |
| DLK1 | 3555.0 |
| SDR9C7 | 3561.0 |
| BDKRB1 | 3562.0 |
| CCNT2 | 3571.0 |
| TRIM27 | 3584.0 |
| EGR1 | 3598.0 |
| ADRB1 | 3612.0 |
| GRK4 | 3623.0 |
| CLTB | 3636.0 |
| PIP4K2C | 3637.0 |
| GPC1 | 3640.0 |
| CBFB | 3647.0 |
| HDAC8 | 3649.5 |
| CCND3 | 3651.0 |
| PSMD13 | 3656.0 |
| WWTR1 | 3663.0 |
| MYO7A | 3664.0 |
| FABP5 | 3676.0 |
| NMB | 3696.0 |
| F3 | 3700.0 |
| PTPN11 | 3701.0 |
| MAPK14 | 3711.0 |
| RHEB | 3718.0 |
| ZDHHC21 | 3720.0 |
| ATP6V1F | 3727.0 |
| GNAI3 | 3733.0 |
| ATP1B4 | 3748.0 |
| COL6A1 | 3749.0 |
| GNG11 | 3752.0 |
| B9D2 | 3753.0 |
| TPH1 | 3766.0 |
| HRH1 | 3792.0 |
| PDE3A | 3794.0 |
| AR | 3802.0 |
| NTF4 | 3813.0 |
| KIT | 3843.0 |
| ATP6V0B | 3850.0 |
| CDK2 | 3851.0 |
| PPP1R1B | 3853.0 |
| PSMA5 | 3857.0 |
| PTPN2 | 3859.0 |
| GPR25 | 3869.0 |
| PPM1A | 3872.0 |
| TGFBR2 | 3873.0 |
| TCIRG1 | 3878.0 |
| BCO1 | 3884.0 |
| DLD | 3894.0 |
| IQGAP1 | 3904.0 |
| MED1 | 3935.0 |
| ADRA1B | 3941.0 |
| PSMC1 | 3947.0 |
| RNF111 | 3951.0 |
| TNS3 | 3965.0 |
| NCBP1 | 3976.0 |
| USP34 | 3993.0 |
| SOCS3 | 3999.0 |
| OR5I1 | 4012.0 |
| SLC24A1 | 4032.0 |
| IKBKB | 4039.0 |
| STK11 | 4058.0 |
| DOK1 | 4062.0 |
| AURKB | 4064.0 |
| SH3GL1 | 4081.0 |
| PRICKLE1 | 4084.0 |
| JAG1 | 4086.0 |
| FKBP5 | 4107.0 |
| CSF2 | 4120.0 |
| CCR8 | 4126.0 |
| RRAGC | 4129.0 |
| ECE2 | 4133.5 |
| RAP1B | 4145.0 |
| GABRB1 | 4149.0 |
| CKAP5 | 4160.0 |
| CTBP1 | 4163.0 |
| FGD2 | 4170.0 |
| ARAP3 | 4175.0 |
| PDE8A | 4181.0 |
| LYPLA1 | 4183.0 |
| DUSP5 | 4190.0 |
| PIK3R4 | 4193.0 |
| STUB1 | 4214.0 |
| ID1 | 4225.0 |
| PTAFR | 4229.0 |
| ZWILCH | 4234.0 |
| GFRA1 | 4239.0 |
| ALDH1A3 | 4259.0 |
| PCSK6 | 4262.0 |
| CCK | 4270.0 |
| AP2B1 | 4289.0 |
| NEDD8 | 4299.0 |
| ARAP1 | 4310.0 |
| BAG4 | 4311.0 |
| MAD1L1 | 4314.0 |
| PDHB | 4315.0 |
| CENPT | 4316.0 |
| SRGAP1 | 4317.0 |
| RAG2 | 4319.0 |
| RLN2 | 4323.5 |
| EPO | 4329.0 |
| MEF2C | 4345.0 |
| CBY1 | 4363.0 |
| PTGES3 | 4369.0 |
| PLPPR2 | 4371.0 |
| GNGT2 | 4376.0 |
| RALA | 4380.0 |
| SOX6 | 4403.0 |
| RGS9BP | 4413.0 |
| HNRNPM | 4417.0 |
| NCKIPSD | 4441.0 |
| ITGB3BP | 4443.0 |
| RGS10 | 4447.0 |
| PRKAA2 | 4452.0 |
| GHRL | 4454.0 |
| BUB1B | 4466.5 |
| CHN1 | 4472.0 |
| EBAG9 | 4476.0 |
| PPP2R1B | 4513.0 |
| PAG1 | 4514.0 |
| GTF2A1 | 4516.0 |
| KHDRBS3 | 4518.0 |
| NMU | 4522.0 |
| CLTC | 4525.0 |
| FOXO1 | 4556.0 |
| PGR | 4557.0 |
| PIN1 | 4562.0 |
| FZD8 | 4573.0 |
| ADRA2A | 4582.0 |
| IER3 | 4585.0 |
| CTNNBIP1 | 4586.0 |
| IGF1R | 4593.0 |
| FZD1 | 4610.0 |
| HBEGF | 4618.0 |
| HTR1B | 4630.0 |
| DGKA | 4645.0 |
| PTPN6 | 4670.0 |
| INTU | 4672.0 |
| RAPGEF4 | 4676.0 |
| WASF1 | 4683.0 |
| MIR21 | 4691.0 |
| OR51D1 | 4699.0 |
| CAMKK1 | 4711.0 |
| MAPK7 | 4725.0 |
| GRB7 | 4726.0 |
| LAMA1 | 4727.0 |
| PDGFRA | 4729.0 |
| PLPPR4 | 4737.0 |
| XIAP | 4741.0 |
| TRPC7 | 4748.0 |
| PSMC6 | 4749.0 |
| COL6A2 | 4759.0 |
| STK3 | 4764.0 |
| PFN1 | 4767.0 |
| SOX17 | 4773.0 |
| SPRY2 | 4777.0 |
| HRH3 | 4786.0 |
| FGF18 | 4796.0 |
| DVL2 | 4800.0 |
| CSK | 4803.0 |
| BRK1 | 4805.0 |
| LRP1 | 4809.0 |
| OCRL | 4825.0 |
| TAX1BP1 | 4835.0 |
| CALCA | 4836.0 |
| DYNC1LI2 | 4837.0 |
| TIAM2 | 4841.0 |
| CCL27 | 4856.0 |
| RBP3 | 4858.0 |
| RAB4A | 4867.0 |
| CDC42EP3 | 4868.0 |
| CILP | 4877.0 |
| MIS12 | 4900.0 |
| ABHD17C | 4922.0 |
| ADRA2C | 4926.0 |
| GPR37 | 4931.0 |
| POGLUT1 | 4942.0 |
| MTMR4 | 4944.0 |
| BTC | 4946.0 |
| MKS1 | 4947.0 |
| ROCK1 | 4962.0 |
| SH3GL3 | 4997.0 |
| RDH10 | 5000.0 |
| FZD6 | 5042.0 |
| CAB39L | 5045.0 |
| EVC | 5047.0 |
| PPP3R1 | 5058.5 |
| DIAPH1 | 5071.0 |
| RGS9 | 5078.0 |
| FGFR3 | 5086.0 |
| EPOR | 5088.0 |
| FGF22 | 5103.0 |
| RAMP3 | 5107.0 |
| ROPN1 | 5110.5 |
| SUFU | 5117.0 |
| BMPR2 | 5124.0 |
| FZD5 | 5173.0 |
| METAP2 | 5174.0 |
| DUSP1 | 5190.0 |
| HCRTR2 | 5199.0 |
| RBBP5 | 5206.0 |
| RASGRF2 | 5220.0 |
| SPDL1 | 5244.0 |
| CENPK | 5248.0 |
| CDC42EP5 | 5251.0 |
| RGSL1 | 5265.0 |
| OXTR | 5278.0 |
| GNA13 | 5282.0 |
| OR6K2 | 5286.0 |
| PSMA7 | 5305.0 |
| CDC73 | 5336.0 |
| ARPC1B | 5378.0 |
| PIP5K1A | 5382.0 |
| EFCAB7 | 5391.0 |
| DYNC1I1 | 5392.0 |
| GIPR | 5394.0 |
| ATP6V0C | 5434.0 |
| E2F5 | 5436.0 |
| MRAS | 5437.0 |
| PSMA6 | 5445.0 |
| PRKX | 5448.5 |
| ADGRE1 | 5461.0 |
| UTS2B | 5468.0 |
| ATP6V1H | 5475.0 |
| AMH | 5478.0 |
| NR2E1 | 5483.0 |
| VGF | 5488.0 |
| PDE10A | 5495.0 |
| PIK3C3 | 5498.0 |
| KNL1 | 5503.0 |
| RHOC | 5509.5 |
| PLCG2 | 5518.0 |
| FFAR2 | 5519.0 |
| NMBR | 5522.0 |
| HDAC3 | 5550.0 |
| KBTBD7 | 5569.5 |
| AVPR1B | 5580.0 |
| ROR2 | 5596.0 |
| S1PR5 | 5597.0 |
| RET | 5599.0 |
| UCN | 5600.0 |
| CYBB | 5605.0 |
| DRD4 | 5612.0 |
| CNOT6L | 5613.0 |
| S1PR2 | 5627.0 |
| PTPRU | 5633.0 |
| HTR2A | 5650.0 |
| H2BU1 | 5658.0 |
| PTCH1 | 5659.0 |
| NR5A2 | 5663.0 |
| ARHGAP10 | 5666.0 |
| RGS19 | 5668.0 |
| PSMA2 | 5670.5 |
| SPOPL | 5678.0 |
| PPP1R12A | 5681.0 |
| PSMD5 | 5684.0 |
| TLR9 | 5692.5 |
| WDR19 | 5700.0 |
| ARHGAP28 | 5709.0 |
| MOB1B | 5722.0 |
| DUSP2 | 5724.0 |
| CYP26A1 | 5725.0 |
| CMKLR1 | 5729.0 |
| GFRA4 | 5742.0 |
| SPPL2A | 5745.0 |
| SMPD2 | 5759.0 |
| GPR18 | 5762.0 |
| OR1F1 | 5776.0 |
| EED | 5777.0 |
| ARPC3 | 5792.0 |
| IL33 | 5812.0 |
| VAV2 | 5813.0 |
| CCNC | 5816.0 |
| PLAT | 5817.0 |
| BUB1 | 5820.0 |
| CENPE | 5825.0 |
| FSTL3 | 5829.0 |
| AMER1 | 5847.0 |
| KRAS | 5849.0 |
| PRMT1 | 5858.0 |
| FGF9 | 5865.0 |
| FRK | 5870.0 |
| PMCH | 5889.0 |
| NUP160 | 5904.0 |
| BAX | 5925.0 |
| XPO1 | 5929.0 |
| MEMO1 | 5942.0 |
| MIR26A1 | 5951.0 |
| MAPK8 | 5956.0 |
| ARHGEF25 | 5966.5 |
| PSMD6 | 5980.0 |
| ZFYVE9 | 5983.0 |
| ACTG1 | 5986.0 |
| RICTOR | 5991.0 |
| PTGDR | 6020.0 |
| SAV1 | 6025.0 |
| FZD2 | 6035.0 |
| ABI1 | 6048.0 |
| WDR35 | 6051.0 |
| MOV10 | 6056.0 |
| BCO2 | 6058.0 |
| RGL3 | 6085.0 |
| SOX9 | 6101.0 |
| ARHGEF12 | 6104.0 |
| CENPA | 6108.0 |
| PARD6A | 6114.0 |
| SPARC | 6116.0 |
| FLRT3 | 6143.0 |
| TAS2R41 | 6144.0 |
| DEPDC1B | 6153.0 |
| PSMC2 | 6158.0 |
| SPHK1 | 6185.0 |
| SCUBE2 | 6192.0 |
| MKRN1 | 6195.0 |
| DZIP1 | 6196.0 |
| DLC1 | 6197.0 |
| DYNC2H1 | 6198.0 |
| SOST | 6204.0 |
| STAG2 | 6209.0 |
| BTRC | 6215.0 |
| DERL2 | 6219.0 |
| CDON | 6222.0 |
| ABCG8 | 6224.0 |
| NAPEPLD | 6226.0 |
| SRF | 6231.0 |
| NCF1 | 6238.0 |
| LRRK2 | 6246.0 |
| RCE1 | 6248.0 |
| GNAZ | 6253.0 |
| FGD3 | 6255.0 |
| GNB2 | 6264.0 |
| OR6N1 | 6265.0 |
| SMAD6 | 6270.0 |
| ACKR3 | 6294.0 |
| CHUK | 6304.0 |
| BMP2 | 6309.0 |
| CRH | 6329.0 |
| VEGFC | 6335.0 |
| RASA1 | 6344.0 |
| DLAT | 6345.0 |
| FGF7 | 6355.0 |
| VIPR2 | 6379.0 |
| SMURF1 | 6387.0 |
| RDH12 | 6399.0 |
| C5AR2 | 6406.0 |
| ARHGAP18 | 6408.0 |
| ARTN | 6410.0 |
| CMA1 | 6414.0 |
| LAMB3 | 6421.0 |
| AP2A2 | 6431.0 |
| ZDHHC7 | 6433.0 |
| CDK4 | 6438.0 |
| OR2K2 | 6446.0 |
| SDC2 | 6449.0 |
| ARL2 | 6454.0 |
| REEP4 | 6463.0 |
| ID3 | 6464.0 |
| RASGRP4 | 6479.0 |
| YES1 | 6489.0 |
| KIF5B | 6494.0 |
| GRIN1 | 6495.0 |
| GRM1 | 6498.0 |
| ICOS | 6504.0 |
| STRA6 | 6510.0 |
| ARHGAP15 | 6512.0 |
| RDH5 | 6515.0 |
| OR4E1 | 6518.0 |
| RPS6KB2 | 6534.0 |
| MIR26A2 | 6542.0 |
| ADRA1A | 6572.0 |
| NUP98 | 6576.0 |
| ELF3 | 6579.0 |
| SPTBN1 | 6584.0 |
| SEL1L | 6588.0 |
| PTPN18 | 6594.0 |
| GNG8 | 6614.0 |
| PTPN12 | 6625.0 |
| SLC38A9 | 6641.0 |
| THEM4 | 6654.0 |
| SHB | 6666.5 |
| ZRANB1 | 6677.0 |
| CDC14A | 6679.0 |
| FGF16 | 6692.0 |
| BMPR1A | 6696.0 |
| FAS | 6708.0 |
| RGS12 | 6733.0 |
| KISS1R | 6746.0 |
| DYNC1LI1 | 6754.0 |
| RAB6A | 6765.0 |
| MAPKAPK3 | 6770.0 |
| TULP3 | 6772.0 |
| PPP2R5B | 6776.0 |
| GNG2 | 6793.0 |
| TGIF2 | 6794.0 |
| ATP6V0E1 | 6801.0 |
| H2BC11 | 6802.0 |
| TAS1R1 | 6812.0 |
| FLT3LG | 6822.0 |
| ADCY8 | 6825.0 |
| PTPN1 | 6830.0 |
| PIK3CG | 6844.0 |
| MTA3 | 6856.0 |
| OPRK1 | 6857.0 |
| CDKN1B | 6858.0 |
| SPINT1 | 6862.0 |
| LAT | 6872.0 |
| WNT2 | 6877.0 |
| CRABP1 | 6878.0 |
| EGR2 | 6879.0 |
| PTGFR | 6884.0 |
| FGFR1 | 6888.0 |
| SOCS1 | 6890.0 |
| GPSM1 | 6904.0 |
| RDH14 | 6911.0 |
| FN1 | 6913.0 |
| H4C1 | 6923.5 |
| TIAM1 | 6942.0 |
| RANBP2 | 6945.0 |
| P2RY1 | 6949.0 |
| STRADB | 6957.0 |
| MAD2L1 | 6958.0 |
| FMNL2 | 6964.0 |
| VAPA | 6965.0 |
| PDHX | 6966.0 |
| LTB4R2 | 6967.0 |
| CITED1 | 6991.0 |
| NTRK2 | 6997.0 |
| RASGRP1 | 7000.0 |
| PSME2 | 7025.0 |
| TNKS | 7029.0 |
| LAMTOR4 | 7030.0 |
| HNRNPF | 7044.0 |
| LAMTOR2 | 7052.0 |
| ARF6 | 7061.0 |
| LPAR4 | 7063.0 |
| ARHGAP42 | 7065.0 |
| GUCA1A | 7066.0 |
| ARPC5 | 7069.0 |
| SHC3 | 7070.0 |
| RPE65 | 7074.0 |
| MAML2 | 7087.0 |
| PTPRO | 7097.0 |
| FUZ | 7105.0 |
| GNG10 | 7112.0 |
| S1PR3 | 7127.0 |
| TGFBR1 | 7130.0 |
| ANXA1 | 7137.0 |
| THBS3 | 7140.0 |
| GABBR2 | 7146.0 |
| NMUR2 | 7148.0 |
| CAB39 | 7150.0 |
| ATP6V1C1 | 7159.0 |
| PPP2R5E | 7165.0 |
| USP15 | 7172.0 |
| HDAC1 | 7175.0 |
| CCL21 | 7185.0 |
| ADCYAP1R1 | 7189.0 |
| PLCB2 | 7190.0 |
| IL2RA | 7237.0 |
| LPAR3 | 7241.0 |
| CYLD | 7243.0 |
| SKIL | 7261.0 |
| NAB1 | 7262.0 |
| PDE4B | 7268.0 |
| CHRDL1 | 7300.0 |
| ABCA4 | 7305.0 |
| INHBA | 7307.0 |
| SDC1 | 7316.0 |
| MYL6 | 7318.0 |
| DHRS9 | 7322.0 |
| CYP26C1 | 7324.0 |
| NCBP2 | 7339.0 |
| ARHGAP36 | 7340.0 |
| GRM7 | 7349.0 |
| ECT2 | 7350.0 |
| ST3GAL4 | 7352.0 |
| LGR4 | 7355.0 |
| RPS27A | 7369.0 |
| PMEPA1 | 7386.0 |
| DGKI | 7390.0 |
| PDE6D | 7397.0 |
| CNKSR2 | 7401.0 |
| GPBAR1 | 7429.0 |
| AGO3 | 7448.0 |
| RRAD | 7453.0 |
| CLIP1 | 7468.0 |
| POLR2H | 7476.0 |
| CAMK2G | 7477.0 |
| APP | 7480.0 |
| ALDH1A2 | 7482.0 |
| FNTA | 7484.0 |
| ACVR2A | 7491.0 |
| AGTR2 | 7492.0 |
| SMAD2 | 7503.0 |
| EDN2 | 7506.0 |
| SPINT2 | 7507.0 |
| MMP9 | 7518.0 |
| ATP6V0A1 | 7535.0 |
| MMP2 | 7540.0 |
| MMP3 | 7551.0 |
| CENPC | 7561.0 |
| BTK | 7564.0 |
| SCMH1 | 7581.0 |
| ACKR2 | 7589.0 |
| PRKG2 | 7597.0 |
| TGIF1 | 7599.0 |
| FSTL1 | 7606.0 |
| SFRP2 | 7613.0 |
| CCR5 | 7623.0 |
| SCAI | 7627.0 |
| ARHGEF3 | 7632.0 |
| PSMB8 | 7643.0 |
| SHC1 | 7644.0 |
| P2RY13 | 7646.0 |
| SOS2 | 7658.0 |
| LRP12 | 7671.0 |
| TNRC6A | 7675.0 |
| FGF5 | 7684.0 |
| VCL | 7696.0 |
| AHCYL1 | 7728.0 |
| PSMA3 | 7732.0 |
| NF1 | 7743.0 |
| PKN2 | 7748.0 |
| PAFAH1B1 | 7753.0 |
| WNT11 | 7757.0 |
| PSMB6 | 7759.0 |
| CENPI | 7773.0 |
| CX3CR1 | 7784.0 |
| THBS2 | 7788.0 |
| CASP8 | 7790.0 |
| RDH13 | 7793.0 |
| KDM4C | 7795.0 |
| VPS29 | 7834.0 |
| HTR1A | 7853.5 |
| HTR1D | 7853.5 |
| MIB1 | 7858.0 |
| ARHGAP19 | 7873.5 |
| WNT10B | 7877.0 |
| FRAT2 | 7883.0 |
| GPER1 | 7908.0 |
| BIRC3 | 7916.0 |
| ATP6V1A | 7920.0 |
| COL9A1 | 7923.0 |
| GNB3 | 7932.0 |
| CUL3 | 7933.0 |
| ESR2 | 7936.0 |
| PNOC | 7937.0 |
| ARHGAP24 | 7944.0 |
| PKN3 | 7945.0 |
| DYNC1H1 | 7965.0 |
| CALCRL | 7971.0 |
| VPS26A | 7977.0 |
| ARHGEF2 | 7980.0 |
| DLG2 | 7984.0 |
| RIT2 | 7986.0 |
| ABHD17B | 7989.0 |
| DRD1 | 8013.0 |
| SMO | 8017.0 |
| CYSLTR1 | 8025.0 |
| PRKAR1B | 8032.0 |
| UCN2 | 8033.0 |
| ULK3 | 8035.0 |
| AWAT2 | 8046.0 |
| ITGA2 | 8050.0 |
| KIF3A | 8088.0 |
| PIK3R1 | 8109.0 |
| IGF1 | 8112.0 |
| OPN1SW | 8117.0 |
| ADORA3 | 8119.0 |
| AXL | 8124.0 |
| SKA2 | 8139.0 |
| HSD17B1 | 8140.0 |
| CSNK1A1 | 8141.0 |
| RSPO2 | 8142.0 |
| MAPK4 | 8149.0 |
| INCENP | 8159.0 |
| RNF2 | 8167.0 |
| NTSR2 | 8169.0 |
| CCL7 | 8170.0 |
| KPNA2 | 8174.0 |
| HES5 | 8176.0 |
| HRH2 | 8194.0 |
| IRS1 | 8196.0 |
| TRPC6 | 8208.0 |
| PSMA4 | 8213.0 |
| GAS1 | 8235.0 |
| STAG1 | 8250.0 |
| CXXC5 | 8253.0 |
| MC4R | 8265.0 |
| PDE6G | 8266.0 |
| POLR2G | 8271.0 |
| VEGFA | 8288.0 |
| NDEL1 | 8300.0 |
| ARHGEF26 | 8302.0 |
| IFT57 | 8304.0 |
| AHCTF1 | 8307.0 |
| BDNF | 8308.0 |
| SMPD3 | 8313.0 |
| SPRY1 | 8321.0 |
| SMAD7 | 8322.0 |
| MAPKAP1 | 8323.0 |
| RASA3 | 8325.0 |
| ABHD6 | 8329.0 |
| ARHGAP5 | 8335.0 |
| CNGB1 | 8343.0 |
| LPAR2 | 8362.0 |
| RALBP1 | 8365.0 |
| LRP6 | 8367.0 |
| LAMA2 | 8370.0 |
| IL17RD | 8393.0 |
| NRIP1 | 8401.0 |
| OPN3 | 8414.0 |
| ID2 | 8421.0 |
| PDGFD | 8426.0 |
| CREB1 | 8434.0 |
| E2F4 | 8446.0 |
| CD86 | 8454.0 |
| AMHR2 | 8466.0 |
| GOPC | 8475.5 |
| TIA1 | 8497.0 |
| CTBP2 | 8503.0 |
| TRIM33 | 8541.0 |
| PLA2G4A | 8549.0 |
| SPTAN1 | 8554.0 |
| OTUD3 | 8564.0 |
| GLP1R | 8565.0 |
| ELMO1 | 8567.0 |
| WNT9B | 8579.0 |
| CLTA | 8586.0 |
| NRG4 | 8589.0 |
| NOX1 | 8593.0 |
| MARK3 | 8594.0 |
| MYB | 8599.0 |
| NUP37 | 8600.0 |
| EGF | 8603.0 |
| RDH11 | 8604.5 |
| AKT3 | 8609.0 |
| ARHGAP22 | 8611.0 |
| KDM1A | 8614.0 |
| ATP6V1C2 | 8616.0 |
| DNM1 | 8624.0 |
| THBS1 | 8627.0 |
| NRG2 | 8629.0 |
| THBS4 | 8652.0 |
| FYN | 8653.0 |
| STAT1 | 8658.0 |
| NCK1 | 8659.0 |
| CENPL | 8678.0 |
| RUNX1 | 8696.0 |
| IL2RG | 8698.5 |
| SRY | 8700.0 |
| TRPC3 | 8707.0 |
| TLE4 | 8719.0 |
| RHOT1 | 8732.0 |
| OPRM1 | 8749.0 |
| E2F1 | 8755.0 |
| RAPGEF2 | 8767.0 |
| PDE7A | 8851.0 |
| GABRB3 | 8852.0 |
| GRIN2D | 8856.0 |
| NTRK3 | 8874.0 |
| ESR1 | 8895.0 |
| ITPR1 | 8900.0 |
| NTF3 | 8909.0 |
| LAMC2 | 8913.0 |
| PPP1CC | 8925.0 |
| RGL2 | 8928.0 |
| ARPC2 | 8939.0 |
| DLG3 | 8951.0 |
Synthesis of substrates in N-glycan biosythesis
| 1256 | |
|---|---|
| set | Synthesis of substrates in N-glycan biosythesis |
| setSize | 61 |
| pANOVA | 0.000869 |
| s.dist | 0.247 |
| p.adjustANOVA | 0.0552 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8761 |
| ST3GAL5 | 8661 |
| GNPNAT1 | 8416 |
| FPGT | 8260 |
| ST8SIA5 | 8129 |
| GNE | 8072 |
| GFPT2 | 7837 |
| NUS1 | 7616 |
| SLC35C1 | 7359 |
| ST3GAL4 | 7352 |
| ST3GAL1 | 7280 |
| CTSA | 7092 |
| ALG5 | 6905 |
| GMDS | 6714 |
| UAP1 | 6709 |
| RENBP | 6496 |
| DPM2 | 6375 |
| PMM1 | 6321 |
| GFPT1 | 6299 |
| FUOM | 6173 |
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8761.0 |
| ST3GAL5 | 8661.0 |
| GNPNAT1 | 8416.0 |
| FPGT | 8260.0 |
| ST8SIA5 | 8129.0 |
| GNE | 8072.0 |
| GFPT2 | 7837.0 |
| NUS1 | 7616.0 |
| SLC35C1 | 7359.0 |
| ST3GAL4 | 7352.0 |
| ST3GAL1 | 7280.0 |
| CTSA | 7092.0 |
| ALG5 | 6905.0 |
| GMDS | 6714.0 |
| UAP1 | 6709.0 |
| RENBP | 6496.0 |
| DPM2 | 6375.0 |
| PMM1 | 6321.0 |
| GFPT1 | 6299.0 |
| FUOM | 6173.0 |
| PGM3 | 6068.0 |
| ST6GALNAC6 | 5713.5 |
| ST8SIA1 | 5516.0 |
| ST6GALNAC5 | 5424.0 |
| GMPPA | 5379.0 |
| SLC17A5 | 5233.0 |
| SLC35A1 | 4879.0 |
| ST3GAL2 | 4615.0 |
| NEU4 | 3618.0 |
| NAGK | 3240.0 |
| ST3GAL6 | 3182.0 |
| CMAS | 2992.0 |
| NEU3 | 2987.0 |
| NPL | 2528.0 |
| ST8SIA6 | 2385.0 |
| NANP | 1740.0 |
| NUDT14 | 1486.0 |
| MPI | 1074.0 |
| ST6GALNAC1 | 531.0 |
| ST8SIA3 | 512.0 |
| DPM1 | -48.0 |
| GMPPB | -73.0 |
| MVD | -874.0 |
| NANS | -1294.0 |
| ST6GALNAC4 | -2240.0 |
| DPM3 | -2690.0 |
| ST6GAL2 | -2799.0 |
| PMM2 | -3168.0 |
| DHDDS | -3360.0 |
| ST8SIA4 | -3388.0 |
| DOLK | -4149.0 |
| AMDHD2 | -4321.5 |
| ST6GALNAC3 | -4499.0 |
| GLB1 | -4829.0 |
| NEU2 | -5224.0 |
| FCSK | -5669.0 |
| ST6GALNAC2 | -5989.0 |
| ST3GAL3 | -5996.0 |
| DOLPP1 | -6989.0 |
| SRD5A3 | -8338.0 |
| ST6GAL1 | -8438.0 |
Plasma lipoprotein assembly
| 881 | |
|---|---|
| set | Plasma lipoprotein assembly |
| setSize | 18 |
| pANOVA | 0.000876 |
| s.dist | -0.453 |
| p.adjustANOVA | 0.0552 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOC1 | -8963.0 |
| APOC3 | -8904.0 |
| APOE | -8836.0 |
| MTTP | -8003.0 |
| PRKACA | -7713.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| APOA4 | -6758.0 |
| PRKACB | -6707.0 |
| ABCA1 | -6097.0 |
| A2M | -3884.0 |
| P4HB | -2423.0 |
| APOC4 | -1990.0 |
| APOA1 | -547.0 |
| APOB | 573.0 |
| SAR1B | 1055.0 |
| ZDHHC8 | 2324.0 |
| BMP1 | 7235.0 |
| GeneID | Gene Rank |
|---|---|
| APOC1 | -8963.0 |
| APOC3 | -8904.0 |
| APOE | -8836.0 |
| MTTP | -8003.0 |
| PRKACA | -7713.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| APOA4 | -6758.0 |
| PRKACB | -6707.0 |
| ABCA1 | -6097.0 |
| A2M | -3884.0 |
| P4HB | -2423.0 |
| APOC4 | -1990.0 |
| APOA1 | -547.0 |
| APOB | 573.0 |
| SAR1B | 1055.0 |
| ZDHHC8 | 2324.0 |
| BMP1 | 7235.0 |
Death Receptor Signalling
| 266 | |
|---|---|
| set | Death Receptor Signalling |
| setSize | 132 |
| pANOVA | 0.00102 |
| s.dist | -0.166 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834 |
| ARHGEF1 | -8718 |
| OBSCN | -8574 |
| ARHGEF7 | -8534 |
| PLEKHG5 | -8454 |
| USP2 | -8432 |
| ITSN1 | -8377 |
| MAGED1 | -8312 |
| ARHGEF11 | -8287 |
| RTN4 | -8274 |
| USP4 | -8272 |
| MADD | -8225 |
| NCSTN | -8213 |
| NGFR | -8192 |
| ARHGEF40 | -7699 |
| MCF2 | -7686 |
| ARHGEF16 | -7667 |
| ABR | -7655 |
| MCF2L | -7517 |
| TNFAIP3 | -7318 |
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834.0 |
| ARHGEF1 | -8718.0 |
| OBSCN | -8574.0 |
| ARHGEF7 | -8534.0 |
| PLEKHG5 | -8454.0 |
| USP2 | -8432.0 |
| ITSN1 | -8377.0 |
| MAGED1 | -8312.0 |
| ARHGEF11 | -8287.0 |
| RTN4 | -8274.0 |
| USP4 | -8272.0 |
| MADD | -8225.0 |
| NCSTN | -8213.0 |
| NGFR | -8192.0 |
| ARHGEF40 | -7699.0 |
| MCF2 | -7686.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| MCF2L | -7517.0 |
| TNFAIP3 | -7318.0 |
| ARHGEF5 | -7293.0 |
| PLEKHG2 | -7206.0 |
| VAV3 | -7088.0 |
| ARHGEF17 | -6885.0 |
| ARHGEF10L | -6624.0 |
| OTUD7B | -6540.0 |
| UBC | -6432.0 |
| APH1B | -6387.0 |
| TRIO | -6348.0 |
| BCL2L11 | -6346.0 |
| USP21 | -6295.0 |
| FGD4 | -6196.0 |
| TAB1 | -6122.0 |
| FGD1 | -5982.0 |
| MAG | -5858.0 |
| YWHAE | -5754.0 |
| ARHGEF19 | -5545.0 |
| BIRC2 | -5344.0 |
| SQSTM1 | -5320.0 |
| ARHGEF6 | -5311.0 |
| FASLG | -5271.0 |
| CASP2 | -5200.0 |
| AKAP13 | -5190.0 |
| TNFSF10 | -5140.0 |
| NET1 | -4984.0 |
| RNF31 | -4944.5 |
| TRAF1 | -4878.0 |
| NGEF | -4851.0 |
| ARHGEF38 | -4562.0 |
| CASP3 | -4363.0 |
| RIPK2 | -4098.0 |
| CFLAR | -4023.0 |
| TNFRSF1A | -4011.0 |
| BEX3 | -3892.0 |
| TNF | -3751.0 |
| PRDM4 | -3727.0 |
| SPPL2B | -3638.0 |
| PSEN1 | -3548.0 |
| MYD88 | -3411.0 |
| PREX1 | -3045.0 |
| SOS1 | -2808.0 |
| ARHGDIA | -2696.0 |
| NFKB1 | -2579.0 |
| ARHGEF18 | -2547.5 |
| LINGO1 | -2353.0 |
| TRAF6 | -2185.0 |
| CLIP3 | -2179.0 |
| AATF | -2176.0 |
| PSEN2 | -2171.5 |
| UBA52 | -2166.0 |
| PRKCI | -2165.0 |
| ADAM17 | -2112.0 |
| RELA | -2108.0 |
| PSENEN | -1907.0 |
| OTULIN | -1856.0 |
| RIPK1 | -1717.0 |
| TAB2 | -1485.0 |
| TRADD | -1426.0 |
| RACK1 | -1396.0 |
| OMG | -1376.0 |
| ARHGEF39 | -1272.0 |
| ARHGEF10 | -775.0 |
| RHOA | -640.0 |
| ARHGEF15 | -470.0 |
| ARHGEF33 | -451.0 |
| FADD | -344.0 |
| KALRN | -177.0 |
| NSMAF | 620.0 |
| IRAK1 | 791.0 |
| BAD | 928.0 |
| SORCS3 | 985.0 |
| APH1A | 1110.0 |
| RBCK1 | 1484.0 |
| TRAF2 | 1651.0 |
| TAB3 | 1681.0 |
| VAV1 | 1912.0 |
| RAC1 | 2240.0 |
| NGF | 2470.0 |
| MAP3K7 | 2825.0 |
| IKBKG | 3133.0 |
| SHARPIN | 3295.0 |
| HDAC2 | 3553.0 |
| IKBKB | 4039.0 |
| FGD2 | 4170.0 |
| BAG4 | 4311.0 |
| ITGB3BP | 4443.0 |
| XIAP | 4741.0 |
| TAX1BP1 | 4835.0 |
| TIAM2 | 4841.0 |
| RASGRF2 | 5220.0 |
| GNA13 | 5282.0 |
| HDAC3 | 5550.0 |
| SPPL2A | 5745.0 |
| SMPD2 | 5759.0 |
| VAV2 | 5813.0 |
| MAPK8 | 5956.0 |
| ARHGEF12 | 6104.0 |
| FGD3 | 6255.0 |
| CHUK | 6304.0 |
| FAS | 6708.0 |
| TIAM1 | 6942.0 |
| HDAC1 | 7175.0 |
| CYLD | 7243.0 |
| ECT2 | 7350.0 |
| RPS27A | 7369.0 |
| ARHGEF3 | 7632.0 |
| SOS2 | 7658.0 |
| CASP8 | 7790.0 |
| BIRC3 | 7916.0 |
| ARHGEF2 | 7980.0 |
| ARHGEF26 | 8302.0 |
| SMPD3 | 8313.0 |
Keratan sulfate degradation
| 623 | |
|---|---|
| set | Keratan sulfate degradation |
| setSize | 12 |
| pANOVA | 0.00108 |
| s.dist | 0.545 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRELP | 8868.0 |
| OGN | 8486.0 |
| FMOD | 7779.0 |
| HEXB | 7586.0 |
| OMD | 7445.0 |
| ACAN | 7037.0 |
| KERA | 6796.0 |
| HEXA | 5131.5 |
| GLB1L | 3354.0 |
| LUM | 941.0 |
| GNS | -359.0 |
| GLB1 | -4829.0 |
| GeneID | Gene Rank |
|---|---|
| PRELP | 8868.0 |
| OGN | 8486.0 |
| FMOD | 7779.0 |
| HEXB | 7586.0 |
| OMD | 7445.0 |
| ACAN | 7037.0 |
| KERA | 6796.0 |
| HEXA | 5131.5 |
| GLB1L | 3354.0 |
| LUM | 941.0 |
| GNS | -359.0 |
| GLB1 | -4829.0 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
| 122 | |
|---|---|
| set | Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| setSize | 75 |
| pANOVA | 0.00115 |
| s.dist | 0.217 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8761 |
| ST3GAL5 | 8661 |
| GNPNAT1 | 8416 |
| FPGT | 8260 |
| ST8SIA5 | 8129 |
| GNE | 8072 |
| GFPT2 | 7837 |
| NUS1 | 7616 |
| SLC35C1 | 7359 |
| ST3GAL4 | 7352 |
| ST3GAL1 | 7280 |
| ALG3 | 7136 |
| CTSA | 7092 |
| ALG5 | 6905 |
| ALG1 | 6760 |
| GMDS | 6714 |
| UAP1 | 6709 |
| RENBP | 6496 |
| DPM2 | 6375 |
| PMM1 | 6321 |
| GeneID | Gene Rank |
|---|---|
| NEU1 | 8761.0 |
| ST3GAL5 | 8661.0 |
| GNPNAT1 | 8416.0 |
| FPGT | 8260.0 |
| ST8SIA5 | 8129.0 |
| GNE | 8072.0 |
| GFPT2 | 7837.0 |
| NUS1 | 7616.0 |
| SLC35C1 | 7359.0 |
| ST3GAL4 | 7352.0 |
| ST3GAL1 | 7280.0 |
| ALG3 | 7136.0 |
| CTSA | 7092.0 |
| ALG5 | 6905.0 |
| ALG1 | 6760.0 |
| GMDS | 6714.0 |
| UAP1 | 6709.0 |
| RENBP | 6496.0 |
| DPM2 | 6375.0 |
| PMM1 | 6321.0 |
| GFPT1 | 6299.0 |
| FUOM | 6173.0 |
| PGM3 | 6068.0 |
| ALG2 | 6038.0 |
| ALG9 | 5896.5 |
| ST6GALNAC6 | 5713.5 |
| ST8SIA1 | 5516.0 |
| ST6GALNAC5 | 5424.0 |
| ALG8 | 5423.0 |
| GMPPA | 5379.0 |
| SLC17A5 | 5233.0 |
| SLC35A1 | 4879.0 |
| ST3GAL2 | 4615.0 |
| RFT1 | 4292.5 |
| NEU4 | 3618.0 |
| NAGK | 3240.0 |
| ST3GAL6 | 3182.0 |
| CMAS | 2992.0 |
| NEU3 | 2987.0 |
| NPL | 2528.0 |
| ST8SIA6 | 2385.0 |
| NANP | 1740.0 |
| NUDT14 | 1486.0 |
| MPI | 1074.0 |
| ST6GALNAC1 | 531.0 |
| ST8SIA3 | 512.0 |
| ALG14 | -47.0 |
| DPM1 | -48.0 |
| GMPPB | -73.0 |
| MVD | -874.0 |
| NANS | -1294.0 |
| ALG11 | -2233.0 |
| ST6GALNAC4 | -2240.0 |
| ALG12 | -2380.0 |
| DPM3 | -2690.0 |
| ST6GAL2 | -2799.0 |
| ALG10 | -3026.5 |
| ALG10B | -3026.5 |
| PMM2 | -3168.0 |
| DHDDS | -3360.0 |
| ST8SIA4 | -3388.0 |
| DPAGT1 | -3429.0 |
| DOLK | -4149.0 |
| MPDU1 | -4181.0 |
| AMDHD2 | -4321.5 |
| ST6GALNAC3 | -4499.0 |
| GLB1 | -4829.0 |
| NEU2 | -5224.0 |
| FCSK | -5669.0 |
| ST6GALNAC2 | -5989.0 |
| ST3GAL3 | -5996.0 |
| ALG6 | -6909.0 |
| DOLPP1 | -6989.0 |
| SRD5A3 | -8338.0 |
| ST6GAL1 | -8438.0 |
GPCR downstream signalling
| 464 | |
|---|---|
| set | GPCR downstream signalling |
| setSize | 829 |
| pANOVA | 0.00116 |
| s.dist | -0.0667 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -9063 |
| C5 | -9060 |
| RDH16 | -9052 |
| KNG1 | -9050 |
| TAS1R2 | -9042 |
| PAK1 | -9034 |
| CRHR2 | -9033 |
| SAG | -9009 |
| EDNRA | -8998 |
| PDE4D | -8956 |
| PTGER3 | -8925 |
| PDE2A | -8915 |
| AKR1B10 | -8911 |
| APOC3 | -8904 |
| CAMK2B | -8898 |
| PRKAR2B | -8880 |
| PDE11A | -8842 |
| TTR | -8839 |
| APOE | -8836 |
| ARHGEF37 | -8834 |
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -9063.0 |
| C5 | -9060.0 |
| RDH16 | -9052.0 |
| KNG1 | -9050.0 |
| TAS1R2 | -9042.0 |
| PAK1 | -9034.0 |
| CRHR2 | -9033.0 |
| SAG | -9009.0 |
| EDNRA | -8998.0 |
| PDE4D | -8956.0 |
| PTGER3 | -8925.0 |
| PDE2A | -8915.0 |
| AKR1B10 | -8911.0 |
| APOC3 | -8904.0 |
| CAMK2B | -8898.0 |
| PRKAR2B | -8880.0 |
| PDE11A | -8842.0 |
| TTR | -8839.0 |
| APOE | -8836.0 |
| ARHGEF37 | -8834.0 |
| CCL28 | -8774.0 |
| RGS17 | -8772.0 |
| RRH | -8768.0 |
| TAS1R3 | -8751.0 |
| DGKE | -8747.0 |
| NTSR1 | -8726.0 |
| ARHGEF1 | -8718.0 |
| P2RY14 | -8673.0 |
| ADORA1 | -8671.0 |
| RPS6KA1 | -8610.0 |
| CXCR1 | -8608.0 |
| GNAS | -8601.0 |
| RGS14 | -8576.0 |
| OBSCN | -8574.0 |
| ARHGEF7 | -8534.0 |
| RGS5 | -8529.0 |
| RGS20 | -8516.0 |
| GRK6 | -8511.0 |
| PPP3CC | -8476.0 |
| RGS6 | -8457.0 |
| PLEKHG5 | -8454.0 |
| CDC42 | -8440.0 |
| PDE1B | -8427.0 |
| PLB1 | -8395.0 |
| ITSN1 | -8377.0 |
| PLCB4 | -8376.0 |
| CXCR6 | -8347.0 |
| CXCR3 | -8323.0 |
| TRH | -8317.0 |
| CHRM3 | -8311.0 |
| ARHGEF11 | -8287.0 |
| VIPR1 | -8263.0 |
| GALR2 | -8209.0 |
| RBP4 | -8178.0 |
| DGKZ | -8155.0 |
| GPSM3 | -8134.0 |
| PRKAR2A | -8106.0 |
| SRC | -8095.0 |
| VIP | -8083.0 |
| GLP2R | -8069.0 |
| NPY | -8050.0 |
| LPAR5 | -8048.0 |
| NPY1R | -8014.0 |
| PDE4C | -7992.5 |
| ADRB3 | -7987.5 |
| QRFPR | -7977.0 |
| PLCB3 | -7957.0 |
| NPFFR1 | -7883.0 |
| OR52W1 | -7878.0 |
| DAGLB | -7867.0 |
| NTS | -7866.0 |
| AGT | -7862.0 |
| RGS2 | -7801.0 |
| EDN3 | -7773.0 |
| PRKACA | -7713.0 |
| GPR27 | -7702.0 |
| ARHGEF40 | -7699.0 |
| MCF2 | -7686.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| RTP2 | -7650.0 |
| GNAI1 | -7649.0 |
| RXFP2 | -7630.0 |
| PDE1C | -7601.0 |
| MGLL | -7581.0 |
| DGKB | -7547.0 |
| PTGER4 | -7545.0 |
| ADORA2B | -7537.0 |
| APOC2 | -7531.5 |
| MCF2L | -7517.0 |
| ABHD12 | -7496.0 |
| ADRA2B | -7489.0 |
| APOA2 | -7400.0 |
| GRK3 | -7362.0 |
| RASGRP2 | -7350.0 |
| GNG4 | -7316.0 |
| DGKG | -7310.0 |
| ARHGEF5 | -7293.0 |
| CNR1 | -7245.0 |
| PLEKHG2 | -7206.0 |
| CHRM5 | -7183.0 |
| GPC4 | -7160.0 |
| PRKCE | -7128.0 |
| GNAL | -7120.0 |
| PIK3R2 | -7098.5 |
| VAV3 | -7088.0 |
| RTP3 | -7086.0 |
| RGS8 | -7040.0 |
| CCR9 | -7000.0 |
| GNA14 | -6980.0 |
| RBP1 | -6975.0 |
| AVPR2 | -6968.0 |
| ARHGEF17 | -6885.0 |
| ADCY6 | -6882.0 |
| PTGER2 | -6876.0 |
| OR51E1 | -6846.0 |
| GPR39 | -6779.0 |
| CNR2 | -6771.0 |
| ADCY4 | -6759.0 |
| APOA4 | -6758.0 |
| ARRB2 | -6754.0 |
| CCL19 | -6713.0 |
| PRKACB | -6707.0 |
| PSAP | -6675.0 |
| ARHGEF10L | -6624.0 |
| HSD17B6 | -6589.0 |
| S1PR4 | -6587.0 |
| TSHR | -6499.0 |
| HTR7 | -6482.0 |
| CXCR5 | -6476.0 |
| ADCY2 | -6434.0 |
| TRIO | -6348.0 |
| SSTR1 | -6304.0 |
| C3 | -6303.0 |
| CHRM4 | -6286.0 |
| GPR132 | -6259.0 |
| PPP2CA | -6258.0 |
| PIK3R6 | -6249.0 |
| REEP6 | -6204.0 |
| FGD4 | -6196.0 |
| TAC3 | -6187.0 |
| RDH8 | -6074.0 |
| RAMP2 | -6073.0 |
| TACR1 | -6047.0 |
| ITPR3 | -6046.0 |
| PTGDR2 | -6038.0 |
| OR52I1 | -6033.5 |
| OR52I2 | -6033.5 |
| PCP2 | -6000.0 |
| FGD1 | -5982.0 |
| TACR3 | -5973.0 |
| OR6S1 | -5969.0 |
| AKT2 | -5958.0 |
| GNG12 | -5884.0 |
| PPP1CA | -5881.0 |
| ITPR2 | -5837.0 |
| SUCNR1 | -5782.0 |
| RAMP1 | -5656.0 |
| P2RY6 | -5637.0 |
| AGTR1 | -5580.0 |
| PTH1R | -5552.0 |
| ARHGEF19 | -5545.0 |
| LRP2 | -5544.0 |
| TACR2 | -5487.0 |
| PIK3R5 | -5482.0 |
| PDE7B | -5405.0 |
| OR6K6 | -5329.0 |
| TSHB | -5315.0 |
| ARHGEF6 | -5311.0 |
| GNAT2 | -5270.0 |
| RLBP1 | -5232.0 |
| PTGER1 | -5226.0 |
| CXCR4 | -5218.0 |
| AKAP13 | -5190.0 |
| PRKCH | -5149.5 |
| GNAO1 | -5147.0 |
| OR6N2 | -5135.0 |
| RCVRN | -5100.0 |
| SSTR4 | -5037.0 |
| NMUR1 | -5014.0 |
| NET1 | -4984.0 |
| PRKAR1A | -4970.0 |
| P2RY10 | -4936.0 |
| NGEF | -4851.0 |
| CXCL9 | -4847.0 |
| GAL | -4837.0 |
| APLNR | -4782.0 |
| NPW | -4751.0 |
| GRM5 | -4699.0 |
| PDE4A | -4632.0 |
| TAS2R60 | -4610.0 |
| GNB4 | -4593.0 |
| XCR1 | -4583.0 |
| ARHGEF38 | -4562.0 |
| PDE6A | -4543.0 |
| FNTB | -4523.5 |
| RGS3 | -4491.0 |
| FPR2 | -4479.5 |
| FPR3 | -4479.5 |
| CCR6 | -4453.0 |
| LRAT | -4448.0 |
| DHRS3 | -4431.0 |
| GNAI2 | -4425.0 |
| MC5R | -4388.0 |
| ADRA1D | -4383.0 |
| PDPK1 | -4325.0 |
| PROKR2 | -4225.0 |
| DGKH | -4197.0 |
| GPR4 | -4192.0 |
| GRPR | -4160.0 |
| TAS2R3 | -4153.0 |
| HTR1F | -4088.0 |
| NMT2 | -4070.0 |
| BDKRB2 | -4057.0 |
| PLCB1 | -4053.0 |
| ADCY1 | -4044.0 |
| LPAR6 | -4022.0 |
| SSTR3 | -3984.0 |
| RHO | -3979.0 |
| GRM8 | -3921.0 |
| GHRHR | -3915.0 |
| CAMK2A | -3898.0 |
| GNB1 | -3895.0 |
| MCHR1 | -3891.0 |
| C3AR1 | -3874.0 |
| OR52B2 | -3822.0 |
| NPB | -3820.0 |
| UTS2 | -3797.0 |
| CCL4 | -3785.5 |
| HSPG2 | -3764.0 |
| RPS6KA3 | -3698.0 |
| CHRM1 | -3677.0 |
| PPP2CB | -3632.0 |
| GNRHR | -3625.0 |
| F2 | -3616.0 |
| CXCL11 | -3606.0 |
| DGKK | -3596.0 |
| GPC2 | -3565.0 |
| PTH2 | -3564.0 |
| PRKCQ | -3483.0 |
| PPP2R1A | -3477.0 |
| GPR84 | -3469.0 |
| RGR | -3467.0 |
| RXFP1 | -3454.0 |
| GPIHBP1 | -3404.0 |
| ROCK2 | -3394.0 |
| CCR3 | -3385.0 |
| OR5B2 | -3361.0 |
| GRB2 | -3336.0 |
| EDN1 | -3312.0 |
| PTGIR | -3311.0 |
| LRP10 | -3298.0 |
| OR51E2 | -3273.0 |
| GPR31 | -3246.0 |
| HTR5A | -3216.0 |
| GPR183 | -3193.0 |
| GUCA1B | -3130.0 |
| HEBP1 | -3127.0 |
| OR8H1 | -3118.0 |
| OR8H2 | -3118.0 |
| OR8H3 | -3118.0 |
| RHOB | -3080.0 |
| GNG7 | -3060.0 |
| PREX1 | -3045.0 |
| SDC4 | -2987.0 |
| GNA11 | -2862.0 |
| SOS1 | -2808.0 |
| SSTR5 | -2799.0 |
| PRKCG | -2783.0 |
| CYP4V2 | -2726.0 |
| PPP3CA | -2656.0 |
| ADORA2A | -2639.0 |
| CDK5 | -2600.0 |
| ARHGEF18 | -2547.5 |
| APLN | -2542.0 |
| PPBP | -2477.0 |
| LPL | -2467.0 |
| P2RY2 | -2415.0 |
| OR8G1 | -2378.5 |
| OR8G5 | -2378.5 |
| ADCY5 | -2343.0 |
| PENK | -2272.0 |
| REEP2 | -2261.0 |
| HRAS | -2253.0 |
| CX3CL1 | -2245.0 |
| OR10G2 | -2217.0 |
| FPR1 | -2214.0 |
| LTB4R | -2187.0 |
| RGS1 | -2147.0 |
| RLN3 | -2119.0 |
| GPC3 | -2107.0 |
| KISS1 | -2106.0 |
| ADM2 | -2081.0 |
| CCKAR | -2081.0 |
| CCR4 | -2081.0 |
| GNG13 | -2081.0 |
| OPN1LW | -2081.0 |
| OPN1MW | -2081.0 |
| OR7E24 | -2063.0 |
| SDC3 | -2040.0 |
| NPFF | -2026.0 |
| OR5P2 | -2010.0 |
| OR6Y1 | -1916.0 |
| OR8K3 | -1912.0 |
| OR2F1 | -1842.5 |
| OR2F2 | -1842.5 |
| GPR176 | -1832.0 |
| F2RL2 | -1823.0 |
| OR11A1 | -1818.0 |
| ADCY9 | -1812.0 |
| OR10K1 | -1811.0 |
| PRKCA | -1808.0 |
| GHSR | -1789.0 |
| DAGLA | -1781.0 |
| GPR55 | -1771.0 |
| OR5G3 | -1752.5 |
| CCKBR | -1743.0 |
| CXCL10 | -1631.0 |
| EGFR | -1624.0 |
| CXCL16 | -1619.0 |
| OR10V1 | -1562.5 |
| OR14J1 | -1562.5 |
| OR1I1 | -1562.5 |
| OR1Q1 | -1562.5 |
| OR4A15 | -1562.5 |
| OR4P4 | -1562.5 |
| OR56B4 | -1562.5 |
| OR5M11 | -1562.5 |
| OR5P3 | -1562.5 |
| OR5T1 | -1562.5 |
| OR5T3 | -1562.5 |
| OR6C2 | -1562.5 |
| OR6C68 | -1562.5 |
| OR8B8 | -1562.5 |
| OR5AK2 | -1523.0 |
| OR5AK3P | -1523.0 |
| TAS2R14 | -1512.0 |
| METAP1 | -1481.0 |
| GALR1 | -1455.0 |
| NPSR1 | -1445.0 |
| TRHR | -1407.0 |
| EDNRB | -1365.0 |
| OR4B1 | -1361.5 |
| GPC6 | -1334.0 |
| PLXNB1 | -1301.0 |
| CASR | -1291.0 |
| C5AR1 | -1280.0 |
| ARHGEF39 | -1272.0 |
| RGS13 | -1258.0 |
| CCR7 | -1237.0 |
| GRM6 | -1224.0 |
| OR10A3 | -1219.5 |
| OR10A6 | -1219.5 |
| HTR4 | -1218.0 |
| GPR45 | -1179.0 |
| GPR143 | -1156.0 |
| CXCL13 | -1141.0 |
| AGRN | -1136.0 |
| OR9G1 | -1126.0 |
| GPSM2 | -1112.0 |
| DRD5 | -987.0 |
| MTNR1A | -987.0 |
| OR10J5 | -987.0 |
| OR11G2 | -987.0 |
| OR12D3 | -987.0 |
| OR1A1 | -987.0 |
| OR1A2 | -987.0 |
| OR1J4 | -987.0 |
| OR1P1 | -987.0 |
| OR2A1 | -987.0 |
| OR2T1 | -987.0 |
| OR2W3 | -987.0 |
| OR4C16 | -987.0 |
| OR4C6 | -987.0 |
| OR51G2 | -987.0 |
| OR51Q1 | -987.0 |
| OR52E4 | -987.0 |
| OR5AL1 | -987.0 |
| OR5R1 | -987.0 |
| OR7G1 | -987.0 |
| OR8B12 | -987.0 |
| OR8B2 | -987.0 |
| OR8B3 | -987.0 |
| OR8D4 | -987.0 |
| OR9K2 | -987.0 |
| PROK1 | -987.0 |
| RBP2 | -987.0 |
| TAAR5 | -987.0 |
| TAS2R1 | -987.0 |
| CHRM2 | -907.5 |
| OR2B11 | -907.5 |
| OR2H1 | -907.5 |
| OR2H2 | -907.5 |
| OR4D1 | -907.5 |
| OR52M1 | -907.5 |
| OR2T29 | -895.0 |
| OR2T4 | -895.0 |
| OR2T5 | -895.0 |
| OR5B3 | -884.0 |
| OR4C15 | -879.0 |
| ARHGEF10 | -775.0 |
| PPP3CB | -748.0 |
| CALCR | -738.0 |
| OR14C36 | -733.5 |
| OR52N2 | -733.5 |
| OR56B2P | -733.5 |
| OR7G2 | -733.5 |
| OPRL1 | -730.0 |
| OR5AC1 | -686.0 |
| RGS4 | -680.0 |
| HCRTR1 | -648.0 |
| RHOA | -640.0 |
| CCR10 | -637.0 |
| RETSAT | -602.0 |
| APOA1 | -547.0 |
| OR2AK2 | -519.5 |
| OR5H1 | -519.5 |
| OR5H14 | -519.5 |
| OR5H15 | -519.5 |
| OR5H6 | -519.5 |
| ARHGEF15 | -470.0 |
| PDE6B | -466.0 |
| BRS3 | -461.0 |
| ARHGEF33 | -451.0 |
| GPHB5 | -374.0 |
| OR52D1 | -338.5 |
| NPY5R | -309.0 |
| OR10G3 | -309.0 |
| OR4A47 | -309.0 |
| OR4F6 | -309.0 |
| OR51F2 | -309.0 |
| OR52P1P | -309.0 |
| OR9A4 | -309.0 |
| CGA | -282.0 |
| DGKD | -273.0 |
| REEP1 | -250.0 |
| REEP5 | -211.0 |
| CAMKK2 | -200.0 |
| CXCL12 | -188.0 |
| OPRD1 | -187.0 |
| KALRN | -177.0 |
| OR7D4 | -133.0 |
| OR5AN1 | -121.5 |
| OR1N1 | -118.0 |
| RGS18 | -112.0 |
| GNB5 | -108.0 |
| CALM1 | -83.0 |
| OR10AG1 | -40.0 |
| GPR37L1 | -27.0 |
| ARRB1 | -23.0 |
| GPR65 | -16.0 |
| REEP3 | -8.0 |
| OR6B2 | 6.5 |
| OR6B3 | 6.5 |
| OR4F17 | 11.0 |
| OR4F4 | 11.0 |
| OR4F5 | 11.0 |
| AVPR1A | 53.0 |
| PIK3CA | 85.0 |
| GNA15 | 89.0 |
| TAS2R4 | 142.0 |
| CALCB | 231.0 |
| CNGA1 | 231.0 |
| FFAR1 | 231.0 |
| IAPP | 231.0 |
| MC3R | 231.0 |
| NPBWR1 | 231.0 |
| OR10W1 | 231.0 |
| OR13F1 | 231.0 |
| OR13J1 | 231.0 |
| OR1B1 | 231.0 |
| OR1J1 | 231.0 |
| OR1M1 | 231.0 |
| OR2A14 | 231.0 |
| OR2A5 | 231.0 |
| OR2AP1 | 231.0 |
| OR2L13 | 231.0 |
| OR2Y1 | 231.0 |
| OR4A16 | 231.0 |
| OR4C11 | 231.0 |
| OR4C12 | 231.0 |
| OR4C3 | 231.0 |
| OR4D11 | 231.0 |
| OR4D2 | 231.0 |
| OR4D6 | 231.0 |
| OR4F15 | 231.0 |
| OR4X2 | 231.0 |
| OR51F1 | 231.0 |
| OR52E2 | 231.0 |
| OR52H1 | 231.0 |
| OR52L1 | 231.0 |
| OR52R1 | 231.0 |
| OR56B1 | 231.0 |
| OR5A1 | 231.0 |
| OR5B17 | 231.0 |
| OR5L1 | 231.0 |
| OR5L2 | 231.0 |
| OR5M8 | 231.0 |
| OR6X1 | 231.0 |
| OR8K5 | 231.0 |
| OR9Q2 | 231.0 |
| PTH2R | 231.0 |
| RGS21 | 231.0 |
| RTP1 | 231.0 |
| TAAR8 | 231.0 |
| TAS2R7 | 231.0 |
| LHCGR | 340.5 |
| GIP | 344.0 |
| OR5C1 | 346.0 |
| TAS2R42 | 355.0 |
| NMT1 | 404.0 |
| OR2B2 | 420.0 |
| NPY4R | 446.5 |
| OXT | 449.0 |
| OR4K15 | 540.0 |
| OR6C1 | 540.0 |
| TAS2R19 | 549.0 |
| TAS2R20 | 549.0 |
| TAS2R30 | 549.0 |
| TAS2R31 | 549.0 |
| TAS2R43 | 549.0 |
| TAS2R46 | 549.0 |
| TAS2R50 | 549.0 |
| OPN4 | 560.0 |
| OR8A1 | 563.0 |
| APOB | 573.0 |
| ADCYAP1 | 576.0 |
| PPP2R5D | 596.0 |
| PIK3R3 | 597.5 |
| GNRH1 | 612.0 |
| F2RL1 | 616.0 |
| OR5W2 | 676.0 |
| GPR17 | 677.0 |
| PPEF1 | 686.0 |
| GRM3 | 693.0 |
| OR2AG1 | 700.0 |
| TAC1 | 700.0 |
| RGS16 | 809.0 |
| F2RL3 | 826.0 |
| OR52E6 | 842.0 |
| OR52E8 | 842.0 |
| OR8D1 | 842.0 |
| FSHR | 861.5 |
| OR4M1 | 861.5 |
| OR4M2 | 861.5 |
| OR4X1 | 861.5 |
| OR51B6 | 861.5 |
| OR51I2 | 861.5 |
| PYY | 861.5 |
| FFAR3 | 896.0 |
| OR10C1 | 896.0 |
| OR10S1 | 896.0 |
| OR2V1 | 896.0 |
| OR4K5 | 896.0 |
| OR51A2 | 896.0 |
| OR51A4 | 896.0 |
| OR51V1 | 896.0 |
| OR52K2 | 896.0 |
| OR2V2 | 917.5 |
| OR2Z1 | 917.5 |
| OPN5 | 921.0 |
| TAS2R13 | 930.0 |
| GNG5 | 992.0 |
| GHRH | 1070.0 |
| OR10H1 | 1093.5 |
| OR10H5 | 1093.5 |
| QRFP | 1095.0 |
| CAMK4 | 1172.0 |
| GRM2 | 1192.0 |
| FFAR4 | 1193.0 |
| GRK2 | 1198.0 |
| TAS2R10 | 1246.0 |
| GNAT3 | 1292.0 |
| RPS6KA2 | 1294.0 |
| SSTR2 | 1311.0 |
| XCL1 | 1380.5 |
| XCL2 | 1380.5 |
| OR52E5 | 1404.0 |
| OR2AG2 | 1419.5 |
| OR7C2 | 1419.5 |
| OR8U1 | 1419.5 |
| TAAR1 | 1419.5 |
| AKT1 | 1488.0 |
| OR4N5 | 1533.0 |
| PRKCD | 1551.0 |
| GPR83 | 1568.0 |
| DRD3 | 1587.0 |
| ADCY3 | 1612.0 |
| GRK1 | 1615.0 |
| ADM | 1625.0 |
| GPR15 | 1643.0 |
| APOM | 1657.0 |
| PDE3B | 1668.0 |
| OR13C3 | 1717.0 |
| CRHR1 | 1747.0 |
| NRAS | 1786.0 |
| GUCY2D | 1791.0 |
| HRH4 | 1810.0 |
| PROK2 | 1822.0 |
| DGKQ | 1845.0 |
| GPRC6A | 1876.0 |
| PNLIP | 1909.0 |
| VAV1 | 1912.0 |
| GRP | 1947.0 |
| CXCL6 | 1966.0 |
| GALR3 | 1969.0 |
| SCTR | 1986.0 |
| OR6K3 | 2052.0 |
| MAPK1 | 2063.0 |
| LRP8 | 2101.0 |
| HTR2B | 2125.0 |
| OR2T12 | 2143.0 |
| OR2T33 | 2143.0 |
| OR2T8 | 2143.0 |
| RTP4 | 2164.0 |
| MC2R | 2177.0 |
| ADCY7 | 2210.0 |
| OR2AT4 | 2241.0 |
| OR6C70 | 2316.5 |
| P2RY12 | 2339.0 |
| OR6C76 | 2370.0 |
| SCT | 2430.0 |
| GRK5 | 2483.0 |
| RGS22 | 2514.0 |
| MAPK3 | 2532.0 |
| PRKCB | 2630.0 |
| GPR68 | 2735.0 |
| GPHA2 | 2779.0 |
| HCRT | 2813.0 |
| TBXA2R | 2824.0 |
| ADRB2 | 2844.0 |
| HCAR2 | 2866.5 |
| HCAR3 | 2866.5 |
| CAMKMT | 2915.0 |
| LDLR | 2957.0 |
| GUCY2F | 3001.0 |
| PDE8B | 3035.5 |
| CCR1 | 3082.0 |
| GNA12 | 3137.0 |
| PDYN | 3143.0 |
| CCL23 | 3192.0 |
| HCAR1 | 3224.0 |
| POMC | 3261.0 |
| AVP | 3271.0 |
| GNG3 | 3307.0 |
| PDE1A | 3353.0 |
| F2R | 3369.0 |
| LPAR1 | 3370.0 |
| RGS7 | 3418.0 |
| GNAT1 | 3423.0 |
| P2RY4 | 3493.0 |
| SDR9C7 | 3561.0 |
| BDKRB1 | 3562.0 |
| ADRB1 | 3612.0 |
| GRK4 | 3623.0 |
| GPC1 | 3640.0 |
| MYO7A | 3664.0 |
| NMB | 3696.0 |
| GNAI3 | 3733.0 |
| GNG11 | 3752.0 |
| HRH1 | 3792.0 |
| PDE3A | 3794.0 |
| PPP1R1B | 3853.0 |
| GPR25 | 3869.0 |
| BCO1 | 3884.0 |
| ADRA1B | 3941.0 |
| OR5I1 | 4012.0 |
| SLC24A1 | 4032.0 |
| CCR8 | 4126.0 |
| FGD2 | 4170.0 |
| PDE8A | 4181.0 |
| PTAFR | 4229.0 |
| CCK | 4270.0 |
| RLN2 | 4323.5 |
| GNGT2 | 4376.0 |
| RGS9BP | 4413.0 |
| RGS10 | 4447.0 |
| GHRL | 4454.0 |
| PPP2R1B | 4513.0 |
| NMU | 4522.0 |
| ADRA2A | 4582.0 |
| HBEGF | 4618.0 |
| HTR1B | 4630.0 |
| DGKA | 4645.0 |
| OR51D1 | 4699.0 |
| CAMKK1 | 4711.0 |
| MAPK7 | 4725.0 |
| TRPC7 | 4748.0 |
| LRP1 | 4809.0 |
| CALCA | 4836.0 |
| TIAM2 | 4841.0 |
| CCL27 | 4856.0 |
| RBP3 | 4858.0 |
| ADRA2C | 4926.0 |
| GPR37 | 4931.0 |
| ROCK1 | 4962.0 |
| RDH10 | 5000.0 |
| PPP3R1 | 5058.5 |
| RGS9 | 5078.0 |
| RAMP3 | 5107.0 |
| METAP2 | 5174.0 |
| HCRTR2 | 5199.0 |
| RASGRF2 | 5220.0 |
| RGSL1 | 5265.0 |
| OXTR | 5278.0 |
| GNA13 | 5282.0 |
| OR6K2 | 5286.0 |
| GIPR | 5394.0 |
| PRKX | 5448.5 |
| UTS2B | 5468.0 |
| PDE10A | 5495.0 |
| RHOC | 5509.5 |
| FFAR2 | 5519.0 |
| NMBR | 5522.0 |
| AVPR1B | 5580.0 |
| S1PR5 | 5597.0 |
| DRD4 | 5612.0 |
| S1PR2 | 5627.0 |
| HTR2A | 5650.0 |
| RGS19 | 5668.0 |
| GPR18 | 5762.0 |
| OR1F1 | 5776.0 |
| VAV2 | 5813.0 |
| KRAS | 5849.0 |
| PMCH | 5889.0 |
| ARHGEF25 | 5966.5 |
| PTGDR | 6020.0 |
| BCO2 | 6058.0 |
| ARHGEF12 | 6104.0 |
| TAS2R41 | 6144.0 |
| NAPEPLD | 6226.0 |
| GNAZ | 6253.0 |
| FGD3 | 6255.0 |
| GNB2 | 6264.0 |
| OR6N1 | 6265.0 |
| ACKR3 | 6294.0 |
| CRH | 6329.0 |
| VIPR2 | 6379.0 |
| RDH12 | 6399.0 |
| OR2K2 | 6446.0 |
| SDC2 | 6449.0 |
| REEP4 | 6463.0 |
| GRM1 | 6498.0 |
| STRA6 | 6510.0 |
| RDH5 | 6515.0 |
| OR4E1 | 6518.0 |
| ADRA1A | 6572.0 |
| GNG8 | 6614.0 |
| RGS12 | 6733.0 |
| KISS1R | 6746.0 |
| GNG2 | 6793.0 |
| TAS1R1 | 6812.0 |
| ADCY8 | 6825.0 |
| PIK3CG | 6844.0 |
| OPRK1 | 6857.0 |
| PTGFR | 6884.0 |
| GPSM1 | 6904.0 |
| TIAM1 | 6942.0 |
| P2RY1 | 6949.0 |
| LTB4R2 | 6967.0 |
| RASGRP1 | 7000.0 |
| LPAR4 | 7063.0 |
| GUCA1A | 7066.0 |
| RPE65 | 7074.0 |
| GNG10 | 7112.0 |
| S1PR3 | 7127.0 |
| ANXA1 | 7137.0 |
| GABBR2 | 7146.0 |
| NMUR2 | 7148.0 |
| CCL21 | 7185.0 |
| ADCYAP1R1 | 7189.0 |
| PLCB2 | 7190.0 |
| LPAR3 | 7241.0 |
| PDE4B | 7268.0 |
| ABCA4 | 7305.0 |
| SDC1 | 7316.0 |
| DHRS9 | 7322.0 |
| GRM7 | 7349.0 |
| ECT2 | 7350.0 |
| DGKI | 7390.0 |
| GPBAR1 | 7429.0 |
| CAMK2G | 7477.0 |
| APP | 7480.0 |
| FNTA | 7484.0 |
| AGTR2 | 7492.0 |
| EDN2 | 7506.0 |
| MMP3 | 7551.0 |
| BTK | 7564.0 |
| CCR5 | 7623.0 |
| ARHGEF3 | 7632.0 |
| P2RY13 | 7646.0 |
| SOS2 | 7658.0 |
| LRP12 | 7671.0 |
| AHCYL1 | 7728.0 |
| CX3CR1 | 7784.0 |
| HTR1D | 7853.5 |
| GPER1 | 7908.0 |
| GNB3 | 7932.0 |
| PNOC | 7937.0 |
| CALCRL | 7971.0 |
| ARHGEF2 | 7980.0 |
| DRD1 | 8013.0 |
| CYSLTR1 | 8025.0 |
| PRKAR1B | 8032.0 |
| AWAT2 | 8046.0 |
| PIK3R1 | 8109.0 |
| OPN1SW | 8117.0 |
| ADORA3 | 8119.0 |
| HSD17B1 | 8140.0 |
| NTSR2 | 8169.0 |
| KPNA2 | 8174.0 |
| HRH2 | 8194.0 |
| TRPC6 | 8208.0 |
| MC4R | 8265.0 |
| PDE6G | 8266.0 |
| ARHGEF26 | 8302.0 |
| ABHD6 | 8329.0 |
| CNGB1 | 8343.0 |
| LPAR2 | 8362.0 |
| OPN3 | 8414.0 |
| CREB1 | 8434.0 |
| PLA2G4A | 8549.0 |
| GLP1R | 8565.0 |
| RDH11 | 8604.5 |
| AKT3 | 8609.0 |
| TRPC3 | 8707.0 |
| OPRM1 | 8749.0 |
| PDE7A | 8851.0 |
| ITPR1 | 8900.0 |
Miscellaneous substrates
| 700 | |
|---|---|
| set | Miscellaneous substrates |
| setSize | 12 |
| pANOVA | 0.00119 |
| s.dist | -0.54 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYP2D6 | -9035.5 |
| CYP3A43 | -8991.0 |
| CYP4F2 | -8108.0 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4B1 | -6651.0 |
| CYP4F3 | -4081.0 |
| CYP2W1 | -3941.0 |
| CYP2S1 | -1638.0 |
| CYP2U1 | 2375.0 |
| CYP4F22 | 4080.0 |
| GeneID | Gene Rank |
|---|---|
| CYP2D6 | -9035.5 |
| CYP3A43 | -8991.0 |
| CYP4F2 | -8108.0 |
| CYP4A11 | -7728.5 |
| CYP4A22 | -7728.5 |
| CYP4F11 | -7728.5 |
| CYP4B1 | -6651.0 |
| CYP4F3 | -4081.0 |
| CYP2W1 | -3941.0 |
| CYP2S1 | -1638.0 |
| CYP2U1 | 2375.0 |
| CYP4F22 | 4080.0 |
Chylomicron remodeling
| 194 | |
|---|---|
| set | Chylomicron remodeling |
| setSize | 10 |
| pANOVA | 0.00125 |
| s.dist | -0.589 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOC3 | -8904.0 |
| APOE | -8836.0 |
| APOA5 | -8466.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| APOA4 | -6758.0 |
| GPIHBP1 | -3404.0 |
| LPL | -2467.0 |
| APOA1 | -547.0 |
| APOB | 573.0 |
| GeneID | Gene Rank |
|---|---|
| APOC3 | -8904.0 |
| APOE | -8836.0 |
| APOA5 | -8466.0 |
| APOC2 | -7531.5 |
| APOA2 | -7400.0 |
| APOA4 | -6758.0 |
| GPIHBP1 | -3404.0 |
| LPL | -2467.0 |
| APOA1 | -547.0 |
| APOB | 573.0 |
Factors involved in megakaryocyte development and platelet production
| 411 | |
|---|---|
| set | Factors involved in megakaryocyte development and platelet production |
| setSize | 124 |
| pANOVA | 0.00127 |
| s.dist | -0.168 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KIFC2 | -9081 |
| KIF18B | -8985 |
| KIF1B | -8978 |
| KIF21A | -8950 |
| PRKAR2B | -8880 |
| EHD3 | -8828 |
| KIF27 | -8612 |
| KIFC1 | -8600 |
| SIN3A | -8558 |
| CDC42 | -8440 |
| PRKAR2A | -8106 |
| HMG20B | -7951 |
| PRKACA | -7713 |
| ITPK1 | -7660 |
| NFE2 | -7514 |
| KIF21B | -7488 |
| KIF9 | -7297 |
| MFN2 | -7233 |
| ZFPM2 | -7162 |
| KIF2C | -7103 |
| GeneID | Gene Rank |
|---|---|
| KIFC2 | -9081 |
| KIF18B | -8985 |
| KIF1B | -8978 |
| KIF21A | -8950 |
| PRKAR2B | -8880 |
| EHD3 | -8828 |
| KIF27 | -8612 |
| KIFC1 | -8600 |
| SIN3A | -8558 |
| CDC42 | -8440 |
| PRKAR2A | -8106 |
| HMG20B | -7951 |
| PRKACA | -7713 |
| ITPK1 | -7660 |
| NFE2 | -7514 |
| KIF21B | -7488 |
| KIF9 | -7297 |
| MFN2 | -7233 |
| ZFPM2 | -7162 |
| KIF2C | -7103 |
| ABL1 | -7066 |
| GATA6 | -6959 |
| KLC3 | -6887 |
| CAPZB | -6870 |
| PRKACB | -6707 |
| KIF5A | -6521 |
| DOCK6 | -6503 |
| KIF16B | -6282 |
| DOCK7 | -5972 |
| DOCK9 | -5908 |
| KIF11 | -5608 |
| SH2B2 | -5588 |
| MAFK | -5510 |
| CABLES1 | -5493 |
| IFNA1 | -5355 |
| IFNA10 | -5355 |
| IFNA14 | -5355 |
| IFNA16 | -5355 |
| IFNA17 | -5355 |
| IFNA2 | -5355 |
| IFNA21 | -5355 |
| IFNA4 | -5355 |
| IFNA5 | -5355 |
| IFNA6 | -5355 |
| IFNA7 | -5355 |
| IFNA8 | -5355 |
| KIF26A | -5302 |
| KIF1A | -5234 |
| KIF19 | -5117 |
| DOCK3 | -5112 |
| PRKAR1A | -4970 |
| IRF1 | -4752 |
| EHD1 | -4733 |
| KIF20B | -4693 |
| EHD2 | -4660 |
| KIF1C | -4619 |
| ZFPM1 | -4493 |
| KIF26B | -3877 |
| JAK2 | -3777 |
| GATA4 | -3432 |
| KIF20A | -3376 |
| RACGAP1 | -2770 |
| CDK5 | -2600 |
| HBE1 | -2432 |
| KIF3C | -2283 |
| SH2B3 | -2226 |
| RCOR1 | -2134 |
| PHF21A | -2021 |
| H3-3A | -1923 |
| GATA3 | -1622 |
| DOCK2 | -1444 |
| KIF2A | -1295 |
| RAB5A | -1243 |
| KIFAP3 | -1209 |
| AK3 | -839 |
| RAD51C | -750 |
| DOCK1 | 104 |
| MAFF | 112 |
| KIF12 | 517 |
| KIF18A | 607 |
| KIF6 | 619 |
| KIF2B | 996 |
| VPS45 | 1048 |
| KLC2 | 1226 |
| SH2B1 | 1236 |
| WEE1 | 1357 |
| GATA2 | 1911 |
| RAC1 | 2240 |
| RBSN | 2306 |
| KIF22 | 2377 |
| AKAP1 | 2494 |
| KLC4 | 2935 |
| DOCK11 | 3031 |
| DOCK4 | 3123 |
| KIF4A | 3248 |
| HDAC2 | 3553 |
| MICAL1 | 3622 |
| GATA1 | 3670 |
| MAFG | 3707 |
| CDK2 | 3851 |
| AKAP10 | 3922 |
| DOCK5 | 4260 |
| GATA5 | 4604 |
| RAD51B | 5276 |
| CAPZA2 | 5364 |
| CENPE | 5825 |
| IRF2 | 5903 |
| KIF5B | 6494 |
| MFN1 | 6573 |
| CBX5 | 6715 |
| HDAC1 | 7175 |
| JMJD1C | 7265 |
| KIF15 | 7285 |
| KIF23 | 7496 |
| CABLES2 | 7630 |
| PRKAR1B | 8032 |
| KIF3B | 8041 |
| KIF3A | 8088 |
| KIF5C | 8217 |
| KIF13B | 8290 |
| DOCK8 | 8423 |
| CARMIL1 | 8526 |
| MYB | 8599 |
| KDM1A | 8614 |
Endosomal/Vacuolar pathway
| 366 | |
|---|---|
| set | Endosomal/Vacuolar pathway |
| setSize | 10 |
| pANOVA | 0.00137 |
| s.dist | -0.585 |
| p.adjustANOVA | 0.0635 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-A | -8118.5 |
| HLA-B | -8118.5 |
| HLA-C | -8118.5 |
| HLA-E | -8118.5 |
| HLA-F | -8118.5 |
| HLA-G | -8118.5 |
| CTSV | -4546.0 |
| LNPEP | -4426.0 |
| B2M | 1971.0 |
| CTSS | 2396.0 |
| GeneID | Gene Rank |
|---|---|
| HLA-A | -8118.5 |
| HLA-B | -8118.5 |
| HLA-C | -8118.5 |
| HLA-E | -8118.5 |
| HLA-F | -8118.5 |
| HLA-G | -8118.5 |
| CTSV | -4546.0 |
| LNPEP | -4426.0 |
| B2M | 1971.0 |
| CTSS | 2396.0 |
Platelet Aggregation (Plug Formation)
| 886 | |
|---|---|
| set | Platelet Aggregation (Plug Formation) |
| setSize | 37 |
| pANOVA | 0.00143 |
| s.dist | -0.303 |
| p.adjustANOVA | 0.0635 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGB | -9053 |
| MPL | -9041 |
| FGA | -8696 |
| THPO | -8655 |
| PTK2 | -8355 |
| GP1BA | -8136 |
| SRC | -8095 |
| FGG | -8035 |
| BCAR1 | -7614 |
| ADRA2B | -7489 |
| RASGRP2 | -7350 |
| VWF | -7285 |
| ITGA2B | -7222 |
| RAPGEF3 | -6504 |
| SYK | -6379 |
| GP5 | -6277 |
| GP9 | -5163 |
| TLN1 | -5122 |
| PDPK1 | -4325 |
| GP1BB | -3680 |
| GeneID | Gene Rank |
|---|---|
| FGB | -9053.0 |
| MPL | -9041.0 |
| FGA | -8696.0 |
| THPO | -8655.0 |
| PTK2 | -8355.0 |
| GP1BA | -8136.0 |
| SRC | -8095.0 |
| FGG | -8035.0 |
| BCAR1 | -7614.0 |
| ADRA2B | -7489.0 |
| RASGRP2 | -7350.0 |
| VWF | -7285.0 |
| ITGA2B | -7222.0 |
| RAPGEF3 | -6504.0 |
| SYK | -6379.0 |
| GP5 | -6277.0 |
| GP9 | -5163.0 |
| TLN1 | -5122.0 |
| PDPK1 | -4325.0 |
| GP1BB | -3680.0 |
| APBB1IP | -3673.0 |
| F2 | -3616.0 |
| ITGB3 | -3380.5 |
| GRB2 | -3336.0 |
| SOS1 | -2808.0 |
| RAP1A | 937.0 |
| AKT1 | 1488.0 |
| CRK | 2198.0 |
| RAP1B | 4145.0 |
| ADRA2A | 4582.0 |
| RAPGEF4 | 4676.0 |
| CSK | 4803.0 |
| ADRA2C | 4926.0 |
| PTPN1 | 6830.0 |
| FN1 | 6913.0 |
| RASGRP1 | 7000.0 |
| SHC1 | 7644.0 |
Formation of the beta-catenin:TCF transactivating complex
| 431 | |
|---|---|
| set | Formation of the beta-catenin:TCF transactivating complex |
| setSize | 41 |
| pANOVA | 0.00145 |
| s.dist | -0.288 |
| p.adjustANOVA | 0.0635 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TLE1 | -9016 |
| KMT2D | -8177 |
| MYC | -8133 |
| H2BC1 | -8026 |
| ASH2L | -7949 |
| RUVBL1 | -7902 |
| AXIN2 | -7523 |
| SMARCA4 | -7503 |
| LEO1 | -7393 |
| LEF1 | -7053 |
| TCF4 | -6313 |
| TCF7 | -6192 |
| BCL9L | -5979 |
| TCF7L1 | -5873 |
| CREBBP | -5548 |
| RUNX3 | -4786 |
| H3-4 | -4773 |
| PYGO1 | -4769 |
| TERT | -4625 |
| TCF7L2 | -4244 |
| GeneID | Gene Rank |
|---|---|
| TLE1 | -9016.0 |
| KMT2D | -8177.0 |
| MYC | -8133.0 |
| H2BC1 | -8026.0 |
| ASH2L | -7949.0 |
| RUVBL1 | -7902.0 |
| AXIN2 | -7523.0 |
| SMARCA4 | -7503.0 |
| LEO1 | -7393.0 |
| LEF1 | -7053.0 |
| TCF4 | -6313.0 |
| TCF7 | -6192.0 |
| BCL9L | -5979.0 |
| TCF7L1 | -5873.0 |
| CREBBP | -5548.0 |
| RUNX3 | -4786.0 |
| H3-4 | -4773.0 |
| PYGO1 | -4769.0 |
| TERT | -4625.0 |
| TCF7L2 | -4244.0 |
| KAT5 | -4080.0 |
| TLE3 | -3738.0 |
| H2BC3 | -3635.0 |
| H2BC12 | -3610.0 |
| H2AJ | -3539.0 |
| PYGO2 | -2886.0 |
| H3-3A | -1923.0 |
| TLE2 | -858.0 |
| H2AZ1 | -773.0 |
| MEN1 | -556.0 |
| BCL9 | -533.0 |
| H2AZ2 | 124.0 |
| EP300 | 1591.0 |
| CTNNB1 | 1809.0 |
| RBBP5 | 5206.0 |
| CDC73 | 5336.0 |
| H2BU1 | 5658.0 |
| H2BC11 | 6802.0 |
| H4C1 | 6923.5 |
| HDAC1 | 7175.0 |
| TLE4 | 8719.0 |
Regulation of lipid metabolism by PPARalpha
| 1051 | |
|---|---|
| set | Regulation of lipid metabolism by PPARalpha |
| setSize | 116 |
| pANOVA | 0.00158 |
| s.dist | -0.17 |
| p.adjustANOVA | 0.0674 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SULT2A1 | -9051.0 |
| ARNT | -8977.0 |
| MED26 | -8830.5 |
| MED13L | -8802.0 |
| AHRR | -8688.0 |
| PPARGC1B | -8580.0 |
| SIN3A | -8558.0 |
| MED16 | -8539.0 |
| NCOR2 | -8506.0 |
| PPARG | -8498.0 |
| APOA5 | -8466.0 |
| NFYB | -8282.0 |
| NCOR1 | -8129.0 |
| PEX11A | -8070.0 |
| RXRB | -7956.0 |
| AGT | -7862.0 |
| CYP4A11 | -7728.5 |
| GLIPR1 | -7664.0 |
| CLOCK | -7607.0 |
| APOA2 | -7400.0 |
| GeneID | Gene Rank |
|---|---|
| SULT2A1 | -9051.0 |
| ARNT | -8977.0 |
| MED26 | -8830.5 |
| MED13L | -8802.0 |
| AHRR | -8688.0 |
| PPARGC1B | -8580.0 |
| SIN3A | -8558.0 |
| MED16 | -8539.0 |
| NCOR2 | -8506.0 |
| PPARG | -8498.0 |
| APOA5 | -8466.0 |
| NFYB | -8282.0 |
| NCOR1 | -8129.0 |
| PEX11A | -8070.0 |
| RXRB | -7956.0 |
| AGT | -7862.0 |
| CYP4A11 | -7728.5 |
| GLIPR1 | -7664.0 |
| CLOCK | -7607.0 |
| APOA2 | -7400.0 |
| NR1H3 | -7384.0 |
| NRF1 | -7330.0 |
| MED12 | -7323.0 |
| CD36 | -7248.0 |
| MED24 | -7004.0 |
| ACOX1 | -6775.0 |
| NCOA1 | -6733.0 |
| MED15 | -6643.0 |
| MED22 | -6572.0 |
| FAM120B | -6268.0 |
| ANGPTL4 | -6243.0 |
| MED23 | -6215.0 |
| SREBF2 | -6205.0 |
| ABCA1 | -6097.0 |
| NCOA6 | -5797.0 |
| GPS2 | -5694.0 |
| CREBBP | -5548.0 |
| MED7 | -5543.0 |
| THRAP3 | -5484.0 |
| CARM1 | -5274.0 |
| RXRA | -5221.0 |
| NCOA2 | -5184.0 |
| TBL1XR1 | -5183.0 |
| FABP1 | -5035.0 |
| NR1H2 | -4967.0 |
| HELZ2 | -4722.0 |
| NCOA3 | -4671.0 |
| SREBF1 | -4592.0 |
| NFYC | -4345.0 |
| MED25 | -4175.0 |
| SIN3B | -3955.0 |
| MED18 | -3878.0 |
| FDFT1 | -3850.0 |
| HMGCS2 | -3389.0 |
| FADS1 | -3316.0 |
| MED27 | -3309.0 |
| CPT2 | -2996.0 |
| ACSL1 | -2747.0 |
| TRIB3 | -2550.0 |
| SLC27A1 | -2355.0 |
| CDK19 | -2351.0 |
| MED30 | -2156.0 |
| SP1 | -1438.0 |
| ACADM | -1408.0 |
| SMARCD3 | -1202.0 |
| PLIN2 | -877.0 |
| NPAS2 | -672.0 |
| APOA1 | -547.0 |
| PPARA | -247.0 |
| CYP1A1 | 359.0 |
| ME1 | 721.0 |
| HMGCR | 979.0 |
| MED19 | 998.0 |
| MED21 | 1133.0 |
| ARNTL | 1164.0 |
| RORA | 1169.0 |
| RGL1 | 1218.0 |
| ARNT2 | 1509.0 |
| EP300 | 1591.0 |
| TBL1X | 1601.5 |
| FHL2 | 1605.0 |
| MED17 | 1792.5 |
| NFYA | 2215.0 |
| MED13 | 2543.0 |
| GRHL1 | 2566.0 |
| AHR | 2943.5 |
| CYP7A1 | 3065.0 |
| PPARGC1A | 3088.0 |
| NR1D1 | 3357.0 |
| CPT1A | 3390.0 |
| HMGCS1 | 3682.0 |
| MED1 | 3935.0 |
| MED11 | 4100.0 |
| TNFRSF21 | 4280.0 |
| NR1H4 | 4600.0 |
| MED31 | 4780.0 |
| TGS1 | 4793.0 |
| TIAM2 | 4841.0 |
| MED4 | 5496.0 |
| HDAC3 | 5550.0 |
| CCNC | 5816.0 |
| MTF1 | 6150.0 |
| TXNRD1 | 6305.0 |
| G0S2 | 6523.0 |
| MED6 | 6537.0 |
| ALAS1 | 6567.0 |
| MED29 | 6632.0 |
| MED10 | 6668.0 |
| MED9 | 7153.0 |
| MED28 | 7354.0 |
| MED20 | 7734.0 |
| ESRRA | 8154.0 |
| ANKRD1 | 8506.0 |
| ABCB4 | 8547.0 |
| CHD9 | 8687.0 |
| MED14 | 8916.0 |
Keratan sulfate/keratin metabolism
| 624 | |
|---|---|
| set | Keratan sulfate/keratin metabolism |
| setSize | 31 |
| pANOVA | 0.00164 |
| s.dist | 0.327 |
| p.adjustANOVA | 0.0677 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRELP | 8868.0 |
| B4GALT6 | 8861.0 |
| OGN | 8486.0 |
| B3GNT3 | 8351.0 |
| FMOD | 7779.0 |
| HEXB | 7586.0 |
| OMD | 7445.0 |
| ST3GAL4 | 7352.0 |
| ST3GAL1 | 7280.0 |
| ACAN | 7037.0 |
| KERA | 6796.0 |
| B4GALT2 | 5318.0 |
| HEXA | 5131.5 |
| ST3GAL2 | 4615.0 |
| B4GALT5 | 4469.0 |
| B3GNT4 | 3805.0 |
| GLB1L | 3354.0 |
| ST3GAL6 | 3182.0 |
| B4GALT4 | 2489.0 |
| CHST1 | 1992.0 |
| GeneID | Gene Rank |
|---|---|
| PRELP | 8868.0 |
| B4GALT6 | 8861.0 |
| OGN | 8486.0 |
| B3GNT3 | 8351.0 |
| FMOD | 7779.0 |
| HEXB | 7586.0 |
| OMD | 7445.0 |
| ST3GAL4 | 7352.0 |
| ST3GAL1 | 7280.0 |
| ACAN | 7037.0 |
| KERA | 6796.0 |
| B4GALT2 | 5318.0 |
| HEXA | 5131.5 |
| ST3GAL2 | 4615.0 |
| B4GALT5 | 4469.0 |
| B3GNT4 | 3805.0 |
| GLB1L | 3354.0 |
| ST3GAL6 | 3182.0 |
| B4GALT4 | 2489.0 |
| CHST1 | 1992.0 |
| LUM | 941.0 |
| GNS | -359.0 |
| SLC35D2 | -885.5 |
| CHST2 | -2100.0 |
| B4GALT3 | -2173.0 |
| B3GNT2 | -2424.0 |
| B4GALT1 | -3055.0 |
| B4GAT1 | -4085.0 |
| GLB1 | -4829.0 |
| B3GNT7 | -5845.0 |
| ST3GAL3 | -5996.0 |
Intrinsic Pathway of Fibrin Clot Formation
| 612 | |
|---|---|
| set | Intrinsic Pathway of Fibrin Clot Formation |
| setSize | 23 |
| pANOVA | 0.00177 |
| s.dist | -0.377 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KNG1 | -9050.0 |
| F10 | -8579.0 |
| F12 | -8319.0 |
| GP1BA | -8136.0 |
| VWF | -7285.0 |
| F11 | -6531.0 |
| GP5 | -6277.0 |
| KLKB1 | -6048.0 |
| F9 | -5791.0 |
| SERPIND1 | -5751.0 |
| GP9 | -5163.0 |
| PROC | -3962.0 |
| A2M | -3884.0 |
| GP1BB | -3680.0 |
| F2 | -3616.0 |
| SERPING1 | -3530.0 |
| SERPINA5 | -1562.5 |
| PRCP | -1478.0 |
| F8 | -1310.0 |
| SERPINC1 | 2277.0 |
| GeneID | Gene Rank |
|---|---|
| KNG1 | -9050.0 |
| F10 | -8579.0 |
| F12 | -8319.0 |
| GP1BA | -8136.0 |
| VWF | -7285.0 |
| F11 | -6531.0 |
| GP5 | -6277.0 |
| KLKB1 | -6048.0 |
| F9 | -5791.0 |
| SERPIND1 | -5751.0 |
| GP9 | -5163.0 |
| PROC | -3962.0 |
| A2M | -3884.0 |
| GP1BB | -3680.0 |
| F2 | -3616.0 |
| SERPING1 | -3530.0 |
| SERPINA5 | -1562.5 |
| PRCP | -1478.0 |
| F8 | -1310.0 |
| SERPINC1 | 2277.0 |
| PROS1 | 4698.0 |
| C1QBP | 5377.0 |
| SERPINE2 | 8181.0 |
Hemostasis
| 534 | |
|---|---|
| set | Hemostasis |
| setSize | 582 |
| pANOVA | 0.00181 |
| s.dist | -0.0759 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KIFC2 | -9081 |
| IGHM | -9080 |
| FGB | -9053 |
| KNG1 | -9050 |
| IGKC | -9044 |
| MPL | -9041 |
| BRPF3 | -9028 |
| ITGAM | -9020 |
| ITIH4 | -9013 |
| PLG | -9005 |
| ITIH3 | -9001 |
| KIF18B | -8985 |
| KIF1B | -8978 |
| IGF2 | -8965 |
| HRG | -8962 |
| CLU | -8960 |
| KIF21A | -8950 |
| PDE2A | -8915 |
| PRKAR2B | -8880 |
| PDE11A | -8842 |
| GeneID | Gene Rank |
|---|---|
| KIFC2 | -9081.0 |
| IGHM | -9080.0 |
| FGB | -9053.0 |
| KNG1 | -9050.0 |
| IGKC | -9044.0 |
| MPL | -9041.0 |
| BRPF3 | -9028.0 |
| ITGAM | -9020.0 |
| ITIH4 | -9013.0 |
| PLG | -9005.0 |
| ITIH3 | -9001.0 |
| KIF18B | -8985.0 |
| KIF1B | -8978.0 |
| IGF2 | -8965.0 |
| HRG | -8962.0 |
| CLU | -8960.0 |
| KIF21A | -8950.0 |
| PDE2A | -8915.0 |
| PRKAR2B | -8880.0 |
| PDE11A | -8842.0 |
| EHD3 | -8828.0 |
| DGKE | -8747.0 |
| CFD | -8722.0 |
| FGA | -8696.0 |
| KCNMB2 | -8691.5 |
| KCNMB1 | -8678.0 |
| SERPINA3 | -8667.0 |
| SRGN | -8663.0 |
| THPO | -8655.0 |
| KIF27 | -8612.0 |
| GNAS | -8601.0 |
| KIFC1 | -8600.0 |
| F10 | -8579.0 |
| PPP2R5C | -8572.0 |
| CYRIB | -8567.0 |
| SIN3A | -8558.0 |
| ATP2B1 | -8502.0 |
| APOH | -8448.0 |
| CDC42 | -8440.0 |
| PDE1B | -8427.0 |
| F5 | -8356.0 |
| PTK2 | -8355.0 |
| F12 | -8319.0 |
| ANGPT2 | -8277.0 |
| L1CAM | -8233.0 |
| CD84 | -8185.0 |
| DGKZ | -8155.0 |
| GP1BA | -8136.0 |
| CD74 | -8112.0 |
| PRKAR2A | -8106.0 |
| SRC | -8095.0 |
| ALDOA | -8055.0 |
| FGG | -8035.0 |
| CHID1 | -7975.0 |
| HMG20B | -7951.0 |
| F13B | -7912.0 |
| DAGLB | -7867.0 |
| NOS2 | -7772.0 |
| ITGA5 | -7756.0 |
| PRKACA | -7713.0 |
| ITPK1 | -7660.0 |
| GNAI1 | -7649.0 |
| BCAR1 | -7614.0 |
| MGLL | -7581.0 |
| CD244 | -7562.0 |
| SELP | -7555.0 |
| DGKB | -7547.0 |
| NFE2 | -7514.0 |
| SLC7A10 | -7506.0 |
| ABHD12 | -7496.0 |
| ADRA2B | -7489.0 |
| KIF21B | -7488.0 |
| SERPINB8 | -7455.0 |
| RAC2 | -7433.0 |
| RASGRP2 | -7350.0 |
| GNG4 | -7316.0 |
| DGKG | -7310.0 |
| APLP2 | -7302.0 |
| PDGFA | -7301.0 |
| IRAG1 | -7300.0 |
| KIF9 | -7297.0 |
| VWF | -7285.0 |
| STIM1 | -7258.0 |
| VEGFD | -7250.0 |
| CD36 | -7248.0 |
| MFN2 | -7233.0 |
| ITGA2B | -7222.0 |
| ZFPM2 | -7162.0 |
| KCNMA1 | -7156.0 |
| PRKCE | -7128.0 |
| KIF2C | -7103.0 |
| PIK3R2 | -7098.5 |
| VAV3 | -7088.0 |
| ABL1 | -7066.0 |
| GNA14 | -6980.0 |
| GATA6 | -6959.0 |
| KLC3 | -6887.0 |
| CAPZB | -6870.0 |
| ITGA3 | -6852.0 |
| AAMP | -6822.0 |
| ARRB2 | -6754.0 |
| SERPINA4 | -6752.0 |
| PRKACB | -6707.0 |
| PSAP | -6675.0 |
| STX4 | -6665.0 |
| P2RX6 | -6557.0 |
| F11 | -6531.0 |
| KIF5A | -6521.0 |
| RAPGEF3 | -6504.0 |
| DOCK6 | -6503.0 |
| SYK | -6379.0 |
| KIF16B | -6282.0 |
| GP5 | -6277.0 |
| PPP2CA | -6258.0 |
| PIK3R6 | -6249.0 |
| PICK1 | -6219.0 |
| PPP2R5A | -6197.0 |
| GYPC | -6089.0 |
| KLKB1 | -6048.0 |
| ITPR3 | -6046.0 |
| LGALS3BP | -6021.0 |
| DOCK7 | -5972.0 |
| DOCK9 | -5908.0 |
| ITGA6 | -5895.0 |
| GNG12 | -5884.0 |
| MAG | -5858.0 |
| ITPR2 | -5837.0 |
| F9 | -5791.0 |
| SERPIND1 | -5751.0 |
| SLC8A3 | -5661.0 |
| ACTN4 | -5646.0 |
| KIF11 | -5608.0 |
| SH2B2 | -5588.0 |
| MAFK | -5510.0 |
| CABLES1 | -5493.0 |
| PIK3R5 | -5482.0 |
| IFNA1 | -5355.0 |
| IFNA10 | -5355.0 |
| IFNA14 | -5355.0 |
| IFNA16 | -5355.0 |
| IFNA17 | -5355.0 |
| IFNA2 | -5355.0 |
| IFNA21 | -5355.0 |
| IFNA4 | -5355.0 |
| IFNA5 | -5355.0 |
| IFNA6 | -5355.0 |
| IFNA7 | -5355.0 |
| IFNA8 | -5355.0 |
| ATP2A3 | -5325.0 |
| F7 | -5305.0 |
| KIF26A | -5302.0 |
| PLCG1 | -5242.0 |
| ITGAX | -5237.0 |
| KIF1A | -5234.0 |
| IGLC1 | -5196.5 |
| IGLC2 | -5196.5 |
| IGLC3 | -5196.5 |
| IGLC7 | -5196.5 |
| IGLL1 | -5196.5 |
| GP9 | -5163.0 |
| PRKCH | -5149.5 |
| TLN1 | -5122.0 |
| KIF19 | -5117.0 |
| DOCK3 | -5112.0 |
| PRKAR1A | -4970.0 |
| PDGFB | -4881.0 |
| IRF1 | -4752.0 |
| EHD1 | -4733.0 |
| KIF20B | -4693.0 |
| ORAI1 | -4684.0 |
| EHD2 | -4660.0 |
| KIF1C | -4619.0 |
| GNB4 | -4593.0 |
| SLC8A1 | -4527.0 |
| ZFPM1 | -4493.0 |
| GNAI2 | -4425.0 |
| CEACAM1 | -4406.5 |
| CEACAM3 | -4406.5 |
| CEACAM5 | -4406.5 |
| CEACAM6 | -4406.5 |
| CEACAM8 | -4406.5 |
| PSG1 | -4406.5 |
| PSG11 | -4406.5 |
| PSG2 | -4406.5 |
| PSG3 | -4406.5 |
| PSG4 | -4406.5 |
| PSG5 | -4406.5 |
| PSG6 | -4406.5 |
| PSG7 | -4406.5 |
| PSG8 | -4406.5 |
| PSG9 | -4406.5 |
| SLC3A2 | -4375.0 |
| PDPK1 | -4325.0 |
| P2RX4 | -4302.0 |
| ITGA4 | -4297.0 |
| ANGPT1 | -4231.0 |
| DGKH | -4197.0 |
| CALU | -4108.0 |
| ATP2A1 | -4002.0 |
| PDE9A | -3993.0 |
| PROC | -3962.0 |
| SOD1 | -3928.0 |
| GLG1 | -3927.0 |
| F11R | -3912.0 |
| GNB1 | -3895.0 |
| GP6 | -3886.0 |
| A2M | -3884.0 |
| STXBP2 | -3879.0 |
| KIF26B | -3877.0 |
| JAK2 | -3777.0 |
| P2RX5 | -3757.5 |
| VTI1B | -3691.0 |
| GP1BB | -3680.0 |
| APBB1IP | -3673.0 |
| PPP2CB | -3632.0 |
| F2 | -3616.0 |
| DGKK | -3596.0 |
| FERMT3 | -3593.0 |
| MIF | -3545.0 |
| SERPING1 | -3530.0 |
| A1BG | -3505.0 |
| PRKCQ | -3483.0 |
| PPP2R1A | -3477.0 |
| GATA4 | -3432.0 |
| LCK | -3384.0 |
| ITGB3 | -3380.5 |
| KIF20A | -3376.0 |
| GRB2 | -3336.0 |
| SERPINE1 | -3327.0 |
| PTGIR | -3311.0 |
| SLC7A5 | -3253.0 |
| INPP5D | -3164.0 |
| JAM3 | -3140.0 |
| SPN | -3134.0 |
| RHOB | -3080.0 |
| ITGA1 | -3067.0 |
| GNG7 | -3060.0 |
| ACTN2 | -3058.0 |
| OLA1 | -3042.0 |
| WDR1 | -3013.0 |
| SDC4 | -2987.0 |
| CD177 | -2979.0 |
| KCNMB4 | -2965.0 |
| GNA11 | -2862.0 |
| IGHV4-34 | -2819.5 |
| IGHV4-39 | -2819.5 |
| IGHV4-59 | -2819.5 |
| SOS1 | -2808.0 |
| PRKCG | -2783.0 |
| RACGAP1 | -2770.0 |
| LYN | -2708.0 |
| TUBA4A | -2627.0 |
| CDK5 | -2600.0 |
| PPBP | -2477.0 |
| PLAU | -2465.0 |
| HBE1 | -2432.0 |
| SCG3 | -2420.0 |
| VEGFB | -2366.0 |
| SELENOP | -2354.0 |
| SPP2 | -2337.0 |
| KIF3C | -2283.0 |
| HRAS | -2253.0 |
| OLR1 | -2229.0 |
| SH2B3 | -2226.0 |
| SELPLG | -2186.0 |
| ESAM | -2174.0 |
| RCOR1 | -2134.0 |
| GNG13 | -2081.0 |
| SLC7A8 | -2065.0 |
| SDC3 | -2040.0 |
| TOR4A | -2039.0 |
| PHF21A | -2021.0 |
| TTN | -1998.0 |
| JAM2 | -1946.0 |
| H3-3A | -1923.0 |
| F2RL2 | -1823.0 |
| PRKCA | -1808.0 |
| DAGLA | -1781.0 |
| ITGAL | -1761.0 |
| CAV1 | -1723.0 |
| GATA3 | -1622.0 |
| SERPINA5 | -1562.5 |
| ORAI2 | -1505.0 |
| PRCP | -1478.0 |
| ATP2B2 | -1475.0 |
| HABP4 | -1469.0 |
| DOCK2 | -1444.0 |
| SLC7A9 | -1420.0 |
| F8 | -1310.0 |
| KIF2A | -1295.0 |
| TIMP1 | -1254.0 |
| TEK | -1251.0 |
| RAB5A | -1243.0 |
| KIFAP3 | -1209.0 |
| ATP1B1 | -1185.0 |
| SELE | -1172.0 |
| TGFB1 | -1162.0 |
| AK3 | -839.0 |
| FGR | -824.0 |
| CYB5R1 | -782.0 |
| QSOX1 | -760.0 |
| RAD51C | -750.0 |
| RHOA | -640.0 |
| APOA1 | -547.0 |
| ITGB2 | -462.0 |
| KCNMB3 | -435.0 |
| YWHAZ | -416.0 |
| SELL | -386.0 |
| DGKD | -273.0 |
| GNB5 | -108.0 |
| CALM1 | -83.0 |
| RARRES2 | -81.0 |
| CTSW | -34.0 |
| ARRB1 | -23.0 |
| PIK3CA | 85.0 |
| GNA15 | 89.0 |
| DOCK1 | 104.0 |
| MAFF | 112.0 |
| CD2 | 119.0 |
| CAP1 | 126.0 |
| PIK3CB | 231.0 |
| IGHV7-81 | 372.5 |
| KIF12 | 517.0 |
| APOB | 573.0 |
| PPP2R5D | 596.0 |
| PIK3R3 | 597.5 |
| KIF18A | 607.0 |
| ATP1B3 | 618.0 |
| KIF6 | 619.0 |
| RHOG | 709.0 |
| TSPAN7 | 719.5 |
| ATP2A2 | 736.0 |
| RAF1 | 737.0 |
| TGFB3 | 801.0 |
| F2RL3 | 826.0 |
| RAP1A | 937.0 |
| IGLV6-57 | 991.0 |
| GNG5 | 992.0 |
| KIF2B | 996.0 |
| VPS45 | 1048.0 |
| ACTN1 | 1114.0 |
| SRI | 1224.0 |
| KLC2 | 1226.0 |
| SH2B1 | 1236.0 |
| CXADR | 1249.0 |
| PRKCZ | 1256.0 |
| JCHAIN | 1276.0 |
| GNAT3 | 1292.0 |
| HGF | 1325.0 |
| WEE1 | 1357.0 |
| LAMP2 | 1397.0 |
| DOK2 | 1445.0 |
| AKT1 | 1488.0 |
| AHSG | 1504.0 |
| PRKCD | 1551.0 |
| SCCPDH | 1662.0 |
| SLC16A1 | 1702.0 |
| PHACTR2 | 1709.0 |
| F13A1 | 1711.0 |
| NRAS | 1786.0 |
| STXBP3 | 1812.0 |
| PPIL2 | 1825.0 |
| DGKQ | 1845.0 |
| GATA2 | 1911.0 |
| VAV1 | 1912.0 |
| ENDOD1 | 1963.0 |
| MMP1 | 2049.0 |
| SLC16A8 | 2061.0 |
| MAPK1 | 2063.0 |
| CD48 | 2067.0 |
| LRP8 | 2101.0 |
| CRK | 2198.0 |
| TREM1 | 2209.0 |
| RAC1 | 2240.0 |
| ITGAV | 2243.0 |
| TIMP3 | 2250.0 |
| SERPINC1 | 2277.0 |
| RBSN | 2306.0 |
| LEFTY2 | 2311.5 |
| CFL1 | 2322.0 |
| ITGA10 | 2327.0 |
| P2RY12 | 2339.0 |
| NHLRC2 | 2355.0 |
| KIF22 | 2377.0 |
| SLC7A11 | 2434.0 |
| NOS3 | 2441.0 |
| CDC37L1 | 2449.0 |
| ITGB1 | 2469.0 |
| AKAP1 | 2494.0 |
| TAGLN2 | 2529.0 |
| MAPK3 | 2532.0 |
| PRTN3 | 2547.0 |
| SIRPA | 2575.5 |
| SIRPG | 2575.5 |
| PRKCB | 2630.0 |
| FLNA | 2688.0 |
| SLC16A3 | 2751.0 |
| IGLV3-16 | 2760.0 |
| IGLV3-22 | 2760.0 |
| IGLV3-25 | 2760.0 |
| IGLV3-27 | 2760.0 |
| TBXA2R | 2824.0 |
| ORM1 | 2834.5 |
| ORM2 | 2834.5 |
| P2RX7 | 2904.0 |
| KLC4 | 2935.0 |
| ATP1B2 | 2959.0 |
| THBD | 3011.0 |
| PDPN | 3026.0 |
| DOCK11 | 3031.0 |
| DOCK4 | 3123.0 |
| MANF | 3124.0 |
| GNA12 | 3137.0 |
| ECM1 | 3174.0 |
| EPCAM | 3220.0 |
| GAS6 | 3228.0 |
| KIF4A | 3248.0 |
| SYTL4 | 3306.0 |
| GNG3 | 3307.0 |
| P2RX1 | 3344.0 |
| IGKV2-30 | 3349.5 |
| IGKV2D-30 | 3349.5 |
| PDE1A | 3353.0 |
| F2R | 3369.0 |
| IGKV1-12 | 3443.5 |
| IGKV1-16 | 3443.5 |
| IGKV1-17 | 3443.5 |
| IGKV1-39 | 3443.5 |
| IGKV1-5 | 3443.5 |
| IGKV1D-12 | 3443.5 |
| IGKV1D-16 | 3443.5 |
| IGKV1D-39 | 3443.5 |
| APOOL | 3468.0 |
| HDAC2 | 3553.0 |
| GRB14 | 3563.0 |
| IGHV2-5 | 3567.0 |
| IGHV2-70 | 3567.0 |
| MICAL1 | 3622.0 |
| GPC1 | 3640.0 |
| ANGPT4 | 3661.0 |
| GATA1 | 3670.0 |
| F3 | 3700.0 |
| PTPN11 | 3701.0 |
| MAFG | 3707.0 |
| MMRN1 | 3708.0 |
| MAPK14 | 3711.0 |
| GNAI3 | 3733.0 |
| GNG11 | 3752.0 |
| FCER1G | 3777.0 |
| PDE5A | 3804.0 |
| CDK2 | 3851.0 |
| PLAUR | 3867.0 |
| AKAP10 | 3922.0 |
| ANXA5 | 4104.0 |
| RAP1B | 4145.0 |
| CD9 | 4248.0 |
| DOCK5 | 4260.0 |
| ATP2B4 | 4304.0 |
| CLEC3B | 4318.0 |
| VPREB3 | 4334.0 |
| ISLR | 4355.0 |
| GNGT2 | 4376.0 |
| MERTK | 4477.0 |
| PPP2R1B | 4513.0 |
| RAB27B | 4550.0 |
| ADRA2A | 4582.0 |
| GATA5 | 4604.0 |
| DGKA | 4645.0 |
| PTPN6 | 4670.0 |
| RAPGEF4 | 4676.0 |
| PROS1 | 4698.0 |
| GRB7 | 4726.0 |
| TRPC7 | 4748.0 |
| PFN1 | 4767.0 |
| CSK | 4803.0 |
| ADRA2C | 4926.0 |
| S100A10 | 4967.0 |
| SLC7A7 | 4974.0 |
| SERPINF2 | 5087.0 |
| LY6G6F | 5161.5 |
| RAD51B | 5276.0 |
| GNA13 | 5282.0 |
| CAPZA2 | 5364.0 |
| C1QBP | 5377.0 |
| IGKV4-1 | 5450.0 |
| PDE10A | 5495.0 |
| PLCG2 | 5518.0 |
| CD109 | 5520.0 |
| VAV2 | 5813.0 |
| PLAT | 5817.0 |
| CENPE | 5825.0 |
| KRAS | 5849.0 |
| GUCY1A2 | 5853.0 |
| IRF2 | 5903.0 |
| ABCC4 | 6019.0 |
| FCAMR | 6076.0 |
| SERPINB6 | 6087.0 |
| SPARC | 6116.0 |
| HSPA5 | 6121.0 |
| CLEC1B | 6137.0 |
| SLC7A6 | 6179.0 |
| FAM3C | 6213.0 |
| NOS1 | 6241.0 |
| GNB2 | 6264.0 |
| CD44 | 6282.0 |
| LHFPL2 | 6310.0 |
| VEGFC | 6335.0 |
| PCDH7 | 6353.0 |
| BSG | 6428.0 |
| SDC2 | 6449.0 |
| TMSB4X | 6485.0 |
| YES1 | 6489.0 |
| KIF5B | 6494.0 |
| MFN1 | 6573.0 |
| GNG8 | 6614.0 |
| CBX5 | 6715.0 |
| PPP2R5B | 6776.0 |
| GNG2 | 6793.0 |
| TMX3 | 6827.0 |
| PTPN1 | 6830.0 |
| PIK3CG | 6844.0 |
| LAT | 6872.0 |
| FN1 | 6913.0 |
| P2RY1 | 6949.0 |
| RASGRP1 | 7000.0 |
| PAFAH2 | 7055.0 |
| GNG10 | 7112.0 |
| PPP2R5E | 7165.0 |
| HDAC1 | 7175.0 |
| JMJD1C | 7265.0 |
| KIF15 | 7285.0 |
| SDC1 | 7316.0 |
| TEX264 | 7338.0 |
| PROCR | 7343.0 |
| DGKI | 7390.0 |
| LCP2 | 7447.0 |
| CD63 | 7455.0 |
| APP | 7480.0 |
| KIF23 | 7496.0 |
| PRKG2 | 7597.0 |
| CABLES2 | 7630.0 |
| SHC1 | 7644.0 |
| VPREB1 | 7668.0 |
| ATP2B3 | 7695.0 |
| VCL | 7696.0 |
| PCYOX1L | 7829.0 |
| PLEK | 7931.0 |
| GNB3 | 7932.0 |
| CD47 | 7939.0 |
| ALB | 7970.0 |
| PRKAR1B | 8032.0 |
| KIF3B | 8041.0 |
| ITGA2 | 8050.0 |
| GTPBP2 | 8085.0 |
| KIF3A | 8088.0 |
| PIK3R1 | 8109.0 |
| IGF1 | 8112.0 |
| SERPINE2 | 8181.0 |
| TRPC6 | 8208.0 |
| KIF5C | 8217.0 |
| CD99L2 | 8283.0 |
| VEGFA | 8288.0 |
| KIF13B | 8290.0 |
| ABHD6 | 8329.0 |
| DOCK8 | 8423.0 |
| TFPI | 8435.0 |
| SLC8A2 | 8512.0 |
| P2RX3 | 8519.0 |
| CARMIL1 | 8526.0 |
| MAGED2 | 8532.0 |
| PLA2G4A | 8549.0 |
| MYB | 8599.0 |
| EGF | 8603.0 |
| KDM1A | 8614.0 |
| CD99 | 8621.0 |
| THBS1 | 8627.0 |
| FYN | 8653.0 |
| TRPC3 | 8707.0 |
| P2RX2 | 8824.0 |
| TGFB2 | 8828.0 |
| PPIA | 8839.5 |
| ITPR1 | 8900.0 |
Chromatin modifying enzymes
| 190 | |
|---|---|
| set | Chromatin modifying enzymes |
| setSize | 208 |
| pANOVA | 0.0019 |
| s.dist | -0.125 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BRPF3 | -9028.0 |
| TADA2A | -8785.0 |
| JADE2 | -8766.0 |
| ARID1B | -8664.0 |
| PRMT7 | -8656.0 |
| REST | -8650.0 |
| EHMT2 | -8623.0 |
| DNMT3A | -8552.0 |
| KMT2E | -8542.0 |
| EP400 | -8532.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| SAP130 | -8463.0 |
| SMARCE1 | -8284.0 |
| SGF29 | -8256.0 |
| WDR77 | -8231.0 |
| KMT2D | -8177.0 |
| SMARCC1 | -8164.0 |
| KDM5A | -8149.0 |
| NCOR1 | -8129.0 |
| GeneID | Gene Rank |
|---|---|
| BRPF3 | -9028.0 |
| TADA2A | -8785.0 |
| JADE2 | -8766.0 |
| ARID1B | -8664.0 |
| PRMT7 | -8656.0 |
| REST | -8650.0 |
| EHMT2 | -8623.0 |
| DNMT3A | -8552.0 |
| KMT2E | -8542.0 |
| EP400 | -8532.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| SAP130 | -8463.0 |
| SMARCE1 | -8284.0 |
| SGF29 | -8256.0 |
| WDR77 | -8231.0 |
| KMT2D | -8177.0 |
| SMARCC1 | -8164.0 |
| KDM5A | -8149.0 |
| NCOR1 | -8129.0 |
| SUPT7L | -8097.0 |
| CHD4 | -8089.5 |
| SETD2 | -8046.0 |
| H2BC1 | -8026.0 |
| DOT1L | -7989.0 |
| HMG20B | -7951.0 |
| ASH2L | -7949.0 |
| RUVBL1 | -7902.0 |
| KAT6A | -7887.0 |
| PHF20 | -7796.0 |
| BRPF1 | -7733.0 |
| CLOCK | -7607.0 |
| ATF2 | -7522.0 |
| SMARCA4 | -7503.0 |
| SMARCC2 | -7231.0 |
| GATAD2B | -7106.0 |
| SMARCD1 | -6982.0 |
| USP22 | -6816.0 |
| EPC1 | -6787.0 |
| NCOA1 | -6733.0 |
| VPS72 | -6623.0 |
| HCFC1 | -6571.0 |
| EZH2 | -6564.0 |
| PHF8 | -6526.0 |
| RBBP7 | -6428.0 |
| KDM5B | -6417.0 |
| KMT5B | -6334.0 |
| KAT8 | -6306.0 |
| SUV39H1 | -6246.0 |
| ATF7IP | -6181.0 |
| KAT2A | -6099.0 |
| GATAD2A | -6019.0 |
| ING4 | -5923.0 |
| KAT6B | -5773.0 |
| KDM2B | -5715.0 |
| GPS2 | -5694.0 |
| MRGBP | -5670.0 |
| ACTB | -5609.0 |
| CHD3 | -5584.0 |
| CREBBP | -5548.0 |
| MSL2 | -5494.0 |
| KDM6B | -5479.0 |
| SAP30L | -5456.0 |
| ELP5 | -5428.0 |
| DPY30 | -5293.0 |
| KMT5C | -5275.0 |
| CARM1 | -5274.0 |
| SMARCD2 | -5251.0 |
| NCOA2 | -5184.0 |
| TBL1XR1 | -5183.0 |
| ARID1A | -5143.0 |
| SETD1A | -4916.0 |
| ELP6 | -4910.0 |
| SMARCA2 | -4640.0 |
| SETD1B | -4579.0 |
| BRWD1 | -4518.0 |
| SUPT3H | -4222.0 |
| KMT2A | -4096.5 |
| ATXN7 | -4086.0 |
| KAT5 | -4080.0 |
| ING3 | -4047.0 |
| H2AC1 | -3942.0 |
| KDM7A | -3854.0 |
| SMYD2 | -3811.0 |
| PHF2 | -3794.0 |
| JAK2 | -3777.0 |
| H2BC3 | -3635.0 |
| KDM4D | -3620.0 |
| H2BC12 | -3610.0 |
| H2AJ | -3539.0 |
| ACTL6B | -3516.0 |
| KDM1B | -3115.0 |
| MORF4L2 | -3053.0 |
| MBIP | -3036.0 |
| H2AC21 | -2911.0 |
| KDM3A | -2751.0 |
| NFKB1 | -2579.0 |
| RBBP4 | -2539.0 |
| PADI4 | -2385.0 |
| KDM2A | -2374.0 |
| DR1 | -2225.0 |
| MBD3 | -2136.0 |
| RCOR1 | -2134.0 |
| RELA | -2108.0 |
| NFKB2 | -2096.0 |
| ASH1L | -2058.0 |
| PHF21A | -2021.0 |
| MCRS1 | -1868.0 |
| EHMT1 | -1807.0 |
| TADA2B | -1722.0 |
| RPS2 | -1703.0 |
| NSD2 | -1676.0 |
| CCND1 | -1414.0 |
| KDM4B | -1378.0 |
| SMARCD3 | -1202.0 |
| ARID4B | -1084.0 |
| H2AZ1 | -773.0 |
| MECOM | -508.0 |
| PADI6 | -408.0 |
| KAT14 | -261.0 |
| SAP18 | -24.0 |
| WDR5 | 13.0 |
| H2AZ2 | 124.0 |
| DMAP1 | 334.0 |
| AEBP2 | 505.0 |
| YEATS4 | 770.0 |
| ENY2 | 954.0 |
| SETD3 | 1060.0 |
| UTY | 1097.0 |
| JADE3 | 1100.0 |
| BRD1 | 1135.0 |
| KAT7 | 1228.0 |
| SETD7 | 1248.0 |
| ARID2 | 1301.0 |
| SUDS3 | 1312.0 |
| PADI3 | 1352.0 |
| KMT2B | 1475.0 |
| KANSL3 | 1571.0 |
| EP300 | 1591.0 |
| TBL1X | 1601.5 |
| NSD1 | 1698.0 |
| JMJD6 | 1968.0 |
| TADA3 | 2021.0 |
| PRMT5 | 2072.0 |
| SUZ12 | 2083.0 |
| HAT1 | 2127.0 |
| RUVBL2 | 2438.0 |
| ELP3 | 2546.0 |
| MTA2 | 2644.0 |
| PRDM9 | 2769.5 |
| PRDM16 | 2793.0 |
| COPRS | 2905.0 |
| KAT2B | 2962.0 |
| PADI1 | 3189.0 |
| SUPT20H | 3305.0 |
| HDAC10 | 3474.0 |
| HDAC2 | 3553.0 |
| HDAC8 | 3649.5 |
| MSL1 | 3703.0 |
| JADE1 | 3784.0 |
| KDM3B | 4291.0 |
| KMT5A | 4560.0 |
| SETDB1 | 4653.0 |
| SMARCB1 | 4808.0 |
| PAX3 | 4963.0 |
| ATXN7L3 | 5041.0 |
| PBRM1 | 5106.0 |
| KANSL2 | 5109.0 |
| RBBP5 | 5206.0 |
| YEATS2 | 5221.0 |
| TAF10 | 5463.0 |
| HDAC3 | 5550.0 |
| H2BU1 | 5658.0 |
| EED | 5777.0 |
| PRMT1 | 5858.0 |
| TAF6L | 5958.0 |
| ARID4A | 6036.0 |
| SETD6 | 6208.0 |
| TAF12 | 6378.0 |
| CDK4 | 6438.0 |
| SUV39H2 | 6444.0 |
| BRMS1 | 6472.0 |
| PADI2 | 6560.0 |
| MEAF6 | 6662.0 |
| KANSL1 | 6678.0 |
| TAF5L | 6749.0 |
| H2BC11 | 6802.0 |
| MTA3 | 6856.0 |
| H4C1 | 6923.5 |
| ING5 | 6996.0 |
| ELP2 | 7021.0 |
| SAP30 | 7068.0 |
| HDAC1 | 7175.0 |
| ACTL6A | 7360.0 |
| SETDB2 | 7381.0 |
| MSL3 | 7411.0 |
| ELP4 | 7726.0 |
| KDM4C | 7795.0 |
| ZZZ3 | 7850.0 |
| PRMT3 | 8104.0 |
| BRD8 | 8177.0 |
| NSD3 | 8183.0 |
| PRMT6 | 8261.0 |
| KDM5D | 8478.0 |
| KDM1A | 8614.0 |
| OGT | 8679.0 |
| TADA1 | 8752.0 |
| KDM5C | 8917.0 |
Chromatin organization
| 191 | |
|---|---|
| set | Chromatin organization |
| setSize | 208 |
| pANOVA | 0.0019 |
| s.dist | -0.125 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BRPF3 | -9028.0 |
| TADA2A | -8785.0 |
| JADE2 | -8766.0 |
| ARID1B | -8664.0 |
| PRMT7 | -8656.0 |
| REST | -8650.0 |
| EHMT2 | -8623.0 |
| DNMT3A | -8552.0 |
| KMT2E | -8542.0 |
| EP400 | -8532.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| SAP130 | -8463.0 |
| SMARCE1 | -8284.0 |
| SGF29 | -8256.0 |
| WDR77 | -8231.0 |
| KMT2D | -8177.0 |
| SMARCC1 | -8164.0 |
| KDM5A | -8149.0 |
| NCOR1 | -8129.0 |
| GeneID | Gene Rank |
|---|---|
| BRPF3 | -9028.0 |
| TADA2A | -8785.0 |
| JADE2 | -8766.0 |
| ARID1B | -8664.0 |
| PRMT7 | -8656.0 |
| REST | -8650.0 |
| EHMT2 | -8623.0 |
| DNMT3A | -8552.0 |
| KMT2E | -8542.0 |
| EP400 | -8532.0 |
| NCOR2 | -8506.0 |
| KDM4A | -8470.5 |
| SAP130 | -8463.0 |
| SMARCE1 | -8284.0 |
| SGF29 | -8256.0 |
| WDR77 | -8231.0 |
| KMT2D | -8177.0 |
| SMARCC1 | -8164.0 |
| KDM5A | -8149.0 |
| NCOR1 | -8129.0 |
| SUPT7L | -8097.0 |
| CHD4 | -8089.5 |
| SETD2 | -8046.0 |
| H2BC1 | -8026.0 |
| DOT1L | -7989.0 |
| HMG20B | -7951.0 |
| ASH2L | -7949.0 |
| RUVBL1 | -7902.0 |
| KAT6A | -7887.0 |
| PHF20 | -7796.0 |
| BRPF1 | -7733.0 |
| CLOCK | -7607.0 |
| ATF2 | -7522.0 |
| SMARCA4 | -7503.0 |
| SMARCC2 | -7231.0 |
| GATAD2B | -7106.0 |
| SMARCD1 | -6982.0 |
| USP22 | -6816.0 |
| EPC1 | -6787.0 |
| NCOA1 | -6733.0 |
| VPS72 | -6623.0 |
| HCFC1 | -6571.0 |
| EZH2 | -6564.0 |
| PHF8 | -6526.0 |
| RBBP7 | -6428.0 |
| KDM5B | -6417.0 |
| KMT5B | -6334.0 |
| KAT8 | -6306.0 |
| SUV39H1 | -6246.0 |
| ATF7IP | -6181.0 |
| KAT2A | -6099.0 |
| GATAD2A | -6019.0 |
| ING4 | -5923.0 |
| KAT6B | -5773.0 |
| KDM2B | -5715.0 |
| GPS2 | -5694.0 |
| MRGBP | -5670.0 |
| ACTB | -5609.0 |
| CHD3 | -5584.0 |
| CREBBP | -5548.0 |
| MSL2 | -5494.0 |
| KDM6B | -5479.0 |
| SAP30L | -5456.0 |
| ELP5 | -5428.0 |
| DPY30 | -5293.0 |
| KMT5C | -5275.0 |
| CARM1 | -5274.0 |
| SMARCD2 | -5251.0 |
| NCOA2 | -5184.0 |
| TBL1XR1 | -5183.0 |
| ARID1A | -5143.0 |
| SETD1A | -4916.0 |
| ELP6 | -4910.0 |
| SMARCA2 | -4640.0 |
| SETD1B | -4579.0 |
| BRWD1 | -4518.0 |
| SUPT3H | -4222.0 |
| KMT2A | -4096.5 |
| ATXN7 | -4086.0 |
| KAT5 | -4080.0 |
| ING3 | -4047.0 |
| H2AC1 | -3942.0 |
| KDM7A | -3854.0 |
| SMYD2 | -3811.0 |
| PHF2 | -3794.0 |
| JAK2 | -3777.0 |
| H2BC3 | -3635.0 |
| KDM4D | -3620.0 |
| H2BC12 | -3610.0 |
| H2AJ | -3539.0 |
| ACTL6B | -3516.0 |
| KDM1B | -3115.0 |
| MORF4L2 | -3053.0 |
| MBIP | -3036.0 |
| H2AC21 | -2911.0 |
| KDM3A | -2751.0 |
| NFKB1 | -2579.0 |
| RBBP4 | -2539.0 |
| PADI4 | -2385.0 |
| KDM2A | -2374.0 |
| DR1 | -2225.0 |
| MBD3 | -2136.0 |
| RCOR1 | -2134.0 |
| RELA | -2108.0 |
| NFKB2 | -2096.0 |
| ASH1L | -2058.0 |
| PHF21A | -2021.0 |
| MCRS1 | -1868.0 |
| EHMT1 | -1807.0 |
| TADA2B | -1722.0 |
| RPS2 | -1703.0 |
| NSD2 | -1676.0 |
| CCND1 | -1414.0 |
| KDM4B | -1378.0 |
| SMARCD3 | -1202.0 |
| ARID4B | -1084.0 |
| H2AZ1 | -773.0 |
| MECOM | -508.0 |
| PADI6 | -408.0 |
| KAT14 | -261.0 |
| SAP18 | -24.0 |
| WDR5 | 13.0 |
| H2AZ2 | 124.0 |
| DMAP1 | 334.0 |
| AEBP2 | 505.0 |
| YEATS4 | 770.0 |
| ENY2 | 954.0 |
| SETD3 | 1060.0 |
| UTY | 1097.0 |
| JADE3 | 1100.0 |
| BRD1 | 1135.0 |
| KAT7 | 1228.0 |
| SETD7 | 1248.0 |
| ARID2 | 1301.0 |
| SUDS3 | 1312.0 |
| PADI3 | 1352.0 |
| KMT2B | 1475.0 |
| KANSL3 | 1571.0 |
| EP300 | 1591.0 |
| TBL1X | 1601.5 |
| NSD1 | 1698.0 |
| JMJD6 | 1968.0 |
| TADA3 | 2021.0 |
| PRMT5 | 2072.0 |
| SUZ12 | 2083.0 |
| HAT1 | 2127.0 |
| RUVBL2 | 2438.0 |
| ELP3 | 2546.0 |
| MTA2 | 2644.0 |
| PRDM9 | 2769.5 |
| PRDM16 | 2793.0 |
| COPRS | 2905.0 |
| KAT2B | 2962.0 |
| PADI1 | 3189.0 |
| SUPT20H | 3305.0 |
| HDAC10 | 3474.0 |
| HDAC2 | 3553.0 |
| HDAC8 | 3649.5 |
| MSL1 | 3703.0 |
| JADE1 | 3784.0 |
| KDM3B | 4291.0 |
| KMT5A | 4560.0 |
| SETDB1 | 4653.0 |
| SMARCB1 | 4808.0 |
| PAX3 | 4963.0 |
| ATXN7L3 | 5041.0 |
| PBRM1 | 5106.0 |
| KANSL2 | 5109.0 |
| RBBP5 | 5206.0 |
| YEATS2 | 5221.0 |
| TAF10 | 5463.0 |
| HDAC3 | 5550.0 |
| H2BU1 | 5658.0 |
| EED | 5777.0 |
| PRMT1 | 5858.0 |
| TAF6L | 5958.0 |
| ARID4A | 6036.0 |
| SETD6 | 6208.0 |
| TAF12 | 6378.0 |
| CDK4 | 6438.0 |
| SUV39H2 | 6444.0 |
| BRMS1 | 6472.0 |
| PADI2 | 6560.0 |
| MEAF6 | 6662.0 |
| KANSL1 | 6678.0 |
| TAF5L | 6749.0 |
| H2BC11 | 6802.0 |
| MTA3 | 6856.0 |
| H4C1 | 6923.5 |
| ING5 | 6996.0 |
| ELP2 | 7021.0 |
| SAP30 | 7068.0 |
| HDAC1 | 7175.0 |
| ACTL6A | 7360.0 |
| SETDB2 | 7381.0 |
| MSL3 | 7411.0 |
| ELP4 | 7726.0 |
| KDM4C | 7795.0 |
| ZZZ3 | 7850.0 |
| PRMT3 | 8104.0 |
| BRD8 | 8177.0 |
| NSD3 | 8183.0 |
| PRMT6 | 8261.0 |
| KDM5D | 8478.0 |
| KDM1A | 8614.0 |
| OGT | 8679.0 |
| TADA1 | 8752.0 |
| KDM5C | 8917.0 |
Mitochondrial translation initiation
| 714 | |
|---|---|
| set | Mitochondrial translation initiation |
| setSize | 85 |
| pANOVA | 0.00193 |
| s.dist | 0.195 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS14 | 8926 |
| MRPS24 | 8562 |
| MRPL1 | 8558 |
| MRPS28 | 8557 |
| MRPS18B | 8556 |
| MRPL36 | 8464 |
| PTCD3 | 8263 |
| DAP3 | 7885 |
| MRPS35 | 7617 |
| CHCHD1 | 7563 |
| MRPL2 | 7250 |
| MRPL17 | 7018 |
| MRPL14 | 6867 |
| MRPL24 | 6176 |
| MRPL42 | 6072 |
| MRPL45 | 5839 |
| MRPS2 | 5800 |
| MRPL50 | 5621 |
| MRPL40 | 5368 |
| MRPL22 | 5146 |
| GeneID | Gene Rank |
|---|---|
| MRPS14 | 8926.0 |
| MRPS24 | 8562.0 |
| MRPL1 | 8558.0 |
| MRPS28 | 8557.0 |
| MRPS18B | 8556.0 |
| MRPL36 | 8464.0 |
| PTCD3 | 8263.0 |
| DAP3 | 7885.0 |
| MRPS35 | 7617.0 |
| CHCHD1 | 7563.0 |
| MRPL2 | 7250.0 |
| MRPL17 | 7018.0 |
| MRPL14 | 6867.0 |
| MRPL24 | 6176.0 |
| MRPL42 | 6072.0 |
| MRPL45 | 5839.0 |
| MRPS2 | 5800.0 |
| MRPL50 | 5621.0 |
| MRPL40 | 5368.0 |
| MRPL22 | 5146.0 |
| MTIF3 | 5074.0 |
| MRPL46 | 4943.0 |
| MRPL20 | 4603.0 |
| MRPL47 | 4579.0 |
| MRPS33 | 4506.0 |
| MRPL12 | 4269.0 |
| MRPS9 | 4258.0 |
| GADD45GIP1 | 3958.0 |
| MRPS6 | 3955.0 |
| MRPL44 | 3931.0 |
| MRPL3 | 3905.0 |
| MRPL11 | 3798.0 |
| MRPL13 | 3789.0 |
| MRPL35 | 3604.0 |
| MRPL32 | 3475.0 |
| MRPL18 | 3358.0 |
| MRPL10 | 3267.0 |
| MRPL33 | 3221.0 |
| MRPL43 | 3190.0 |
| MRPL52 | 2647.0 |
| MRPS18C | 2564.0 |
| MRPS16 | 2548.0 |
| MRPL19 | 2510.0 |
| MRPL27 | 2126.0 |
| MRPS23 | 1674.0 |
| MTIF2 | 1252.0 |
| MRPL21 | 1230.0 |
| MRPL15 | 1187.0 |
| MRPL55 | 741.0 |
| MRPL53 | 586.0 |
| MRPL49 | 582.0 |
| MRPL54 | 450.0 |
| MRPL39 | 395.0 |
| MRPS31 | 362.0 |
| MRPS30 | 45.0 |
| MRPS34 | -44.0 |
| MRPS5 | -53.0 |
| MRPS7 | -161.0 |
| MRPS15 | -371.0 |
| MRPS12 | -431.0 |
| MRPS11 | -799.0 |
| MRPS26 | -888.0 |
| MRPL48 | -1212.0 |
| MRPS22 | -1452.0 |
| MRPL9 | -1492.0 |
| MRPS18A | -1837.0 |
| MRPL16 | -2312.0 |
| MRPS10 | -2682.0 |
| MRPS27 | -2810.0 |
| MRPL58 | -3023.0 |
| MRPS25 | -3279.0 |
| MTFMT | -3773.0 |
| MRPL28 | -3922.0 |
| MRPL38 | -4142.0 |
| OXA1L | -4251.0 |
| MRPL34 | -4385.0 |
| MRPL41 | -4451.0 |
| MRPL30 | -4489.5 |
| MRPL4 | -4800.0 |
| ERAL1 | -5635.0 |
| MRPS21 | -6064.0 |
| MRPS36 | -6427.0 |
| MRPL51 | -6884.0 |
| MRPL37 | -7284.0 |
| MRPS17 | -7874.5 |
Rho GTPase cycle
| 1083 | |
|---|---|
| set | Rho GTPase cycle |
| setSize | 134 |
| pANOVA | 0.00201 |
| s.dist | -0.155 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| STARD8 | -9030.0 |
| MYO9B | -8944.0 |
| SRGAP2 | -8939.0 |
| ARHGEF37 | -8834.0 |
| ARHGAP17 | -8816.0 |
| ARHGEF1 | -8718.0 |
| OBSCN | -8574.0 |
| OPHN1 | -8557.0 |
| ARHGEF7 | -8534.0 |
| GMIP | -8479.0 |
| PLEKHG5 | -8454.0 |
| CDC42 | -8440.0 |
| ITSN1 | -8377.0 |
| ARAP2 | -8318.0 |
| CHN2 | -8291.5 |
| ARHGEF11 | -8287.0 |
| DEPDC7 | -8183.0 |
| ARHGAP20 | -8012.0 |
| ARHGAP6 | -7915.0 |
| ARHGEF40 | -7699.0 |
| GeneID | Gene Rank |
|---|---|
| STARD8 | -9030.0 |
| MYO9B | -8944.0 |
| SRGAP2 | -8939.0 |
| ARHGEF37 | -8834.0 |
| ARHGAP17 | -8816.0 |
| ARHGEF1 | -8718.0 |
| OBSCN | -8574.0 |
| OPHN1 | -8557.0 |
| ARHGEF7 | -8534.0 |
| GMIP | -8479.0 |
| PLEKHG5 | -8454.0 |
| CDC42 | -8440.0 |
| ITSN1 | -8377.0 |
| ARAP2 | -8318.0 |
| CHN2 | -8291.5 |
| ARHGEF11 | -8287.0 |
| DEPDC7 | -8183.0 |
| ARHGAP20 | -8012.0 |
| ARHGAP6 | -7915.0 |
| ARHGEF40 | -7699.0 |
| MCF2 | -7686.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| MCF2L | -7517.0 |
| RAC2 | -7433.0 |
| ARHGEF5 | -7293.0 |
| ARHGAP12 | -7221.0 |
| PLEKHG2 | -7206.0 |
| ARHGAP8 | -7192.5 |
| PIK3R2 | -7098.5 |
| VAV3 | -7088.0 |
| ARHGAP35 | -6956.0 |
| ARHGEF17 | -6885.0 |
| ARHGEF10L | -6624.0 |
| TRIO | -6348.0 |
| MYO9A | -6231.0 |
| RHOH | -6217.0 |
| FGD4 | -6196.0 |
| FGD1 | -5982.0 |
| RHOJ | -5569.0 |
| RHOBTB1 | -5555.0 |
| ARHGEF19 | -5545.0 |
| ARHGAP32 | -5460.0 |
| ARHGAP9 | -5430.0 |
| ARHGEF6 | -5311.0 |
| AKAP13 | -5190.0 |
| ARHGDIB | -5167.0 |
| ARHGAP11A | -5134.0 |
| NET1 | -4984.0 |
| ARHGAP21 | -4926.0 |
| SYDE2 | -4921.0 |
| NGEF | -4851.0 |
| ARHGAP1 | -4806.0 |
| ARHGEF38 | -4562.0 |
| STARD13 | -4246.0 |
| A2M | -3884.0 |
| RHOV | -3598.0 |
| GDI2 | -3504.0 |
| ARHGAP39 | -3310.0 |
| RHOB | -3080.0 |
| PREX1 | -3045.0 |
| FAM13A | -2836.0 |
| SOS1 | -2808.0 |
| RACGAP1 | -2770.0 |
| ARHGDIA | -2696.0 |
| ARHGAP31 | -2557.0 |
| ARHGEF18 | -2547.5 |
| ARHGAP26 | -2118.0 |
| RHOT2 | -2024.0 |
| RHOD | -2015.0 |
| RHOU | -1725.0 |
| ARHGAP29 | -1488.0 |
| RHOBTB2 | -1304.0 |
| ARHGEF39 | -1272.0 |
| ARHGAP40 | -907.5 |
| ARHGEF10 | -775.0 |
| RHOA | -640.0 |
| ARHGEF15 | -470.0 |
| ARHGEF33 | -451.0 |
| ARHGAP30 | -260.0 |
| KALRN | -177.0 |
| RHOF | -150.0 |
| RAC3 | 84.0 |
| BCR | 111.0 |
| ARHGAP44 | 622.0 |
| RHOG | 709.0 |
| SYDE1 | 773.0 |
| RHOQ | 950.0 |
| TRIP10 | 1231.0 |
| SRGAP3 | 1255.0 |
| GDI1 | 1433.0 |
| ARHGAP33 | 1479.0 |
| ARHGAP27 | 1497.0 |
| VAV1 | 1912.0 |
| RAC1 | 2240.0 |
| ARHGAP4 | 2279.0 |
| INPP5B | 2405.0 |
| TAGAP | 2414.0 |
| ARHGAP25 | 2629.0 |
| ARHGAP23 | 2812.0 |
| FAM13B | 3460.0 |
| FGD2 | 4170.0 |
| ARAP3 | 4175.0 |
| ARAP1 | 4310.0 |
| SRGAP1 | 4317.0 |
| CHN1 | 4472.0 |
| OCRL | 4825.0 |
| TIAM2 | 4841.0 |
| RASGRF2 | 5220.0 |
| GNA13 | 5282.0 |
| RHOC | 5509.5 |
| ARHGAP10 | 5666.0 |
| ARHGAP28 | 5709.0 |
| VAV2 | 5813.0 |
| ARHGEF12 | 6104.0 |
| DEPDC1B | 6153.0 |
| DLC1 | 6197.0 |
| FGD3 | 6255.0 |
| ARHGAP18 | 6408.0 |
| ARHGAP15 | 6512.0 |
| TIAM1 | 6942.0 |
| ARHGAP42 | 7065.0 |
| ARHGAP36 | 7340.0 |
| ECT2 | 7350.0 |
| ARHGEF3 | 7632.0 |
| SOS2 | 7658.0 |
| ARHGAP19 | 7873.5 |
| ARHGAP24 | 7944.0 |
| ARHGEF2 | 7980.0 |
| ARHGEF26 | 8302.0 |
| ARHGAP5 | 8335.0 |
| RALBP1 | 8365.0 |
| ARHGAP22 | 8611.0 |
| RHOT1 | 8732.0 |
GRB2:SOS provides linkage to MAPK signaling for Integrins
| 469 | |
|---|---|
| set | GRB2:SOS provides linkage to MAPK signaling for Integrins |
| setSize | 15 |
| pANOVA | 0.00205 |
| s.dist | -0.46 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGB | -9053.0 |
| FGA | -8696.0 |
| PTK2 | -8355.0 |
| SRC | -8095.0 |
| FGG | -8035.0 |
| VWF | -7285.0 |
| ITGA2B | -7222.0 |
| TLN1 | -5122.0 |
| APBB1IP | -3673.0 |
| ITGB3 | -3380.5 |
| GRB2 | -3336.0 |
| SOS1 | -2808.0 |
| RAP1A | 937.0 |
| RAP1B | 4145.0 |
| FN1 | 6913.0 |
| GeneID | Gene Rank |
|---|---|
| FGB | -9053.0 |
| FGA | -8696.0 |
| PTK2 | -8355.0 |
| SRC | -8095.0 |
| FGG | -8035.0 |
| VWF | -7285.0 |
| ITGA2B | -7222.0 |
| TLN1 | -5122.0 |
| APBB1IP | -3673.0 |
| ITGB3 | -3380.5 |
| GRB2 | -3336.0 |
| SOS1 | -2808.0 |
| RAP1A | 937.0 |
| RAP1B | 4145.0 |
| FN1 | 6913.0 |
Aflatoxin activation and detoxification
| 67 | |
|---|---|
| set | Aflatoxin activation and detoxification |
| setSize | 18 |
| pANOVA | 0.00205 |
| s.dist | -0.42 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP3A4 | -8991.0 |
| CYP3A5 | -8991.0 |
| DPEP1 | -8348.0 |
| MGST1 | -8188.0 |
| GGT6 | -7974.0 |
| AKR7L | -7680.0 |
| AKR7A3 | -7174.0 |
| CYP1A2 | -6798.0 |
| GGT5 | -5861.0 |
| DPEP2 | -4879.0 |
| GGT7 | -3254.0 |
| ACY1 | 106.5 |
| GGT1 | 592.0 |
| MGST2 | 2307.0 |
| ACY3 | 3112.0 |
| MGST3 | 4742.0 |
| DPEP3 | 7176.0 |
| GeneID | Gene Rank |
|---|---|
| CYP2A13 | -9057.0 |
| CYP3A4 | -8991.0 |
| CYP3A5 | -8991.0 |
| DPEP1 | -8348.0 |
| MGST1 | -8188.0 |
| GGT6 | -7974.0 |
| AKR7L | -7680.0 |
| AKR7A3 | -7174.0 |
| CYP1A2 | -6798.0 |
| GGT5 | -5861.0 |
| DPEP2 | -4879.0 |
| GGT7 | -3254.0 |
| ACY1 | 106.5 |
| GGT1 | 592.0 |
| MGST2 | 2307.0 |
| ACY3 | 3112.0 |
| MGST3 | 4742.0 |
| DPEP3 | 7176.0 |
Formation of Fibrin Clot (Clotting Cascade)
| 421 | |
|---|---|
| set | Formation of Fibrin Clot (Clotting Cascade) |
| setSize | 37 |
| pANOVA | 0.00208 |
| s.dist | -0.292 |
| p.adjustANOVA | 0.0685 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGB | -9053 |
| KNG1 | -9050 |
| FGA | -8696 |
| F10 | -8579 |
| F5 | -8356 |
| F12 | -8319 |
| GP1BA | -8136 |
| FGG | -8035 |
| F13B | -7912 |
| VWF | -7285 |
| F11 | -6531 |
| GP5 | -6277 |
| KLKB1 | -6048 |
| F9 | -5791 |
| SERPIND1 | -5751 |
| F7 | -5305 |
| GP9 | -5163 |
| PROC | -3962 |
| A2M | -3884 |
| GP1BB | -3680 |
| GeneID | Gene Rank |
|---|---|
| FGB | -9053.0 |
| KNG1 | -9050.0 |
| FGA | -8696.0 |
| F10 | -8579.0 |
| F5 | -8356.0 |
| F12 | -8319.0 |
| GP1BA | -8136.0 |
| FGG | -8035.0 |
| F13B | -7912.0 |
| VWF | -7285.0 |
| F11 | -6531.0 |
| GP5 | -6277.0 |
| KLKB1 | -6048.0 |
| F9 | -5791.0 |
| SERPIND1 | -5751.0 |
| F7 | -5305.0 |
| GP9 | -5163.0 |
| PROC | -3962.0 |
| A2M | -3884.0 |
| GP1BB | -3680.0 |
| F2 | -3616.0 |
| SERPING1 | -3530.0 |
| CD177 | -2979.0 |
| SERPINA5 | -1562.5 |
| PRCP | -1478.0 |
| F8 | -1310.0 |
| F13A1 | 1711.0 |
| SERPINC1 | 2277.0 |
| PRTN3 | 2547.0 |
| THBD | 3011.0 |
| F2R | 3369.0 |
| F3 | 3700.0 |
| PROS1 | 4698.0 |
| C1QBP | 5377.0 |
| PROCR | 7343.0 |
| SERPINE2 | 8181.0 |
| TFPI | 8435.0 |
Protein ubiquitination
| 929 | |
|---|---|
| set | Protein ubiquitination |
| setSize | 65 |
| pANOVA | 0.00219 |
| s.dist | -0.22 |
| p.adjustANOVA | 0.0697 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UBE2A | -8808.0 |
| SHPRH | -8299.0 |
| HLA-A | -8118.5 |
| HLA-B | -8118.5 |
| UBE2D3 | -8068.0 |
| H2BC1 | -8026.0 |
| UBE2H | -7872.0 |
| PEX12 | -7633.0 |
| LEO1 | -7393.0 |
| UBE2E1 | -6946.0 |
| UBE2G2 | -6704.0 |
| DERL1 | -6635.0 |
| PEX13 | -6630.0 |
| UBC | -6432.0 |
| UBE2C | -6289.0 |
| HLTF | -5920.0 |
| PEX10 | -5886.0 |
| UBE2W | -5708.5 |
| UBE2S | -5679.0 |
| RNF40 | -5625.0 |
| GeneID | Gene Rank |
|---|---|
| UBE2A | -8808.0 |
| SHPRH | -8299.0 |
| HLA-A | -8118.5 |
| HLA-B | -8118.5 |
| UBE2D3 | -8068.0 |
| H2BC1 | -8026.0 |
| UBE2H | -7872.0 |
| PEX12 | -7633.0 |
| LEO1 | -7393.0 |
| UBE2E1 | -6946.0 |
| UBE2G2 | -6704.0 |
| DERL1 | -6635.0 |
| PEX13 | -6630.0 |
| UBC | -6432.0 |
| UBE2C | -6289.0 |
| HLTF | -5920.0 |
| PEX10 | -5886.0 |
| UBE2W | -5708.5 |
| UBE2S | -5679.0 |
| RNF40 | -5625.0 |
| UBE2R2 | -5017.0 |
| PAF1 | -4974.0 |
| UBA1 | -4768.0 |
| TMEM129 | -4659.0 |
| RTF1 | -4243.0 |
| RNF20 | -4206.0 |
| WDR61 | -3743.0 |
| PRKDC | -3663.0 |
| H2BC3 | -3635.0 |
| H2BC12 | -3610.0 |
| UBA6 | -3393.0 |
| VCP | -3356.0 |
| UBE2G1 | -3271.0 |
| CDC34 | -2463.0 |
| RAD18 | -2341.0 |
| UBE2V2 | -2190.0 |
| UBA52 | -2166.0 |
| USP9X | -2105.0 |
| WAC | -2027.0 |
| OTULIN | -1856.0 |
| UCHL3 | -1809.0 |
| UBE2D1 | -1275.0 |
| UBE2B | -887.0 |
| UBE2Q2 | -822.0 |
| UBE2J2 | -353.0 |
| CTR9 | -85.0 |
| BCL10 | 666.0 |
| UBE2T | 1282.0 |
| UBE2K | 1320.0 |
| UBE2D2 | 1984.0 |
| RRAGA | 2158.0 |
| PCNA | 3070.0 |
| PEX14 | 3074.0 |
| USP7 | 3382.0 |
| UBE2N | 4121.5 |
| USP5 | 4331.0 |
| PEX5 | 4716.0 |
| RNF152 | 5085.0 |
| CDC73 | 5336.0 |
| PEX2 | 5543.0 |
| RNF144A | 5836.0 |
| UBE2Z | 6638.0 |
| H2BC11 | 6802.0 |
| RPS27A | 7369.0 |
| SELENOS | 8727.0 |
Signaling by GPCR
| 1170 | |
|---|---|
| set | Signaling by GPCR |
| setSize | 895 |
| pANOVA | 0.00226 |
| s.dist | -0.0605 |
| p.adjustANOVA | 0.0697 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -9063 |
| C5 | -9060 |
| RDH16 | -9052 |
| KNG1 | -9050 |
| TAS1R2 | -9042 |
| PAK1 | -9034 |
| CRHR2 | -9033 |
| SAG | -9009 |
| EDNRA | -8998 |
| PDE4D | -8956 |
| PTGER3 | -8925 |
| PDE2A | -8915 |
| AKR1B10 | -8911 |
| APOC3 | -8904 |
| CAMK2B | -8898 |
| PRKAR2B | -8880 |
| PDE11A | -8842 |
| TTR | -8839 |
| APOE | -8836 |
| ARHGEF37 | -8834 |
| GeneID | Gene Rank |
|---|---|
| GABBR1 | -9063.0 |
| C5 | -9060.0 |
| RDH16 | -9052.0 |
| KNG1 | -9050.0 |
| TAS1R2 | -9042.0 |
| PAK1 | -9034.0 |
| CRHR2 | -9033.0 |
| SAG | -9009.0 |
| EDNRA | -8998.0 |
| PDE4D | -8956.0 |
| PTGER3 | -8925.0 |
| PDE2A | -8915.0 |
| AKR1B10 | -8911.0 |
| APOC3 | -8904.0 |
| CAMK2B | -8898.0 |
| PRKAR2B | -8880.0 |
| PDE11A | -8842.0 |
| TTR | -8839.0 |
| APOE | -8836.0 |
| ARHGEF37 | -8834.0 |
| PLPPR3 | -8805.0 |
| CCL28 | -8774.0 |
| RGS17 | -8772.0 |
| RRH | -8768.0 |
| WNT4 | -8755.0 |
| TAS1R3 | -8751.0 |
| DGKE | -8747.0 |
| NTSR1 | -8726.0 |
| ARHGEF1 | -8718.0 |
| P2RY14 | -8673.0 |
| ADORA1 | -8671.0 |
| RPS6KA1 | -8610.0 |
| CXCR1 | -8608.0 |
| GNAS | -8601.0 |
| RGS14 | -8576.0 |
| OBSCN | -8574.0 |
| ARHGEF7 | -8534.0 |
| RGS5 | -8529.0 |
| RGS20 | -8516.0 |
| GRK6 | -8511.0 |
| CCL11 | -8487.0 |
| PPP3CC | -8476.0 |
| RGS6 | -8457.0 |
| PLEKHG5 | -8454.0 |
| CDC42 | -8440.0 |
| PDE1B | -8427.0 |
| PLB1 | -8395.0 |
| PLPPR1 | -8390.0 |
| ITSN1 | -8377.0 |
| PLCB4 | -8376.0 |
| CXCR6 | -8347.0 |
| CXCR3 | -8323.0 |
| TRH | -8317.0 |
| CHRM3 | -8311.0 |
| ARHGEF11 | -8287.0 |
| VIPR1 | -8263.0 |
| GALR2 | -8209.0 |
| RBP4 | -8178.0 |
| DGKZ | -8155.0 |
| GPSM3 | -8134.0 |
| PRKAR2A | -8106.0 |
| SRC | -8095.0 |
| VIP | -8083.0 |
| GLP2R | -8069.0 |
| NPY | -8050.0 |
| LPAR5 | -8048.0 |
| NPY1R | -8014.0 |
| XK | -7994.0 |
| PDE4C | -7992.5 |
| ADRB3 | -7987.5 |
| QRFPR | -7977.0 |
| PLCB3 | -7957.0 |
| NPFFR1 | -7883.0 |
| OR52W1 | -7878.0 |
| DAGLB | -7867.0 |
| NTS | -7866.0 |
| AGT | -7862.0 |
| RGS2 | -7801.0 |
| EDN3 | -7773.0 |
| PRKACA | -7713.0 |
| GPR27 | -7702.0 |
| ARHGEF40 | -7699.0 |
| MCF2 | -7686.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| RTP2 | -7650.0 |
| GNAI1 | -7649.0 |
| RXFP2 | -7630.0 |
| PDE1C | -7601.0 |
| MGLL | -7581.0 |
| DGKB | -7547.0 |
| PTGER4 | -7545.0 |
| ADORA2B | -7537.0 |
| APOC2 | -7531.5 |
| MCF2L | -7517.0 |
| ABHD12 | -7496.0 |
| ADRA2B | -7489.0 |
| IHH | -7487.0 |
| APOA2 | -7400.0 |
| GRK3 | -7362.0 |
| RASGRP2 | -7350.0 |
| GNG4 | -7316.0 |
| DGKG | -7310.0 |
| ARHGEF5 | -7293.0 |
| CNR1 | -7245.0 |
| PLEKHG2 | -7206.0 |
| WNT10A | -7189.0 |
| CHRM5 | -7183.0 |
| GPC4 | -7160.0 |
| PRKCE | -7128.0 |
| GNAL | -7120.0 |
| S1PR1 | -7115.0 |
| PIK3R2 | -7098.5 |
| VAV3 | -7088.0 |
| RTP3 | -7086.0 |
| RGS8 | -7040.0 |
| CCR9 | -7000.0 |
| GNA14 | -6980.0 |
| RBP1 | -6975.0 |
| AVPR2 | -6968.0 |
| ARHGEF17 | -6885.0 |
| ADCY6 | -6882.0 |
| PTGER2 | -6876.0 |
| OR51E1 | -6846.0 |
| GPR39 | -6779.0 |
| CNR2 | -6771.0 |
| ADCY4 | -6759.0 |
| APOA4 | -6758.0 |
| ARRB2 | -6754.0 |
| ECE1 | -6749.0 |
| CCL19 | -6713.0 |
| PRKACB | -6707.0 |
| PSAP | -6675.0 |
| ARHGEF10L | -6624.0 |
| HSD17B6 | -6589.0 |
| S1PR4 | -6587.0 |
| TSHR | -6499.0 |
| HTR7 | -6482.0 |
| CXCR5 | -6476.0 |
| ADCY2 | -6434.0 |
| TRIO | -6348.0 |
| SSTR1 | -6304.0 |
| C3 | -6303.0 |
| CHRM4 | -6286.0 |
| GPR132 | -6259.0 |
| PPP2CA | -6258.0 |
| PIK3R6 | -6249.0 |
| REEP6 | -6204.0 |
| FGD4 | -6196.0 |
| TAC3 | -6187.0 |
| WNT6 | -6186.0 |
| RDH8 | -6074.0 |
| RAMP2 | -6073.0 |
| FZD3 | -6063.0 |
| TACR1 | -6047.0 |
| ITPR3 | -6046.0 |
| PTGDR2 | -6038.0 |
| OR52I1 | -6033.5 |
| OR52I2 | -6033.5 |
| PCP2 | -6000.0 |
| FGD1 | -5982.0 |
| TACR3 | -5973.0 |
| OR6S1 | -5969.0 |
| AKT2 | -5958.0 |
| GNG12 | -5884.0 |
| PPP1CA | -5881.0 |
| WNT2B | -5857.0 |
| ITPR2 | -5837.0 |
| SUCNR1 | -5782.0 |
| KEL | -5755.0 |
| WNT8B | -5701.0 |
| RAMP1 | -5656.0 |
| P2RY6 | -5637.0 |
| AGTR1 | -5580.0 |
| PTH1R | -5552.0 |
| ARHGEF19 | -5545.0 |
| LRP2 | -5544.0 |
| TACR2 | -5487.0 |
| PIK3R5 | -5482.0 |
| PDE7B | -5405.0 |
| OR6K6 | -5329.0 |
| TSHB | -5315.0 |
| ARHGEF6 | -5311.0 |
| GNAT2 | -5270.0 |
| RLBP1 | -5232.0 |
| PTGER1 | -5226.0 |
| CXCR4 | -5218.0 |
| AKAP13 | -5190.0 |
| WNT16 | -5176.0 |
| PRKCH | -5149.5 |
| GNAO1 | -5147.0 |
| OR6N2 | -5135.0 |
| CCL22 | -5101.0 |
| RCVRN | -5100.0 |
| SSTR4 | -5037.0 |
| NMUR1 | -5014.0 |
| NET1 | -4984.0 |
| PRKAR1A | -4970.0 |
| P2RY10 | -4936.0 |
| NGEF | -4851.0 |
| CXCL9 | -4847.0 |
| ADGRE5 | -4844.0 |
| GAL | -4837.0 |
| CRHBP | -4802.0 |
| APLNR | -4782.0 |
| NPW | -4751.0 |
| GRM5 | -4699.0 |
| PDE4A | -4632.0 |
| TAS2R60 | -4610.0 |
| GNB4 | -4593.0 |
| XCR1 | -4583.0 |
| ARHGEF38 | -4562.0 |
| PDE6A | -4543.0 |
| FNTB | -4523.5 |
| RGS3 | -4491.0 |
| FPR2 | -4479.5 |
| FPR3 | -4479.5 |
| CCR6 | -4453.0 |
| LRAT | -4448.0 |
| DHRS3 | -4431.0 |
| GNAI2 | -4425.0 |
| MC5R | -4388.0 |
| ADRA1D | -4383.0 |
| PDPK1 | -4325.0 |
| PTCH2 | -4298.0 |
| PROKR2 | -4225.0 |
| DGKH | -4197.0 |
| GPR4 | -4192.0 |
| GRPR | -4160.0 |
| TAS2R3 | -4153.0 |
| HTR1F | -4088.0 |
| NMT2 | -4070.0 |
| BDKRB2 | -4057.0 |
| PLCB1 | -4053.0 |
| ADCY1 | -4044.0 |
| LPAR6 | -4022.0 |
| SSTR3 | -3984.0 |
| RHO | -3979.0 |
| GRM8 | -3921.0 |
| GHRHR | -3915.0 |
| CAMK2A | -3898.0 |
| GNB1 | -3895.0 |
| MCHR1 | -3891.0 |
| C3AR1 | -3874.0 |
| OR52B2 | -3822.0 |
| NPB | -3820.0 |
| UTS2 | -3797.0 |
| CCL4 | -3785.5 |
| HSPG2 | -3764.0 |
| RPS6KA3 | -3698.0 |
| CHRM1 | -3677.0 |
| WNT9A | -3665.0 |
| PPP2CB | -3632.0 |
| GNRHR | -3625.0 |
| F2 | -3616.0 |
| CXCL11 | -3606.0 |
| DGKK | -3596.0 |
| GPC2 | -3565.0 |
| PTH2 | -3564.0 |
| PRKCQ | -3483.0 |
| PPP2R1A | -3477.0 |
| GPR84 | -3469.0 |
| RGR | -3467.0 |
| RXFP1 | -3454.0 |
| GPIHBP1 | -3404.0 |
| ROCK2 | -3394.0 |
| CCR3 | -3385.0 |
| ACKR4 | -3367.0 |
| OR5B2 | -3361.0 |
| GRB2 | -3336.0 |
| EDN1 | -3312.0 |
| PTGIR | -3311.0 |
| LRP10 | -3298.0 |
| OR51E2 | -3273.0 |
| GPR31 | -3246.0 |
| CD55 | -3223.0 |
| HTR5A | -3216.0 |
| GPR183 | -3193.0 |
| GUCA1B | -3130.0 |
| HEBP1 | -3127.0 |
| OR8H1 | -3118.0 |
| OR8H2 | -3118.0 |
| OR8H3 | -3118.0 |
| RHOB | -3080.0 |
| GNG7 | -3060.0 |
| PREX1 | -3045.0 |
| SDC4 | -2987.0 |
| WNT7B | -2916.0 |
| GNA11 | -2862.0 |
| SOS1 | -2808.0 |
| SSTR5 | -2799.0 |
| PRKCG | -2783.0 |
| CCL17 | -2763.0 |
| CYP4V2 | -2726.0 |
| PPP3CA | -2656.0 |
| ADORA2A | -2639.0 |
| CCL2 | -2628.0 |
| CDK5 | -2600.0 |
| ARHGEF18 | -2547.5 |
| APLN | -2542.0 |
| PPBP | -2477.0 |
| LPL | -2467.0 |
| WNT8A | -2439.0 |
| P2RY2 | -2415.0 |
| OR8G1 | -2378.5 |
| OR8G5 | -2378.5 |
| ADCY5 | -2343.0 |
| FZD7 | -2287.0 |
| PENK | -2272.0 |
| REEP2 | -2261.0 |
| HRAS | -2253.0 |
| CX3CL1 | -2245.0 |
| OR10G2 | -2217.0 |
| FPR1 | -2214.0 |
| LTB4R | -2187.0 |
| RGS1 | -2147.0 |
| RLN3 | -2119.0 |
| GPC3 | -2107.0 |
| KISS1 | -2106.0 |
| ADM2 | -2081.0 |
| CCKAR | -2081.0 |
| CCR4 | -2081.0 |
| GNG13 | -2081.0 |
| OPN1LW | -2081.0 |
| OPN1MW | -2081.0 |
| OR7E24 | -2063.0 |
| SDC3 | -2040.0 |
| NPFF | -2026.0 |
| OR5P2 | -2010.0 |
| OR6Y1 | -1916.0 |
| OR8K3 | -1912.0 |
| PLPPR5 | -1872.0 |
| WNT7A | -1849.0 |
| OR2F1 | -1842.5 |
| OR2F2 | -1842.5 |
| GPR176 | -1832.0 |
| F2RL2 | -1823.0 |
| OR11A1 | -1818.0 |
| ADCY9 | -1812.0 |
| OR10K1 | -1811.0 |
| PRKCA | -1808.0 |
| GHSR | -1789.0 |
| DAGLA | -1781.0 |
| GPR55 | -1771.0 |
| OR5G3 | -1752.5 |
| CCKBR | -1743.0 |
| CXCL10 | -1631.0 |
| EGFR | -1624.0 |
| CXCL16 | -1619.0 |
| OR10V1 | -1562.5 |
| OR14J1 | -1562.5 |
| OR1I1 | -1562.5 |
| OR1Q1 | -1562.5 |
| OR4A15 | -1562.5 |
| OR4P4 | -1562.5 |
| OR56B4 | -1562.5 |
| OR5M11 | -1562.5 |
| OR5P3 | -1562.5 |
| OR5T1 | -1562.5 |
| OR5T3 | -1562.5 |
| OR6C2 | -1562.5 |
| OR6C68 | -1562.5 |
| OR8B8 | -1562.5 |
| OR5AK2 | -1523.0 |
| OR5AK3P | -1523.0 |
| TAS2R14 | -1512.0 |
| METAP1 | -1481.0 |
| GALR1 | -1455.0 |
| NPSR1 | -1445.0 |
| WNT3 | -1443.0 |
| TRHR | -1407.0 |
| WNT3A | -1406.0 |
| EDNRB | -1365.0 |
| OR4B1 | -1361.5 |
| GPC6 | -1334.0 |
| PLXNB1 | -1301.0 |
| CASR | -1291.0 |
| C5AR1 | -1280.0 |
| ARHGEF39 | -1272.0 |
| RGS13 | -1258.0 |
| CCR7 | -1237.0 |
| GRM6 | -1224.0 |
| OR10A3 | -1219.5 |
| OR10A6 | -1219.5 |
| HTR4 | -1218.0 |
| GPR45 | -1179.0 |
| GPR143 | -1156.0 |
| GPR35 | -1144.0 |
| CXCL13 | -1141.0 |
| AGRN | -1136.0 |
| OR9G1 | -1126.0 |
| GPSM2 | -1112.0 |
| DRD5 | -987.0 |
| MTNR1A | -987.0 |
| OR10J5 | -987.0 |
| OR11G2 | -987.0 |
| OR12D3 | -987.0 |
| OR1A1 | -987.0 |
| OR1A2 | -987.0 |
| OR1J4 | -987.0 |
| OR1P1 | -987.0 |
| OR2A1 | -987.0 |
| OR2T1 | -987.0 |
| OR2W3 | -987.0 |
| OR4C16 | -987.0 |
| OR4C6 | -987.0 |
| OR51G2 | -987.0 |
| OR51Q1 | -987.0 |
| OR52E4 | -987.0 |
| OR5AL1 | -987.0 |
| OR5R1 | -987.0 |
| OR7G1 | -987.0 |
| OR8B12 | -987.0 |
| OR8B2 | -987.0 |
| OR8B3 | -987.0 |
| OR8D4 | -987.0 |
| OR9K2 | -987.0 |
| PROK1 | -987.0 |
| RBP2 | -987.0 |
| TAAR5 | -987.0 |
| TAS2R1 | -987.0 |
| CHRM2 | -907.5 |
| OR2B11 | -907.5 |
| OR2H1 | -907.5 |
| OR2H2 | -907.5 |
| OR4D1 | -907.5 |
| OR52M1 | -907.5 |
| OR2T29 | -895.0 |
| OR2T4 | -895.0 |
| OR2T5 | -895.0 |
| OR5B3 | -884.0 |
| OR4C15 | -879.0 |
| ARHGEF10 | -775.0 |
| PPP3CB | -748.0 |
| CALCR | -738.0 |
| OR14C36 | -733.5 |
| OR52N2 | -733.5 |
| OR56B2P | -733.5 |
| OR7G2 | -733.5 |
| OPRL1 | -730.0 |
| OR5AC1 | -686.0 |
| RGS4 | -680.0 |
| HCRTR1 | -648.0 |
| RHOA | -640.0 |
| CCR10 | -637.0 |
| RETSAT | -602.0 |
| APOA1 | -547.0 |
| OR2AK2 | -519.5 |
| OR5H1 | -519.5 |
| OR5H14 | -519.5 |
| OR5H15 | -519.5 |
| OR5H6 | -519.5 |
| ARHGEF15 | -470.0 |
| PDE6B | -466.0 |
| BRS3 | -461.0 |
| ARHGEF33 | -451.0 |
| GPHB5 | -374.0 |
| FZD9 | -370.0 |
| OR52D1 | -338.5 |
| NPY5R | -309.0 |
| OR10G3 | -309.0 |
| OR4A47 | -309.0 |
| OR4F6 | -309.0 |
| OR51F2 | -309.0 |
| OR52P1P | -309.0 |
| OR9A4 | -309.0 |
| CGA | -282.0 |
| DGKD | -273.0 |
| REEP1 | -250.0 |
| REEP5 | -211.0 |
| CAMKK2 | -200.0 |
| CXCL12 | -188.0 |
| OPRD1 | -187.0 |
| KALRN | -177.0 |
| OR7D4 | -133.0 |
| OR5AN1 | -121.5 |
| OR1N1 | -118.0 |
| RGS18 | -112.0 |
| GNB5 | -108.0 |
| CALM1 | -83.0 |
| OR10AG1 | -40.0 |
| GPR37L1 | -27.0 |
| ARRB1 | -23.0 |
| GPR65 | -16.0 |
| REEP3 | -8.0 |
| OR6B2 | 6.5 |
| OR6B3 | 6.5 |
| OR4F17 | 11.0 |
| OR4F4 | 11.0 |
| OR4F5 | 11.0 |
| AVPR1A | 53.0 |
| PIK3CA | 85.0 |
| GNA15 | 89.0 |
| TAS2R4 | 142.0 |
| CALCB | 231.0 |
| CNGA1 | 231.0 |
| FFAR1 | 231.0 |
| IAPP | 231.0 |
| MC3R | 231.0 |
| NPBWR1 | 231.0 |
| OR10W1 | 231.0 |
| OR13F1 | 231.0 |
| OR13J1 | 231.0 |
| OR1B1 | 231.0 |
| OR1J1 | 231.0 |
| OR1M1 | 231.0 |
| OR2A14 | 231.0 |
| OR2A5 | 231.0 |
| OR2AP1 | 231.0 |
| OR2L13 | 231.0 |
| OR2Y1 | 231.0 |
| OR4A16 | 231.0 |
| OR4C11 | 231.0 |
| OR4C12 | 231.0 |
| OR4C3 | 231.0 |
| OR4D11 | 231.0 |
| OR4D2 | 231.0 |
| OR4D6 | 231.0 |
| OR4F15 | 231.0 |
| OR4X2 | 231.0 |
| OR51F1 | 231.0 |
| OR52E2 | 231.0 |
| OR52H1 | 231.0 |
| OR52L1 | 231.0 |
| OR52R1 | 231.0 |
| OR56B1 | 231.0 |
| OR5A1 | 231.0 |
| OR5B17 | 231.0 |
| OR5L1 | 231.0 |
| OR5L2 | 231.0 |
| OR5M8 | 231.0 |
| OR6X1 | 231.0 |
| OR8K5 | 231.0 |
| OR9Q2 | 231.0 |
| PTH2R | 231.0 |
| RGS21 | 231.0 |
| RTP1 | 231.0 |
| TAAR8 | 231.0 |
| TAS2R7 | 231.0 |
| LHCGR | 340.5 |
| GIP | 344.0 |
| OR5C1 | 346.0 |
| TAS2R42 | 355.0 |
| NMT1 | 404.0 |
| OR2B2 | 420.0 |
| NPY4R | 446.5 |
| OXT | 449.0 |
| PRLHR | 457.0 |
| OR4K15 | 540.0 |
| OR6C1 | 540.0 |
| TAS2R19 | 549.0 |
| TAS2R20 | 549.0 |
| TAS2R30 | 549.0 |
| TAS2R31 | 549.0 |
| TAS2R43 | 549.0 |
| TAS2R46 | 549.0 |
| TAS2R50 | 549.0 |
| OPN4 | 560.0 |
| OR8A1 | 563.0 |
| APOB | 573.0 |
| ADCYAP1 | 576.0 |
| PPP2R5D | 596.0 |
| PIK3R3 | 597.5 |
| GNRH1 | 612.0 |
| F2RL1 | 616.0 |
| OR5W2 | 676.0 |
| GPR17 | 677.0 |
| PPEF1 | 686.0 |
| GRM3 | 693.0 |
| OR2AG1 | 700.0 |
| TAC1 | 700.0 |
| RGS16 | 809.0 |
| F2RL3 | 826.0 |
| OR52E6 | 842.0 |
| OR52E8 | 842.0 |
| OR8D1 | 842.0 |
| FSHR | 861.5 |
| OR4M1 | 861.5 |
| OR4M2 | 861.5 |
| OR4X1 | 861.5 |
| OR51B6 | 861.5 |
| OR51I2 | 861.5 |
| PYY | 861.5 |
| FFAR3 | 896.0 |
| OR10C1 | 896.0 |
| OR10S1 | 896.0 |
| OR2V1 | 896.0 |
| OR4K5 | 896.0 |
| OR51A2 | 896.0 |
| OR51A4 | 896.0 |
| OR51V1 | 896.0 |
| OR52K2 | 896.0 |
| OR2V2 | 917.5 |
| OR2Z1 | 917.5 |
| OPN5 | 921.0 |
| TAS2R13 | 930.0 |
| NLN | 943.0 |
| CCL3 | 960.0 |
| GNG5 | 992.0 |
| GHRH | 1070.0 |
| OR10H1 | 1093.5 |
| OR10H5 | 1093.5 |
| QRFP | 1095.0 |
| CAMK4 | 1172.0 |
| GRM2 | 1192.0 |
| FFAR4 | 1193.0 |
| GRK2 | 1198.0 |
| TAS2R10 | 1246.0 |
| GNAT3 | 1292.0 |
| RPS6KA2 | 1294.0 |
| SSTR2 | 1311.0 |
| XCL1 | 1380.5 |
| XCL2 | 1380.5 |
| OR52E5 | 1404.0 |
| OR2AG2 | 1419.5 |
| OR7C2 | 1419.5 |
| OR8U1 | 1419.5 |
| TAAR1 | 1419.5 |
| AKT1 | 1488.0 |
| OR4N5 | 1533.0 |
| PRKCD | 1551.0 |
| GPR83 | 1568.0 |
| DRD3 | 1587.0 |
| ADCY3 | 1612.0 |
| GRK1 | 1615.0 |
| ADM | 1625.0 |
| GPR15 | 1643.0 |
| APOM | 1657.0 |
| PDE3B | 1668.0 |
| OR13C3 | 1717.0 |
| CRHR1 | 1747.0 |
| NRAS | 1786.0 |
| GUCY2D | 1791.0 |
| HRH4 | 1810.0 |
| PROK2 | 1822.0 |
| DGKQ | 1845.0 |
| GPRC6A | 1876.0 |
| PNLIP | 1909.0 |
| VAV1 | 1912.0 |
| GRP | 1947.0 |
| CXCL6 | 1966.0 |
| GALR3 | 1969.0 |
| SCTR | 1986.0 |
| OR6K3 | 2052.0 |
| FZD4 | 2057.0 |
| MAPK1 | 2063.0 |
| LRP8 | 2101.0 |
| HTR2B | 2125.0 |
| OR2T12 | 2143.0 |
| OR2T33 | 2143.0 |
| OR2T8 | 2143.0 |
| DHH | 2159.0 |
| RTP4 | 2164.0 |
| MC2R | 2177.0 |
| DRD2 | 2184.0 |
| ADCY7 | 2210.0 |
| OR2AT4 | 2241.0 |
| OR6C70 | 2316.5 |
| P2RY12 | 2339.0 |
| OR6C76 | 2370.0 |
| SCT | 2430.0 |
| WNT5A | 2473.0 |
| GRK5 | 2483.0 |
| RGS22 | 2514.0 |
| MAPK3 | 2532.0 |
| PRKCB | 2630.0 |
| GPR68 | 2735.0 |
| GPHA2 | 2779.0 |
| HCRT | 2813.0 |
| TBXA2R | 2824.0 |
| ADRB2 | 2844.0 |
| HCAR2 | 2866.5 |
| HCAR3 | 2866.5 |
| WNT1 | 2881.0 |
| CAMKMT | 2915.0 |
| LDLR | 2957.0 |
| GUCY2F | 3001.0 |
| PDE8B | 3035.5 |
| CCR1 | 3082.0 |
| GNA12 | 3137.0 |
| PDYN | 3143.0 |
| CCL23 | 3192.0 |
| SHH | 3214.0 |
| HCAR1 | 3224.0 |
| POMC | 3261.0 |
| AVP | 3271.0 |
| GNG3 | 3307.0 |
| PDE1A | 3353.0 |
| F2R | 3369.0 |
| LPAR1 | 3370.0 |
| RGS7 | 3418.0 |
| GNAT1 | 3423.0 |
| P2RY4 | 3493.0 |
| CCRL2 | 3501.0 |
| SDR9C7 | 3561.0 |
| BDKRB1 | 3562.0 |
| ADRB1 | 3612.0 |
| GRK4 | 3623.0 |
| GPC1 | 3640.0 |
| MYO7A | 3664.0 |
| NMB | 3696.0 |
| GNAI3 | 3733.0 |
| GNG11 | 3752.0 |
| HRH1 | 3792.0 |
| PDE3A | 3794.0 |
| PPP1R1B | 3853.0 |
| GPR25 | 3869.0 |
| BCO1 | 3884.0 |
| ADRA1B | 3941.0 |
| OR5I1 | 4012.0 |
| SLC24A1 | 4032.0 |
| CCR8 | 4126.0 |
| ECE2 | 4133.5 |
| FGD2 | 4170.0 |
| PDE8A | 4181.0 |
| PTAFR | 4229.0 |
| CCK | 4270.0 |
| RLN2 | 4323.5 |
| PLPPR2 | 4371.0 |
| GNGT2 | 4376.0 |
| RGS9BP | 4413.0 |
| RGS10 | 4447.0 |
| GHRL | 4454.0 |
| PPP2R1B | 4513.0 |
| NMU | 4522.0 |
| FZD8 | 4573.0 |
| ADRA2A | 4582.0 |
| FZD1 | 4610.0 |
| HBEGF | 4618.0 |
| HTR1B | 4630.0 |
| DGKA | 4645.0 |
| OR51D1 | 4699.0 |
| CAMKK1 | 4711.0 |
| MAPK7 | 4725.0 |
| PLPPR4 | 4737.0 |
| TRPC7 | 4748.0 |
| HRH3 | 4786.0 |
| LRP1 | 4809.0 |
| CALCA | 4836.0 |
| TIAM2 | 4841.0 |
| CCL27 | 4856.0 |
| RBP3 | 4858.0 |
| ADRA2C | 4926.0 |
| GPR37 | 4931.0 |
| ROCK1 | 4962.0 |
| RDH10 | 5000.0 |
| FZD6 | 5042.0 |
| PPP3R1 | 5058.5 |
| RGS9 | 5078.0 |
| RAMP3 | 5107.0 |
| FZD5 | 5173.0 |
| METAP2 | 5174.0 |
| HCRTR2 | 5199.0 |
| RASGRF2 | 5220.0 |
| RGSL1 | 5265.0 |
| OXTR | 5278.0 |
| GNA13 | 5282.0 |
| OR6K2 | 5286.0 |
| GIPR | 5394.0 |
| PRKX | 5448.5 |
| ADGRE1 | 5461.0 |
| UTS2B | 5468.0 |
| PDE10A | 5495.0 |
| RHOC | 5509.5 |
| FFAR2 | 5519.0 |
| NMBR | 5522.0 |
| AVPR1B | 5580.0 |
| S1PR5 | 5597.0 |
| UCN | 5600.0 |
| DRD4 | 5612.0 |
| S1PR2 | 5627.0 |
| HTR2A | 5650.0 |
| PTCH1 | 5659.0 |
| RGS19 | 5668.0 |
| CMKLR1 | 5729.0 |
| GPR18 | 5762.0 |
| OR1F1 | 5776.0 |
| VAV2 | 5813.0 |
| KRAS | 5849.0 |
| PMCH | 5889.0 |
| ARHGEF25 | 5966.5 |
| PTGDR | 6020.0 |
| FZD2 | 6035.0 |
| BCO2 | 6058.0 |
| ARHGEF12 | 6104.0 |
| TAS2R41 | 6144.0 |
| NAPEPLD | 6226.0 |
| GNAZ | 6253.0 |
| FGD3 | 6255.0 |
| GNB2 | 6264.0 |
| OR6N1 | 6265.0 |
| ACKR3 | 6294.0 |
| CRH | 6329.0 |
| VIPR2 | 6379.0 |
| RDH12 | 6399.0 |
| C5AR2 | 6406.0 |
| OR2K2 | 6446.0 |
| SDC2 | 6449.0 |
| REEP4 | 6463.0 |
| GRM1 | 6498.0 |
| STRA6 | 6510.0 |
| RDH5 | 6515.0 |
| OR4E1 | 6518.0 |
| ADRA1A | 6572.0 |
| GNG8 | 6614.0 |
| RGS12 | 6733.0 |
| KISS1R | 6746.0 |
| GNG2 | 6793.0 |
| TAS1R1 | 6812.0 |
| ADCY8 | 6825.0 |
| PIK3CG | 6844.0 |
| OPRK1 | 6857.0 |
| WNT2 | 6877.0 |
| PTGFR | 6884.0 |
| GPSM1 | 6904.0 |
| TIAM1 | 6942.0 |
| P2RY1 | 6949.0 |
| LTB4R2 | 6967.0 |
| RASGRP1 | 7000.0 |
| LPAR4 | 7063.0 |
| GUCA1A | 7066.0 |
| RPE65 | 7074.0 |
| GNG10 | 7112.0 |
| S1PR3 | 7127.0 |
| ANXA1 | 7137.0 |
| GABBR2 | 7146.0 |
| NMUR2 | 7148.0 |
| CCL21 | 7185.0 |
| ADCYAP1R1 | 7189.0 |
| PLCB2 | 7190.0 |
| LPAR3 | 7241.0 |
| PDE4B | 7268.0 |
| ABCA4 | 7305.0 |
| SDC1 | 7316.0 |
| DHRS9 | 7322.0 |
| GRM7 | 7349.0 |
| ECT2 | 7350.0 |
| DGKI | 7390.0 |
| GPBAR1 | 7429.0 |
| CAMK2G | 7477.0 |
| APP | 7480.0 |
| FNTA | 7484.0 |
| AGTR2 | 7492.0 |
| EDN2 | 7506.0 |
| MMP3 | 7551.0 |
| BTK | 7564.0 |
| ACKR2 | 7589.0 |
| CCR5 | 7623.0 |
| ARHGEF3 | 7632.0 |
| P2RY13 | 7646.0 |
| SOS2 | 7658.0 |
| LRP12 | 7671.0 |
| AHCYL1 | 7728.0 |
| WNT11 | 7757.0 |
| CX3CR1 | 7784.0 |
| HTR1A | 7853.5 |
| HTR1D | 7853.5 |
| WNT10B | 7877.0 |
| GPER1 | 7908.0 |
| GNB3 | 7932.0 |
| PNOC | 7937.0 |
| CALCRL | 7971.0 |
| ARHGEF2 | 7980.0 |
| DRD1 | 8013.0 |
| SMO | 8017.0 |
| CYSLTR1 | 8025.0 |
| PRKAR1B | 8032.0 |
| UCN2 | 8033.0 |
| AWAT2 | 8046.0 |
| PIK3R1 | 8109.0 |
| OPN1SW | 8117.0 |
| ADORA3 | 8119.0 |
| HSD17B1 | 8140.0 |
| NTSR2 | 8169.0 |
| CCL7 | 8170.0 |
| KPNA2 | 8174.0 |
| HRH2 | 8194.0 |
| TRPC6 | 8208.0 |
| MC4R | 8265.0 |
| PDE6G | 8266.0 |
| ARHGEF26 | 8302.0 |
| ABHD6 | 8329.0 |
| CNGB1 | 8343.0 |
| LPAR2 | 8362.0 |
| OPN3 | 8414.0 |
| CREB1 | 8434.0 |
| PLA2G4A | 8549.0 |
| GLP1R | 8565.0 |
| WNT9B | 8579.0 |
| RDH11 | 8604.5 |
| AKT3 | 8609.0 |
| TRPC3 | 8707.0 |
| OPRM1 | 8749.0 |
| PDE7A | 8851.0 |
| ITPR1 | 8900.0 |
Cytosolic tRNA aminoacylation
| 245 | |
|---|---|
| set | Cytosolic tRNA aminoacylation |
| setSize | 23 |
| pANOVA | 0.00226 |
| s.dist | 0.368 |
| p.adjustANOVA | 0.0697 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NARS1 | 8198.0 |
| EPRS1 | 7828.0 |
| TARS1 | 7731.0 |
| GARS1 | 7641.0 |
| IARS1 | 7272.0 |
| PPA1 | 7256.0 |
| WARS1 | 6861.0 |
| HARS1 | 6860.0 |
| AIMP1 | 6191.0 |
| EEF1E1 | 5978.5 |
| CARS1 | 4806.0 |
| MARS1 | 4257.0 |
| DARS1 | 3988.0 |
| AIMP2 | 3169.0 |
| FARSA | 1906.0 |
| YARS1 | 1102.0 |
| LARS1 | 795.0 |
| KARS1 | 648.0 |
| RARS1 | -424.0 |
| FARSB | -1497.0 |
| GeneID | Gene Rank |
|---|---|
| NARS1 | 8198.0 |
| EPRS1 | 7828.0 |
| TARS1 | 7731.0 |
| GARS1 | 7641.0 |
| IARS1 | 7272.0 |
| PPA1 | 7256.0 |
| WARS1 | 6861.0 |
| HARS1 | 6860.0 |
| AIMP1 | 6191.0 |
| EEF1E1 | 5978.5 |
| CARS1 | 4806.0 |
| MARS1 | 4257.0 |
| DARS1 | 3988.0 |
| AIMP2 | 3169.0 |
| FARSA | 1906.0 |
| YARS1 | 1102.0 |
| LARS1 | 795.0 |
| KARS1 | 648.0 |
| RARS1 | -424.0 |
| FARSB | -1497.0 |
| VARS1 | -5052.0 |
| AARS1 | -5067.0 |
| SARS1 | -5612.0 |
p130Cas linkage to MAPK signaling for integrins
| 1427 | |
|---|---|
| set | p130Cas linkage to MAPK signaling for integrins |
| setSize | 15 |
| pANOVA | 0.00231 |
| s.dist | -0.454 |
| p.adjustANOVA | 0.0697 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGB | -9053.0 |
| FGA | -8696.0 |
| PTK2 | -8355.0 |
| SRC | -8095.0 |
| FGG | -8035.0 |
| BCAR1 | -7614.0 |
| VWF | -7285.0 |
| ITGA2B | -7222.0 |
| TLN1 | -5122.0 |
| APBB1IP | -3673.0 |
| ITGB3 | -3380.5 |
| RAP1A | 937.0 |
| CRK | 2198.0 |
| RAP1B | 4145.0 |
| FN1 | 6913.0 |
| GeneID | Gene Rank |
|---|---|
| FGB | -9053.0 |
| FGA | -8696.0 |
| PTK2 | -8355.0 |
| SRC | -8095.0 |
| FGG | -8035.0 |
| BCAR1 | -7614.0 |
| VWF | -7285.0 |
| ITGA2B | -7222.0 |
| TLN1 | -5122.0 |
| APBB1IP | -3673.0 |
| ITGB3 | -3380.5 |
| RAP1A | 937.0 |
| CRK | 2198.0 |
| RAP1B | 4145.0 |
| FN1 | 6913.0 |
NRAGE signals death through JNK
| 753 | |
|---|---|
| set | NRAGE signals death through JNK |
| setSize | 56 |
| pANOVA | 0.00238 |
| s.dist | -0.235 |
| p.adjustANOVA | 0.0704 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834 |
| ARHGEF1 | -8718 |
| OBSCN | -8574 |
| ARHGEF7 | -8534 |
| PLEKHG5 | -8454 |
| ITSN1 | -8377 |
| MAGED1 | -8312 |
| ARHGEF11 | -8287 |
| NGFR | -8192 |
| ARHGEF40 | -7699 |
| MCF2 | -7686 |
| ARHGEF16 | -7667 |
| ABR | -7655 |
| MCF2L | -7517 |
| ARHGEF5 | -7293 |
| PLEKHG2 | -7206 |
| VAV3 | -7088 |
| ARHGEF17 | -6885 |
| ARHGEF10L | -6624 |
| TRIO | -6348 |
| GeneID | Gene Rank |
|---|---|
| ARHGEF37 | -8834.0 |
| ARHGEF1 | -8718.0 |
| OBSCN | -8574.0 |
| ARHGEF7 | -8534.0 |
| PLEKHG5 | -8454.0 |
| ITSN1 | -8377.0 |
| MAGED1 | -8312.0 |
| ARHGEF11 | -8287.0 |
| NGFR | -8192.0 |
| ARHGEF40 | -7699.0 |
| MCF2 | -7686.0 |
| ARHGEF16 | -7667.0 |
| ABR | -7655.0 |
| MCF2L | -7517.0 |
| ARHGEF5 | -7293.0 |
| PLEKHG2 | -7206.0 |
| VAV3 | -7088.0 |
| ARHGEF17 | -6885.0 |
| ARHGEF10L | -6624.0 |
| TRIO | -6348.0 |
| BCL2L11 | -6346.0 |
| FGD4 | -6196.0 |
| FGD1 | -5982.0 |
| ARHGEF19 | -5545.0 |
| ARHGEF6 | -5311.0 |
| AKAP13 | -5190.0 |
| NET1 | -4984.0 |
| NGEF | -4851.0 |
| ARHGEF38 | -4562.0 |
| PREX1 | -3045.0 |
| SOS1 | -2808.0 |
| ARHGEF18 | -2547.5 |
| AATF | -2176.0 |
| ARHGEF39 | -1272.0 |
| ARHGEF10 | -775.0 |
| ARHGEF15 | -470.0 |
| ARHGEF33 | -451.0 |
| KALRN | -177.0 |
| BAD | 928.0 |
| VAV1 | 1912.0 |
| RAC1 | 2240.0 |
| NGF | 2470.0 |
| FGD2 | 4170.0 |
| TIAM2 | 4841.0 |
| RASGRF2 | 5220.0 |
| GNA13 | 5282.0 |
| VAV2 | 5813.0 |
| MAPK8 | 5956.0 |
| ARHGEF12 | 6104.0 |
| FGD3 | 6255.0 |
| TIAM1 | 6942.0 |
| ECT2 | 7350.0 |
| ARHGEF3 | 7632.0 |
| SOS2 | 7658.0 |
| ARHGEF2 | 7980.0 |
| ARHGEF26 | 8302.0 |
Influenza Infection
| 563 | |
|---|---|
| set | Influenza Infection |
| setSize | 128 |
| pANOVA | 0.00253 |
| s.dist | 0.155 |
| p.adjustANOVA | 0.0725 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL13A | 8957 |
| RPL3 | 8943 |
| RPS15A | 8920 |
| RPL29 | 8919 |
| RPS16 | 8907 |
| RPL6 | 8889 |
| NUP58 | 8776 |
| NUP37 | 8600 |
| CLTA | 8586 |
| POLR2G | 8271 |
| KPNA2 | 8174 |
| RPL37 | 8039 |
| POLR2H | 7476 |
| DNAJC3 | 7406 |
| RPL30 | 7370 |
| RPS27A | 7369 |
| RPL7A | 7100 |
| RPS23 | 7033 |
| RANBP2 | 6945 |
| EIF2AK2 | 6933 |
| GeneID | Gene Rank |
|---|---|
| RPL13A | 8957.0 |
| RPL3 | 8943.0 |
| RPS15A | 8920.0 |
| RPL29 | 8919.0 |
| RPS16 | 8907.0 |
| RPL6 | 8889.0 |
| NUP58 | 8776.0 |
| NUP37 | 8600.0 |
| CLTA | 8586.0 |
| POLR2G | 8271.0 |
| KPNA2 | 8174.0 |
| RPL37 | 8039.0 |
| POLR2H | 7476.0 |
| DNAJC3 | 7406.0 |
| RPL30 | 7370.0 |
| RPS27A | 7369.0 |
| RPL7A | 7100.0 |
| RPS23 | 7033.0 |
| RANBP2 | 6945.0 |
| EIF2AK2 | 6933.0 |
| NUP153 | 6854.0 |
| PABPN1 | 6598.5 |
| NUP98 | 6576.0 |
| RPS18 | 6557.0 |
| RPLP2 | 6538.0 |
| RPL10L | 6517.0 |
| KPNA5 | 6286.0 |
| RPS15 | 6242.0 |
| NDC1 | 6233.0 |
| RPS5 | 6228.0 |
| RPL22 | 5939.0 |
| XPO1 | 5929.0 |
| NUP160 | 5904.0 |
| RPS14 | 5784.0 |
| GRSF1 | 5690.0 |
| RPL31 | 5673.0 |
| CALR | 5643.0 |
| NUP93 | 5363.0 |
| RPS26 | 5195.0 |
| RPL9 | 4882.0 |
| RPS3A | 4794.0 |
| KPNA7 | 4735.0 |
| NUP155 | 4673.0 |
| CLTC | 4525.0 |
| RPL19 | 4494.0 |
| KPNA4 | 4361.0 |
| RPL5 | 4255.0 |
| RPS21 | 4017.0 |
| RPS13 | 3688.0 |
| POLR2D | 3487.0 |
| POLR2I | 3477.0 |
| RPS8 | 3383.0 |
| NUP50 | 3293.0 |
| RPS28 | 3175.0 |
| RPL7 | 3151.0 |
| NUP188 | 3150.0 |
| RPL27 | 2912.0 |
| RPL18 | 2790.0 |
| RPS3 | 2715.0 |
| NUP54 | 2641.0 |
| NUP35 | 2557.0 |
| RPS4X | 2555.0 |
| NUP88 | 2333.0 |
| RPS11 | 2321.0 |
| POLR2B | 2214.0 |
| RPS19 | 2111.0 |
| CPSF4 | 2107.0 |
| RPL37A | 2071.0 |
| ISG15 | 1321.0 |
| RPL36 | 1297.0 |
| KPNB1 | 1280.0 |
| SEC13 | 1065.0 |
| NUP107 | 935.0 |
| RPL10A | 667.0 |
| RPL11 | 231.0 |
| RPL21 | 231.0 |
| NUP42 | -38.0 |
| TPR | -207.0 |
| RPS25 | -242.0 |
| AAAS | -496.0 |
| RPLP1 | -660.0 |
| RAN | -987.0 |
| TGFB1 | -1162.0 |
| RPSA | -1493.0 |
| RPS2 | -1703.0 |
| POLR2F | -1805.0 |
| RPS17 | -1958.0 |
| RPS10 | -1984.5 |
| RPL23 | -2023.0 |
| RPL18A | -2151.0 |
| RPS7 | -2157.0 |
| UBA52 | -2166.0 |
| KPNA3 | -2304.0 |
| KPNA1 | -2755.0 |
| RPS27L | -3093.0 |
| NUP62 | -3094.0 |
| GTF2F1 | -3198.0 |
| RPL35 | -3206.0 |
| GTF2F2 | -3213.0 |
| NUP205 | -3219.0 |
| RPL24 | -3268.0 |
| RPL28 | -3293.0 |
| POM121 | -3732.5 |
| POM121C | -3732.5 |
| NUP133 | -4126.0 |
| RPL8 | -4167.0 |
| CANX | -4217.0 |
| IPO5 | -4272.0 |
| NUP210 | -4336.0 |
| RAE1 | -4461.0 |
| POLR2C | -4917.0 |
| HSPA1A | -4959.5 |
| RPL38 | -5629.0 |
| RPS6 | -5720.0 |
| POLR2A | -5792.0 |
| RPL15 | -6128.0 |
| RPL23A | -6843.0 |
| POLR2L | -6941.0 |
| RPL3L | -7058.0 |
| PARP1 | -7161.0 |
| RPL13 | -7209.0 |
| RPS9 | -7535.0 |
| NUP85 | -8017.0 |
| NUP43 | -8128.0 |
| POLR2E | -8423.0 |
| FAU | -8625.0 |
| NUP214 | -8732.0 |
| RPL35A | -8900.0 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.3 (2020-10-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.1.0 GGally_2.0.0
## [3] ggplot2_3.3.2 beeswarm_0.2.3
## [5] gtools_3.8.2 tibble_3.0.4
## [7] dplyr_1.0.2 echarts4r_0.3.3
## [9] gplots_3.1.0 mitch_1.2.2
## [11] DESeq2_1.30.0 SummarizedExperiment_1.20.0
## [13] Biobase_2.50.0 MatrixGenerics_1.2.0
## [15] matrixStats_0.57.0 GenomicRanges_1.42.0
## [17] GenomeInfoDb_1.26.0 IRanges_2.24.0
## [19] S4Vectors_0.28.0 BiocGenerics_0.36.0
## [21] reshape2_1.4.4
##
## loaded via a namespace (and not attached):
## [1] httr_1.4.2 jsonlite_1.7.1 bit64_4.0.5
## [4] splines_4.0.3 assertthat_0.2.1 shiny_1.5.0
## [7] highr_0.8 blob_1.2.1 GenomeInfoDbData_1.2.4
## [10] yaml_2.2.1 backports_1.2.0 pillar_1.4.6
## [13] RSQLite_2.2.1 lattice_0.20-41 glue_1.4.2
## [16] digest_0.6.27 RColorBrewer_1.1-2 promises_1.1.1
## [19] XVector_0.30.0 colorspace_2.0-0 htmltools_0.5.0
## [22] httpuv_1.5.4 Matrix_1.2-18 plyr_1.8.6
## [25] XML_3.99-0.5 pkgconfig_2.0.3 genefilter_1.72.0
## [28] zlibbioc_1.36.0 purrr_0.3.4 xtable_1.8-4
## [31] scales_1.1.1 later_1.1.0.1 BiocParallel_1.24.1
## [34] annotate_1.68.0 generics_0.1.0 ellipsis_0.3.1
## [37] withr_2.3.0 survival_3.2-7 magrittr_1.5
## [40] crayon_1.3.4 mime_0.9 evaluate_0.14
## [43] memoise_1.1.0 MASS_7.3-53 tools_4.0.3
## [46] lifecycle_0.2.0 stringr_1.4.0 munsell_0.5.0
## [49] locfit_1.5-9.4 DelayedArray_0.16.0 AnnotationDbi_1.52.0
## [52] compiler_4.0.3 caTools_1.18.0 rlang_0.4.8
## [55] grid_4.0.3 RCurl_1.98-1.2 htmlwidgets_1.5.2
## [58] rmarkdown_2.5 bitops_1.0-6 testthat_3.0.0
## [61] gtable_0.3.0 DBI_1.1.0 reshape_0.8.8
## [64] R6_2.5.0 gridExtra_2.3 knitr_1.30
## [67] fastmap_1.0.1 bit_4.0.4 rprojroot_1.3-2
## [70] desc_1.2.0 KernSmooth_2.23-18 stringi_1.5.3
## [73] Rcpp_1.0.5 vctrs_0.3.4 geneplotter_1.68.0
## [76] tidyselect_1.1.0 xfun_0.19
END of report